1	AIDS	NNP	MISC	AIDS	nn	2	SENT_1	[p1l58t81r134b107],
2	RESEARCH	NNP	O	RESEARCH	_	0	SENT_1	[p1l149t81r328b107],
3	AND	CC	O	and	_	0	SENT_1	[p1l341t82r410b107],
4	HUMAN	NNP	O	HUMAN	nn	5	SENT_1	[p1l424t82r541b107],
5	RETROVIRUSES	NNP	O	RETROVIRUSES	conj_and	2	SENT_1	[p1l557t81r814b107],
6	Volume	NN	O	volume	dep	2	SENT_1	[p1l59t119r169b144],
7	28	CD	NUMBER	28	num	6	SENT_1	[p1l181t120r224b148],
8	,	,	O	,	_	0	SENT_1	[p1l181t120r224b148],
9	Number	NNP	DATE	Number	appos	6	SENT_1	[p1l240t119r356b144],
10	9	CD	DATE	9	num	9	SENT_1	[p1l367t120r391b148],
11	,	,	DATE	,	_	0	SENT_1	[p1l367t120r391b148],
12	2012	CD	DATE	2012	num	16	SENT_1	[p1l405t120r477b144],
13	©	CD	NUMBER	©	num	16	SENT_1	[p1l59t157r83b181],
14	Mary	NNP	PERSON	Mary	nn	16	SENT_1	[p1l97t156r168b187],
15	Ann	NNP	PERSON	Ann	nn	16	SENT_1	[p1l180t156r237b180],
16	Liebert	NNP	PERSON	Liebert	appos	6	SENT_1	[p1l252t156r357b185],
17	,	,	O	,	_	0	SENT_1	[p1l252t156r357b185],
18	lnc	NN	O	lnc	appos	6	SENT_1	[p1l373t156r422b181],
19	.	.	O	.	_	0	SENT_1	[p1l373t156r422b181],

1	DO	NN	O	do	_	0	SENT_2	[p1l60t192r124b218],
2	]	CD	NUMBER	]	num	1	SENT_2	[p1l60t192r124b218],
3	:	:	O	:	_	0	SENT_2	[p1l60t192r124b218],
4	10.1089	CD	NUMBER	10.1089	dep	1	SENT_2	[p1l140t192r474b218],
5	/	:	O	/	punct	6	SENT_2	[p1l140t192r474b218],
6	aid	NN	O	aid	dep	4	SENT_2	[p1l140t192r474b218],
7	.2011.0242	CD	NUMBER	.2011.0242	num	6	SENT_2	[p1l140t192r474b218],

1	Short	JJ	O	short	amod	2	SENT_3	[p1l723t293r896b350],
2	Communication	NN	O	communication	_	0	SENT_3	[p1l926t293r1435b350],

1	Phenotypic	JJ	O	phenotypic	amod	4	SENT_4	[p1l399t377r759b447],
2	Protease	NN	O	protease	nn	4	SENT_4	[p1l792t377r1081b432],
3	Inhibitor	NNP	O	Inhibitor	nn	4	SENT_4	[p1l1115t377r1373b432],
4	Resistance	NNP	O	Resistance	_	0	SENT_4	[p1l1404t377r1764b432],
5	and	CC	O	and	_	0	SENT_4	[p1l323t459r440b515],
6	Cross-Resistance	NNP	O	Cross-Resistance	conj_and	4	SENT_4	[p1l472t458r1054b515],
7	in	IN	O	in	_	0	SENT_4	[p1l1087t459r1135b514],
8	the	DT	O	the	det	9	SENT_4	[p1l1165t459r1265b515],
9	Clinic	NNP	MISC	Clinic	prep_in	4	SENT_4	[p1l1296t458r1472b515],
10	from	IN	DATE	from	_	0	SENT_4	[p1l1500t459r1644b515],
11	2006	CD	DATE	2006	num	13	SENT_4	[p1l1675t460r1836b515],
12	to	TO	DATE	to	dep	13	SENT_4	[p1l363t546r422b597],
13	2008	CD	DATE	2008	prep_from	9	SENT_4	[p1l451t543r612b598],
14	and	CC	O	and	_	0	SENT_4	[p1l641t542r759b598],
15	Mutational	JJ	O	mutational	amod	16	SENT_4	[p1l793t542r1126b598],
16	Prevalences	NNS	O	prevalence	conj_and	4	SENT_4	[p1l1162t542r1563b598],
17	in	IN	O	in	_	0	SENT_4	[p1l1595t542r1643b597],
18	HIV	NN	MISC	hiv	prep_in	16	SENT_4	[p1l1678t542r1796b597],
19	from	IN	O	from	dep	4	SENT_4	[p1l412t624r556b680],
20	Patients	NNS	O	patient	pobj	19	SENT_4	[p1l591t625r852b680],
21	with	IN	O	with	dep	4	SENT_4	[p1l881t625r1007b679],
22	Discordant	JJ	O	discordant	amod	23	SENT_4	[p1l1042t625r1391b680],
23	Tipranavir	NN	O	tipranavir	pobj	21	SENT_4	[p1l1418t625r1748b694],
24	and	CC	O	and	_	0	SENT_4	[p1l408t707r525b763],
25	Darunavir	NNP	O	Darunavir	nn	27	SENT_4	[p1l560t708r876b763],
26	Susceptibility	NN	O	susceptibility	nn	27	SENT_4	[p1l905t706r1334b778],
27	Phenotypes	NNS	O	phenotype	pobj	21	SENT_4	[p1l1367t708r1751b778],

1	Richard	NNP	PERSON	Richard	nn	4	SENT_5	[p1l134t862r273b893],
2	Bethelll	NNP	PERSON	Bethelll	nn	4	SENT_5	[p1l293t854r427b898],
3	Joseph	NNP	PERSON	Joseph	nn	4	SENT_5	[p1l447t862r580b901],
4	Scherer	NNP	PERSON	Scherer	_	0	SENT_5	[p1l598t854r762b898],
5	?	.	O	?	_	0	SENT_5	[p1l598t854r762b898],

1	Myriam	NNP	PERSON	Myriam	nn	2	SENT_6	[p1l780t862r910b901],
2	Witvrouw	NNP	PERSON	Witvrouw	nsubj	10	SENT_6	[p1l926t853r1133b898],
3	,	,	O	,	_	0	SENT_6	[p1l926t853r1133b898],
4	”	NNP	O	”	nn	6	SENT_6	[p1l926t853r1133b898],
5	Agnes	NNP	PERSON	Agnes	nn	6	SENT_6	[p1l1149t862r1266b901],
6	Paquet	NNP	PERSON	Paquet	appos	2	SENT_6	[p1l1285t854r1435b901],
7	,3	CD	NUMBER	,3	num	9	SENT_6	[p1l1285t854r1435b901],
8	Eoin	NNP	PERSON	Eoin	nn	9	SENT_6	[p1l1453t862r1527b893],
9	Coak	NNP	PERSON	Coak	dep	6	SENT_6	[p1l1546t854r1716b901],
10	|	VBD	O	|	_	0	SENT_6	[p1l1546t854r1716b901],
11	ey	NN	O	ey	nn	12	SENT_6	[p1l1546t854r1716b901],
12	,3	NN	O	,3	dobj	10	SENT_6	[p1l1546t854r1716b901],
13	and	CC	O	and	_	0	SENT_6	[p1l1733t862r1799b893],
14	David	NNP	PERSON	David	nn	15	SENT_6	[p1l1819t862r1921b893],
15	Hall4	NNP	PERSON	Hall4	conj_and	12	SENT_6	[p1l1941t854r2027b893],

1	Abstract	JJ	O	abstract	_	0	SENT_7	[p1l59t976r208b1004],

1	To	TO	O	to	aux	2	SENT_8	[p1l59t1069r105b1099],
2	test	VB	O	test	csubj	23	SENT_8	[p1l123t1072r186b1099],
3	tipranavir	JJ	O	tipranavir	amod	5	SENT_8	[p1l204t1069r386b1110],
4	(	NN	O	(	nn	5	SENT_8	[p1l405t1068r507b1107],
5	TPV	NN	O	tpv	dobj	2	SENT_8	[p1l405t1068r507b1107],
6	)	CD	NUMBER	)	dep	5	SENT_8	[p1l405t1068r507b1107],
7	or	CC	O	or	_	0	SENT_8	[p1l528t1078r565b1099],
8	darunavir	JJ	O	darunavir	amod	10	SENT_8	[p1l583t1068r764b1099],
9	(	NN	O	(	nn	10	SENT_8	[p1l784t1068r896b1107],
10	DRV	NN	O	drv	conj_or	5	SENT_8	[p1l784t1068r896b1107],
11	)	RB	O	)	advmod	10	SENT_8	[p1l784t1068r896b1107],
12	as	IN	O	as	_	0	SENT_8	[p1l916t1078r952b1099],
13	treatment	NN	O	treatment	nn	14	SENT_8	[p1l971t1072r1146b1099],
14	options	NNS	O	option	prep_as	10	SENT_8	[p1l1165t1069r1298b1110],
15	for	IN	O	for	_	0	SENT_8	[p1l1317t1068r1368b1099],
16	patients	NNS	O	patient	prep_for	14	SENT_8	[p1l1386t1069r1529b1110],
17	with	IN	O	with	_	0	SENT_8	[p1l1547t1068r1631b1099],
18	phenotypic	JJ	O	phenotypic	amod	19	SENT_8	[p1l1648t1068r1852b1110],
19	resistance	NN	O	resistance	prep_with	16	SENT_8	[p1l1871t1069r2047b1099],
20	to	TO	O	to	_	0	SENT_8	[p1l2066t1072r2100b1099],
21	protease	NN	O	protease	nn	22	SENT_8	[p1l58t1122r211b1159],
22	inhibitors	NNS	O	inhibitor	prep_to	2	SENT_8	[p1l230t1117r403b1148],
23	(	VBP	O	(	_	0	SENT_8	[p1l423t1117r513b1156],
24	PIs	NNS	O	pi	dobj	23	SENT_8	[p1l423t1117r513b1156],
25	)	CD	NUMBER	)	num	24	SENT_8	[p1l423t1117r513b1156],
26	,	,	O	,	_	0	SENT_8	[p1l423t1117r513b1156],
27	including	VBG	O	include	_	0	SENT_8	[p1l532t1117r705b1159],
28	lopinavir	NN	O	lopinavir	nn	32	SENT_8	[p1l722t1117r897b1159],
29	,	,	O	,	_	0	SENT_8	[p1l722t1117r897b1159],
30	saquinavir	NN	O	saquinavir	dep	32	SENT_8	[p1l917t1119r1118b1159],
31	,	,	O	,	_	0	SENT_8	[p1l917t1119r1118b1159],
32	atazanavir	NN	O	atazanavir	prep_including	24	SENT_8	[p1l1138t1119r1338b1154],
33	,	,	O	,	_	0	SENT_8	[p1l1138t1119r1338b1154],
34	and	CC	O	and	_	0	SENT_8	[p1l1357t1117r1425b1148],
35	fosamprenavir	NN	O	fosamprenavir	prep_including	24	SENT_8	[p1l1444t1117r1718b1159],
36	,	,	O	,	_	0	SENT_8	[p1l1444t1117r1718b1159],
37	the	DT	O	the	det	40	SENT_8	[p1l1738t1117r1793b1148],
38	PhenoSense	NNP	O	PhenoSense	nn	40	SENT_8	[p1l1812t1117r2026b1148],
39	GT	NN	O	gt	nn	40	SENT_8	[p1l2045t1118r2100b1148],
40	database	NN	O	database	nsubjpass	42	SENT_8	[p1l59t1166r218b1197],
41	was	VBD	O	be	auxpass	42	SENT_8	[p1l230t1177r301b1197],
42	analyzed	VBN	O	analyze	rcmod	32	SENT_8	[p1l314t1166r478b1208],
43	for	IN	O	for	_	0	SENT_8	[p1l490t1166r541b1197],
44	susceptibility	NN	O	susceptibility	prep_for	42	SENT_8	[p1l554t1166r794b1208],
45	to	TO	O	to	_	0	SENT_8	[p1l806t1171r840b1197],
46	DRV	NN	O	drv	prep_to	42	SENT_8	[p1l852t1167r941b1197],
47	or	CC	O	or	_	0	SENT_8	[p1l953t1177r990b1197],
48	TPV	NN	O	tpv	conj_or	46	SENT_8	[p1l1002t1167r1081b1197],
49	among	IN	O	among	_	0	SENT_8	[p1l1094t1177r1218b1208],
50	PI-resistant	JJ	O	pi-resistant	amod	51	SENT_8	[p1l1230t1167r1435b1197],
51	isolates	NNS	O	isolate	prep_among	42	SENT_8	[p1l1447t1166r1588b1197],
52	.	.	O	.	_	0	SENT_8	[p1l1447t1166r1588b1197],

1	The	DT	O	the	det	5	SENT_9	[p1l1602t1166r1669b1197],
2	Monogram	NNP	O	Monogram	nn	5	SENT_9	[p1l1681t1167r1885b1208],
3	Biosciences	NNP	O	Biosciences	nn	5	SENT_9	[p1l1897t1167r2100b1197],
4	HIV	NN	O	hiv	nn	5	SENT_9	[p1l59t1216r135b1246],
5	database	NN	O	database	nsubjpass	31	SENT_9	[p1l150t1215r309b1246],
6	(	CD	NUMBER	(	num	9	SENT_9	[p1l325t1215r442b1254],
7	South	NNP	LOCATION	South	nn	9	SENT_9	[p1l325t1215r442b1254],
8	San	NNP	LOCATION	San	nn	9	SENT_9	[p1l456t1215r522b1246],
9	Francisco	NNP	LOCATION	Francisco	nsubj	17	SENT_9	[p1l535t1216r715b1252],
10	,	,	O	,	_	0	SENT_9	[p1l535t1216r715b1252],
11	CA	NNP	LOCATION	CA	appos	9	SENT_9	[p1l730t1215r803b1254],
12	)	CD	NUMBER	)	num	11	SENT_9	[p1l730t1215r803b1254],
13	containing	VBG	O	contain	partmod	11	SENT_9	[p1l819t1216r1010b1257],
14	7775	CD	DATE	7775	num	16	SENT_9	[p1l1025t1216r1105b1246],
15	clinical	JJ	O	clinical	amod	16	SENT_9	[p1l1121t1215r1247b1246],
16	isolates	NNS	O	isolate	dobj	13	SENT_9	[p1l1261t1215r1394b1246],
17	(	VBP	O	(	rcmod	5	SENT_9	[p1l1410t1215r1620b1254],
18	2006-2008	CD	DATE	2006-2008	num	19	SENT_9	[p1l1410t1215r1620b1254],
19	)	CD	NUMBER	)	npadvmod	20	SENT_9	[p1l1410t1215r1620b1254],
20	not	RB	O	not	neg	17	SENT_9	[p1l1635t1219r1695b1246],
21	susceptible	JJ	O	susceptible	amod	29	SENT_9	[p1l1709t1215r1908b1257],
22	to	TO	O	to	_	0	SENT_9	[p1l1923t1219r1957b1246],
23	at	IN	O	at	quantmod	25	SENT_9	[p1l1972t1219r2005b1246],
24	least	JJS	O	least	mwe	23	SENT_9	[p1l2019t1215r2101b1246],
25	one	CD	NUMBER	one	prep_to	21	SENT_9	[p1l59t1275r123b1296],
26	first	JJ	ORDINAL	first	amod	29	SENT_9	[p1l139t1264r417b1307],
27	—	NN	O	—	nn	29	SENT_9	[p1l139t1264r417b1307],
28	generation	NN	O	generation	nn	29	SENT_9	[p1l139t1264r417b1307],
29	P1	NN	O	p1	dobj	17	SENT_9	[p1l432t1266r469b1295],
30	was	VBD	O	be	auxpass	31	SENT_9	[p1l484t1275r556b1296],
31	analyzed	VBN	O	analyze	_	0	SENT_9	[p1l572t1264r744b1307],
32	.	.	O	.	_	0	SENT_9	[p1l572t1264r744b1307],

1	Phenotypic	JJ	O	phenotypic	amod	2	SENT_10	[p1l761t1264r965b1307],
2	responses	NNS	O	response	nsubj	18	SENT_10	[p1l981t1275r1157b1307],
3	[	JJ	O	[	amod	13	SENT_10	[p1l1176t1264r1339b1303],
4	resistant	JJ	O	resistant	amod	13	SENT_10	[p1l1176t1264r1339b1303],
5	(	NN	O	(	nn	7	SENT_10	[p1l1356t1264r1417b1304],
6	R	NN	O	r	nn	7	SENT_10	[p1l1356t1264r1417b1304],
7	)	NN	O	)	tmod	4	SENT_10	[p1l1356t1264r1417b1304],
8	,	,	O	,	_	0	SENT_10	[p1l1356t1264r1417b1304],
9	partially	RB	O	partially	advmod	10	SENT_10	[p1l1432t1264r1586b1307],
10	susceptible	JJ	O	susceptible	amod	7	SENT_10	[p1l1601t1264r1801b1307],
11	(	NN	O	(	nn	13	SENT_10	[p1l1818t1264r1897b1304],
12	P8	NN	O	p8	nn	13	SENT_10	[p1l1818t1264r1897b1304],
13	)	NN	O	)	dep	2	SENT_10	[p1l1818t1264r1897b1304],
14	,	,	O	,	_	0	SENT_10	[p1l1818t1264r1897b1304],
15	or	CC	O	or	_	0	SENT_10	[p1l1914t1275r1951b1296],
16	susceptible	JJ	O	susceptible	amod	17	SENT_10	[p1l1967t1275r2100b1307, p1l59t1314r136b1345],
17	(	NN	O	(	nsubj	18	SENT_10	[p1l152t1314r209b1353],
18	S	NN	O	s	_	0	SENT_10	[p1l152t1314r209b1353],
19	)	CD	NUMBER	)	num	20	SENT_10	[p1l152t1314r209b1353],
20	]	NN	O	]	nsubjpass	22	SENT_10	[p1l152t1314r209b1353],
21	were	VBD	O	be	auxpass	22	SENT_10	[p1l224t1325r313b1345],
22	defined	VBN	O	define	ccomp	18	SENT_10	[p1l328t1314r464b1345],
23	by	IN	O	by	_	0	SENT_10	[p1l476t1314r523b1356],
24	upper	JJ	O	upper	agent	22	SENT_10	[p1l536t1325r645b1356],
25	and	CC	O	and	_	0	SENT_10	[p1l659t1314r727b1345],
26	lower	JJR	O	lower	amod	28	SENT_10	[p1l741t1314r844b1345],
27	clinical	JJ	O	clinical	amod	28	SENT_10	[p1l858t1314r984b1345],
28	cut-offs	NNS	O	cut-off	agent	22	SENT_10	[p1l998t1314r1132b1345],
29	to	TO	O	to	_	0	SENT_10	[p1l1147t1318r1181b1345],
30	each	DT	O	each	det	31	SENT_10	[p1l1196t1314r1277b1345],
31	PI	NN	O	pi	prep_to	22	SENT_10	[p1l1290t1315r1336b1345],
32	.	.	O	.	_	0	SENT_10	[p1l1290t1315r1336b1345],

1	Genotypes	NNS	O	genotype	nsubjpass	3	SENT_11	[p1l1352t1315r1545b1356],
2	were	VBD	O	be	auxpass	3	SENT_11	[p1l1559t1325r1648b1345],
3	screened	VBN	O	screen	_	0	SENT_11	[p1l1662t1314r1819b1345],
4	for	IN	O	for	_	0	SENT_11	[p1l1834t1314r1884b1345],
5	amino	NN	O	amino	nn	7	SENT_11	[p1l1898t1316r2011b1345],
6	acid	NN	O	acid	nn	7	SENT_11	[p1l2026t1314r2100b1345],
7	substitutions	NNS	O	substitution	prep_for	3	SENT_11	[p1l59t1363r291b1394],
8	associated	VBN	O	associate	partmod	7	SENT_11	[p1l307t1363r492b1394],
9	with	IN	O	with	_	0	SENT_11	[p1l506t1363r590b1394],
10	TPV-R/DRV-S	NN	O	tpv-r/drv-s	nn	13	SENT_11	[p1l604t1363r873b1399],
11	and	CC	O	and	_	0	SENT_11	[p1l889t1363r956b1394],
12	TPV-S/DRV-R	NN	O	tpv-s/drv-r	conj_and	10	SENT_11	[p1l971t1363r1242b1399],
13	phenotypes	NNS	O	phenotype	prep_with	8	SENT_11	[p1l1255t1363r1475b1405],
14	.	.	O	.	_	0	SENT_11	[p1l1255t1363r1475b1405],

1	In	IN	O	in	_	0	SENT_12	[p1l1492t1364r1529b1394],
2	all	DT	O	all	prep_in	24	SENT_12	[p1l1544t1363r1596b1400],
3	,	,	O	,	_	0	SENT_12	[p1l1544t1363r1596b1400],
4	4.9	CD	PERCENT	4.9	num	5	SENT_12	[p1l1611t1364r1696b1394],
5	%	NN	PERCENT	%	nsubj	24	SENT_12	[p1l1611t1364r1696b1394],
6	(	CD	NUMBER	(	number	7	SENT_12	[p1l1713t1363r1798b1402],
7	378	CD	NUMBER	378	num	8	SENT_12	[p1l1713t1363r1798b1402],
8	)	NN	O	)	nsubj	12	SENT_12	[p1l1713t1363r1798b1402],
9	of	IN	O	of	_	0	SENT_12	[p1l1815t1363r1851b1394],
10	isolates	NNS	O	isolate	prep_of	8	SENT_12	[p1l1864t1363r1997b1394],
11	were	VBD	O	be	cop	12	SENT_12	[p1l2011t1374r2100b1394],
12	resistant	JJ	O	resistant	rcmod	5	SENT_12	[p1l58t1413r211b1443],
13	to	TO	O	to	_	0	SENT_12	[p1l222t1416r256b1443],
14	all	DT	O	all	det	16	SENT_12	[p1l268t1412r311b1443],
15	six	CD	NUMBER	six	num	16	SENT_12	[p1l322t1414r370b1443],
16	Pls	NNS	O	pl	prep_to	12	SENT_12	[p1l381t1413r435b1443],
17	and	CC	O	and	_	0	SENT_12	[p1l448t1412r515b1443],
18	31.0	CD	PERCENT	31.0	num	19	SENT_12	[p1l526t1413r632b1443],
19	%	NN	PERCENT	%	conj_and	16	SENT_12	[p1l526t1413r632b1443],
20	(	CD	NUMBER	(	number	21	SENT_12	[p1l645t1412r751b1451],
21	2407	CD	DATE	2407	num	22	SENT_12	[p1l645t1412r751b1451],
22	)	NN	O	)	dep	19	SENT_12	[p1l645t1412r751b1451],
23	were	VBD	O	be	cop	24	SENT_12	[p1l763t1423r852b1443],
24	resistant	JJ	O	resistant	_	0	SENT_12	[p1l863t1414r1015b1443],
25	to	TO	O	to	_	0	SENT_12	[p1l1026t1416r1060b1443],
26	none	NN	O	none	prep_to	24	SENT_12	[p1l1071t1423r1168b1443],
27	.	.	O	.	_	0	SENT_12	[p1l1071t1423r1168b1443],

1	Among	IN	O	among	_	0	SENT_13	[p1l1181t1413r1318b1454],
2	isolates	NNS	O	isolate	prep_among	14	SENT_13	[p1l1329t1412r1462b1443],
3	resistant	JJ	O	resistant	amod	2	SENT_13	[p1l1473t1414r1626b1443],
4	to	TO	O	to	_	0	SENT_13	[p1l1636t1416r1670b1443],
5	all	DT	O	all	det	10	SENT_13	[p1l1682t1412r1725b1443],
6	four	CD	NUMBER	four	num	10	SENT_13	[p1l1736t1412r1811b1443],
7	first	JJ	ORDINAL	first	amod	10	SENT_13	[p1l1822t1412r2101b1454],
8	—	NN	O	—	nn	10	SENT_13	[p1l1822t1412r2101b1454],
9	generation	NN	O	generation	nn	10	SENT_13	[p1l1822t1412r2101b1454],
10	Pls	NNS	O	pl	prep_to	3	SENT_13	[p1l59t1462r123b1498],
11	,	,	O	,	_	0	SENT_13	[p1l59t1462r123b1498],
12	DRV	NN	ORGANIZATION	drv	nn	13	SENT_13	[p1l144t1462r233b1492],
13	resistance	NN	O	resistance	nsubj	14	SENT_13	[p1l253t1462r429b1492],
14	increased	VBN	O	increase	_	0	SENT_13	[p1l450t1461r620b1492],
15	from	IN	O	from	_	0	SENT_13	[p1l641t1461r728b1492],
16	21.2	CD	PERCENT	21.2	number	20	SENT_13	[p1l748t1461r854b1492],
17	%	NN	PERCENT	%	dep	20	SENT_13	[p1l748t1461r854b1492],
18	to	TO	O	to	dep	20	SENT_13	[p1l875t1465r909b1492],
19	41.9	CD	PERCENT	41.9	number	20	SENT_13	[p1l929t1461r1035b1492],
20	%	NN	PERCENT	%	prep_from	14	SENT_13	[p1l929t1461r1035b1492],
21	from	IN	O	from	_	0	SENT_13	[p1l1056t1461r1144b1492],
22	2006	CD	DATE	2006	num	24	SENT_13	[p1l1163t1462r1245b1492],
23	to	TO	DATE	to	dep	24	SENT_13	[p1l1266t1465r1300b1492],
24	2008	CD	DATE	2008	prep_from	14	SENT_13	[p1l1321t1462r1413b1498],
25	,	,	O	,	_	0	SENT_13	[p1l1321t1462r1413b1498],
26	respectively	RB	O	respectively	advmod	14	SENT_13	[p1l1434t1461r1660b1503],
27	,	,	O	,	_	0	SENT_13	[p1l1434t1461r1660b1503],
28	and	CC	O	and	_	0	SENT_13	[p1l1682t1461r1749b1492],
29	resistance	NN	O	resistance	nsubj	34	SENT_13	[p1l1770t1462r1946b1492],
30	to	TO	O	to	_	0	SENT_13	[p1l1967t1465r2001b1492],
31	TPV	NN	O	tpv	prep_to	29	SENT_13	[p1l2022t1462r2100b1492],
32	remained	VBD	O	remain	cop	34	SENT_13	[p1l59t1510r230b1541],
33	steady	JJ	O	steady	amod	34	SENT_13	[p1l245t1510r362b1552],
34	(	NN	O	(	conj_and	14	SENT_13	[p1l377t1510r459b1549],
35	53.9	CD	NUMBER	53.9	number	37	SENT_13	[p1l377t1510r459b1549],
36	to	TO	O	to	dep	37	SENT_13	[p1l474t1515r509b1541],
37	57.3	CD	PERCENT	57.3	num	38	SENT_13	[p1l523t1511r639b1547],
38	%	NN	PERCENT	%	dep	34	SENT_13	[p1l523t1511r639b1547],
39	,	,	O	,	_	0	SENT_13	[p1l523t1511r639b1547],
40	respectively	RB	O	respectively	advmod	34	SENT_13	[p1l653t1510r892b1552],
41	)	CD	NUMBER	)	tmod	34	SENT_13	[p1l653t1510r892b1552],
42	.	.	O	.	_	0	SENT_13	[p1l653t1510r892b1552],

1	Higher	JJR	O	higher	amod	3	SENT_14	[p1l907t1510r1035b1552],
2	prevalence	NN	O	prevalence	nn	3	SENT_14	[p1l1048t1510r1244b1552],
3	substitutions	NNS	O	substitution	_	0	SENT_14	[p1l1259t1510r1491b1541],
4	in	IN	O	in	_	0	SENT_14	[p1l1505t1512r1540b1541],
5	DRV-S/TPV-R	NN	O	drv-s/tpv-r	nn	6	SENT_14	[p1l1553t1510r1823b1546],
6	isolates	NNS	O	isolate	prep_in	3	SENT_14	[p1l1836t1510r1969b1541],
7	versus	CC	O	versus	prep	3	SENT_14	[p1l1983t1521r2100b1541],
8	DRV	NN	O	drv	dep	7	SENT_14	[p1l59t1559r328b1594],
9	.	.	O	.	_	0	SENT_14	[p1l59t1559r328b1594],

1	—	NN	O	—	_	0	SENT_15	[p1l59t1559r328b1594],
2	.	.	O	.	_	0	SENT_15	[p1l59t1559r328b1594],

1	R/TPV	NN	O	r/tpv	_	0	SENT_16	[p1l59t1559r328b1594],
2	.	.	O	.	_	0	SENT_16	[p1l59t1559r328b1594],

1	—	NN	O	—	_	0	SENT_17	[p1l59t1559r328b1594],
2	.	.	O	.	_	0	SENT_17	[p1l59t1559r328b1594],

1	S	NN	O	s	nn	2	SENT_18	[p1l59t1559r328b1594],
2	isolates	NNS	O	isolate	nsubj	7	SENT_18	[p1l347t1559r490b1596],
3	,	,	O	,	_	0	SENT_18	[p1l347t1559r490b1596],
4	respectively	RB	O	respectively	advmod	7	SENT_18	[p1l510t1559r736b1601],
5	,	,	O	,	_	0	SENT_18	[p1l510t1559r736b1601],
6	were	VBD	O	be	cop	7	SENT_18	[p1l756t1570r845b1590],
7	82L	NN	O	82l	_	0	SENT_18	[p1l865t1559r952b1594],
8	/	:	O	/	punct	12	SENT_18	[p1l865t1559r952b1594],
9	T	NN	O	t	dep	12	SENT_18	[p1l956t1560r980b1590],
10	(	CD	PERCENT	(	number	11	SENT_18	[p1l1001t1559r1118b1598],
11	44.4	CD	PERCENT	44.4	num	12	SENT_18	[p1l1001t1559r1118b1598],
12	%	NN	PERCENT	%	dep	7	SENT_18	[p1l1001t1559r1118b1598],
13	vs.	CC	O	vs.	prep	12	SENT_18	[p1l1137t1570r1186b1590],
14	o	NN	PERCENT	o	nn	15	SENT_18	[p1l1208t1559r1274b1598],
15	%	NN	PERCENT	%	dep	13	SENT_18	[p1l1208t1559r1274b1598],
16	)	CD	NUMBER	)	advmod	15	SENT_18	[p1l1208t1559r1274b1598],
17	and	CC	O	and	_	0	SENT_18	[p1l1295t1559r1362b1590],
18	83D	CD	PERCENT	83d	conj_and	16	SENT_18	[p1l1382t1560r1454b1590],
19	(	CD	PERCENT	(	number	20	SENT_18	[p1l1475t1559r1572b1598],
20	5.8	CD	PERCENT	5.8	dep	21	SENT_18	[p1l1475t1559r1572b1598],
21	%	NN	PERCENT	%	dep	7	SENT_18	[p1l1475t1559r1572b1598],
22	vs.	CC	O	vs.	prep	7	SENT_18	[p1l1591t1570r1640b1590],
23	o	NN	O	o	nn	24	SENT_18	[p1l1661t1559r1737b1598],
24	%	NN	O	%	dep	22	SENT_18	[p1l1661t1559r1737b1598],
25	)	CD	NUMBER	)	num	24	SENT_18	[p1l1661t1559r1737b1598],
26	.	.	O	.	_	0	SENT_18	[p1l1661t1559r1737b1598],

1	Higher	JJR	O	higher	amod	3	SENT_19	[p1l1758t1559r1885b1601],
2	prevalence	NN	O	prevalence	nn	3	SENT_19	[p1l1904t1559r2100b1601],
3	substitutions	NNS	O	substitution	_	0	SENT_19	[p1l59t1608r291b1639],
4	in	IN	O	in	_	0	SENT_19	[p1l304t1609r339b1638],
5	DRV	NNP	O	DRV	prep_in	3	SENT_19	[p1l351t1608r621b1643],
6	.	.	O	.	_	0	SENT_19	[p1l351t1608r621b1643],

1	—	NN	O	—	_	0	SENT_20	[p1l351t1608r621b1643],
2	.	.	O	.	_	0	SENT_20	[p1l351t1608r621b1643],

1	R/TPV	NN	O	r/tpv	_	0	SENT_21	[p1l351t1608r621b1643],
2	.	.	O	.	_	0	SENT_21	[p1l351t1608r621b1643],

1	—	NN	O	—	_	0	SENT_22	[p1l351t1608r621b1643],
2	.	.	O	.	_	0	SENT_22	[p1l351t1608r621b1643],

1	S	NN	O	s	nn	2	SENT_23	[p1l351t1608r621b1643],
2	virus	NN	O	virus	nsubj	5	SENT_23	[p1l633t1609r725b1639],
3	were	VBD	O	be	cop	5	SENT_23	[p1l737t1618r826b1639],
4	50V	CD	NUMBER	50v	number	5	SENT_23	[p1l839t1609r909b1639],
5	(	CD	NUMBER	(	_	0	SENT_23	[p1l923t1608r1020b1647],
6	o.	NN	O	o.	nn	8	SENT_23	[p1l923t1608r1020b1647],
7	o	NN	PERCENT	o	nn	8	SENT_23	[p1l923t1608r1020b1647],
8	%	NN	PERCENT	%	dep	5	SENT_23	[p1l923t1608r1020b1647],
9	vs.	CC	O	vs.	_	0	SENT_23	[p1l1032t1618r1081b1639],
10	28.9	CD	PERCENT	28.9	num	11	SENT_23	[p1l1095t1608r1225b1647],
11	%	NN	PERCENT	%	conj_vs.	5	SENT_23	[p1l1095t1608r1225b1647],
12	)	CD	NUMBER	)	dep	11	SENT_23	[p1l1095t1608r1225b1647],
13	,	,	O	,	_	0	SENT_23	[p1l1095t1608r1225b1647],
14	54L	NN	O	54l	conj_vs.	5	SENT_23	[p1l1238t1609r1303b1639],
15	(	CD	PERCENT	(	number	16	SENT_23	[p1l1318t1608r1414b1647],
16	1.0	CD	PERCENT	1.0	num	17	SENT_23	[p1l1318t1608r1414b1647],
17	%	NN	PERCENT	%	dep	14	SENT_23	[p1l1318t1608r1414b1647],
18	vs.	CC	O	vs.	_	0	SENT_23	[p1l1427t1618r1475b1639],
19	36.1	CD	PERCENT	36.1	num	20	SENT_23	[p1l1490t1608r1619b1647],
20	%	NN	PERCENT	%	conj_vs.	5	SENT_23	[p1l1490t1608r1619b1647],
21	)	CD	NUMBER	)	dep	20	SENT_23	[p1l1490t1608r1619b1647],
22	,	,	O	,	_	0	SENT_23	[p1l1490t1608r1619b1647],
23	and	CC	O	and	_	0	SENT_23	[p1l1633t1608r1701b1639],
24	76V	NN	O	76v	conj_and	5	SENT_23	[p1l1714t1609r1784b1639],
25	(	CD	PERCENT	(	number	27	SENT_23	[p1l1798t1608r1895b1647],
26	0.4	CD	PERCENT	0.4	number	27	SENT_23	[p1l1798t1608r1895b1647],
27	%	NN	PERCENT	%	amod	24	SENT_23	[p1l1798t1608r1895b1647],
28	vs.	CC	O	vs.	_	0	SENT_23	[p1l1907t1618r1955b1639],
29	15.5	CD	PERCENT	15.5	num	30	SENT_23	[p1l1972t1608r2098b1647],
30	%	NN	PERCENT	%	conj_vs.	24	SENT_23	[p1l1972t1608r2098b1647],
31	)	CD	NUMBER	)	dep	30	SENT_23	[p1l1972t1608r2098b1647],
32	.	.	O	.	_	0	SENT_23	[p1l1972t1608r2098b1647],

1	Mutations	NNS	O	mutation	nsubjpass	20	SENT_24	[p1l58t1659r244b1689],
2	to	TO	O	to	aux	3	SENT_24	[p1l260t1662r294b1689],
3	help	VB	O	help	infmod	1	SENT_24	[p1l310t1658r388b1700],
4	predict	VB	O	predict	xcomp	3	SENT_24	[p1l405t1658r534b1700],
5	discordant	JJ	O	discordant	amod	6	SENT_24	[p1l550t1658r742b1689],
6	susceptibility	NN	O	susceptibility	dobj	4	SENT_24	[p1l758t1658r998b1700],
7	to	TO	O	to	_	0	SENT_24	[p1l1014t1662r1048b1689],
8	DRV	NN	O	drv	prep_to	4	SENT_24	[p1l1065t1659r1153b1689],
9	and	CC	O	and	_	0	SENT_24	[p1l1170t1658r1238b1689],
10	TPV	NN	O	tpv	prep_to	4	SENT_24	[p1l1254t1659r1332b1689],
11	in	IN	O	in	_	0	SENT_24	[p1l1348t1659r1384b1688],
12	isolates	NNS	O	isolate	prep_in	4	SENT_24	[p1l1399t1658r1531b1689],
13	with	IN	O	with	_	0	SENT_24	[p1l1547t1658r1631b1689],
14	reduced	VBN	O	reduce	amod	15	SENT_24	[p1l1646t1658r1793b1689],
15	susceptibility	NN	O	susceptibility	prep_with	12	SENT_24	[p1l1810t1658r2050b1700],
16	to	TO	O	to	_	0	SENT_24	[p1l2066t1662r2100b1689],
17	other	JJ	O	other	amod	18	SENT_24	[p1l59t1707r153b1738],
18	PIS	NN	O	pi	prep_to	15	SENT_24	[p1l167t1708r222b1738],
19	were	VBD	O	be	auxpass	20	SENT_24	[p1l236t1718r325b1738],
20	identified	VBN	O	identify	_	0	SENT_24	[p1l340t1707r522b1738],
21	.	.	O	.	_	0	SENT_24	[p1l340t1707r522b1738],

1	DRV	NN	O	drv	nn	3	SENT_25	[p1l539t1708r627b1738],
2	resistance	NN	O	resistance	nn	3	SENT_25	[p1l642t1709r818b1738],
3	mutations	NNS	O	mutation	nsubj	13	SENT_25	[p1l833t1709r1016b1738],
4	associated	VBN	O	associate	partmod	3	SENT_25	[p1l1031t1707r1216b1738],
5	with	IN	O	with	_	0	SENT_25	[p1l1230t1707r1314b1738],
6	improved	VBN	O	improve	amod	8	SENT_25	[p1l1328t1707r1506b1749],
7	virologic	JJ	O	virologic	amod	8	SENT_25	[p1l1520t1707r1680b1749],
8	response	NN	O	response	prep_with	4	SENT_25	[p1l1695t1718r1854b1749],
9	to	TO	O	to	_	0	SENT_25	[p1l1869t1712r1903b1738],
10	TPV	NN	O	tpv	prep_to	8	SENT_25	[p1l1918t1708r1997b1738],
11	were	VBD	O	be	cop	13	SENT_25	[p1l2011t1718r2100b1738],
12	more	RBR	O	more	advmod	13	SENT_25	[p1l58t1767r152b1787],
13	prevalent	JJ	O	prevalent	_	0	SENT_25	[p1l165t1756r338b1798],
14	in	IN	O	in	_	0	SENT_25	[p1l351t1758r386b1787],
15	DRV	NNP	O	DRV	prep_in	13	SENT_25	[p1l399t1756r669b1792],
16	.	.	O	.	_	0	SENT_25	[p1l399t1756r669b1792],

1	—	NN	O	—	_	0	SENT_26	[p1l399t1756r669b1792],
2	.	.	O	.	_	0	SENT_26	[p1l399t1756r669b1792],

1	R/TPV	NN	O	r/tpv	_	0	SENT_27	[p1l399t1756r669b1792],
2	.	.	O	.	_	0	SENT_27	[p1l399t1756r669b1792],

1	—	NN	O	—	_	0	SENT_28	[p1l399t1756r669b1792],
2	.	.	O	.	_	0	SENT_28	[p1l399t1756r669b1792],

1	S	NN	O	s	nn	2	SENT_29	[p1l399t1756r669b1792],
2	isolates	NNS	O	isolate	_	0	SENT_29	[p1l682t1756r824b1787],
3	.	.	O	.	_	0	SENT_29	[p1l682t1756r824b1787],

1	TPV	NN	O	tpv	nn	3	SENT_30	[p1l839t1757r918b1787],
2	resistance	NN	O	resistance	nn	3	SENT_30	[p1l932t1758r1108b1787],
3	mutations	NNS	O	mutation	nsubj	6	SENT_30	[p1l1122t1758r1304b1787],
4	were	VBD	O	be	cop	6	SENT_30	[p1l1318t1767r1407b1787],
5	more	RBR	O	more	advmod	6	SENT_30	[p1l1420t1767r1514b1787],
6	prevalent	JJ	O	prevalent	_	0	SENT_30	[p1l1527t1756r1700b1798],
7	in	IN	O	in	_	0	SENT_30	[p1l1713t1758r1748b1787],
8	TPV-R	NN	O	tpv-r	nn	11	SENT_30	[p1l1761t1757r1881b1787],
9	and	CC	O	and	_	0	SENT_30	[p1l1895t1756r1963b1787],
10	DRV-S	NN	O	drv-s	nn	11	SENT_30	[p1l1977t1757r2100b1787],
11	isolates	NNS	O	isolate	prep_in	6	SENT_30	[p1l58t1806r200b1837],
12	.	.	O	.	_	0	SENT_30	[p1l58t1806r200b1837],

1	These	DT	O	these	det	2	SENT_31	[p1l218t1806r321b1837],
2	results	NNS	O	result	nsubj	3	SENT_31	[p1l337t1806r455b1837],
3	confirm	VBP	O	confirm	_	0	SENT_31	[p1l471t1806r613b1837],
4	the	DT	O	the	det	5	SENT_31	[p1l628t1806r683b1837],
5	impact	NN	O	impact	dobj	3	SENT_31	[p1l698t1808r823b1848],
6	of	IN	O	of	_	0	SENT_31	[p1l838t1806r874b1837],
7	genotype	NN	O	genotype	prep_of	5	SENT_31	[p1l888t1810r1056b1848],
8	on	IN	O	on	_	0	SENT_31	[p1l1072t1817r1117b1837],
9	phenotype	NN	O	phenotype	prep_on	3	SENT_31	[p1l1131t1806r1335b1848],
10	,	,	O	,	_	0	SENT_31	[p1l1131t1806r1335b1848],
11	illustrating	VBG	O	illustrate	partmod	3	SENT_31	[p1l1352t1806r1550b1848],
12	how	WRB	O	how	advmod	18	SENT_31	[p1l1564t1806r1645b1837],
13	HIV	NN	MISC	hiv	nn	14	SENT_31	[p1l1660t1807r1737b1837],
14	genotype	NN	O	genotype	nsubj	18	SENT_31	[p1l1753t1810r1921b1848],
15	and	CC	O	and	_	0	SENT_31	[p1l1936t1806r2004b1837],
16	phenotype	NN	O	phenotype	nn	17	SENT_31	[p1l2019t1806r2100b1848, p1l7t1873r275b1953],
17	data	NNS	O	datum	conj_and	14	SENT_31	[p1l309t1864r474b1929],
18	assist	VBP	O	assist	ccomp	11	SENT_31	[p1l508t1867r713b1930],
19	regimen	NN	O	regimen	nn	20	SENT_31	[p1l745t1867r1062b1953],
20	optimization	NN	O	optimization	dobj	18	SENT_31	[p1l1093t1867r1603b1953],
21	.	.	O	.	_	0	SENT_31	[p1l1093t1867r1603b1953],

1	Introduction	NN	O	introduction	_	0	SENT_32	[p1l11t2112r466b2171],

1	DIRECT	JJ	O	direct	amod	2	SENT_33	[p1l6t2306r378b2459],
2	COMPARISONS	NNS	O	comparison	nn	9	SENT_33	[p1l425t2323r904b2364],
3	or	CC	O	or	_	0	SENT_33	[p1l953t2323r1032b2364],
4	HIV	NN	MISC	hiv	nn	5	SENT_33	[p1l1078t2307r1224b2364],
5	GENOTYPES	NNS	O	genotype	nn	9	SENT_33	[p1l1269t2323r1643b2364],
6	and	CC	O	and	_	0	SENT_33	[p1l1691t2305r1820b2364],
7	in	FW	O	in	nn	8	SENT_33	[p1l1866t2306r1926b2363],
8	vitro	FW	O	vitro	advmod	2	SENT_33	[p1l1972t2306r2121b2364],
9	phenotypes	NNS	O	phenotype	nsubj	25	SENT_33	[p1l187t2401r589b2482],
10	can	MD	O	can	aux	11	SENT_33	[p1l627t2422r745b2461],
11	provide	VB	O	provide	_	0	SENT_33	[p1l779t2401r1050b2482],
12	useful	JJ	O	useful	amod	13	SENT_33	[p1l1087t2401r1297b2461],
13	information	NN	O	information	iobj	11	SENT_33	[p1l1333t2401r1744b2461],
14	to	TO	O	to	_	0	SENT_33	[p1l1779t2410r1845b2461],
15	further	JJ	O	further	amod	16	SENT_33	[p1l1882t2401r2122b2461],
16	guide	NN	O	guide	prep_to	13	SENT_33	[p1l9t2499r204b2579],
17	the	DT	O	the	det	18	SENT_33	[p1l243t2499r348b2559],
18	development	NN	O	development	dobj	11	SENT_33	[p1l387t2499r841b2579],
19	of	IN	O	of	_	0	SENT_33	[p1l880t2499r948b2559],
20	resistance	NN	O	resistance	nn	22	SENT_33	[p1l983t2502r1319b2559],
21	prediction	NN	O	prediction	nn	22	SENT_33	[p1l1356t2499r1712b2579],
22	algorithms	NNS	O	algorithm	prep_of	18	SENT_33	[p1l1750t2499r2121b2579],
23	and	CC	O	and	_	0	SENT_33	[p1l9t2595r137b2654],
24	ultimately	RB	O	ultimately	advmod	11	SENT_33	[p1l171t2595r518b2676],
25	help	VB	O	help	conj_and	11	SENT_33	[p1l551t2595r698b2676],
26	to	TO	O	to	_	0	SENT_33	[p1l734t2603r798b2655],
27	guide	NN	O	guide	nn	29	SENT_33	[p1l834t2595r1027b2676],
28	treatment	NN	O	treatment	nn	29	SENT_33	[p1l1060t2603r1390b2655],
29	decisions	NNS	O	decision	prep_to	25	SENT_33	[p1l1423t2595r1748b2655],
30	.	.	O	.	_	0	SENT_33	[p1l1423t2595r1748b2655],

1	However	RB	O	however	advmod	15	SENT_34	[p1l1786t2597r2121b2665],
2	,	,	O	,	_	0	SENT_34	[p1l1786t2597r2121b2665],
3	routine	JJ	O	routine	amod	4	SENT_34	[p1l8t2695r253b2752],
4	evaluations	NNS	O	evaluation	nsubj	15	SENT_34	[p1l292t2692r682b2752],
5	of	IN	O	of	_	0	SENT_34	[p1l722t2692r790b2752],
6	HIV	NN	MISC	hiv	prep_of	4	SENT_34	[p1l826t2695r971b2751],
7	genotypic	JJ	O	genotypic	amod	10	SENT_34	[p1l1011t2695r1344b2773],
8	and	CC	O	and	_	0	SENT_34	[p1l1384t2692r1513b2751],
9	phenotypic	JJ	O	phenotypic	conj_and	7	SENT_34	[p1l1551t2692r1933b2773],
10	data	NNS	O	datum	dep	6	SENT_34	[p1l1975t2692r2121b2751],
11	from	IN	O	from	_	0	SENT_34	[p1l8t2789r174b2848],
12	patient-derived	JJ	O	patient-derived	amod	13	SENT_34	[p1l196t2789r719b2869],
13	isolates	NNS	O	isolate	prep_from	10	SENT_34	[p1l744t2789r992b2848],
14	are	VBP	O	be	cop	15	SENT_34	[p1l1018t2809r1120b2848],
15	uncommon	JJ	O	uncommon	_	0	SENT_34	[p1l1144t2775r1639b2859],
16	,1	CD	NUMBER	,1	number	17	SENT_34	[p1l1144t2775r1639b2859],
17	‘	CD	NUMBER	‘	dep	15	SENT_34	[p1l1144t2775r1639b2859],
18	3	CD	NUMBER	3	dep	17	SENT_34	[p1l1144t2775r1639b2859],
19	and	CC	O	and	_	0	SENT_34	[p1l1665t2789r1793b2848],
20	these	DT	O	these	det	21	SENT_34	[p1l1818t2789r1991b2848],
21	analyses	NNS	O	analysis	nsubj	30	SENT_34	[p1l2016t2809r2122b2848, p1l9t2884r210b2965],
22	are	VBP	O	be	auxpass	24	SENT_34	[p1l242t2904r345b2944],
23	generally	RB	O	generally	advmod	24	SENT_34	[p1l375t2884r688b2965],
24	limited	VBN	O	limit	conj_and	15	SENT_34	[p1l717t2884r956b2944],
25	to	TO	O	to	_	0	SENT_34	[p1l987t2892r1052b2944],
26	an	DT	O	a	det	28	SENT_34	[p1l1083t2904r1165b2943],
27	individual	JJ	O	individual	amod	28	SENT_34	[p1l1193t2884r1547b2943],
28	drug	NN	O	drug	prep_to	24	SENT_34	[p1l1576t2884r1741b2965],
29	or	CC	O	or	_	0	SENT_34	[p1l1770t2904r1841b2944],
30	involve	VB	O	involve	conj_and	15	SENT_34	[p1l1869t2884r2122b2944],
31	only	RB	O	only	advmod	34	SENT_34	[p1l9t2981r159b3061],
32	a	DT	O	a	det	34	SENT_34	[p1l192t3001r228b3040],
33	small	JJ	O	small	amod	34	SENT_34	[p1l263t2981r444b3040],
34	number	NN	O	number	dobj	30	SENT_34	[p1l474t2981r743b3040],
35	of	IN	O	of	_	0	SENT_34	[p1l777t2981r845b3040],
36	patients	NNS	O	patient	prep_of	34	SENT_34	[p1l873t2967r1190b3061],
37	}	CD	NUMBER	}	npadvmod	38	SENT_34	[p1l873t2967r1190b3061],
38	thus	RB	O	thus	advmod	39	SENT_34	[p1l1223t2981r1369b3040],
39	limiting	VBG	O	limit	partmod	36	SENT_34	[p1l1402t2981r1669b3061],
40	their	PRP$	O	they	poss	42	SENT_34	[p1l1701t2981r1858b3040],
41	overall	JJ	O	overall	amod	42	SENT_34	[p1l1890t2981r2123b3040],
42	utility	NN	O	utility	dobj	39	SENT_34	[p1l8t3077r226b3157],
43	.	.	O	.	_	0	SENT_34	[p1l8t3077r226b3157],

1	Furthermore	RB	O	furthermore	advmod	8	SENT_35	[p1l262t3077r710b3147],
2	,	,	O	,	_	0	SENT_35	[p1l262t3077r710b3147],
3	the	DT	O	the	det	4	SENT_35	[p1l743t3076r847b3136],
4	emergence	NN	O	emergence	nsubj	8	SENT_35	[p1l880t3097r1243b3157],
5	of	IN	O	of	_	0	SENT_35	[p1l1276t3076r1344b3136],
6	mutations	NNS	O	mutation	prep_of	4	SENT_35	[p1l1373t3079r1716b3136],
7	that	WDT	O	that	rcmod	6	SENT_35	[p1l1748t3077r1880b3136],
8	confer	VBP	O	confer	_	0	SENT_35	[p1l1912t3076r2122b3136],

1	1Boehringer	NNP	O	1Boehringer	nn	6	SENT_36	[p1l90t3302r453b3385],
2	Ingelheim	NNP	O	Ingelheim	nn	6	SENT_36	[p1l477t3314r786b3385],
3	(	NNP	O	(	nn	6	SENT_36	[p1l814t3314r1090b3381],
4	Canada	NNP	LOCATION	Canada	nn	6	SENT_36	[p1l814t3314r1090b3381],
5	)	NNP	O	)	nn	6	SENT_36	[p1l814t3314r1090b3381],
6	Ltd.	NNP	ORGANIZATION	Ltd.	_	0	SENT_36	[p1l1118t3314r1258b3376],
7	,	,	O	,	_	0	SENT_36	[p1l1118t3314r1258b3376],
8	Laval	NNP	LOCATION	Laval	nn	12	SENT_36	[p1l1284t3314r1471b3376],
9	,	,	O	,	_	0	SENT_36	[p1l1284t3314r1471b3376],
10	Québec	NNP	O	Québec	appos	12	SENT_36	[p1l1498t3314r1744b3378],
11	,	,	O	,	_	0	SENT_36	[p1l1498t3314r1744b3378],
12	Canada	NNP	LOCATION	Canada	appos	6	SENT_36	[p1l1771t3314r2021b3367],
13	.	.	O	.	_	0	SENT_36	[p1l1771t3314r2021b3367],

1	2Boehringer	NNP	O	2Boehringer	nn	3	SENT_37	[p1l87t3381r453b3465],
2	Ingelheim	NNP	LOCATION	Ingelheim	nn	3	SENT_37	[p1l477t3393r786b3465],
3	Germany	NNP	LOCATION	Germany	_	0	SENT_37	[p1l811t3394r1115b3465],
4	,	,	O	,	_	0	SENT_37	[p1l811t3394r1115b3465],
5	Ingelheim	NNP	LOCATION	Ingelheim	nn	7	SENT_37	[p1l1141t3393r1465b3465],
6	,	,	O	,	_	0	SENT_37	[p1l1141t3393r1465b3465],
7	Germany	NNP	LOCATION	Germany	appos	3	SENT_37	[p1l1492t3394r1794b3465],
8	.	.	O	.	_	0	SENT_37	[p1l1492t3394r1794b3465],

1	3Monogram	NNP	O	3Monogram	nn	2	SENT_38	[p1l87t3460r458b3545],
2	Biosciences	NNP	O	Biosciences	_	0	SENT_38	[p1l483t3475r843b3536],
3	,	,	O	,	_	0	SENT_38	[p1l483t3475r843b3536],
4	South	NNP	LOCATION	South	nn	6	SENT_38	[p1l870t3473r1049b3526],
5	San	NNP	LOCATION	San	nn	6	SENT_38	[p1l1073t3474r1185b3526],
6	Francisco	NNP	LOCATION	Francisco	appos	2	SENT_38	[p1l1209t3475r1514b3536],
7	,	,	O	,	_	0	SENT_38	[p1l1209t3475r1514b3536],
8	California	NNP	LOCATION	California	appos	6	SENT_38	[p1l1540t3473r1860b3526],
9	.	.	O	.	_	0	SENT_38	[p1l1540t3473r1860b3526],

1	4Boehringer	NN	O	4boehringer	nn	3	SENT_39	[p1l87t3540r453b3624],
2	Ingelheim	NNP	ORGANIZATION	Ingelheim	nn	3	SENT_39	[p1l477t3552r786b3624],
3	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	_	0	SENT_39	[p1l811t3553r1329b3615],
4	,	,	O	,	_	0	SENT_39	[p1l811t3553r1329b3615],
5	Ridgefield	NNP	LOCATION	Ridgefield	nn	7	SENT_39	[p1l1356t3552r1689b3624],
6	,	,	O	,	_	0	SENT_39	[p1l1356t3552r1689b3624],
7	Connecticut	NNP	LOCATION	Connecticut	appos	3	SENT_39	[p1l1716t3554r2097b3605],
8	.	.	O	.	_	0	SENT_39	[p1l1716t3554r2097b3605],

1	resistance	NN	O	resistance	dep	104	SENT_40	[p2l80t88r403b143],
2	to	TO	O	to	dep	104	SENT_40	[p2l435t93r498b143],
3	protease	NN	O	protease	dep	104	SENT_40	[p2l530t93r811b164],
4	inhibitors	NNS	O	inhibitor	dep	104	SENT_40	[p2l843t85r1160b143],
5	(	VBP	O	(	dep	104	SENT_40	[p2l1196t86r1341b158],
6	Pls	NNS	O	pl	dep	104	SENT_40	[p2l1196t86r1341b158],
7	)	RB	O	)	dep	104	SENT_40	[p2l1196t86r1341b158],
8	in	IN	O	in	dep	104	SENT_40	[p2l1374t88r1440b142],
9	the	DT	O	the	dep	104	SENT_40	[p2l1470t85r1572b143],
10	context	NN	O	context	dep	104	SENT_40	[p2l1604t93r1845b143],
11	of	IN	O	of	dep	104	SENT_40	[p2l1877t85r1944b143],
12	background	NN	O	background	dep	104	SENT_40	[p2l1970t85r2151b143, p2l81t179r326b257],
13	substitutions	NNS	O	substitution	dep	104	SENT_40	[p2l361t179r786b237],
14	in	IN	O	in	dep	104	SENT_40	[p2l820t182r885b236],
15	the	DT	O	the	dep	104	SENT_40	[p2l917t179r1019b237],
16	protease	NN	O	protease	dep	104	SENT_40	[p2l1051t187r1331b257],
17	enzyme	NN	O	enzyme	dep	104	SENT_40	[p2l1366t199r1627b257],
18	itself	PRP	O	itself	dep	104	SENT_40	[p2l1660t179r1819b237],
19	has	VBZ	O	have	dep	104	SENT_40	[p2l1848t179r1961b237],
20	been	VBN	O	be	dep	104	SENT_40	[p2l1993t179r2153b237],
21	reported	VBN	O	report	dep	104	SENT_40	[p2l80t260r411b353],
22	,5	CD	NUMBER	,5	dep	104	SENT_40	[p2l80t260r411b353],
23	but	CC	O	but	dep	104	SENT_40	[p2l431t273r545b331],
24	few	JJ	O	few	dep	104	SENT_40	[p2l567t273r688b332],
25	large-scale	JJ	O	large-scale	dep	104	SENT_40	[p2l711t273r1060b353],
26	examinations	NNS	O	examination	dep	104	SENT_40	[p2l1081t277r1524b332],
27	of	IN	O	of	dep	104	SENT_40	[p2l1547t273r1613b332],
28	the	DT	O	the	dep	104	SENT_40	[p2l1632t273r1734b332],
29	relationship	NN	O	relationship	dep	104	SENT_40	[p2l1756t273r2149b353],
30	between	IN	O	between	dep	104	SENT_40	[p2l78t397r362b455],
31	genotype	NN	O	genotype	dep	104	SENT_40	[p2l422t405r730b476],
32	and	CC	O	and	dep	104	SENT_40	[p2l792t397r917b455],
33	phenotype	NN	O	phenotype	dep	104	SENT_40	[p2l977t397r1335b476],
34	across	IN	O	across	dep	104	SENT_40	[p2l1397t417r1598b455],
35	multiple	JJ	O	multiple	dep	104	SENT_40	[p2l1660t397r1940b476],
36	antiretroviral	JJ	O	antiretroviral	dep	104	SENT_40	[p2l2001t400r2151b455, p2l80t491r391b549],
37	drugs	NNS	O	drug	dep	104	SENT_40	[p2l431t491r622b569],
38	in	IN	O	in	dep	104	SENT_40	[p2l661t494r727b548],
39	the	DT	O	the	dep	104	SENT_40	[p2l763t491r865b549],
40	same	JJ	O	same	dep	104	SENT_40	[p2l905t511r1076b549],
41	class	NN	O	class	dep	104	SENT_40	[p2l1115t491r1269b549],
42	have	VBP	O	have	dep	104	SENT_40	[p2l1306t491r1467b549],
43	been	VBN	O	be	dep	104	SENT_40	[p2l1503t491r1663b549],
44	conducted	VBN	O	conduct	dep	104	SENT_40	[p2l1700t491r2047b549],
45	to	TO	O	to	dep	104	SENT_40	[p2l2086t499r2150b549],
46	date	NN	O	date	dep	104	SENT_40	[p2l82t571r313b643],
47	.6	NN	NUMBER	.6	dep	104	SENT_40	[p2l82t571r313b643],
48	'	''	O	'	_	0	SENT_40	[p2l82t571r313b643],
49	7	CD	NUMBER	7	dep	104	SENT_40	[p2l82t571r313b643],
50	A	DT	O	a	dep	104	SENT_40	[p2l338t586r396b642],
51	decline	NN	O	decline	dep	104	SENT_40	[p2l423t584r657b643],
52	in	IN	O	in	dep	104	SENT_40	[p2l683t588r749b642],
53	the	DT	O	the	dep	104	SENT_40	[p2l773t584r875b643],
54	prevalence	NN	O	prevalence	dep	104	SENT_40	[p2l900t585r1260b664],
55	of	IN	O	of	dep	104	SENT_40	[p2l1287t584r1353b643],
56	resistance	NN	O	resistance	dep	104	SENT_40	[p2l1377t588r1699b643],
57	mutations	NNS	O	mutation	dep	104	SENT_40	[p2l1724t588r2060b643],
58	to	TO	O	to	dep	104	SENT_40	[p2l2086t593r2150b643],
59	reverse	VB	O	reverse	dep	104	SENT_40	[p2l80t699r318b737],
60	transcriptase	NN	O	transcriptase	dep	104	SENT_40	[p2l355t682r779b758],
61	and	CC	O	and	dep	104	SENT_40	[p2l816t679r942b737],
62	protease	NN	O	protease	dep	104	SENT_40	[p2l977t687r1258b758],
63	inhibitors	NNS	O	inhibitor	dep	104	SENT_40	[p2l1295t679r1611b737],
64	[	VBP	O	[	dep	104	SENT_40	[p2l1654t679r2026b750],
65	nucleoside	JJ	O	nucleoside	dep	104	SENT_40	[p2l1654t679r2026b750],
66	reverse	JJ	O	reverse	dep	104	SENT_40	[p2l2063t699r2151b737, p2l79t793r253b832],
67	transcriptase	NN	O	transcriptase	dep	104	SENT_40	[p2l286t776r709b852],
68	inhibitors	NNS	O	inhibitor	dep	104	SENT_40	[p2l741t774r1059b832],
69	(	VBN	O	(	dep	104	SENT_40	[p2l1093t774r1371b847],
70	NRTIs	NNS	O	nrti	dep	104	SENT_40	[p2l1093t774r1371b847],
71	)	CD	NUMBER	)	dep	104	SENT_40	[p2l1093t774r1371b847],
72	,	,	O	,	_	0	SENT_40	[p2l1093t774r1371b847],
73	non-NRTIs	JJ	O	non-nrtis	dep	104	SENT_40	[p2l1403t776r1773b832],
74	(	CD	NUMBER	(	dep	104	SENT_40	[p2l1807t774r2149b847],
75	NNRTIS	NN	ORGANIZATION	nnrti	dep	104	SENT_40	[p2l1807t774r2149b847],
76	)	NN	O	)	dep	104	SENT_40	[p2l1807t774r2149b847],
77	,	,	O	,	_	0	SENT_40	[p2l1807t774r2149b847],
78	and	CC	O	and	dep	104	SENT_40	[p2l81t867r207b925],
79	PIs	NN	O	pi	dep	104	SENT_40	[p2l241t867r362b938],
80	]	NN	O	]	dep	104	SENT_40	[p2l241t867r362b938],
81	has	VBZ	O	have	dep	104	SENT_40	[p2l398t867r511b925],
82	been	VBN	O	be	dep	104	SENT_40	[p2l543t867r703b925],
83	reported	VBN	O	report	dep	104	SENT_40	[p2l735t867r1020b946],
84	in	IN	O	in	dep	104	SENT_40	[p2l1054t870r1119b924],
85	a	DT	O	a	dep	104	SENT_40	[p2l1152t887r1187b925],
86	recent	JJ	O	recent	dep	104	SENT_40	[p2l1222t875r1423b925],
87	study	NN	O	study	dep	104	SENT_40	[p2l1457t867r1645b946],
88	of	IN	O	of	dep	104	SENT_40	[p2l1679t867r1746b925],
89	phenotypic	JJ	O	phenotypic	dep	104	SENT_40	[p2l1775t867r2151b946],
90	resistance	NN	O	resistance	dep	104	SENT_40	[p2l80t964r403b1019],
91	mutation	NN	O	mutation	dep	104	SENT_40	[p2l450t964r756b1019],
92	patterns	NNS	O	pattern	dep	104	SENT_40	[p2l800t969r1071b1040],
93	using	VBG	O	use	dep	104	SENT_40	[p2l1119t964r1301b1040],
94	patient-derived	JJ	O	patient-derived	dep	104	SENT_40	[p2l1347t961r1860b1040],
95	isolates	NNS	O	isolate	dep	104	SENT_40	[p2l1907t961r2150b1019],
96	from	IN	O	from	dep	104	SENT_40	[p2l81t1056r242b1114],
97	routine	JJ	O	routine	dep	104	SENT_40	[p2l256t1059r496b1114],
98	clinical	JJ	O	clinical	dep	104	SENT_40	[p2l512t1056r743b1114],
99	samples	NNS	O	sample	dep	104	SENT_40	[p2l759t1056r1026b1135],
100	collected	VBN	O	collect	dep	104	SENT_40	[p2l1044t1056r1332b1114],
101	between	IN	O	between	dep	104	SENT_40	[p2l1346t1056r1630b1114],
102	1998	CD	DATE	1998	dep	104	SENT_40	[p2l1647t1058r1793b1114],
103	and	CC	O	and	dep	104	SENT_40	[p2l1812t1056r1937b1114],
104	2007.8	CD	NUMBER	2007.8	_	0	SENT_40	[p2l1952t1042r2150b1114],

1	*	NNP	O	*	nn	3	SENT_41	[p2l568t1211r693b1235],
2	Current	NNP	DATE	Current	nn	3	SENT_41	[p2l568t1211r693b1235],
3	affiliation	NN	O	affiliation	_	0	SENT_41	[p2l705t1210r850b1235],
4	:	:	O	:	_	0	SENT_41	[p2l705t1210r850b1235],
5	Katholieke	NNP	ORGANIZATION	Katholieke	nn	7	SENT_41	[p2l864t1210r1019b1235],
6	Universteit	NNP	ORGANIZATION	Universteit	nn	7	SENT_41	[p2l1030t1211r1191b1235],
7	Leuven	NNP	ORGANIZATION	Leuven	dep	3	SENT_41	[p2l1203t1211r1318b1240],
8	,	,	O	,	_	0	SENT_41	[p2l1203t1211r1318b1240],
9	Leuven	NNP	LOCATION	Leuven	nn	11	SENT_41	[p2l1330t1211r1445b1240],
10	,	,	O	,	_	0	SENT_41	[p2l1330t1211r1445b1240],
11	Belgium	NNP	LOCATION	Belgium	appos	7	SENT_41	[p2l1458t1210r1585b1244],
12	.	.	O	.	_	0	SENT_41	[p2l1458t1210r1585b1244],

1	1019	CD	DATE	1019	_	0	SENT_42	[p2l1512t1257r1591b1285],

1	Decisions	NNS	O	decision	nsubj	15	SENT_43	[p2l100t1661r431b1719],
2	regarding	VBG	O	regard	_	0	SENT_43	[p2l466t1659r807b1740],
3	the	DT	O	the	det	5	SENT_43	[p2l842t1658r949b1719],
4	next	JJ	O	next	amod	5	SENT_43	[p2l983t1667r1132b1719],
5	regimen	NN	O	regimen	prep_regarding	1	SENT_43	[p2l1167t1661r1453b1740],
6	to	TO	O	to	aux	7	SENT_43	[p2l1487t1667r1553b1719],
7	use	VB	O	use	infmod	5	SENT_43	[p2l1590t1679r1706b1719],
8	for	IN	O	for	_	0	SENT_43	[p2l1741t1658r1839b1719],
9	an	DT	O	a	det	14	SENT_43	[p2l1875t1679r1960b1718],
10	antiretroviral	JJ	O	antiretroviral	amod	14	SENT_43	[p2l1994t1661r2151b1718, p2l10t1756r335b1816],
11	therapy-experienced	JJ	O	therapy-experienced	amod	13	SENT_43	[p2l355t1755r1085b1837],
12	,	,	O	,	_	0	SENT_43	[p2l355t1755r1085b1837],
13	HIV-1-infected	JJ	O	hiv-1-infected	amod	14	SENT_43	[p2l1107t1755r1621b1816],
14	patient	NN	O	patient	prep_for	7	SENT_43	[p2l1641t1758r1883b1837],
15	require	VBP	O	require	_	0	SENT_43	[p2l1903t1758r2150b1837],
16	an	DT	O	a	det	17	SENT_43	[p2l11t1873r95b1912],
17	assessment	NN	O	assessment	dobj	15	SENT_43	[p2l120t1861r506b1913],
18	of	IN	O	of	_	0	SENT_43	[p2l530t1852r599b1913],
19	resistance	NN	O	resistance	prep_of	17	SENT_43	[p2l621t1855r974b1913],
20	.	.	O	.	_	0	SENT_43	[p2l621t1855r974b1913],

1	This	DT	O	this	det	2	SENT_44	[p2l1003t1852r1150b1913],
2	assessment	NN	O	assessment	nsubj	4	SENT_44	[p2l1176t1861r1562b1913],
3	may	MD	O	may	aux	4	SENT_44	[p2l1585t1873r1739b1934],
4	involve	VB	O	involve	_	0	SENT_44	[p2l1763t1852r2021b1913],
5	genotypic	JJ	O	genotypic	amod	6	SENT_44	[p2l2046t1873r2151b1934, p2l9t1953r270b2032],
6	sequencing	NN	O	sequencing	dobj	4	SENT_44	[p2l302t1953r690b2032],
7	of	IN	O	of	_	0	SENT_44	[p2l720t1950r789b2011],
8	the	DT	O	the	det	10	SENT_44	[p2l816t1950r923b2011],
9	viral	JJ	O	viral	amod	10	SENT_44	[p2l951t1951r1111b2010],
10	population	NN	O	population	prep_of	6	SENT_44	[p2l1139t1951r1523b2032],
11	circulating	VBG	O	circulate	partmod	10	SENT_44	[p2l1552t1950r1919b2032],
12	in	IN	O	in	_	0	SENT_44	[p2l1948t1953r2016b2010],
13	the	DT	O	the	det	15	SENT_44	[p2l2043t1951r2150b2011],
14	peripheral	JJ	O	peripheral	amod	15	SENT_44	[p2l9t2076r369b2157],
15	blood	NN	O	blood	prep_in	11	SENT_44	[p2l411t2076r612b2136],
16	or	CC	O	or	_	0	SENT_44	[p2l659t2096r731b2136],
17	an	DT	O	a	det	18	SENT_44	[p2l777t2096r861b2136],
18	assessment	NN	O	assessment	prep_in	11	SENT_44	[p2l906t2084r1292b2136],
19	of	IN	O	of	_	0	SENT_44	[p2l1338t2075r1406b2136],
20	both	CC	O	both	preconj	21	SENT_44	[p2l1446t2076r1607b2136],
21	genotype	NN	O	genotype	prep_of	18	SENT_44	[p2l1652t2084r1973b2157],
22	and	CC	O	and	_	0	SENT_44	[p2l2020t2076r2150b2136],
23	phenotype	NN	O	phenotype	prep_of	18	SENT_44	[p2l9t2202r397b2284],
24	.	.	O	.	_	0	SENT_44	[p2l9t2202r397b2284],

1	Evaluations	NNS	O	evaluation	nsubj	7	SENT_45	[p2l435t2202r844b2263],
2	based	VBN	O	base	_	0	SENT_45	[p2l875t2202r1078b2263],
3	on	IN	O	on	prepc_based_on	1	SENT_45	[p2l1113t2223r1201b2263],
4	phenotypic	JJ	O	phenotypic	amod	5	SENT_45	[p2l1231t2202r1623b2284],
5	testing	NN	O	testing	pobj	1	SENT_45	[p2l1657t2205r1889b2284],
6	are	VBP	O	be	cop	7	SENT_45	[p2l1923t2223r2027b2263],
7	attractive	JJ	O	attractive	_	0	SENT_45	[p2l2062t2211r2151b2262, p2l10t2302r269b2360],
8	when	WRB	O	when	advmod	9	SENT_45	[p2l291t2300r486b2360],
9	considering	VBG	O	consider	ccomp	7	SENT_45	[p2l508t2299r912b2381],
10	the	DT	O	the	det	11	SENT_45	[p2l934t2300r1041b2360],
11	choice	NN	O	choice	dobj	9	SENT_45	[p2l1064t2300r1280b2360],
12	of	IN	O	of	_	0	SENT_45	[p2l1303t2299r1372b2360],
13	P1	NN	O	p1	prep_of	11	SENT_45	[p2l1392t2302r1463b2359],
14	in	IN	O	in	_	0	SENT_45	[p2l1486t2302r1553b2359],
15	a	DT	O	a	det	17	SENT_45	[p2l1575t2320r1611b2359],
16	PI-experienced	JJ	O	pi-experienced	amod	17	SENT_45	[p2l1635t2300r2150b2381],
17	patient	NN	O	patient	prep_in	13	SENT_45	[p2l9t2401r252b2479],
18	because	IN	O	because	_	0	SENT_45	[p2l284t2398r559b2458],
19	the	DT	O	the	det	21	SENT_45	[p2l593t2398r700b2458],
20	complex	NN	O	complex	nn	21	SENT_45	[p2l735t2398r1028b2479],
21	pattems	NNS	O	pattem	prep_because	9	SENT_45	[p2l1062t2406r1345b2479],
22	of	IN	O	of	_	0	SENT_45	[p2l1381t2397r1450b2458],
23	mutations	NNS	O	mutation	prep_of	21	SENT_45	[p2l1482t2401r1831b2458],
24	in	IN	O	in	_	0	SENT_45	[p2l1867t2401r1935b2457],
25	treatment-experienced	JJ	O	treatment-experienced	prep_in	23	SENT_45	[p2l1968t2406r2151b2458, p2l10t2521r631b2603],

1	patients	NNS	O	patient	nsubj	2	SENT_46	[p2l655t2524r930b2603],
2	make	VBP	O	make	_	0	SENT_46	[p2l956t2521r1145b2582],
3	interpretations	NNS	O	interpretation	dobj	2	SENT_46	[p2l1171t2524r1680b2603],
4	based	VBN	O	base	_	0	SENT_46	[p2l1703t2521r1906b2582],
5	on	IN	O	on	prepc_based_on	2	SENT_46	[p2l1934t2542r2021b2582],
6	genotype	NN	O	genotype	pobj	2	SENT_46	[p2l2046t2542r2151b2603, p2l9t2627r251b2700],
7	alone	RB	O	alone	advmod	6	SENT_46	[p2l272t2619r458b2679],
8	extremely	RB	O	extremely	advmod	9	SENT_46	[p2l479t2619r822b2700],
9	difficult	JJ	O	difficult	amod	6	SENT_46	[p2l842t2618r1132b2689],
10	,	,	O	,	_	0	SENT_46	[p2l842t2618r1132b2689],
11	despite	IN	O	despite	_	0	SENT_46	[p2l1154t2619r1401b2700],
12	the	DT	O	the	det	13	SENT_46	[p2l1422t2619r1528b2679],
13	development	NN	O	development	prep_despite	2	SENT_46	[p2l1550t2619r2006b2700],
14	of	IN	O	of	_	0	SENT_46	[p2l2026t2618r2095b2679],
15	a	DT	O	a	det	16	SENT_46	[p2l2113t2639r2150b2678],
16	number	NN	O	number	prep_of	13	SENT_46	[p2l9t2716r284b2776],
17	of	IN	O	of	_	0	SENT_46	[p2l308t2715r377b2776],
18	different	JJ	O	different	amod	20	SENT_46	[p2l399t2715r696b2776],
19	interpretative	JJ	O	interpretative	amod	20	SENT_46	[p2l718t2719r1188b2797],
20	algorithms	NNS	O	algorithm	prep_of	16	SENT_46	[p2l1213t2716r1602b2797],
21	.	.	O	.	_	0	SENT_46	[p2l1213t2716r1602b2797],

1	The	DT	O	the	det	6	SENT_47	[p2l99t2814r229b2875],
2	combination	NN	O	combination	nn	6	SENT_47	[p2l275t2814r713b2875],
3	phenotype	NN	O	phenotype	nn	6	SENT_47	[p2l756t2814r1497b2895],
4	—	CD	NUMBER	—	num	6	SENT_47	[p2l756t2814r1497b2895],
5	genotype	NN	O	genotype	nn	6	SENT_47	[p2l756t2814r1497b2895],
6	test	NN	O	test	_	0	SENT_47	[p2l1544t2822r1665b2875],
7	(	CD	NUMBER	(	num	9	SENT_47	[p2l1712t2814r2150b2890],
8	PhenoSense	NN	O	phenosense	nn	9	SENT_47	[p2l1712t2814r2150b2890],
9	GT	NN	O	gt	dep	6	SENT_47	[p2l10t2913r136b2982],
10	;	:	O	;	_	0	SENT_47	[p2l10t2913r136b2982],
11	Monogram	NNP	ORGANIZATION	Monogram	nn	12	SENT_47	[p2l180t2914r573b2993],
12	Biosciences	NNP	ORGANIZATION	Biosciences	dep	6	SENT_47	[p2l614t2914r1025b2982],
13	,	,	O	,	_	0	SENT_47	[p2l614t2914r1025b2982],
14	South	NNP	LOCATION	South	nn	16	SENT_47	[p2l1069t2911r1273b2972],
15	San	NNP	LOCATION	San	nn	16	SENT_47	[p2l1314t2913r1441b2972],
16	Francisco	NNP	LOCATION	Francisco	appos	12	SENT_47	[p2l1482t2914r1830b2982],
17	,	,	O	,	_	0	SENT_47	[p2l1482t2914r1830b2982],
18	CA	NNP	LOCATION	CA	nn	19	SENT_47	[p2l1873t2912r2013b2987],
19	)	NNP	O	)	appos	12	SENT_47	[p2l1873t2912r2013b2987],
20	includes	VBZ	O	include	rcmod	19	SENT_47	[p2l2058t2914r2150b2971, p2l11t3009r232b3069],
21	both	CC	O	both	preconj	19	SENT_47	[p2l256t3009r417b3069],
22	the	DT	O	the	det	25	SENT_47	[p2l442t3009r549b3069],
23	phenotypic	JJ	O	phenotypic	amod	25	SENT_47	[p2l574t3009r968b3090],
24	resistance	NN	O	resistance	nn	25	SENT_47	[p2l995t3012r1335b3069],
25	measure	NN	O	measure	conj	19	SENT_47	[p2l1361t3029r1656b3069],
26	and	CC	O	and	_	0	SENT_47	[p2l1683t3009r1814b3069],
27	a	DT	O	a	det	28	SENT_47	[p2l1841t3029r1877b3069],
28	prediction	NN	O	prediction	conj_and	25	SENT_47	[p2l1903t3009r2150b3090, p2l10t3108r147b3165],
29	of	IN	O	of	_	0	SENT_47	[p2l172t3105r241b3166],
30	the	DT	O	the	det	31	SENT_47	[p2l264t3105r371b3165],
31	susceptibility	NN	O	susceptibility	prep_of	28	SENT_47	[p2l397t3105r861b3186],
32	of	IN	O	of	_	0	SENT_47	[p2l887t3105r956b3165],
33	the	DT	O	the	det	34	SENT_47	[p2l979t3105r1085b3165],
34	isolate	NN	O	isolate	prep_of	31	SENT_47	[p2l1111t3105r1335b3166],
35	based	VBN	O	base	partmod	34	SENT_47	[p2l1358t3105r1562b3165],
36	on	IN	O	on	_	0	SENT_47	[p2l1588t3125r1676b3166],
37	its	PRP$	O	its	poss	38	SENT_47	[p2l1700t3108r1779b3165],
38	genotype	NN	O	genotype	prep_on	35	SENT_47	[p2l1806t3113r2146b3186],
39	.	.	O	.	_	0	SENT_47	[p2l1806t3113r2146b3186],

1	The	DT	O	the	det	2	SENT_48	[p2l10t3203r139b3263],
2	analysis	NN	O	analysis	nsubjpass	8	SENT_48	[p2l169t3202r447b3284],
3	presented	VBN	O	present	partmod	2	SENT_48	[p2l475t3202r818b3284],
4	in	IN	O	in	_	0	SENT_48	[p2l846t3205r914b3262],
5	this	DT	O	this	det	6	SENT_48	[p2l940t3202r1065b3263],
6	report	NN	O	report	prep_in	3	SENT_48	[p2l1093t3211r1308b3284],
7	was	VBD	O	be	auxpass	8	SENT_48	[p2l1333t3223r1472b3263],
8	derived	VBN	O	derive	_	0	SENT_48	[p2l1501t3202r1768b3263],
9	from	IN	O	from	_	0	SENT_48	[p2l1796t3202r1965b3263],
10	7775	CD	DATE	7775	num	12	SENT_48	[p2l1994t3205r2148b3263],
11	clinical	JJ	O	clinical	amod	12	SENT_48	[p2l11t3301r255b3361],
12	isolates	NNS	O	isolate	prep_from	8	SENT_48	[p2l277t3301r533b3361],
13	with	IN	O	with	_	0	SENT_48	[p2l554t3301r716b3361],
14	matched	VBN	O	match	amod	18	SENT_48	[p2l737t3301r1038b3361],
15	genotypic	JJ	O	genotypic	nn	18	SENT_48	[p2l1061t3304r1404b3382],
16	and	CC	O	and	_	0	SENT_48	[p2l1428t3301r1559b3361],
17	phenotypic	JJ	O	phenotypic	nn	18	SENT_48	[p2l1580t3301r1975b3382],
18	data	NNS	O	datum	prep_with	8	SENT_48	[p2l1999t3301r2149b3361],
19	for	IN	O	for	_	0	SENT_48	[p2l10t3397r108b3458],
20	the	DT	DATE	the	det	21	SENT_48	[p2l137t3397r244b3457],
21	years	NNS	DATE	year	prep_for	18	SENT_48	[p2l271t3417r456b3478],
22	2006	CD	DATE	2006	tmod	21	SENT_48	[p2l485t3400r642b3458],
23	and	CC	DATE	and	_	0	SENT_48	[p2l673t3397r804b3457],
24	2008	CD	DATE	2008	tmod	21	SENT_48	[p2l832t3400r1007b3457],
25	.	.	O	.	_	0	SENT_48	[p2l832t3400r1007b3457],

1	To	TO	O	to	aux	3	SENT_49	[p2l1040t3399r1129b3458],
2	be	VB	O	be	auxpass	3	SENT_49	[p2l1155t3397r1237b3457],
3	included	VBN	O	include	purpcl	11	SENT_49	[p2l1266t3397r1571b3458],
4	in	IN	O	in	_	0	SENT_49	[p2l1600t3400r1668b3456],
5	this	DT	O	this	det	6	SENT_49	[p2l1696t3397r1820b3458],
6	analysis	NN	O	analysis	prep_in	3	SENT_49	[p2l1851t3397r2149b3478],
7	,	,	O	,	_	0	SENT_49	[p2l1851t3397r2149b3478],
8	each	DT	O	each	det	9	SENT_49	[p2l11t3494r168b3555],
9	isolate	NN	O	isolate	nsubjpass	11	SENT_49	[p2l189t3495r412b3555],
10	was	VBD	O	be	auxpass	11	SENT_49	[p2l434t3515r573b3555],
11	required	VBN	O	require	_	0	SENT_49	[p2l595t3495r892b3576],
12	to	TO	O	to	aux	13	SENT_49	[p2l915t3503r981b3555],
13	show	VB	O	show	xcomp	11	SENT_49	[p2l1006t3494r1192b3555],
14	reduced	VBN	O	reduce	dep	13	SENT_49	[p2l1214t3495r1497b3555],
15	susceptibility	NN	O	susceptibility	dobj	14	SENT_49	[p2l1521t3494r1984b3576],
16	[	CD	NUMBER	[	num	15	SENT_49	[p2l2011t3494r2149b3568],
17	i.e.	FW	O	i.e.	dep	15	SENT_49	[p2l2011t3494r2149b3568],
18	,	,	O	,	_	0	SENT_49	[p2l2011t3494r2149b3568],
19	partially	RB	O	partially	advmod	20	SENT_49	[p2l9t3592r305b3673],
20	susceptible	JJ	O	susceptible	amod	21	SENT_49	[p2l324t3592r708b3673],
21	(	NN	O	(	conj_or	15	SENT_49	[p2l730t3592r863b3668],
22	PS	NNP	O	PS	dep	21	SENT_49	[p2l730t3592r863b3668],
23	)	CD	NUMBER	)	num	22	SENT_49	[p2l730t3592r863b3668],
24	or	CC	O	or	_	0	SENT_49	[p2l885t3612r957b3652],
25	resistant	JJ	O	resistant	amod	27	SENT_49	[p2l974t3595r1269b3652],
26	(	NN	O	(	nn	27	SENT_49	[p2l1290t3592r1411b3668],
27	R	NN	O	r	conj_or	15	SENT_49	[p2l1290t3592r1411b3668],
28	)	CD	NUMBER	)	num	29	SENT_49	[p2l1290t3592r1411b3668],
29	]	NN	O	]	dep	27	SENT_49	[p2l1290t3592r1411b3668],
30	to	TO	O	to	_	0	SENT_49	[p2l1434t3600r1500b3652],
31	at	IN	O	at	quantmod	33	SENT_49	[p2l1520t3600r1583b3652],
32	least	JJS	O	least	mwe	31	SENT_49	[p2l1600t3592r1759b3652],
33	one	CD	TIME	one	prep_to	14	SENT_49	[p2l1777t3612r1901b3652],
34	of	IN	TIME	of	_	0	SENT_49	[p2l1920t3591r1989b3652],
35	four	CD	TIME	four	num	37	SENT_49	[p2l2004t3591r2150b3652],
36	first-generation	JJ	O	first-generation	amod	37	SENT_49	[p2l10t3688r548b3769],
37	PIs	NNS	O	pi	prep_of	33	SENT_49	[p2l576t3690r697b3748],
38	.	.	O	.	_	0	SENT_49	[p2l576t3690r697b3748],

1	The	DT	O	the	det	2	SENT_50	[p2l729t3688r859b3748],
2	dataset	NN	O	dataset	nsubjpass	4	SENT_50	[p2l888t3688r1136b3749],
3	was	VBD	O	be	auxpass	4	SENT_50	[p2l1163t3708r1301b3749],
4	queried	VBN	O	query	_	0	SENT_50	[p2l1331t3688r1596b3769],
5	to	TO	O	to	aux	6	SENT_50	[p2l1625t3696r1691b3749],
6	see	VB	O	see	xcomp	4	SENT_50	[p2l1720t3708r1825b3749],
7	what	WP	O	what	dep	8	SENT_50	[p2l1852t3688r2031b3748],
8	resistance	NN	O	resistance	dep	6	SENT_50	[p2l2058t3708r2150b3748, p3l11t18r282b76],

1	patterns	NNS	O	pattern	nsubjpass	3	SENT_51	[p3l329t24r615b97],
2	were	VBD	O	be	auxpass	3	SENT_51	[p3l663t35r834b76],
3	observed	VBN	O	observe	_	0	SENT_51	[p3l884t15r1201b76],
4	and	CC	O	and	_	0	SENT_51	[p3l1251t15r1381b75],
5	how	WRB	O	how	advmod	10	SENT_51	[p3l1429t15r1584b76],
6	those	DT	O	those	det	7	SENT_51	[p3l1633t15r1816b76],
7	patterns	NNS	O	pattern	nsubj	10	SENT_51	[p3l1864t23r2149b97],
8	might	MD	O	might	aux	10	SENT_51	[p3l10t113r218b194],
9	have	VB	O	have	aux	10	SENT_51	[p3l241t113r408b173],
10	changed	VBN	O	change	conj_and	3	SENT_51	[p3l434t113r728b194],
11	during	IN	O	during	_	0	SENT_51	[p3l755t113r992b194],
12	that	DT	O	that	det	13	SENT_51	[p3l1016t113r1153b173],
13	timeframe	NN	O	timeframe	prep_during	10	SENT_51	[p3l1177t112r1552b173],
14	.	.	O	.	_	0	SENT_51	[p3l1177t112r1552b173],

1	Darunavir	NNP	O	Darunavir	nsubjpass	12	SENT_52	[p3l100t211r463b269],
2	(	CD	NUMBER	(	num	4	SENT_52	[p3l499t209r716b285],
3	DRV	NN	O	drv	nn	4	SENT_52	[p3l499t209r716b285],
4	)	NN	O	)	dep	1	SENT_52	[p3l499t209r716b285],
5	and	CC	O	and	_	0	SENT_52	[p3l754t209r884b269],
6	tipranavir	NN	O	tipranavir	nn	9	SENT_52	[p3l919t212r1269b290],
7	(	CD	NUMBER	(	num	9	SENT_52	[p3l1306t209r1503b285],
8	TPV	NN	O	tpv	nn	9	SENT_52	[p3l1306t209r1503b285],
9	)	NN	O	)	nsubjpass	12	SENT_52	[p3l1306t209r1503b285],
10	were	VBD	O	be	auxpass	12	SENT_52	[p3l1538t229r1710b270],
11	both	DT	O	both	dep	12	SENT_52	[p3l1741t209r1903b269],
12	developed	VBN	O	develop	_	0	SENT_52	[p3l1936t209r2150b270, p3l11t307r184b389],
13	as	IN	O	as	_	0	SENT_52	[p3l212t327r281b368],
14	agents	NNS	O	agent	prep_as	12	SENT_52	[p3l309t315r532b389],
15	capable	JJ	O	capable	amod	14	SENT_52	[p3l559t307r824b389],
16	of	IN	O	of	_	0	SENT_52	[p3l851t307r920b368],
17	treating	VBG	O	treat	prepc_of	15	SENT_52	[p3l942t310r1214b389],
18	patients	NNS	O	patient	dobj	17	SENT_52	[p3l1238t310r1516b389],
19	who	WP	O	who	nsubj	21	SENT_52	[p3l1541t307r1695b368],
20	already	RB	O	already	advmod	21	SENT_52	[p3l1723t307r1984b389],
21	harbored	VBD	O	harbor	rcmod	18	SENT_52	[p3l2008t307r2150b367, p3l8t405r212b465],
22	resistance	NN	O	resistance	dobj	21	SENT_52	[p3l251t408r591b465],
23	to	TO	O	to	_	0	SENT_52	[p3l630t413r696b465],
24	one	CD	NUMBER	one	num	27	SENT_52	[p3l736t425r859b465],
25	or	CC	O	or	_	0	SENT_52	[p3l899t425r971b465],
26	more	JJR	O	more	num	27	SENT_52	[p3l1008t425r1188b465],
27	Pls	NNS	O	pl	prep_to	21	SENT_52	[p3l1226t407r1348b465],
28	.	.	O	.	_	0	SENT_52	[p3l1226t407r1348b465],

1	The	DT	O	the	det	2	SENT_53	[p3l1390t405r1520b465],
2	objectives	NNS	O	objective	nsubj	7	SENT_53	[p3l1559t405r1898b486],
3	of	IN	O	of	_	0	SENT_53	[p3l1939t404r2008b465],
4	the	DT	O	the	det	6	SENT_53	[p3l2043t405r2150b465],
5	present	JJ	DATE	present	amod	6	SENT_53	[p3l9t511r268b584],
6	study	NN	O	study	prep_of	2	SENT_53	[p3l305t503r502b584],
7	were	VBD	O	be	_	0	SENT_53	[p3l536t523r708b564],
8	to	TO	O	to	aux	9	SENT_53	[p3l745t511r811b563],
9	identify	VB	O	identify	ccomp	7	SENT_53	[p3l848t503r1120b584],
10	patterns	NNS	O	pattern	dobj	9	SENT_53	[p3l1155t511r1440b584],
11	of	IN	O	of	_	0	SENT_53	[p3l1479t503r1548b564],
12	phenotypic	JJ	O	phenotypic	amod	13	SENT_53	[p3l1580t503r1975b584],
13	susceptibility	NN	O	susceptibility	prep_of	10	SENT_53	[p3l2013t523r2150b564, p3l11t600r360b682],
14	to	TO	O	to	_	0	SENT_53	[p3l385t609r451b661],
15	TPV	NN	O	tpv	prep_to	9	SENT_53	[p3l478t602r630b660],
16	and	CC	O	and	_	0	SENT_53	[p3l656t600r787b660],
17	DRV	NN	O	drv	conj_and	15	SENT_53	[p3l813t603r984b660],
18	in	IN	O	in	_	0	SENT_53	[p3l1009t603r1077b659],
19	this	DT	O	this	det	21	SENT_53	[p3l1101t600r1226b661],
20	commercial	NN	O	commercial	nn	21	SENT_53	[p3l1253t600r1659b661],
21	database	NN	O	database	prep_in	9	SENT_53	[p3l1685t600r1992b661],
22	and	CC	O	and	_	0	SENT_53	[p3l2018t600r2149b660],
23	to	TO	O	to	aux	24	SENT_53	[p3l10t706r76b758],
24	identify	VB	O	identify	ccomp	7	SENT_53	[p3l104t697r376b779],
25	amino	NN	O	amino	nn	27	SENT_53	[p3l403t701r621b758],
26	acid	NN	O	acid	nn	27	SENT_53	[p3l650t698r792b758],
27	substitutions	NNS	O	substitution	dobj	24	SENT_53	[p3l820t698r1268b758],
28	associated	VBN	O	associate	partmod	27	SENT_53	[p3l1297t698r1654b758],
29	with	IN	O	with	_	0	SENT_53	[p3l1680t698r1842b758],
30	samples	NNS	O	sample	prep_with	28	SENT_53	[p3l1868t698r2149b779],
31	having	VBG	O	have	partmod	30	SENT_53	[p3l9t796r252b877],
32	divergent	JJ	O	divergent	amod	34	SENT_53	[p3l308t796r644b877],
33	phenotypic	JJ	O	phenotypic	amod	34	SENT_53	[p3l696t796r1090b877],
34	susceptibility	NN	O	susceptibility	dobj	31	SENT_53	[p3l1146t796r1609b877],
35	to	TO	O	to	_	0	SENT_53	[p3l1663t804r1729b857],
36	these	DT	O	these	det	38	SENT_53	[p3l1784t796r1962b857],
37	two	CD	NUMBER	two	num	38	SENT_53	[p3l2016t804r2149b857],
38	agents	NNS	O	agent	prep_to	34	SENT_53	[p3l11t901r251b975],
39	.	.	O	.	_	0	SENT_53	[p3l11t901r251b975],

1	These	DT	O	these	det	2	SENT_54	[p3l290t893r491b954],
2	findings	NNS	O	finding	nsubj	3	SENT_54	[p3l525t893r811b975],
3	add	VBP	O	add	_	0	SENT_54	[p3l848t893r981b953],
4	new	JJ	O	new	amod	5	SENT_54	[p3l1015t913r1163b954],
5	insights	NNS	O	insight	dobj	3	SENT_54	[p3l1199t893r1470b975],
6	for	IN	O	for	_	0	SENT_54	[p3l1505t893r1604b954],
7	clinicians	NNS	O	clinician	prep_for	3	SENT_54	[p3l1638t893r1961b954],
8	who	WP	O	who	nsubjpass	10	SENT_54	[p3l1995t893r2150b954],
9	are	VBP	O	be	auxpass	10	SENT_54	[p3l11t1011r116b1051],
10	faced	VBN	O	face	rcmod	7	SENT_54	[p3l151t990r335b1051],
11	with	IN	O	with	_	0	SENT_54	[p3l368t991r530b1051],
12	difficult	JJ	O	difficult	amod	14	SENT_54	[p3l564t990r837b1051],
13	therapeutic	JJ	O	therapeutic	amod	14	SENT_54	[p3l871t991r1265b1072],
14	decisions	NNS	O	decision	prep_with	10	SENT_54	[p3l1301t991r1619b1051],
15	for	IN	O	for	_	0	SENT_54	[p3l1654t990r1752b1051],
16	treatmentexperienced	JJ	O	treatmentexperienced	amod	17	SENT_54	[p3l1786t999r2150b1051, p3l11t1087r425b1168],
17	patients	NNS	O	patient	prep_for	14	SENT_54	[p3l445t1090r739b1168],
18	,	,	O	,	_	0	SENT_54	[p3l445t1090r739b1168],
19	specifically	RB	O	specifically	advmod	7	SENT_54	[p3l761t1087r1145b1168],
20	those	DT	O	those	dep	7	SENT_54	[p3l1165t1087r1347b1147],
21	with	IN	O	with	_	0	SENT_54	[p3l1366t1087r1526b1147],
22	PI	NN	O	pi	nn	25	SENT_54	[p3l1545t1089r1936b1148],
23	—	NN	O	—	nn	25	SENT_54	[p3l1545t1089r1936b1148],
24	resistant	JJ	O	resistant	amod	25	SENT_54	[p3l1545t1089r1936b1148],
25	virus	NN	O	virus	prep_with	20	SENT_54	[p3l1953t1090r2147b1147],
26	.	.	O	.	_	0	SENT_54	[p3l1953t1090r2147b1147],

1	Materials	NNPS	O	Materials	_	0	SENT_55	[p3l14t1283r354b1343],
2	and	CC	O	and	_	0	SENT_55	[p3l385t1284r521b1343],
3	Methods	NNS	O	method	conj_and	1	SENT_55	[p3l558t1284r881b1343],

1	Laboratory	NNP	O	Laboratory	nn	2	SENT_56	[p3l15t1431r399b1506],
2	methods	NNS	O	method	_	0	SENT_56	[p3l423t1431r728b1490],

1	Assays	NNS	O	assay	nsubjpass	9	SENT_57	[p3l99t1578r348b1658],
2	for	IN	O	for	_	0	SENT_57	[p3l377t1576r477b1637],
3	phenotypic	JJ	O	phenotypic	amod	7	SENT_57	[p3l503t1576r905b1658],
4	and	CC	O	and	_	0	SENT_57	[p3l935t1576r1067b1636],
5	genotypic	JJ	O	genotypic	conj_and	3	SENT_57	[p3l1098t1579r1447b1658],
6	drug	NN	O	drug	nn	7	SENT_57	[p3l1477t1576r1648b1658],
7	susceptibility	NN	O	susceptibility	prep_for	1	SENT_57	[p3l1677t1576r2150b1658],
8	were	VBD	O	be	auxpass	9	SENT_57	[p3l9t1693r183b1733],
9	performed	VBN	O	perform	conj_and	9	SENT_57	[p3l227t1673r605b1754],
10	at	IN	O	at	_	0	SENT_57	[p3l652t1681r717b1733],
11	a	DT	O	a	det	13	SENT_57	[p3l762t1693r798b1733],
12	commercial	JJ	O	commercial	amod	13	SENT_57	[p3l845t1673r1259b1734],
13	laboratory	NN	O	laboratory	prep_at	9	SENT_57	[p3l1303t1673r1675b1754],
14	(	CD	NUMBER	(	num	16	SENT_57	[p3l1723t1673r2151b1754],
15	Monogram	NNP	ORGANIZATION	Monogram	nn	16	SENT_57	[p3l1723t1673r2151b1754],
16	Biosciences	NNP	ORGANIZATION	Biosciences	dobj	9	SENT_57	[p3l11t1773r431b1841],
17	,	,	O	,	_	0	SENT_57	[p3l11t1773r431b1841],
18	South	NNP	LOCATION	South	nn	20	SENT_57	[p3l467t1770r673b1831],
19	San	NNP	LOCATION	San	nn	20	SENT_57	[p3l707t1771r834b1831],
20	Francisco	NNP	LOCATION	Francisco	appos	16	SENT_57	[p3l867t1773r1222b1841],
21	,	,	O	,	_	0	SENT_57	[p3l867t1773r1222b1841],
22	CA	NNP	LOCATION	CA	nn	23	SENT_57	[p3l1257t1770r1421b1846],
23	)	NNP	O	)	appos	16	SENT_57	[p3l1257t1770r1421b1846],
24	,	,	O	,	_	0	SENT_57	[p3l1257t1770r1421b1846],
25	as	IN	O	as	mark	26	SENT_57	[p3l1457t1790r1527b1831],
26	described	VBN	O	describe	dep	16	SENT_57	[p3l1563t1770r1904b1831],
27	previously	RB	DATE	previously	advmod	26	SENT_57	[p3l1938t1773r2151b1852, p3l11t1854r344b1950],
28	.9	CD	DATE	.9	number	29	SENT_57	[p3l1938t1773r2151b1852, p3l11t1854r344b1950],
29	'11	CD	DATE	'11	num	31	SENT_57	[p3l1938t1773r2151b1852, p3l11t1854r344b1950],
30	Phenotypic	JJ	O	phenotypic	amod	31	SENT_57	[p3l372t1868r773b1950],
31	outcomes	NNS	O	outcome	dobj	26	SENT_57	[p3l800t1877r1139b1929],
32	were	VBD	O	be	auxpass	33	SENT_57	[p3l1163t1889r1337b1929],
33	categorized	VBN	O	categorize	rcmod	31	SENT_57	[p3l1363t1868r1774b1950],
34	according	VBG	O	accord	_	0	SENT_57	[p3l1801t1868r2151b1950],
35	to	TO	O	to	prepc_according_to	33	SENT_57	[p3l10t1973r77b2025],
36	previously	RB	DATE	previously	advmod	37	SENT_57	[p3l98t1965r481b2046],
37	established	VBN	O	establish	amod	38	SENT_57	[p3l502t1965r899b2026],
38	values	NNS	O	value	pobj	33	SENT_57	[p3l920t1965r1149b2026],
39	for	IN	O	for	_	0	SENT_57	[p3l1171t1965r1271b2025],
40	the	DT	O	the	det	46	SENT_57	[p3l1292t1965r1401b2025],
41	lower	JJR	O	lower	amod	46	SENT_57	[p3l1423t1965r1625b2026],
42	clinical	JJ	O	clinical	amod	46	SENT_57	[p3l1647t1965r1896b2026],
43	cut-off	JJ	O	cut-off	amod	46	SENT_57	[p3l1918t1965r2153b2026],
44	(	NN	O	(	nn	46	SENT_57	[p3l13t2062r229b2138],
45	LCO	NN	O	lco	nn	46	SENT_57	[p3l13t2062r229b2138],
46	)	NN	O	)	prep_for	9	SENT_57	[p3l13t2062r229b2138],
47	and	CC	O	and	_	0	SENT_57	[p3l255t2062r388b2122],
48	the	DT	O	the	det	53	SENT_57	[p3l411t2062r520b2123],
49	upper	JJ	O	upper	amod	53	SENT_57	[p3l543t2082r756b2144],
50	clinical	JJ	O	clinical	amod	53	SENT_57	[p3l779t2062r1030b2123],
51	cut-off	JJ	O	cut-off	amod	53	SENT_57	[p3l1053t2062r1287b2123],
52	(	NN	O	(	nn	53	SENT_57	[p3l1310t2048r1701b2138],
53	UCO	NN	ORGANIZATION	uco	prep_for	9	SENT_57	[p3l1310t2048r1701b2138],
54	)	CD	NUMBER	)	nsubjpass	81	SENT_57	[p3l1310t2048r1701b2138],
55	.12	CD	NUMBER	.12	number	56	SENT_57	[p3l1310t2048r1701b2138],
56	'13	CD	NUMBER	'13	num	58	SENT_57	[p3l1310t2048r1701b2138],
57	Each	DT	O	each	det	58	SENT_57	[p3l1725t2062r1896b2123],
58	cut-off	JJ	O	cut-off	nsubjpass	60	SENT_57	[p3l1918t2062r2153b2123],
59	was	VBD	O	be	auxpass	60	SENT_57	[p3l9t2180r149b2220],
60	derived	VBN	O	derive	rcmod	54	SENT_57	[p3l189t2159r460b2220],
61	by	IN	O	by	_	0	SENT_57	[p3l496t2159r586b2241],
62	analyses	NNS	O	analysis	agent	60	SENT_57	[p3l624t2159r922b2241],
63	of	IN	O	of	_	0	SENT_57	[p3l962t2159r1032b2220],
64	virologic	JJ	O	virologic	amod	65	SENT_57	[p3l1065t2159r1380b2241],
65	outcomes	NNS	O	outcome	prep_of	62	SENT_57	[p3l1419t2168r1758b2220],
66	in	IN	O	in	_	0	SENT_57	[p3l1796t2162r1864b2219],
67	clinical	JJ	O	clinical	amod	69	SENT_57	[p3l1901t2159r2151b2220],
68	trial	NN	O	trial	nn	69	SENT_57	[p3l10t2257r154b2316],
69	datasets	NNS	O	dataset	prep_in	65	SENT_57	[p3l178t2257r464b2317],
70	where	WRB	O	where	advmod	74	SENT_57	[p3l487t2256r708b2317],
71	the	DT	O	the	det	73	SENT_57	[p3l731t2257r840b2317],
72	specific	JJ	O	specific	amod	73	SENT_57	[p3l865t2256r1126b2338],
73	PI	NN	O	pi	nsubj	74	SENT_57	[p3l1150t2259r1222b2316],
74	boosted	VBD	O	boost	advcl	60	SENT_57	[p3l1243t2256r1524b2317],
75	with	IN	O	with	_	0	SENT_57	[p3l1547t2257r1711b2316],
76	ritonavir	NN	O	ritonavir	nn	79	SENT_57	[p3l1733t2259r2045b2317],
77	(	CD	NUMBER	(	num	79	SENT_57	[p3l2071t2257r2148b2332],
78	r	NN	O	r	nn	79	SENT_57	[p3l2071t2257r2148b2332],
79	)	NN	O	)	prep_with	74	SENT_57	[p3l2071t2257r2148b2332],
80	was	VBD	O	be	auxpass	81	SENT_57	[p3l9t2373r149b2414],
81	used	VBN	O	use	rcmod	53	SENT_57	[p3l183t2353r349b2414],
82	as	IN	O	as	_	0	SENT_57	[p3l384t2373r455b2414],
83	a	DT	O	a	det	85	SENT_57	[p3l490t2373r526b2413],
84	new	JJ	O	new	amod	85	SENT_57	[p3l559t2373r709b2414],
85	agent	NN	O	agent	prep_as	81	SENT_57	[p3l743t2362r939b2435],
86	and	CC	O	and	_	0	SENT_57	[p3l972t2353r1104b2413],
87	after	IN	O	after	_	0	SENT_57	[p3l1139t2353r1300b2414],
88	accounting	VBG	O	account	prepc_after	9	SENT_57	[p3l1334t2356r1725b2435],
89	for	IN	O	for	_	0	SENT_57	[p3l1758t2353r1857b2414],
90	the	DT	O	the	det	91	SENT_57	[p3l1890t2353r1999b2414],
91	impact	NN	O	impact	prep_for	88	SENT_57	[p3l2032t2356r2151b2412, p3l9t2459r160b2532],
92	of	IN	O	of	_	0	SENT_57	[p3l192t2450r262b2511],
93	background	NN	O	background	nn	94	SENT_57	[p3l287t2450r720b2532],
94	therapy	NN	O	therapy	prep_of	91	SENT_57	[p3l752t2450r1044b2532],
95	.	.	O	.	_	0	SENT_57	[p3l752t2450r1044b2532],

1	A	DT	O	a	det	2	SENT_58	[p3l1080t2452r1139b2510],
2	value	NN	O	value	nsubj	6	SENT_58	[p3l1170t2450r1365b2511],
3	below	IN	O	below	_	0	SENT_58	[p3l1394t2450r1612b2511],
4	the	DT	O	the	det	5	SENT_58	[p3l1644t2450r1752b2511],
5	LCO	NNP	O	LCO	prep_below	2	SENT_58	[p3l1784t2451r1952b2511],
6	indicates	VBZ	O	indicate	_	0	SENT_58	[p3l1984t2450r2151b2510, p3l11t2556r183b2608],
7	a	DT	O	a	det	12	SENT_58	[p3l207t2568r243b2607],
8	fully	RB	O	fully	advmod	11	SENT_58	[p3l267t2547r432b2629],
9	responsive	JJ	O	responsive	amod	11	SENT_58	[p3l454t2550r857b2629],
10	,	,	O	,	_	0	SENT_58	[p3l454t2550r857b2629],
11	susceptible	JJ	O	susceptible	amod	12	SENT_58	[p3l882t2547r1275b2629],
12	(	NN	O	(	dobj	6	SENT_58	[p3l1302t2548r1389b2624],
13	S	NN	O	s	prep	12	SENT_58	[p3l1302t2548r1389b2624],
14	)	NN	O	)	nn	15	SENT_58	[p3l1302t2548r1389b2624],
15	virus	NN	O	virus	dep	13	SENT_58	[p3l1413t2550r1612b2608],
16	.	.	O	.	_	0	SENT_58	[p3l1413t2550r1612b2608],

1	A	DT	O	a	det	2	SENT_59	[p3l1638t2549r1699b2607],
2	value	NN	O	value	nsubj	6	SENT_59	[p3l1721t2547r1916b2608],
3	above	IN	O	above	_	0	SENT_59	[p3l1940t2548r2151b2608],
4	the	DT	O	the	det	5	SENT_59	[p3l10t2644r119b2705],
5	UCO	NNP	ORGANIZATION	UCO	prep_above	2	SENT_59	[p3l156t2645r337b2705],
6	indicates	VBZ	O	indicate	_	0	SENT_59	[p3l375t2644r691b2705],
7	a	DT	O	a	det	11	SENT_59	[p3l730t2664r766b2704],
8	nonresponsive	JJ	O	nonresponsive	amod	11	SENT_59	[p3l804t2647r1346b2726],
9	,	,	O	,	_	0	SENT_59	[p3l804t2647r1346b2726],
10	R	NN	O	r	dep	11	SENT_59	[p3l1386t2647r1439b2703],
11	virus	NN	O	virus	dobj	6	SENT_59	[p3l1473t2647r1672b2705],
12	.	.	O	.	_	0	SENT_59	[p3l1473t2647r1672b2705],

1	A	DT	O	a	det	2	SENT_60	[p3l1714t2646r1774b2703],
2	value	NN	O	value	nsubj	9	SENT_60	[p3l1810t2644r2006b2705],
3	between	IN	O	between	_	0	SENT_60	[p3l2041t2644r2151b2705, p3l10t2750r226b2802],
4	the	DT	O	the	det	5	SENT_60	[p3l244t2741r352b2802],
5	LCD	NNS	O	lcd	prep_between	2	SENT_60	[p3l371t2742r538b2802],
6	and	CC	O	and	_	0	SENT_60	[p3l557t2741r690b2801],
7	the	DT	O	the	det	8	SENT_60	[p3l709t2741r818b2802],
8	UCO	NNP	ORGANIZATION	UCO	prep_between	2	SENT_60	[p3l836t2742r1017b2802],
9	indicates	VBZ	O	indicate	_	0	SENT_60	[p3l1036t2741r1350b2802],
10	a	DT	O	a	det	16	SENT_60	[p3l1371t2762r1407b2801],
11	partially	RB	O	partially	advmod	12	SENT_60	[p3l1425t2741r1729b2823],
12	responsive	JJ	O	responsive	amod	16	SENT_60	[p3l1746t2744r2149b2823],
13	,	,	O	,	_	0	SENT_60	[p3l1746t2744r2149b2823],
14	partially	RB	O	partially	advmod	15	SENT_60	[p3l9t2839r312b2920],
15	susceptible	JJ	O	susceptible	amod	16	SENT_60	[p3l354t2838r747b2920],
16	virus	NN	O	virus	dobj	9	SENT_60	[p3l787t2841r986b2899],
17	.	.	O	.	_	0	SENT_60	[p3l787t2841r986b2899],

1	Values	NNS	O	value	nsubj	7	SENT_61	[p3l1031t2839r1273b2899],
2	between	IN	O	between	_	0	SENT_61	[p3l1313t2838r1616b2899],
3	the	DT	O	the	det	4	SENT_61	[p3l1656t2838r1765b2899],
4	LCO	NN	O	lco	prep_between	1	SENT_61	[p3l1807t2840r1974b2899],
5	and	CC	O	and	_	0	SENT_61	[p3l2017t2838r2150b2898],
6	UCO	NN	ORGANIZATION	uco	prep_between	1	SENT_61	[p3l10t2936r190b2996],
7	demonstrate	VBP	O	demonstrate	_	0	SENT_61	[p3l214t2935r659b2996],
8	residual	JJ	O	residual	amod	10	SENT_61	[p3l681t2935r968b2996],
9	drug	NN	O	drug	nn	10	SENT_61	[p3l991t2935r1162b3017],
10	activity	NN	O	activity	dobj	7	SENT_61	[p3l1184t2938r1450b3017],
11	that	WDT	O	that	nsubj	12	SENT_61	[p3l1471t2935r1609b2995],
12	diminishes	VBZ	O	diminish	rcmod	10	SENT_61	[p3l1632t2935r2019b2996],
13	the	DT	O	the	det	14	SENT_61	[p3l2041t2935r2150b2996],
14	closer	JJR	O	closer	dobj	12	SENT_61	[p3l11t3032r215b3093],
15	the	DT	O	the	det	20	SENT_61	[p3l240t3032r349b3093],
16	fold-change	JJ	O	fold-change	amod	20	SENT_61	[p3l375t3032r795b3114],
17	(	CD	NUMBER	(	num	20	SENT_61	[p3l824t3032r971b3108],
18	FC	NN	O	fc	nn	20	SENT_61	[p3l824t3032r971b3108],
19	)	NN	O	)	nn	20	SENT_61	[p3l824t3032r971b3108],
20	value	NN	O	value	nsubj	21	SENT_61	[p3l998t3032r1193b3093],
21	is	VBZ	O	be	rcmod	14	SENT_61	[p3l1219t3035r1272b3093],
22	to	TO	O	to	_	0	SENT_61	[p3l1298t3041r1365b3093],
23	the	DT	O	the	det	24	SENT_61	[p3l1392t3032r1499b3093],
24	UCO	NNP	ORGANIZATION	UCO	prep_to	21	SENT_61	[p3l1524t3033r1722b3093],
25	.	.	O	.	_	0	SENT_61	[p3l1524t3033r1722b3093],

1	For	IN	O	for	_	0	SENT_62	[p3l1752t3035r1870b3093],
2	TPV/r	NN	O	tpv/r	prep_for	8	SENT_62	[p3l1895t3032r2149b3103],
3	,	,	O	,	_	0	SENT_62	[p3l1895t3032r2149b3103],
4	the	DT	O	the	det	5	SENT_62	[p3l10t3130r119b3191],
5	LCD	NNS	O	lcd	nsubj	8	SENT_62	[p3l158t3132r324b3191],
6	is	VBZ	O	be	cop	8	SENT_62	[p3l364t3133r417b3191],
7	2	CD	NUMBER	2	num	8	SENT_62	[p3l457t3133r494b3190],
8	FC	NN	ORGANIZATION	fc	_	0	SENT_62	[p3l534t3132r631b3191],
9	and	CC	O	and	_	0	SENT_62	[p3l673t3131r805b3190],
10	the	DT	O	the	det	11	SENT_62	[p3l845t3131r953b3191],
11	UCO	NNP	ORGANIZATION	UCO	nsubj	14	SENT_62	[p3l992t3132r1172b3191],
12	is	VBZ	O	be	cop	14	SENT_62	[p3l1212t3133r1266b3191],
13	8	CD	NUMBER	8	num	14	SENT_62	[p3l1306t3133r1341b3191],
14	FC	NN	ORGANIZATION	fc	conj_and	8	SENT_62	[p3l1382t3116r1641b3191],
15	.12	CD	NUMBER	.12	number	16	SENT_62	[p3l1382t3116r1641b3191],
16	’13	CD	NUMBER	’13	num	14	SENT_62	[p3l1382t3116r1641b3191],
17	Similarly	RB	O	similarly	advmod	14	SENT_62	[p3l1681t3130r2004b3212],
18	the	DT	O	the	det	20	SENT_62	[p3l2041t3131r2150b3191],
19	following	VBG	O	follow	amod	20	SENT_62	[p3l10t3229r353b3311],
20	LCO/UCO	NN	O	lco/uco	nsubjpass	22	SENT_62	[p3l378t3229r779b3298],
21	was	VBD	O	be	auxpass	22	SENT_62	[p3l803t3250r944b3290],
22	used	VBN	O	use	rcmod	14	SENT_62	[p3l970t3229r1136b3290],
23	for	IN	O	for	_	0	SENT_62	[p3l1163t3229r1263b3290],
24	this	DT	O	this	det	25	SENT_62	[p3l1288t3229r1416b3290],
25	analysis	NN	O	analysis	prep_for	22	SENT_62	[p3l1442t3229r1745b3311],
26	:	:	O	:	_	0	SENT_62	[p3l1442t3229r1745b3311],
27	atazanavir	NN	O	atazanavir	dep	25	SENT_62	[p3l1775t3232r2151b3289],
28	(	CD	NUMBER	(	num	27	SENT_62	[p3l13t3326r229b3402],
29	ATV	NN	O	atv	dep	27	SENT_62	[p3l13t3326r229b3402],
30	)	CD	NUMBER	)	num	29	SENT_62	[p3l13t3326r229b3402],
31	/	:	O	/	punct	32	SENT_62	[p3l239t3326r274b3395],
32	r	NN	O	r	dep	29	SENT_62	[p3l283t3347r312b3385],
33	at	IN	O	at	_	0	SENT_62	[p3l352t3335r417b3386],
34	5.2	CD	NUMBER	5.2	prep_at	32	SENT_62	[p3l455t3326r706b3397],
35	/	:	O	/	punct	32	SENT_62	[p3l455t3326r706b3397],
36	30	CD	NUMBER	30	dep	29	SENT_62	[p3l455t3326r706b3397],
37	,	,	O	,	_	0	SENT_62	[p3l455t3326r706b3397],
38	lopinavir	JJ	O	lopinavir	amod	40	SENT_62	[p3l746t3326r1072b3408],
39	(	NN	O	(	nn	40	SENT_62	[p3l1114t3326r1316b3402],
40	LPV	NN	O	lpv	dep	14	SENT_62	[p3l1114t3326r1316b3402],
41	)	CD	NUMBER	)	dep	40	SENT_62	[p3l1114t3326r1316b3402],
42	/	:	O	/	punct	40	SENT_62	[p3l1326t3326r1361b3395],
43	r	NN	O	r	dep	40	SENT_62	[p3l1371t3347r1400b3385],
44	at	IN	O	at	_	0	SENT_62	[p3l1439t3335r1504b3386],
45	9/55	CD	NUMBER	9/55	prep_at	43	SENT_62	[p3l1542t3326r1731b3397],
46	,	,	O	,	_	0	SENT_62	[p3l1542t3326r1731b3397],
47	saquinavir	NN	O	saquinavir	appos	45	SENT_62	[p3l1773t3329r2151b3408],
48	(	CD	NUMBER	(	num	47	SENT_62	[p3l13t3423r269b3500],
49	SQV	NN	O	sqv	dep	47	SENT_62	[p3l13t3423r269b3500],
50	)	CD	NUMBER	)	num	49	SENT_62	[p3l13t3423r269b3500],
51	/	:	O	/	punct	40	SENT_62	[p3l13t3423r269b3500],
52	r	NN	O	r	dep	40	SENT_62	[p3l279t3444r307b3483],
53	at	IN	O	at	_	0	SENT_62	[p3l356t3432r420b3483],
54	2.3	CD	NUMBER	2.3	prep_at	52	SENT_62	[p3l467t3423r717b3494],
55	/	:	O	/	punct	52	SENT_62	[p3l467t3423r717b3494],
56	12	CD	NUMBER	12	dep	52	SENT_62	[p3l467t3423r717b3494],
57	,	,	O	,	_	0	SENT_62	[p3l467t3423r717b3494],
58	fosamprenavir	NN	O	fosamprenavir	dep	56	SENT_62	[p3l766t3423r1288b3505],
59	(	CD	NUMBER	(	num	58	SENT_62	[p3l1338t3424r1536b3499],
60	FPV	NN	O	fpv	dep	58	SENT_62	[p3l1338t3424r1536b3499],
61	)	CD	NUMBER	)	num	60	SENT_62	[p3l1338t3424r1536b3499],
62	/	:	O	/	punct	58	SENT_62	[p3l1546t3423r1581b3492],
63	r	NN	O	r	dep	58	SENT_62	[p3l1590t3444r1619b3483],
64	at	IN	O	at	_	0	SENT_62	[p3l1668t3432r1732b3483],
65	4/11	CD	NUMBER	4/11	prep_at	63	SENT_62	[p3l1777t3423r1968b3495],
66	,	,	O	,	_	0	SENT_62	[p3l1777t3423r1968b3495],
67	and	CC	O	and	_	0	SENT_62	[p3l2017t3424r2150b3483],
68	DRV/r14	NN	O	drv/r14	dep	52	SENT_62	[p3l10t3506r325b3589],
69	at	IN	O	at	_	0	SENT_62	[p3l352t3529r417b3581],
70	10/90	CD	NUMBER	10/90	prep_at	68	SENT_62	[p3l445t3520r669b3589],
71	.	.	O	.	_	0	SENT_62	[p3l445t3520r669b3589],

1	The	DT	O	the	det	3	SENT_63	[p3l698t3521r830b3581],
2	selection	NN	O	selection	nn	3	SENT_63	[p3l857t3521r1166b3581],
3	criteria	NNS	O	criterion	nsubj	7	SENT_63	[p3l1191t3524r1438b3581],
4	for	IN	O	for	_	0	SENT_63	[p3l1466t3520r1565b3581],
5	this	DT	O	this	det	6	SENT_63	[p3l1591t3521r1718b3581],
6	analysis	NN	O	analysis	prep_for	3	SENT_63	[p3l1745t3521r2031b3602],
7	included	VBD	O	include	_	0	SENT_63	[p3l2057t3524r2151b3580, p3l11t3618r252b3678],
8	any	DT	O	any	det	9	SENT_63	[p3l277t3638r406b3699],
9	specimen	NN	O	specimen	dobj	7	SENT_63	[p3l430t3620r764b3699],
10	with	IN	O	with	_	0	SENT_63	[p3l785t3618r949b3677],
11	>	JJR	O	>	amod	12	SENT_63	[p3l984t3634r1025b3676],
12	LCD	NNS	O	lcd	prep_with	7	SENT_63	[p3l1043t3619r1209b3678],
13	for	IN	O	for	_	0	SENT_63	[p3l1234t3617r1334b3678],
14	at	IN	O	at	quantmod	16	SENT_63	[p3l1358t3626r1422b3677],
15	least	JJS	O	least	mwe	14	SENT_63	[p3l1445t3618r1606b3678],
16	one	CD	NUMBER	one	prep_for	7	SENT_63	[p3l1629t3638r1755b3678],
17	of	IN	O	of	_	0	SENT_63	[p3l1780t3617r1849b3678],
18	the	DT	O	the	det	21	SENT_63	[p3l1870t3617r1978b3678],
19	four	CD	NUMBER	four	num	21	SENT_63	[p3l2002t3617r2150b3678],
20	first-generation	JJ	O	first-generation	amod	21	SENT_63	[p3l10t3714r560b3796],
21	Pls	NNS	O	pl	prep_of	16	SENT_63	[p3l580t3717r687b3775],
22	or	CC	O	or	_	0	SENT_63	[p3l711t3735r783b3775],
23	for	IN	O	for	_	0	SENT_63	[p3l806t3714r905b3775],
24	DRV	NN	O	drv	prep_for	7	SENT_63	[p3l927t3717r1116b3774],
25	.	.	O	.	_	0	SENT_63	[p3l927t3717r1116b3774],

1	Exactly	RB	O	exactly	advmod	2	SENT_64	[p3l1142t3714r1403b3796],
2	1	CD	NUMBER	1	nsubj	9	SENT_64	[p3l1427t3717r1457b3774],
3	of	IN	O	of	_	0	SENT_64	[p3l1485t3714r1555b3775],
4	the	DT	O	the	det	6	SENT_64	[p3l1574t3714r1682b3775],
5	7775	CD	DATE	7775	num	6	SENT_64	[p3l1707t3717r1863b3775],
6	isolates	NNS	O	isolate	prep_of	2	SENT_64	[p3l1887t3715r2149b3775],
7	qualified	VBN	O	qualify	amod	6	SENT_64	[p4l11t14r345b96],
8	,	,	O	,	_	0	SENT_64	[p4l11t14r345b96],
9	based	VBN	O	base	_	0	SENT_64	[p4l378t15r585b75],
10	on	IN	O	on	_	0	SENT_64	[p4l620t35r708b75],
11	susceptibility	NN	O	susceptibility	prep_on	9	SENT_64	[p4l742t15r1215b96],
12	to	TO	O	to	_	0	SENT_64	[p4l1249t23r1316b75],
13	DRV	NN	O	drv	prep_to	9	SENT_64	[p4l1350t17r1523b75],
14	and	CC	O	and	_	0	SENT_64	[p4l1557t15r1690b75],
15	all	PDT	O	all	predet	18	SENT_64	[p4l1725t15r1809b75],
16	the	DT	O	the	det	18	SENT_64	[p4l1842t15r1951b75],
17	firstgeneration	NN	O	firstgeneration	nn	18	SENT_64	[p4l1985t14r2150b75, p4l11t114r391b192],
18	PIS	NN	O	pi	conj_and	13	SENT_64	[p4l415t114r539b171],
19	.	.	O	.	_	0	SENT_64	[p4l415t114r539b171],

1	BETHELL	NNP	PERSON	BETHELL	nn	3	SENT_65	[p4l1500t235r1863b293],
2	ET	NNP	O	ET	nn	3	SENT_65	[p4l1898t235r1995b293],
3	AL.	NNP	O	AL.	_	0	SENT_65	[p4l2024t235r2148b293],
4	.	.	O	.	_	0	SENT_65	[p4l2024t235r2148b293],

1	Genotypic	JJ	O	genotypic	amod	2	SENT_66	[p4l97t449r459b530],
2	characterization	NN	O	characterization	nsubjpass	4	SENT_66	[p4l488t448r1049b509],
3	was	VBD	O	be	auxpass	4	SENT_66	[p4l1075t469r1214b509],
4	made	VBN	O	make	_	0	SENT_66	[p4l1242t448r1436b509],
5	using	VBG	O	use	xcomp	4	SENT_66	[p4l1464t451r1657b530],
6	pol	NN	O	pol	nn	8	SENT_66	[p4l1682t448r1778b529],
7	genotypic	JJ	O	genotypic	amod	8	SENT_66	[p4l1807t451r2150b530],
8	data	NNS	O	datum	dobj	5	SENT_66	[p4l9t531r160b590],
9	derived	VBN	O	derive	partmod	8	SENT_66	[p4l191t531r458b591],
10	from	IN	O	from	_	0	SENT_66	[p4l488t530r658b591],
11	the	DT	O	the	det	14	SENT_66	[p4l686t531r792b591],
12	same	JJ	O	same	amod	14	SENT_66	[p4l823t551r1002b591],
13	test	NN	O	test	nn	14	SENT_66	[p4l1031t539r1152b591],
14	vector	NN	O	vector	prep_from	9	SENT_66	[p4l1179t539r1397b591],
15	used	VBN	O	use	partmod	14	SENT_66	[p4l1426t531r1590b591],
16	to	TO	O	to	aux	17	SENT_66	[p4l1620t539r1687b591],
17	generate	VB	O	generate	xcomp	15	SENT_66	[p4l1717t539r2014b612],
18	the	DT	O	the	det	20	SENT_66	[p4l2044t530r2151b591],
19	phenogrpic	JJ	O	phenogrpic	amod	20	SENT_66	[p4l7t628r402b770],
20	data	NNS	O	datum	dobj	17	SENT_66	[p4l434t628r602b688],
21	.	.	O	.	_	0	SENT_66	[p4l434t628r602b688],

1	Genotypic	JJ	O	genotypic	amod	3	SENT_67	[p4l637t629r998b710],
2	resistance	NN	O	resistance	nn	3	SENT_67	[p4l1029t631r1369b689],
3	calls	NNS	O	call	nsubj	6	SENT_67	[p4l1400t628r1551b689],
4	used	VBN	O	use	partmod	3	SENT_67	[p4l1582t628r1746b689],
5	previously	RB	DATE	previously	advmod	4	SENT_67	[p4l1776t628r2152b710],
6	define	VB	O	define	_	0	SENT_67	[p4l9t710r224b771],
7	algorithms	NNS	O	algorithm	dobj	6	SENT_67	[p4l323t710r716b792],
8	.	.	O	.	_	0	SENT_67	[p4l323t710r716b792],

1	These	DT	O	these	det	2	SENT_68	[p4l768t710r970b771],
2	algorithms	NNS	O	algorithm	nsubjpass	4	SENT_68	[p4l1020t710r1396b792],
3	were	VBD	O	be	auxpass	4	SENT_68	[p4l1444t731r1616b771],
4	derived	VBN	O	derive	_	0	SENT_68	[p4l1666t710r1933b771],
5	from	IN	O	from	_	0	SENT_68	[p4l1983t710r2152b771],
6	phenotypic	JJ	O	phenotypic	amod	9	SENT_68	[p4l7t809r789b890],
7	—	NN	O	—	nn	9	SENT_68	[p4l7t809r789b890],
8	genotypic	JJ	O	genotypic	amod	9	SENT_68	[p4l7t809r789b890],
9	correlations	NNS	O	correlation	prep_from	4	SENT_68	[p4l821t809r1230b869],
10	of	IN	O	of	_	0	SENT_68	[p4l1262t808r1331b869],
11	isolates	NNS	O	isolate	prep_of	9	SENT_68	[p4l1358t809r1614b869],
12	within	IN	O	within	_	0	SENT_68	[p4l1644t808r1874b868],
13	the	DT	O	the	det	14	SENT_68	[p4l1902t808r2009b869],
14	database	NN	O	database	prep_within	11	SENT_68	[p4l2040t809r2151b868, p4l8t907r227b967],
15	and	CC	O	and	_	0	SENT_68	[p4l254t907r384b967],
16	that	IN	O	that	nsubjpass	18	SENT_68	[p4l411t907r547b967],
17	were	VBD	O	be	auxpass	18	SENT_68	[p4l570t927r742b967],
18	distributed	VBN	O	distribute	prep_from	4	SENT_68	[p4l768t907r1153b967],
19	around	IN	O	around	_	0	SENT_68	[p4l1179t907r1433b967],
20	the	DT	O	the	det	22	SENT_68	[p4l1458t907r1565b967],
21	LCO	NN	O	lco	nn	22	SENT_68	[p4l1591t892r1956b967],
22	.9	NN	NUMBER	.9	prep_around	18	SENT_68	[p4l1591t892r1956b967],
23	'	''	DATE	'	_	0	SENT_68	[p4l1591t892r1956b967],
24	10	CD	DATE	10	number	25	SENT_68	[p4l1591t892r1956b967],
25	’15	CD	NUMBER	’15	dep	22	SENT_68	[p4l1591t892r1956b967],

1	Sample	VB	O	sample	_	0	SENT_69	[p4l14t1067r281b1142],
2	population	NN	O	population	dobj	1	SENT_69	[p4l306t1068r676b1142],

1	The	DT	O	the	det	4	SENT_70	[p4l97t1215r224b1275],
2	complete	JJ	O	complete	amod	4	SENT_70	[p4l278t1215r585b1296],
3	commercial	NN	O	commercial	nn	4	SENT_70	[p4l640t1215r1032b1275],
4	database	NN	O	database	nsubj	5	SENT_70	[p4l1087t1214r1382b1275],
5	includes	VBZ	O	include	_	0	SENT_70	[p4l1437t1214r1716b1275],
6	more	JJR	O	more	mwe	7	SENT_70	[p4l1770t1235r1946b1275],
7	than	IN	O	than	quantmod	8	SENT_70	[p4l2000t1215r2152b1274],
8	110,000	CD	NUMBER	110,000	num	10	SENT_70	[p4l11t1314r256b1383],
9	commercial	JJ	O	commercial	amod	10	SENT_70	[p4l282t1312r674b1372],
10	samples	NNS	O	sample	dobj	5	SENT_70	[p4l698t1312r971b1393],
11	with	IN	O	with	_	0	SENT_70	[p4l995t1312r1152b1372],
12	matched	VBN	O	match	prepc_with	5	SENT_70	[p4l1174t1312r1466b1372],
13	genotypic	JJ	O	genotypic	amod	16	SENT_70	[p4l1492t1315r1822b1393],
14	and	CC	O	and	_	0	SENT_70	[p4l1848t1312r1976b1372],
15	phenotypic	JJ	O	phenotypic	amod	16	SENT_70	[p4l2000t1312r2152b1393, p4l7t1411r261b1489],
16	information	NN	O	information	dobj	12	SENT_70	[p4l291t1408r706b1469],
17	.	.	O	.	_	0	SENT_70	[p4l291t1408r706b1469],

1	It	PRP	O	it	nsubj	12	SENT_71	[p4l739t1410r789b1468],
2	does	VBZ	O	do	aux	4	SENT_71	[p4l819t1408r973b1469],
3	not	RB	O	not	neg	4	SENT_71	[p4l1003t1416r1114b1468],
4	include	VB	O	include	_	0	SENT_71	[p4l1143t1408r1391b1469],
5	samples	NNS	O	sample	dobj	4	SENT_71	[p4l1422t1408r1694b1489],
6	from	IN	O	from	_	0	SENT_71	[p4l1724t1408r1889b1469],
7	clinical	JJ	O	clinical	amod	8	SENT_71	[p4l1918t1408r2152b1469],
8	trials	NNS	O	trial	prep_from	4	SENT_71	[p4l8t1505r173b1566],
9	and	CC	O	and	_	0	SENT_71	[p4l197t1506r325b1565],
10	so	RB	O	so	advmod	4	SENT_71	[p4l349t1526r421b1566],
11	is	VBZ	O	be	cop	12	SENT_71	[p4l445t1508r496b1566],
12	independent	JJ	O	independent	conj_and	4	SENT_71	[p4l520t1505r947b1587],
13	of	IN	O	of	_	0	SENT_71	[p4l970t1505r1038b1566],
14	the	DT	O	the	det	15	SENT_71	[p4l1058t1506r1162b1566],
15	databases	NNS	O	database	prep_of	12	SENT_71	[p4l1186t1506r1513b1566],
16	used	VBN	O	use	partmod	15	SENT_71	[p4l1537t1505r1697b1566],
17	to	TO	O	to	aux	18	SENT_71	[p4l1720t1514r1785b1566],
18	determine	VB	O	determine	xcomp	16	SENT_71	[p4l1810t1505r2151b1566],
19	clinical	JJ	O	clinical	amod	22	SENT_71	[p4l9t1603r243b1663],
20	cut	NN	O	cut	nn	22	SENT_71	[p4l271t1602r534b1663],
21	—	CD	NUMBER	—	num	22	SENT_71	[p4l271t1602r534b1663],
22	offs	NNS	O	off	dobj	18	SENT_71	[p4l271t1602r534b1663],
23	.	.	O	.	_	0	SENT_71	[p4l271t1602r534b1663],

1	The	DT	O	the	det	3	SENT_72	[p4l567t1603r693b1663],
2	database	NN	O	database	nn	3	SENT_72	[p4l723t1603r1019b1663],
3	population	NN	O	population	nsubjpass	5	SENT_72	[p4l1047t1603r1420b1684],
4	was	VBD	O	be	auxpass	5	SENT_72	[p4l1445t1623r1581b1663],
5	queried	VBN	O	query	_	0	SENT_72	[p4l1611t1603r1867b1684],
6	for	IN	O	for	_	0	SENT_72	[p4l1895t1602r1991b1663],
7	pattems	NNS	O	pattem	prep_for	5	SENT_72	[p4l2017t1611r2151b1684, p4l8t1707r173b1759],
8	of	IN	O	of	_	0	SENT_72	[p4l206t1699r274b1759],
9	resistance	NN	O	resistance	prep_of	7	SENT_72	[p4l304t1702r630b1760],
10	over	IN	O	over	_	0	SENT_72	[p4l663t1719r814b1759],
11	the	DT	O	the	det	12	SENT_72	[p4l845t1699r949b1760],
12	period	NN	O	period	prep_over	5	SENT_72	[p4l980t1699r1202b1780],
13	2006	CD	DATE	2006	nsubj	19	SENT_72	[p4l1234t1702r1387b1760],
14	through	IN	DATE	through	_	0	SENT_72	[p4l1421t1699r1695b1780],
15	2008	CD	DATE	2008	num	17	SENT_72	[p4l1726t1702r1879b1760],
16	to	TO	O	to	dep	17	SENT_72	[p4l1913t1707r1977b1759],
17	four	CD	NUMBER	four	prep_through	13	SENT_72	[p4l2011t1699r2152b1760],
18	widely	RB	O	widely	advmod	19	SENT_72	[p4l7t1796r242b1878],
19	used	VBN	O	use	rcmod	12	SENT_72	[p4l275t1796r435b1857],
20	Pls	NNS	O	pl	nsubj	21	SENT_72	[p4l471t1799r573b1857],
21	(	CD	NUMBER	(	ccomp	19	SENT_72	[p4l611t1797r743b1872],
22	i.e.	FW	O	i.e.	dobj	21	SENT_72	[p4l611t1797r743b1872],
23	,	,	O	,	_	0	SENT_72	[p4l611t1797r743b1872],
24	ATV	NNP	O	ATV	dobj	21	SENT_72	[p4l778t1798r959b1867],
25	,	,	O	,	_	0	SENT_72	[p4l778t1798r959b1867],
26	FPV	NN	O	fpv	dobj	21	SENT_72	[p4l995t1799r1156b1868],
27	,	,	O	,	_	0	SENT_72	[p4l995t1799r1156b1868],
28	LPV	NN	O	lpv	dobj	21	SENT_72	[p4l1192t1799r1358b1867],
29	,	,	O	,	_	0	SENT_72	[p4l1192t1799r1358b1867],
30	and	CC	O	and	_	0	SENT_72	[p4l1395t1797r1523b1856],
31	SQV	NN	O	sqv	conj_and	22	SENT_72	[p4l1558t1797r1737b1873],
32	)	CD	NUMBER	)	npadvmod	21	SENT_72	[p4l1558t1797r1737b1873],
33	along	IN	O	along	_	0	SENT_72	[p4l1775t1797r1963b1878],
34	with	IN	O	with	_	0	SENT_72	[p4l1996t1797r2152b1856],
35	patterns	NNS	O	pattern	prep_along_with	21	SENT_72	[p4l7t1902r282b1975],
36	of	IN	O	of	_	0	SENT_72	[p4l318t1893r385b1954],
37	resistance	NN	O	resistance	prep_of	35	SENT_72	[p4l416t1897r743b1954],
38	and	CC	O	and	_	0	SENT_72	[p4l778t1894r906b1954],
39	cross-resistance	NN	O	cross-resistance	prep_of	35	SENT_72	[p4l940t1897r1460b1954],
40	with	IN	O	with	_	0	SENT_72	[p4l1493t1894r1649b1954],
41	the	DT	O	the	det	42	SENT_72	[p4l1682t1894r1786b1954],
42	two	CD	NUMBER	two	prep_with	19	SENT_72	[p4l1820t1902r1951b1954],
43	most	RBS	O	most	advmod	44	SENT_72	[p4l1985t1902r2153b1954],
44	recently	RB	DATE	recently	advmod	45	SENT_72	[p4l8t1990r276b2071],
45	introduced	VBN	O	introduce	partmod	42	SENT_72	[p4l326t1990r695b2051],
46	second	JJ	ORDINAL	second	amod	48	SENT_72	[p4l747t1990r1365b2071],
47	—	NN	O	—	nn	48	SENT_72	[p4l747t1990r1365b2071],
48	generation	NN	O	generation	nn	50	SENT_72	[p4l747t1990r1365b2071],
49	Plsz	NNP	O	Plsz	nn	50	SENT_72	[p4l1414t1992r1531b2051],
50	DRV	NNP	O	DRV	dobj	45	SENT_72	[p4l1586t1992r1754b2050],
51	and	CC	O	and	_	0	SENT_72	[p4l1805t1990r1933b2050],
52	TPV	NNP	O	TPV	conj_and	50	SENT_72	[p4l1984t1992r2147b2050],
53	.	.	O	.	_	0	SENT_72	[p4l1984t1992r2147b2050],

1	Clinical	JJ	O	clinical	amod	2	SENT_73	[p4l8t2087r265b2148],
2	isolates	NNS	O	isolate	nsubj	9	SENT_73	[p4l283t2088r529b2148],
3	with	IN	O	with	_	0	SENT_73	[p4l548t2088r705b2147],
4	both	DT	O	both	det	8	SENT_73	[p4l720t2088r877b2148],
5	phenotypic	JJ	O	phenotypic	amod	8	SENT_73	[p4l894t2088r1275b2169],
6	and	CC	O	and	_	0	SENT_73	[p4l1297t2088r1424b2147],
7	genotypic	JJ	O	genotypic	amod	8	SENT_73	[p4l1445t2090r1776b2169],
8	test	NN	O	test	prep_with	2	SENT_73	[p4l1796t2096r1913b2148],
9	results	VBZ	O	result	_	0	SENT_73	[p4l1932t2088r2151b2148],
10	available	JJ	O	available	acomp	9	SENT_73	[p4l9t2185r309b2245],
11	(	NN	O	(	nsubjpass	17	SENT_73	[p4l344t2185r406b2261],
12	11	CD	NUMBER	11	num	11	SENT_73	[p4l344t2185r406b2261],
13	=	JJ	O	=	amod	11	SENT_73	[p4l421t2212r464b2232],
14	7775	CD	NUMBER	7775	number	15	SENT_73	[p4l480t2185r653b2261],
15	)	CD	NUMBER	)	dep	13	SENT_73	[p4l480t2185r653b2261],
16	were	VBD	O	be	auxpass	17	SENT_73	[p4l686t2205r854b2245],
17	selected	VBN	O	select	ccomp	10	SENT_73	[p4l887t2185r1151b2245],
18	from	IN	O	from	_	0	SENT_73	[p4l1184t2184r1348b2245],
19	subtype	NN	O	subtype	nn	22	SENT_73	[p4l1380t2185r1648b2266],
20	B	NN	O	b	nn	22	SENT_73	[p4l1681t2187r1727b2244],
21	commercial	JJ	O	commercial	amod	22	SENT_73	[p4l1760t2185r2151b2245],
22	samples	NNS	O	sample	prep_from	17	SENT_73	[p4l9t2281r281b2362],
23	submitted	VBN	O	submit	partmod	22	SENT_73	[p4l299t2281r638b2342],
24	between	IN	O	between	_	0	SENT_73	[p4l652t2281r941b2342],
25	2006	CD	DATE	2006	prep_between	23	SENT_73	[p4l955t2284r1108b2342],
26	and	CC	DATE	and	_	0	SENT_73	[p4l1126t2281r1253b2341],
27	2008	CD	DATE	2008	conj_and	25	SENT_73	[p4l1270t2284r1441b2352],
28	,	,	O	,	_	0	SENT_73	[p4l1270t2284r1441b2352],
29	based	VBN	O	base	_	0	SENT_73	[p4l1455t2281r1653b2342],
30	on	IN	O	on	prepc_based_on	9	SENT_73	[p4l1671t2301r1757b2342],
31	phenotypic	JJ	O	phenotypic	amod	33	SENT_73	[p4l1770t2281r2151b2362],
32	drug	NN	O	drug	nn	33	SENT_73	[p4l9t2379r173b2460],
33	resistance	NN	O	resistance	pobj	9	SENT_73	[p4l196t2382r523b2439],
34	to	TO	O	to	_	0	SENT_73	[p4l548t2387r612b2439],
35	PIs	NNS	O	pi	prep_to	33	SENT_73	[p4l638t2381r754b2439],
36	.	.	O	.	_	0	SENT_73	[p4l638t2381r754b2439],

1	All	DT	O	all	det	2	SENT_74	[p4l782t2379r884b2438],
2	isolates	NNS	O	isolate	nsubj	3	SENT_74	[p4l908t2379r1154b2439],
3	demonstrated	VBD	O	demonstrate	_	0	SENT_74	[p4l1179t2379r1647b2439],
4	some	DT	O	some	det	6	SENT_74	[p4l1673t2399r1850b2439],
5	drug	NN	O	drug	nn	6	SENT_74	[p4l1875t2379r2039b2460],
6	resistance	NN	O	resistance	dobj	3	SENT_74	[p4l2062t2399r2152b2439, p4l9t2479r269b2536],
7	by	IN	O	by	_	0	SENT_74	[p4l300t2476r388b2557],
8	having	VBG	O	have	prepc_by	3	SENT_74	[p4l419t2476r655b2557],
9	a	DT	O	a	det	11	SENT_74	[p4l688t2496r724b2536],
10	phenotypic	JJ	O	phenotypic	amod	11	SENT_74	[p4l757t2476r1138b2557],
11	result	NN	O	result	nsubj	22	SENT_74	[p4l1172t2476r1361b2536],
12	above	IN	O	above	_	0	SENT_74	[p4l1394t2476r1595b2536],
13	the	DT	O	the	det	14	SENT_74	[p4l1628t2476r1732b2536],
14	LCD	NNS	O	lcd	prep_above	11	SENT_74	[p4l1766t2477r1928b2536],
15	for	IN	O	for	_	0	SENT_74	[p4l1961t2475r2056b2536],
16	at	IN	O	at	quantmod	18	SENT_74	[p4l2090t2484r2152b2536],
17	least	JJS	O	least	mwe	16	SENT_74	[p4l8t2572r160b2632],
18	one	CD	NUMBER	one	prep_for	14	SENT_74	[p4l184t2592r304b2632],
19	of	IN	O	of	_	0	SENT_74	[p4l329t2572r397b2632],
20	the	DT	O	the	det	21	SENT_74	[p4l417t2572r521b2632],
21	four	CD	NUMBER	four	prep_of	18	SENT_74	[p4l544t2572r686b2632],
22	boosted	VBD	O	boost	ccomp	8	SENT_74	[p4l706t2572r973b2632],
23	PIS	NN	O	pi	iobj	22	SENT_74	[p4l997t2574r1099b2632],
24	(	CD	NUMBER	(	num	25	SENT_74	[p4l1126t2572r1327b2647],
25	ATV	NN	O	atv	dobj	22	SENT_74	[p4l1126t2572r1327b2647],
26	,	,	O	,	_	0	SENT_74	[p4l1126t2572r1327b2647],
27	FPV	NN	O	fpv	conj_and	25	SENT_74	[p4l1352t2574r1513b2643],
28	,	,	O	,	_	0	SENT_74	[p4l1352t2574r1513b2643],
29	LPV	NN	O	lpv	conj_and	25	SENT_74	[p4l1538t2574r1704b2643],
30	,	,	O	,	_	0	SENT_74	[p4l1538t2574r1704b2643],
31	and	CC	O	and	_	0	SENT_74	[p4l1729t2572r1857b2631],
32	SQV	NN	O	sqv	nn	33	SENT_74	[p4l1881t2572r2077b2647],
33	)	NN	O	)	conj_and	25	SENT_74	[p4l1881t2572r2077b2647],
34	.	.	O	.	_	0	SENT_74	[p4l1881t2572r2077b2647],

1	Statistical	JJ	O	statistical	amod	2	SENT_75	[p4l14t2730r357b2791],
2	methods	NNS	O	method	_	0	SENT_75	[p4l383t2732r688b2791],

1	Results	NNS	O	result	nsubjpass	3	SENT_76	[p4l97t2878r349b2939],
2	were	VBD	O	be	auxpass	3	SENT_76	[p4l383t2899r554b2939],
3	reported	VBN	O	report	_	0	SENT_76	[p4l589t2878r889b2960],
4	descriptively	RB	O	descriptively	advmod	3	SENT_76	[p4l925t2878r1377b2960],
5	as	IN	O	as	_	0	SENT_76	[p4l1412t2899r1481b2939],
6	rates	NNS	O	rate	prep_as	3	SENT_76	[p4l1516t2887r1682b2939],
7	and	CC	O	and	_	0	SENT_76	[p4l1717t2878r1848b2938],
8	proportions	NNS	O	proportion	prep_as	3	SENT_76	[p4l1882t2899r2151b2960, p4l8t2979r193b3037],
9	.	.	O	.	_	0	SENT_76	[p4l1882t2899r2151b2960, p4l8t2979r193b3037],

1	Changes	NNS	O	change	nsubjpass	7	SENT_77	[p4l228t2976r530b3057],
2	in	IN	O	in	_	0	SENT_77	[p4l562t2979r630b3035],
3	rates	NNS	O	rate	prep_in	1	SENT_77	[p4l659t2984r824b3037],
4	over	IN	O	over	_	0	SENT_77	[p4l856t2996r1011b3037],
5	time	NN	O	time	prep_over	3	SENT_77	[p4l1042t2979r1196b3036],
6	were	VBD	O	be	auxpass	7	SENT_77	[p4l1226t2996r1397b3037],
7	tested	VBN	O	test	_	0	SENT_77	[p4l1428t2976r1634b3037],
8	using	VBG	O	use	xcomp	7	SENT_77	[p4l1666t2979r1859b3057],
9	the	DT	O	the	det	10	SENT_77	[p4l1889t2976r1996b3036],
10	Cochran	NNP	O	Cochran	dobj	8	SENT_77	[p4l2027t2977r2151b3037, p4l9t3073r578b3155],
11	.	.	O	.	_	0	SENT_77	[p4l2027t2977r2151b3037, p4l9t3073r578b3155],

1	—	NN	O	—	_	0	SENT_78	[p4l2027t2977r2151b3037, p4l9t3073r578b3155],
2	.	.	O	.	_	0	SENT_78	[p4l2027t2977r2151b3037, p4l9t3073r578b3155],

1	Armitage	NNP	PERSON	Armitage	nsubj	2	SENT_79	[p4l2027t2977r2151b3037, p4l9t3073r578b3155],
2	test	NN	O	test	_	0	SENT_79	[p4l604t3082r725b3134],
3	for	IN	O	for	_	0	SENT_79	[p4l750t3073r848b3134],
4	trend	NN	O	trend	prep_for	2	SENT_79	[p4l873t3073r1076b3134],
5	.	.	O	.	_	0	SENT_79	[p4l873t3073r1076b3134],

1	Resuﬂs	NNS	O	resuﬂs	_	0	SENT_80	[p4l12t3234r294b3293],

1	Phenotypic	JJ	O	phenotypic	amod	3	SENT_81	[p4l13t3381r408b3456],
2	resistance	NN	O	resistance	nn	3	SENT_81	[p4l436t3381r798b3440],
3	assessments	NNS	O	assessment	_	0	SENT_81	[p4l827t3384r1293b3440],
4	over	IN	O	over	_	0	SENT_81	[p4l1324t3395r1483b3440],
5	time	NN	O	time	prep_over	3	SENT_81	[p4l1508t3381r1654b3440],
6	and	CC	O	and	_	0	SENT_81	[p4l11t3479r148b3538],
7	cross-resistance	NN	O	cross-resistance	prep_over	3	SENT_81	[p4l173t3479r753b3538],

1	As	IN	O	as	mark	2	SENT_82	[p5l97t52r190b111],
2	seen	VBN	O	see	_	0	SENT_82	[p5l223t70r376b111],
3	in	IN	O	in	_	0	SENT_82	[p5l406t53r474b109],
4	Fig	NN	O	fig	prep_in	2	SENT_82	[p5l504t53r629b132],
5	.	.	O	.	_	0	SENT_82	[p5l504t53r629b132],

1	1A	NN	O	1a	dep	21	SENT_83	[p5l668t52r783b121],
2	,	,	O	,	_	0	SENT_83	[p5l668t52r783b121],
3	the	DT	O	the	det	4	SENT_83	[p5l816t50r923b111],
4	rate	NN	O	rate	appos	1	SENT_83	[p5l954t59r1086b111],
5	of	IN	O	of	_	0	SENT_83	[p5l1119t50r1188b111],
6	phenotypic	JJ	O	phenotypic	amod	7	SENT_83	[p5l1216t50r1610b132],
7	resistance	NN	O	resistance	prep_of	4	SENT_83	[p5l1643t53r1983b111],
8	(	RB	O	(	advmod	9	SENT_83	[p5l2018t50r2151b126, p5l8t147r186b208],
9	defined	VBN	O	define	partmod	7	SENT_83	[p5l2018t50r2151b126, p5l8t147r186b208],
10	as	IN	O	as	_	0	SENT_83	[p5l206t168r276b208],
11	an	DT	O	a	det	13	SENT_83	[p5l296t168r381b207],
12	FC	NN	O	fc	dep	13	SENT_83	[p5l398t148r495b208],
13	greater	JJR	O	greater	prep_as	9	SENT_83	[p5l516t156r761b229],
14	than	IN	O	than	_	0	SENT_83	[p5l779t147r936b207],
15	the	DT	O	the	det	16	SENT_83	[p5l954t147r1061b208],
16	UCO	NNP	ORGANIZATION	UCO	prep_than	13	SENT_83	[p5l1079t148r1283b223],
17	)	CD	NUMBER	)	num	16	SENT_83	[p5l1079t148r1283b223],
18	to	TO	O	to	_	0	SENT_83	[p5l1304t156r1370b208],
19	TPV	NNP	O	TPV	prep_to	9	SENT_83	[p5l1389t150r1541b207],
20	actually	RB	O	actually	advmod	21	SENT_83	[p5l1561t147r1837b229],
21	declined	VBD	O	decline	_	0	SENT_83	[p5l1856t147r2151b208],
22	from	IN	O	from	_	0	SENT_83	[p5l8t243r177b303],
23	2006	CD	PERCENT	2006	prep_from	21	SENT_83	[p5l214t246r372b303],
24	(	CD	PERCENT	(	number	25	SENT_83	[p5l414t243r665b319],
25	22.2	CD	PERCENT	22.2	dep	26	SENT_83	[p5l414t243r665b319],
26	%	NN	PERCENT	%	dep	23	SENT_83	[p5l414t243r665b319],
27	)	CD	NUMBER	)	num	29	SENT_83	[p5l414t243r665b319],
28	to	TO	O	to	dep	29	SENT_83	[p5l706t252r772b303],
29	2008	CD	PERCENT	2008	nsubj	21	SENT_83	[p5l810t246r967b303],
30	(	CD	PERCENT	(	number	31	SENT_83	[p5l1010t243r1280b318],
31	18.5	CD	PERCENT	18.5	num	32	SENT_83	[p5l1010t243r1280b318],
32	%	NN	PERCENT	%	dep	29	SENT_83	[p5l1010t243r1280b318],
33	)	CD	NUMBER	)	dep	32	SENT_83	[p5l1010t243r1280b318],
34	.	.	O	.	_	0	SENT_83	[p5l1010t243r1280b318],

1	However	RB	O	however	advmod	6	SENT_84	[p5l1322t246r1666b314],
2	,	,	O	,	_	0	SENT_84	[p5l1322t246r1666b314],
3	resistance	NN	O	resistance	nsubj	6	SENT_84	[p5l1706t246r2046b303],
4	to	TO	O	to	_	0	SENT_84	[p5l2084t251r2150b303],
5	DRV	NN	ORGANIZATION	drv	prep_to	3	SENT_84	[p5l8t343r179b400],
6	increased	VBD	O	increase	_	0	SENT_84	[p5l231t340r560b401],
7	significantly	RB	O	significantly	prep	6	SENT_84	[p5l614t340r1043b422],
8	(	CD	NUMBER	(	num	9	SENT_84	[p5l1098t341r1171b421],
9	p	NN	O	p	npadvmod	10	SENT_84	[p5l1098t341r1171b421],
10	<	JJR	O	<	pobj	7	SENT_84	[p5l1188t357r1229b399],
11	0.0001	CD	NUMBER	0.0001	num	12	SENT_84	[p5l1246t341r1509b417],
12	)	NN	O	)	dobj	6	SENT_84	[p5l1246t341r1509b417],
13	,	,	O	,	_	0	SENT_84	[p5l1246t341r1509b417],
14	nearly	RB	O	nearly	advmod	15	SENT_84	[p5l1561t341r1782b422],
15	doubling	VBG	O	double	partmod	6	SENT_84	[p5l1835t340r2152b422],
16	from	IN	O	from	_	0	SENT_84	[p5l8t436r177b496],
17	2006	CD	PERCENT	2006	num	18	SENT_84	[p5l213t439r370b496],
18	(	CD	PERCENT	(	prep_from	15	SENT_84	[p5l411t437r622b511],
19	6.8	CD	PERCENT	6.8	num	20	SENT_84	[p5l411t437r622b511],
20	%	NN	PERCENT	%	dobj	15	SENT_84	[p5l411t437r622b511],
21	)	CD	NUMBER	)	number	24	SENT_84	[p5l411t437r622b511],
22	to	TO	O	to	dep	24	SENT_84	[p5l661t445r727b496],
23	2008	CD	PERCENT	2008	number	24	SENT_84	[p5l764t439r921b496],
24	(	CD	PERCENT	(	num	20	SENT_84	[p5l963t437r1233b511],
25	11.6	CD	PERCENT	11.6	number	26	SENT_84	[p5l963t437r1233b511],
26	%	NN	PERCENT	%	amod	20	SENT_84	[p5l963t437r1233b511],
27	)	CD	NUMBER	)	tmod	20	SENT_84	[p5l963t437r1233b511],
28	.	.	O	.	_	0	SENT_84	[p5l963t437r1233b511],

1	This	DT	O	this	det	2	SENT_85	[p5l1272t436r1420b496],
2	trend	NN	O	trend	nsubj	6	SENT_85	[p5l1457t436r1644b496],
3	is	VBZ	O	be	cop	6	SENT_85	[p5l1681t439r1734b496],
4	even	RB	O	even	advmod	6	SENT_85	[p5l1771t456r1936b496],
5	more	RBR	O	more	advmod	6	SENT_85	[p5l1971t456r2151b496],
6	apparent	JJ	O	apparent	_	0	SENT_85	[p5l9t542r323b615],
7	when	WRB	O	when	advmod	12	SENT_85	[p5l347t534r544b594],
8	subgroups	NNS	O	subgroup	nsubj	12	SENT_85	[p5l569t534r939b615],
9	of	IN	O	of	_	0	SENT_85	[p5l966t533r1035b594],
10	resistant	JJ	O	resistant	amod	11	SENT_85	[p5l1058t536r1353b594],
11	isolates	NNS	O	isolate	prep_of	8	SENT_85	[p5l1378t534r1634b594],
12	(	VBP	O	(	advcl	6	SENT_85	[p5l1663t534r1943b609],
13	isolates	NNS	O	isolate	nsubjpass	23	SENT_85	[p5l1663t534r1943b609],
14	resistant	JJ	O	resistant	amod	13	SENT_85	[p5l1970t536r2152b594, p5l8t639r145b690],
15	to	TO	O	to	_	0	SENT_85	[p5l194t639r260b691],
16	two	CD	NUMBER	two	num	20	SENT_85	[p5l310t639r443b691],
17	or	CC	O	or	_	0	SENT_85	[p5l494t651r566b691],
18	more	JJR	O	more	num	20	SENT_85	[p5l614t651r795b691],
19	first-generation	JJ	O	first-generation	amod	20	SENT_85	[p5l845t630r1384b712],
20	Pls	NNS	O	pl	prep_to	14	SENT_85	[p5l1432t631r1561b706],
21	)	CD	NUMBER	)	tmod	14	SENT_85	[p5l1432t631r1561b706],
22	were	VBD	O	be	auxpass	23	SENT_85	[p5l1612t651r1784b691],
23	analyzed	VBN	O	analyze	ccomp	12	SENT_85	[p5l1835t631r2151b712],
24	(	RB	O	(	advmod	23	SENT_85	[p5l11t728r155b809],
25	Fig	NN	O	fig	dobj	23	SENT_85	[p5l11t728r155b809],
26	.	.	O	.	_	0	SENT_85	[p5l11t728r155b809],

1	1B	NN	O	1b	_	0	SENT_86	[p5l201t727r422b803],
2	.	.	O	.	_	0	SENT_86	[p5l201t727r422b803],

1	—	NN	O	—	_	0	SENT_87	[p5l201t727r422b803],
2	.	.	O	.	_	0	SENT_87	[p5l201t727r422b803],

1	D	NN	O	d	_	0	SENT_88	[p5l201t727r422b803],
2	)	NN	O	)	dep	1	SENT_88	[p5l201t727r422b803],
3	.	.	O	.	_	0	SENT_88	[p5l201t727r422b803],

1	Low	JJ	O	low	amod	2	SENT_89	[p5l465t730r620b788],
2	levels	NNS	O	level	nsubjpass	6	SENT_89	[p5l658t727r848b788],
3	of	IN	O	of	_	0	SENT_89	[p5l889t727r957b788],
4	resistance	NN	O	resistance	prep_of	2	SENT_89	[p5l993t730r1323b788],
5	were	VBD	O	be	auxpass	6	SENT_89	[p5l1360t748r1530b788],
6	seen	VBN	O	see	_	0	SENT_89	[p5l1569t748r1718b788],
7	for	IN	O	for	_	0	SENT_89	[p5l1756t727r1853b788],
8	secondgeneration	NN	O	secondgeneration	nn	9	SENT_89	[p5l1891t727r2152b788, p5l9t827r371b906],
9	Pls	NNS	O	pl	prep_for	6	SENT_89	[p5l403t827r506b885],
10	among	IN	O	among	_	0	SENT_89	[p5l540t845r777b906],
11	isolates	NNS	O	isolate	prep_among	6	SENT_89	[p5l809t825r1057b885],
12	exhibiting	VBG	O	exhibit	partmod	11	SENT_89	[p5l1091t825r1433b906],
13	resistance	NN	O	resistance	dobj	12	SENT_89	[p5l1464t827r1794b885],
14	to	TO	O	to	_	0	SENT_89	[p5l1827t833r1892b885],
15	one	CD	NUMBER	one	prep_to	13	SENT_89	[p5l1926t845r2048b885],
16	or	CC	O	or	_	0	SENT_89	[p5l2082t845r2152b885],
17	none	NN	O	none	conj_or	13	SENT_89	[p5l7t942r175b982],
18	of	IN	O	of	_	0	SENT_89	[p5l195t921r263b982],
19	the	DT	O	the	det	21	SENT_89	[p5l278t921r383b982],
20	first-generation	JJ	O	first-generation	amod	21	SENT_89	[p5l402t921r925b1003],
21	Pls	NNS	O	pl	prep_of	17	SENT_89	[p5l942t924r1060b982],
22	.	.	O	.	_	0	SENT_89	[p5l942t924r1060b982],

1	These	DT	O	these	det	2	SENT_90	[p5l1082t921r1280b982],
2	rates	NNS	O	rate	nsubj	5	SENT_90	[p5l1298t930r1458b982],
3	did	VBD	O	do	aux	5	SENT_90	[p5l1479t922r1591b981],
4	not	RB	O	not	neg	5	SENT_90	[p5l1610t930r1722b982],
5	change	VB	O	change	_	0	SENT_90	[p5l1741t922r1981b1003],
6	over	IN	O	over	_	0	SENT_90	[p5l2001t942r2152b982],
7	the	DT	O	the	det	9	SENT_90	[p5l8t1018r113b1079],
8	3-year	JJ	DURATION	3-year	amod	9	SENT_90	[p5l136t1021r348b1100],
9	period	NN	O	period	prep_over	5	SENT_90	[p5l371t1018r594b1100],
10	analyzed	VBN	O	analyze	partmod	9	SENT_90	[p5l619t1018r927b1100],
11	for	IN	O	for	_	0	SENT_90	[p5l951t1018r1047b1079],
12	this	DT	O	this	det	13	SENT_90	[p5l1071t1018r1192b1079],
13	study	NN	O	study	prep_for	10	SENT_90	[p5l1217t1018r1410b1100],
14	(	CD	NUMBER	(	num	15	SENT_90	[p5l1436t1018r1606b1094],
15	data	NNS	O	datum	npadvmod	16	SENT_90	[p5l1436t1018r1606b1094],
16	not	RB	O	not	neg	17	SENT_90	[p5l1629t1027r1744b1079],
17	shown	VBN	O	show	partmod	13	SENT_90	[p5l1766t1018r2034b1094],
18	)	NN	O	)	dobj	17	SENT_90	[p5l1766t1018r2034b1094],
19	.	.	O	.	_	0	SENT_90	[p5l1766t1018r2034b1094],

1	Samples	NNS	O	sample	nsubj	2	SENT_91	[p5l98t1116r384b1197],
2	had	VBD	O	have	_	0	SENT_91	[p5l402t1115r535b1175],
3	to	TO	O	to	aux	5	SENT_91	[p5l555t1124r620b1176],
4	have	VB	O	have	aux	5	SENT_91	[p5l639t1115r805b1176],
5	reduced	VBN	O	reduce	xcomp	2	SENT_91	[p5l824t1116r1102b1176],
6	susceptibility	NN	O	susceptibility	dobj	5	SENT_91	[p5l1123t1115r1577b1197],
7	in	IN	O	in	_	0	SENT_91	[p5l1596t1118r1663b1175],
8	at	IN	O	at	quantmod	10	SENT_91	[p5l1682t1124r1745b1175],
9	least	JJS	O	least	mwe	8	SENT_91	[p5l1764t1115r1919b1176],
10	one	CD	NUMBER	one	num	11	SENT_91	[p5l1938t1136r2060b1176],
11	P1	NN	O	p1	prep_in	6	SENT_91	[p5l2080t1118r2152b1175],
12	in	IN	O	in	mark	16	SENT_91	[p5l8t1216r76b1272],
13	order	NN	O	order	dep	16	SENT_91	[p5l92t1213r278b1273],
14	to	TO	O	to	aux	16	SENT_91	[p5l294t1221r360b1273],
15	be	VB	O	be	auxpass	16	SENT_91	[p5l375t1213r457b1273],
16	included	VBN	O	include	purpcl	5	SENT_91	[p5l473t1213r774b1273],
17	in	IN	O	in	_	0	SENT_91	[p5l791t1216r859b1272],
18	the	DT	O	the	det	19	SENT_91	[p5l874t1213r979b1273],
19	study	NN	O	study	prep_in	16	SENT_91	[p5l997t1213r1210b1294],
20	,	,	O	,	_	0	SENT_91	[p5l997t1213r1210b1294],
21	and	CC	O	and	_	0	SENT_91	[p5l1228t1213r1358b1273],
22	31.0	CD	PERCENT	31.0	num	23	SENT_91	[p5l1375t1214r1576b1273],
23	%	NN	PERCENT	%	nsubj	25	SENT_91	[p5l1375t1214r1576b1273],
24	were	VBD	O	be	cop	25	SENT_91	[p5l1593t1233r1764b1273],
25	resistant	JJ	O	resistant	conj_and	2	SENT_91	[p5l1780t1216r2069b1273],
26	to	TO	O	to	_	0	SENT_91	[p5l2085t1221r2150b1273],
27	none	NN	O	none	prep_to	25	SENT_91	[p5l7t1330r177b1370],
28	of	IN	O	of	_	0	SENT_91	[p5l201t1309r270b1370],
29	the	DT	O	the	det	30	SENT_91	[p5l289t1309r395b1370],
30	six	CD	NUMBER	six	prep_of	27	SENT_91	[p5l418t1312r511b1370],
31	evaluated	VBN	O	evaluate	partmod	30	SENT_91	[p5l534t1309r870b1370],
32	Pls	NNS	O	pl	dobj	31	SENT_91	[p5l894t1312r1014b1370],
33	.	.	O	.	_	0	SENT_91	[p5l894t1312r1014b1370],

1	Only	RB	O	only	quantmod	2	SENT_92	[p5l1041t1309r1213b1391],
2	4.9	CD	PERCENT	4.9	num	3	SENT_92	[p5l1233t1310r1395b1370],
3	%	NN	PERCENT	%	nsubj	13	SENT_92	[p5l1233t1310r1395b1370],
4	of	IN	O	of	_	0	SENT_92	[p5l1421t1309r1490b1370],
5	the	DT	O	the	det	7	SENT_92	[p5l1509t1309r1615b1370],
6	clinical	JJ	O	clinical	amod	7	SENT_92	[p5l1638t1309r1878b1370],
7	isolates	NNS	O	isolate	prep_of	3	SENT_92	[p5l1900t1309r2151b1370],
8	included	VBN	O	include	partmod	7	SENT_92	[p5l8t1406r310b1467],
9	in	IN	O	in	_	0	SENT_92	[p5l340t1409r406b1466],
10	this	DT	O	this	det	11	SENT_92	[p5l435t1407r559b1467],
11	study	NN	O	study	prep_in	8	SENT_92	[p5l589t1407r784b1488],
12	were	VBD	O	be	cop	13	SENT_92	[p5l812t1427r982b1467],
13	resistant	JJ	O	resistant	_	0	SENT_92	[p5l1012t1409r1301b1467],
14	to	TO	O	to	_	0	SENT_92	[p5l1330t1415r1395b1467],
15	all	DT	O	all	det	16	SENT_92	[p5l1427t1407r1508b1466],
16	six	CD	NUMBER	six	prep_to	13	SENT_92	[p5l1539t1409r1631b1467],
17	evaluated	VBN	O	evaluate	partmod	16	SENT_92	[p5l1661t1407r1998b1467],
18	Pls	NNS	O	pl	dobj	17	SENT_92	[p5l2028t1409r2148b1467],
19	.	.	O	.	_	0	SENT_92	[p5l2028t1409r2148b1467],

1	Even	RB	O	even	advmod	2	SENT_93	[p5l8t1506r183b1564],
2	among	IN	O	among	advcl	32	SENT_93	[p5l201t1524r440b1585],
3	viruses	NNS	O	virus	pobj	2	SENT_93	[p5l457t1507r702b1564],
4	that	WDT	O	that	nsubj	6	SENT_93	[p5l722t1504r857b1564],
5	were	VBD	O	be	cop	6	SENT_93	[p5l874t1524r1044b1564],
6	resistant	JJ	O	resistant	rcmod	3	SENT_93	[p5l1063t1507r1352b1564],
7	to	TO	O	to	_	0	SENT_93	[p5l1370t1512r1437b1564],
8	the	DT	O	the	det	10	SENT_93	[p5l1456t1504r1562b1564],
9	majority	NN	O	majority	nn	10	SENT_93	[p5l1581t1507r1871b1585],
10	(	NN	O	(	prep_to	6	SENT_93	[p5l1892t1504r1978b1580],
11	at	IN	O	at	quantmod	13	SENT_93	[p5l1892t1504r1978b1580],
12	least	JJS	O	least	mwe	11	SENT_93	[p5l1997t1504r2152b1564],
13	three	CD	NUMBER	three	npadvmod	10	SENT_93	[p5l8t1600r181b1660],
14	of	IN	O	of	_	0	SENT_93	[p5l207t1599r276b1660],
15	the	DT	O	the	det	17	SENT_93	[p5l298t1600r403b1660],
16	five	CD	NUMBER	five	num	17	SENT_93	[p5l429t1599r578b1675],
17	)	NN	O	)	prep_of	10	SENT_93	[p5l429t1599r578b1675],
18	of	IN	O	of	_	0	SENT_93	[p5l607t1599r676b1660],
19	the	DT	O	the	det	21	SENT_93	[p5l698t1600r804b1660],
20	other	JJ	O	other	amod	21	SENT_93	[p5l830t1600r1008b1660],
21	Pls	NNS	O	pl	prep_of	17	SENT_93	[p5l1033t1602r1155b1670],
22	,	,	O	,	_	0	SENT_93	[p5l1033t1602r1155b1670],
23	1592	CD	DATE	1592	nsubj	32	SENT_93	[p5l1184t1602r1336b1660],
24	of	IN	DATE	of	_	0	SENT_93	[p5l1363t1599r1432b1660],
25	2906	CD	DATE	2906	prep_of	23	SENT_93	[p5l1453t1602r1609b1660],
26	(	CD	PERCENT	(	number	27	SENT_93	[p5l1638t1600r1885b1675],
27	54.8	CD	PERCENT	54.8	num	28	SENT_93	[p5l1638t1600r1885b1675],
28	%	NN	PERCENT	%	dep	25	SENT_93	[p5l1638t1600r1885b1675],
29	)	CD	NUMBER	)	num	31	SENT_93	[p5l1638t1600r1885b1675],
30	clinical	JJ	O	clinical	amod	31	SENT_93	[p5l1913t1600r2152b1660],
31	isolates	NNS	O	isolate	dep	28	SENT_93	[p5l8t1696r259b1757],
32	remained	VBD	O	remain	_	0	SENT_93	[p5l289t1697r614b1757],
33	partially	RB	O	partially	advmod	32	SENT_93	[p5l642t1696r933b1778],
34	or	CC	O	or	_	0	SENT_93	[p5l962t1717r1033b1757],
35	fully	RB	O	fully	advmod	36	SENT_93	[p5l1061t1696r1220b1778],
36	susceptible	JJ	O	susceptible	conj_or	32	SENT_93	[p5l1248t1697r1626b1778],
37	to	TO	O	to	_	0	SENT_93	[p5l1654t1705r1719b1757],
38	TPV	NN	O	tpv	prep_to	36	SENT_93	[p5l1749t1699r1915b1756],
39	.	.	O	.	_	0	SENT_93	[p5l1749t1699r1915b1756],

1	In	IN	O	in	_	0	SENT_94	[p5l1947t1699r2019b1756],
2	the	DT	O	the	det	4	SENT_94	[p5l2045t1697r2151b1757],
3	552	CD	NUMBER	552	num	4	SENT_94	[p5l8t1796r124b1854],
4	patients	NNS	O	patient	prep_in	19	SENT_94	[p5l152t1797r424b1875],
5	whose	WP$	O	whose	poss	6	SENT_94	[p5l451t1794r674b1854],
6	virus	NN	O	virus	nsubj	8	SENT_94	[p5l701t1797r877b1854],
7	was	VBD	O	be	cop	8	SENT_94	[p5l904t1814r1041b1854],
8	resistant	JJ	O	resistant	rcmod	4	SENT_94	[p5l1070t1797r1359b1854],
9	to	TO	O	to	_	0	SENT_94	[p5l1386t1802r1451b1854],
10	all	DT	O	all	quantmod	11	SENT_94	[p5l1481t1794r1562b1854],
11	five	CD	NUMBER	five	prep_to	8	SENT_94	[p5l1589t1793r1717b1854],
12	of	IN	O	of	_	0	SENT_94	[p5l1746t1793r1815b1854],
13	the	DT	O	the	det	15	SENT_94	[p5l1839t1794r1945b1854],
14	other	JJ	O	other	amod	15	SENT_94	[p5l1974t1794r2152b1854],
15	Pls	NNS	O	pl	prep_of	11	SENT_94	[p5l8t1892r131b1961],
16	,	,	O	,	_	0	SENT_94	[p5l8t1892r131b1961],
17	TPV	NN	O	tpv	nsubjpass	19	SENT_94	[p5l156t1892r307b1950],
18	was	VBD	O	be	auxpass	19	SENT_94	[p5l330t1910r467b1950],
19	predicted	VBN	O	predict	_	0	SENT_94	[p5l491t1890r819b1971],
20	to	TO	O	to	aux	25	SENT_94	[p5l843t1898r908b1951],
21	be	VB	O	be	cop	25	SENT_94	[p5l931t1890r1013b1951],
22	a	DT	O	a	det	25	SENT_94	[p5l1039t1910r1074b1950],
23	viable	JJ	O	viable	amod	25	SENT_94	[p5l1099t1890r1306b1950],
24	therapeutic	JJ	O	therapeutic	amod	25	SENT_94	[p5l1331t1890r1719b1971],
25	option	NN	O	option	xcomp	19	SENT_94	[p5l1744t1893r1967b1971],
26	(	CD	NUMBER	(	num	27	SENT_94	[p5l1994t1890r2055b1966],
27	S	NN	O	s	dep	25	SENT_94	[p5l1994t1890r2055b1966],
28	or	CC	O	or	_	0	SENT_94	[p5l2081t1910r2152b1950],
29	PS	NNP	O	PS	nn	30	SENT_94	[p5l8t1988r118b2063],
30	)	NNP	O	)	conj_or	25	SENT_94	[p5l8t1988r118b2063],
31	in	IN	O	in	_	0	SENT_94	[p5l147t1990r214b2047],
32	174	CD	PERCENT	174	prep_in	30	SENT_94	[p5l242t1990r355b2047],
33	(	CD	PERCENT	(	number	34	SENT_94	[p5l385t1988r633b2063],
34	31.5	CD	PERCENT	31.5	num	35	SENT_94	[p5l385t1988r633b2063],
35	%	NN	PERCENT	%	dep	30	SENT_94	[p5l385t1988r633b2063],
36	)	CD	NUMBER	)	num	37	SENT_94	[p5l385t1988r633b2063],
37	patients	NNS	O	patient	dep	35	SENT_94	[p5l660t1990r952b2069],
38	;	:	O	;	_	0	SENT_94	[p5l660t1990r952b2069],
39	furthermore	RB	O	furthermore	advmod	57	SENT_94	[p5l979t1987r1415b2059],
40	,	,	O	,	_	0	SENT_94	[p5l979t1987r1415b2059],
41	16.1	CD	PERCENT	16.1	num	42	SENT_94	[p5l1446t1989r1644b2048],
42	%	NN	PERCENT	%	nsubj	57	SENT_94	[p5l1446t1989r1644b2048],
43	of	IN	O	of	_	0	SENT_94	[p5l1673t1987r1742b2048],
44	patient	NN	O	patient	nn	45	SENT_94	[p5l1763t1990r2006b2069],
45	isolates	NNS	O	isolate	prep_of	42	SENT_94	[p5l2031t1990r2152b2048, p5l8t2085r162b2145],
46	not	RB	O	not	neg	47	SENT_94	[p5l186t2093r300b2145],
47	susceptible	JJ	O	susceptible	amod	45	SENT_94	[p5l325t2085r702b2166],
48	to	TO	O	to	_	0	SENT_94	[p5l727t2093r793b2145],
49	any	DT	O	any	prep_to	47	SENT_94	[p5l819t2105r946b2166],
50	of	IN	O	of	_	0	SENT_94	[p5l970t2084r1040b2145],
51	the	DT	O	the	det	54	SENT_94	[p5l1061t2085r1167b2145],
52	other	JJ	O	other	amod	54	SENT_94	[p5l1192t2085r1370b2145],
53	five	CD	NUMBER	five	num	54	SENT_94	[p5l1395t2084r1522b2145],
54	Pls	NNS	O	pl	prep_of	49	SENT_94	[p5l1547t2087r1650b2145],
55	were	VBD	O	be	cop	57	SENT_94	[p5l1675t2105r1845b2145],
56	still	RB	O	still	advmod	57	SENT_94	[p5l1870t2085r1992b2145],
57	susceptible	JJ	O	susceptible	parataxis	19	SENT_94	[p5l2016t2105r2152b2145, p5l9t2181r274b2262],
58	to	TO	O	to	_	0	SENT_94	[p5l294t2189r360b2242],
59	TPV	NN	O	tpv	prep_to	57	SENT_94	[p5l380t2183r547b2241],
60	.	.	O	.	_	0	SENT_94	[p5l380t2183r547b2241],

1	Also	RB	O	also	advmod	20	SENT_95	[p5l569t2181r744b2252],
2	,	,	O	,	_	0	SENT_95	[p5l569t2181r744b2252],
3	37.5	CD	PERCENT	37.5	num	4	SENT_95	[p5l765t2182r966b2242],
4	%	NN	PERCENT	%	nsubj	20	SENT_95	[p5l765t2182r966b2242],
5	of	IN	O	of	_	0	SENT_95	[p5l988t2181r1057b2242],
6	patient	NN	O	patient	nn	7	SENT_95	[p5l1073t2184r1314b2262],
7	isolates	NNS	O	isolate	prep_of	4	SENT_95	[p5l1333t2181r1584b2242],
8	susceptible	JJ	O	susceptible	amod	7	SENT_95	[p5l1605t2181r1983b2262],
9	to	TO	O	to	_	0	SENT_95	[p5l2002t2189r2068b2242],
10	at	IN	O	at	quantmod	12	SENT_95	[p5l2089t2189r2153b2241],
11	least	JJS	O	least	mwe	10	SENT_95	[p5l8t2279r164b2339],
12	one	CD	NUMBER	one	prep_to	8	SENT_95	[p5l188t2299r310b2339],
13	of	IN	O	of	_	0	SENT_95	[p5l335t2278r404b2339],
14	the	DT	O	the	det	17	SENT_95	[p5l425t2279r530b2339],
15	other	JJ	O	other	amod	17	SENT_95	[p5l556t2279r734b2339],
16	five	CD	NUMBER	five	num	17	SENT_95	[p5l757t2278r885b2339],
17	Pls	NNS	O	pl	prep_of	12	SENT_95	[p5l909t2281r1013b2339],
18	were	VBD	O	be	cop	20	SENT_95	[p5l1036t2299r1207b2339],
19	also	RB	O	also	advmod	20	SENT_95	[p5l1231t2278r1365b2339],
20	susceptible	JJ	O	susceptible	_	0	SENT_95	[p5l1390t2278r1768b2360],
21	to	TO	O	to	_	0	SENT_95	[p5l1792t2287r1857b2339],
22	TPV	NN	O	tpv	prep_to	20	SENT_95	[p5l1882t2281r2049b2338],
23	.	.	O	.	_	0	SENT_95	[p5l1882t2281r2049b2338],

1	Assessment	NNP	O	Assessment	_	0	SENT_96	[p5l8t2435r451b2494],
2	of	IN	O	of	_	0	SENT_96	[p5l477t2434r549b2494],
3	mutations	NNS	O	mutation	prep_of	1	SENT_96	[p5l570t2435r915b2494],
4	associated	VBN	O	associate	partmod	3	SENT_96	[p5l945t2435r1331b2494],
5	with	IN	O	with	_	0	SENT_96	[p5l1359t2435r1493b2493],
6	phenotypic	JJ	O	phenotypic	amod	7	SENT_96	[p5l1520t2435r1910b2510],
7	resistance	NN	O	resistance	prep_with	4	SENT_96	[p5l13t2532r374b2591],
8	to	TO	O	to	_	0	SENT_96	[p5l407t2536r469b2591],
9	DRV	NN	O	drv	prep_to	4	SENT_96	[p5l499t2532r673b2590],
10	and	CC	O	and	_	0	SENT_96	[p5l694t2532r830b2591],
11	TPV	NN	O	tpv	conj_and	9	SENT_96	[p5l861t2532r1017b2590],

1	A	DT	O	a	det	2	SENT_97	[p5l97t2681r157b2738],
2	number	NN	O	number	nsubjpass	8	SENT_97	[p5l186t2679r462b2739],
3	of	IN	O	of	_	0	SENT_97	[p5l493t2678r562b2739],
4	resistance-scoring	JJ	O	resistance-scoring	amod	5	SENT_97	[p5l589t2682r1213b2760],
5	algorithms	NNS	O	algorithm	prep_of	2	SENT_97	[p5l1244t2679r1620b2760],
6	have	VBP	O	have	aux	8	SENT_97	[p5l1650t2679r1817b2739],
7	been	VBN	O	be	auxpass	8	SENT_97	[p5l1845t2679r2013b2739],
8	developed	VBN	O	develop	_	0	SENT_97	[p5l2042t2679r2151b2739, p5l7t2776r288b2858],
9	based	VBN	O	base	_	0	SENT_97	[p5l312t2776r515b2837],
10	on	IN	O	on	prepc_based_on	8	SENT_97	[p5l542t2797r630b2837],
11	changes	NNS	O	change	pobj	8	SENT_97	[p5l654t2776r933b2858],
12	in	IN	O	in	_	0	SENT_97	[p5l960t2779r1027b2836],
13	the	DT	O	the	det	15	SENT_97	[p5l1050t2776r1157b2837],
14	baseline	NN	O	baseline	nn	15	SENT_97	[p5l1180t2776r1465b2837],
15	sequence	NN	O	sequence	prep_in	11	SENT_97	[p5l1491t2797r1808b2858],
16	and	CC	O	and	_	0	SENT_97	[p5l1834t2776r1965b2836],
17	their	PRP$	O	they	conj_and	15	SENT_97	[p5l1990t2776r2152b2837],

1	PI	NN	O	pi	nn	2	SENT_98	[p5l6t2904r72b2963],
2	RESISTANCE	NN	O	resistance	_	0	SENT_98	[p5l110t2902r620b2964],
3	WITH	IN	O	with	dep	2	SENT_98	[p5l652t2904r852b2963],
4	DISCORDANT	JJ	O	discordant	amod	5	SENT_98	[p5l890t2902r1420b2964],
5	PHENOTYPES	NNS	O	phenotype	pobj	3	SENT_98	[p5l1454t2902r1996b2964],

1	1	CD	NUMBER	1	num	2	SENT_99	[p5l43t3195r62b3246],
2	O	NN	O	o	_	0	SENT_99	[p5l98t3195r133b3247],
3	I	PRP	O	I	dep	2	SENT_99	[p5l1921t3124r1981b3183],
4	TPV	SYM	O	tpv	dep	10	SENT_99	[p5l2009t3128r2145b3180],
5	-	:	O	-	_	0	SENT_99	[p5l82t3238r90b3246],
6	A	NN	O	a	dep	9	SENT_99	[p5l238t3213r312b3291],
7	09	CD	NUMBER	09	num	8	SENT_99	[p5l43t3292r138b3344],
8	1	CD	NUMBER	1	dep	6	SENT_99	[p5l169t3217r199b3441],
9	I	PRP	O	I	nsubj	10	SENT_99	[p5l1922t3245r1983b3305],
10	DRV	VBP	O	drv	dep	3	SENT_99	[p5l2013t3250r2153b3303],
11	0.8	CD	NUMBER	0.8	dobj	10	SENT_99	[p5l43t3388r138b3440],

1	0.6	CD	NUMBER	0.6	_	0	SENT_100	[p5l43t3666r138b3718],
2	‘	CD	NUMBER	‘	num	3	SENT_100	[p5l169t3622r199b3719],
3	l	NN	O	l	dep	1	SENT_100	[p5l169t3622r199b3719],

1	0.5	CD	NUMBER	0.5	num	2	SENT_101	[p6l43t70r138b123],
2	l	NN	O	l	_	0	SENT_101	[p6l169t29r199b124],

1	Total	JJ	O	total	amod	2	SENT_102	[p6l363t668r518b722],
2	2006 2007 2008	CD	NUMBER	2006 2007 2008	_	0	SENT_102	[p6l1806t670r1963b722],[p6l843t670r999b722],
3	N	NN	O	n	dep	4	SENT_102	[p6l320t759r567b813],
4	=	JJ	O	=	rcmod	2	SENT_102	[p6l320t759r567b813],
5	7775	CD	NUMBER	7775	num	6	SENT_102	[p6l320t759r567b813],
6	n	NN	O	n	iobj	4	SENT_102	[p6l804t761r1028b813],
7	=	JJ	O	=	amod	9	SENT_102	[p6l804t761r1028b813],
8	2081	CD	DATE	2081	tmod	7	SENT_102	[p6l804t761r1028b813],
9	n	NN	O	n	dobj	4	SENT_102	[p6l1275t761r1511b813],
10	=	JJ	O	=	amod	12	SENT_102	[p6l1275t761r1511b813],
11	3556	CD	NUMBER	3556	tmod	10	SENT_102	[p6l1275t761r1511b813],
12	n	NN	O	n	dep	2	SENT_102	[p6l1768t760r2003b813],
13	=	JJ	O	=	amod	12	SENT_102	[p6l1768t760r2003b813],
14	2138	CD	DATE	2138	tmod	13	SENT_102	[p6l1768t760r2003b813],

1	Total	JJ	O	total	amod	2	SENT_103	[p6l363t2015r518b2069],
2	2006 2007 2008	CD	NUMBER	2006 2007 2008	_	0	SENT_103	[p6l1806t2016r1963b2069],[p6l843t2016r999b2069],
3	N	NN	O	n	dep	4	SENT_103	[p6l320t2101r567b2155],
4	=	JJ	O	=	rcmod	2	SENT_103	[p6l320t2101r567b2155],
5	1098	CD	DATE	1098	num	6	SENT_103	[p6l320t2101r567b2155],
6	n	NN	O	n	iobj	4	SENT_103	[p6l824t2102r1020b2155],
7	=	JJ	O	=	amod	9	SENT_103	[p6l824t2102r1020b2155],
8	327	CD	NUMBER	327	tmod	7	SENT_103	[p6l824t2102r1020b2155],
9	n	NN	O	n	dobj	4	SENT_103	[p6l1295t2102r1490b2155],
10	=	JJ	O	=	quantmod	11	SENT_103	[p6l1295t2102r1490b2155],
11	519	CD	NUMBER	519	num	12	SENT_103	[p6l1295t2102r1490b2155],
12	n	NN	O	n	dep	2	SENT_103	[p6l1788t2102r1983b2155],
13	=	JJ	O	=	amod	12	SENT_103	[p6l1788t2102r1983b2155],
14	252	CD	NUMBER	252	tmod	13	SENT_103	[p6l1788t2102r1983b2155],

1	Total	JJ	O	total	amod	2	SENT_104	[p6l334t3487r492b3541],
2	2006 2007 2008	CD	NUMBER	2006 2007 2008	_	0	SENT_104	[p6l1798t3488r1956b3541],[p6l821t3488r979b3541],
3	N	NN	O	n	dep	4	SENT_104	[p6l291t3574r541b3629],
4	=	JJ	O	=	rcmod	2	SENT_104	[p6l291t3574r541b3629],
5	1738	CD	DATE	1738	num	6	SENT_104	[p6l291t3574r541b3629],
6	n	NN	O	n	iobj	4	SENT_104	[p6l802t3575r999b3629],
7	=	JJ	O	=	amod	9	SENT_104	[p6l802t3575r999b3629],
8	482	CD	NUMBER	482	tmod	7	SENT_104	[p6l802t3575r999b3629],
9	n	NN	O	n	dobj	4	SENT_104	[p6l1279t3576r1477b3629],
10	=	JJ	O	=	quantmod	11	SENT_104	[p6l1279t3576r1477b3629],
11	855	CD	NUMBER	855	num	12	SENT_104	[p6l1279t3576r1477b3629],
12	n	NN	O	n	dep	2	SENT_104	[p6l1779t3576r1965b3629],
13	=	JJ	O	=	amod	12	SENT_104	[p6l1779t3576r1965b3629],
14	401	CD	NUMBER	401	tmod	13	SENT_104	[p6l1779t3576r1965b3629],

1	0.2	CD	NUMBER	0.2	num	2	SENT_105	[p7l27t872r123b925],
2	14-7	CD	NUMBER	14-7	_	0	SENT_105	[p7l419t833r552b885],
3	14.0	CD	NUMBER	14.0	number	4	SENT_105	[p7l897t847r1030b901],
4	14.4	CD	NUMBER	14.4	dep	2	SENT_105	[p7l1395t843r1528b895],
5	I	PRP	O	I	dep	4	SENT_105	[p7l1803t944r1812b953],
6	15-8	CD	NUMBER	15-8	dep	2	SENT_105	[p7l1879t828r2011b882],

1	Total	JJ	O	total	_	0	SENT_106	[p7l334t1143r491b1198],
2	2006 2007 2008	CD	NUMBER	2006 2007 2008	num	3	SENT_106	[p7l1798t1144r1956b1198],[p7l821t1144r979b1198],
3	N	NN	O	n	dep	1	SENT_106	[p7l291t1231r541b1286],
4	=	JJ	O	=	dep	3	SENT_106	[p7l291t1231r541b1286],
5	1173	CD	DATE	1173	num	6	SENT_106	[p7l291t1231r541b1286],
6	n	NN	O	n	iobj	4	SENT_106	[p7l802t1232r999b1286],
7	=	JJ	O	=	quantmod	8	SENT_106	[p7l802t1232r999b1286],
8	315	CD	NUMBER	315	num	9	SENT_106	[p7l802t1232r999b1286],
9	n	NN	O	n	dobj	4	SENT_106	[p7l1279t1232r1478b1286],
10	=	JJ	O	=	quantmod	11	SENT_106	[p7l1279t1232r1478b1286],
11	547	CD	NUMBER	547	num	12	SENT_106	[p7l1279t1232r1478b1286],
12	n	NN	O	n	npadvmod	13	SENT_106	[p7l1779t1232r1966b1286],
13	=	JJ	O	=	amod	9	SENT_106	[p7l1779t1232r1966b1286],
14	311	CD	NUMBER	311	dep	1	SENT_106	[p7l1779t1232r1966b1286],

1	FIG	NNP	O	FIG	_	0	SENT_107	[p7l59t1336r132b1363],
2	.	.	O	.	_	0	SENT_107	[p7l59t1336r132b1363],

1	1	LS	NUMBER	1	_	0	SENT_108	[p7l145t1337r170b1363],
2	.	.	O	.	_	0	SENT_108	[p7l145t1337r170b1363],

1	Rates	NNS	O	rate	nsubj	9	SENT_109	[p7l210t1336r297b1363],
2	of	IN	O	of	_	0	SENT_109	[p7l309t1335r342b1363],
3	phenotypic	JJ	O	phenotypic	amod	4	SENT_109	[p7l351t1335r534b1373],
4	resistance	NN	O	resistance	prep_of	1	SENT_109	[p7l546t1336r705b1363],
5	to	TO	O	to	_	0	SENT_109	[p7l716t1339r747b1363],
6	second-generation	JJ	O	second-generation	amod	8	SENT_109	[p7l759t1335r1058b1373],
7	protease	NN	O	protease	nn	8	SENT_109	[p7l1068t1339r1206b1373],
8	inhibitors	NNS	O	inhibitor	prep_to	4	SENT_109	[p7l1217t1335r1373b1363],
9	(	VBP	O	(	_	0	SENT_109	[p7l1386t1335r1457b1371],
10	Pls	NNS	O	pl	dep	15	SENT_109	[p7l1386t1335r1457b1371],
11	)	JJ	O	)	amod	15	SENT_109	[p7l1386t1335r1457b1371],
12	tipranavir	NN	O	tipranavir	nn	15	SENT_109	[p7l1469t1336r1632b1373],
13	(	CD	NUMBER	(	num	15	SENT_109	[p7l1645t1335r1737b1371],
14	TPV	NN	O	tpv	nn	15	SENT_109	[p7l1645t1335r1737b1371],
15	)	NN	O	)	dep	9	SENT_109	[p7l1645t1335r1737b1371],
16	and	CC	O	and	_	0	SENT_109	[p7l1750t1335r1811b1363],
17	darunavir	NN	O	darunavir	dep	19	SENT_109	[p7l1823t1335r1986b1363],
18	(	CD	NUMBER	(	num	17	SENT_109	[p7l1998t1335r2099b1371],
19	DRV	NN	O	drv	dep	9	SENT_109	[p7l1998t1335r2099b1371],
20	)	CD	NUMBER	)	num	19	SENT_109	[p7l1998t1335r2099b1371],
21	from	IN	O	from	_	0	SENT_109	[p7l59t1376r138b1404],
22	2006	CD	DATE	2006	num	24	SENT_109	[p7l152t1377r225b1404],
23	to	TO	DATE	to	dep	24	SENT_109	[p7l241t1380r272b1404],
24	2008	CD	DATE	2008	prep_from	19	SENT_109	[p7l287t1377r360b1404],
25	as	IN	O	as	_	0	SENT_109	[p7l376t1386r409b1404],
26	a	DT	O	a	det	27	SENT_109	[p7l424t1386r441b1404],
27	function	NN	O	function	prep_as	24	SENT_109	[p7l457t1376r592b1404],
28	of	IN	O	of	_	0	SENT_109	[p7l607t1376r639b1404],
29	resistance	NN	O	resistance	prep_of	27	SENT_109	[p7l653t1378r811b1404],
30	to	TO	O	to	_	0	SENT_109	[p7l826t1380r857b1404],
31	first-generation	JJ	O	first-generation	amod	32	SENT_109	[p7l873t1376r1123b1414],
32	Pls	NNS	O	pl	prep_to	9	SENT_109	[p7l1137t1377r1195b1409],
33	,	,	O	,	_	0	SENT_109	[p7l1137t1377r1195b1409],
34	lopinavir	NN	O	lopinavir	appos	32	SENT_109	[p7l1211t1376r1368b1414],
35	,	,	O	,	_	0	SENT_109	[p7l1211t1376r1368b1414],
36	saquinavir	NN	O	saquinavir	appos	32	SENT_109	[p7l1384t1378r1565b1414],
37	,	,	O	,	_	0	SENT_109	[p7l1384t1378r1565b1414],
38	atazanavir	NN	O	atazanavir	appos	32	SENT_109	[p7l1581t1378r1761b1409],
39	,	,	O	,	_	0	SENT_109	[p7l1581t1378r1761b1409],
40	and	CC	O	and	_	0	SENT_109	[p7l1777t1376r1838b1404],
41	fosamprenavir	NN	O	fosamprenavir	appos	32	SENT_109	[p7l1853t1376r2098b1414],
42	.	.	O	.	_	0	SENT_109	[p7l1853t1376r2098b1414],

1	Proportion	NN	O	proportion	_	0	SENT_110	[p7l59t1418r236b1455],
2	of	IN	O	of	_	0	SENT_110	[p7l249t1417r282b1445],
3	isolates	NNS	O	isolate	prep_of	1	SENT_110	[p7l293t1417r413b1445],
4	resistant	JJ	O	resistant	amod	1	SENT_110	[p7l426t1419r563b1445],
5	to	TO	O	to	_	0	SENT_110	[p7l576t1421r607b1445],
6	(	CD	NUMBER	(	prep_to	4	SENT_110	[p7l622t1417r671b1448],
7	A	DT	O	a	det	12	SENT_110	[p7l622t1417r671b1448],
8	)	NN	O	)	nn	12	SENT_110	[p7l622t1417r671b1448],
9	second	JJ	ORDINAL	second	amod	12	SENT_110	[p7l686t1417r985b1455],
10	—	NN	O	—	nn	12	SENT_110	[p7l686t1417r985b1455],
11	generation	NN	O	generation	nn	12	SENT_110	[p7l686t1417r985b1455],
12	Pls	NNS	O	pl	dep	6	SENT_110	[p7l997t1418r1055b1450],
13	,	,	O	,	_	0	SENT_110	[p7l997t1418r1055b1450],
14	(	NN	O	(	nn	15	SENT_110	[p7l1071t1417r1116b1448],
15	B	NN	O	b	conj_and	6	SENT_110	[p7l1071t1417r1116b1448],
16	)	CD	NUMBER	)	number	17	SENT_110	[p7l1071t1417r1116b1448],
17	four	CD	NUMBER	four	num	19	SENT_110	[p7l1130t1417r1198b1445],
18	first-generation	JJ	O	first-generation	amod	19	SENT_110	[p7l1211t1417r1462b1455],
19	Pls	NNS	O	pl	dep	15	SENT_110	[p7l1474t1418r1532b1450],
20	,	,	O	,	_	0	SENT_110	[p7l1474t1418r1532b1450],
21	(	NN	O	(	nn	22	SENT_110	[p7l1548t1417r1595b1448],
22	C	NN	O	c	conj_and	6	SENT_110	[p7l1548t1417r1595b1448],
23	)	CD	NUMBER	)	number	24	SENT_110	[p7l1548t1417r1595b1448],
24	three	CD	NUMBER	three	num	26	SENT_110	[p7l1609t1417r1691b1445],
25	first-generation	JJ	O	first-generation	amod	26	SENT_110	[p7l1704t1417r1954b1455],
26	PIS	NN	O	pi	dep	22	SENT_110	[p7l1967t1418r2025b1450],
27	,	,	O	,	_	0	SENT_110	[p7l1967t1418r2025b1450],
28	and	CC	O	and	_	0	SENT_110	[p7l2039t1417r2100b1445],
29	(	NN	O	(	nn	30	SENT_110	[p7l61t1458r111b1489],
30	D	NN	O	d	prep_to	4	SENT_110	[p7l61t1458r111b1489],
31	)	CD	NUMBER	)	number	32	SENT_110	[p7l61t1458r111b1489],
32	two	CD	NUMBER	two	num	34	SENT_110	[p7l126t1462r188b1486],
33	first-generation	JJ	O	first-generation	amod	34	SENT_110	[p7l201t1458r451b1496],
34	PIs	NNS	O	pi	dep	30	SENT_110	[p7l463t1459r520b1486],
35	.	.	O	.	_	0	SENT_110	[p7l463t1459r520b1486],

1	Histograms	NNS	MISC	histogram	nsubj	2	SENT_111	[p7l534t1459r724b1496],
2	present	VBP	DATE	present	conj_and	2	SENT_111	[p7l736t1462r857b1496],
3	the	DT	O	the	det	4	SENT_111	[p7l869t1458r919b1486],
4	proportion	NN	O	proportion	dobj	2	SENT_111	[p7l931t1459r1109b1496],
5	of	IN	O	of	_	0	SENT_111	[p7l1122t1458r1154b1486],
6	resistant	JJ	O	resistant	amod	7	SENT_111	[p7l1165t1459r1302b1486],
7	isolates	NNS	O	isolate	prep_of	4	SENT_111	[p7l1314t1458r1434b1486],
8	in	IN	O	in	_	0	SENT_111	[p7l1447t1459r1478b1486],
9	total	JJ	O	total	prep_in	2	SENT_111	[p7l1490t1458r1563b1486],
10	and	CC	O	and	_	0	SENT_111	[p7l1576t1458r1637b1486],
11	per	IN	O	per	_	0	SENT_111	[p7l1649t1467r1703b1496],
12	year	NN	DURATION	year	prep_per	2	SENT_111	[p7l1715t1467r1786b1496],
13	for	IN	O	for	_	0	SENT_111	[p7l1798t1458r1844b1486],
14	each	DT	O	each	det	16	SENT_111	[p7l1857t1458r1930b1486],
15	resistance	NN	O	resistance	nn	16	SENT_111	[p7l1942t1459r2100b1486],
16	category	NN	O	category	prep_for	12	SENT_111	[p7l59t1503r199b1537],
17	presented	VBN	O	present	partmod	16	SENT_111	[p7l213t1499r380b1537],
18	.	.	O	.	_	0	SENT_111	[p7l213t1499r380b1537],

1	The	DT	O	the	det	2	SENT_112	[p7l397t1499r458b1527],
2	numbers	NNS	O	number	nsubj	6	SENT_112	[p7l472t1499r616b1527],
3	above	IN	O	above	_	0	SENT_112	[p7l631t1499r728b1527],
4	each	DT	O	each	det	5	SENT_112	[p7l743t1499r816b1527],
5	bar	NN	O	bar	prep_above	2	SENT_112	[p7l829t1499r883b1527],
6	indicate	VBP	O	indicate	_	0	SENT_112	[p7l898t1499r1026b1527],
7	the	DT	O	the	det	8	SENT_112	[p7l1041t1499r1091b1527],
8	percent	NN	O	percent	dobj	6	SENT_112	[p7l1106t1503r1227b1537],
9	of	IN	O	of	_	0	SENT_112	[p7l1242t1499r1274b1527],
10	isolates	NNS	O	isolate	prep_of	8	SENT_112	[p7l1288t1499r1407b1527],
11	in	IN	O	in	_	0	SENT_112	[p7l1422t1500r1453b1527],
12	each	DT	O	each	det	13	SENT_112	[p7l1468t1499r1541b1527],
13	category	NN	O	category	prep_in	10	SENT_112	[p7l1556t1503r1702b1537],
14	.	.	O	.	_	0	SENT_112	[p7l1556t1503r1702b1537],

1	The	DT	O	the	det	2	SENT_113	[p7l1719t1499r1779b1527],
2	values	NNS	O	value	nsubj	6	SENT_113	[p7l1794t1499r1898b1527],
3	below	IN	O	below	_	0	SENT_113	[p7l1912t1499r2012b1527],
4	each	DT	O	each	det	5	SENT_113	[p7l2028t1499r2101b1527],
5	figure	NN	O	figure	prep_below	2	SENT_113	[p7l59t1540r155b1578],
6	represent	VBP	O	represent	_	0	SENT_113	[p7l169t1544r321b1578],
7	the	DT	O	the	det	9	SENT_113	[p7l334t1540r384b1568],
8	respective	JJ	O	respective	amod	9	SENT_113	[p7l397t1542r561b1578],
9	N	NN	O	n	dobj	6	SENT_113	[p7l574t1541r604b1568],
10	(	CD	NUMBER	(	num	12	SENT_113	[p7l617t1540r711b1576],
11	total	JJ	O	total	amod	12	SENT_113	[p7l617t1540r711b1576],
12	)	NN	O	)	dep	9	SENT_113	[p7l617t1540r711b1576],
13	and	CC	O	and	_	0	SENT_113	[p7l726t1540r787b1568],
14	11	CD	NUMBER	11	number	15	SENT_113	[p7l801t1549r819b1568],
15	(	CD	NUMBER	(	dobj	6	SENT_113	[p7l835t1540r899b1578],
16	per	IN	O	per	_	0	SENT_113	[p7l835t1540r899b1578],
17	year	NN	DURATION	year	nn	18	SENT_113	[p7l912t1540r994b1578],
18	)	NN	O	)	prep_per	15	SENT_113	[p7l912t1540r994b1578],
19	for	IN	O	for	_	0	SENT_113	[p7l1008t1540r1054b1568],
20	set	NN	O	set	prep_for	18	SENT_113	[p7l1068t1544r1112b1568],
21	of	IN	O	of	_	0	SENT_113	[p7l1125t1540r1158b1568],
22	tipranavir	NN	O	tipranavir	prep_of	20	SENT_113	[p7l1170t1542r1332b1578],
23	versus	CC	O	versus	prep	22	SENT_113	[p7l1345t1550r1451b1568],
24	darunavir	NN	O	darunavir	nn	25	SENT_113	[p7l1465t1540r1627b1568],
25	comparisons	NNS	O	comparison	dep	23	SENT_113	[p7l1641t1542r1855b1578],
26	.	.	O	.	_	0	SENT_113	[p7l1641t1542r1855b1578],

1	associated	JJ	O	associated	amod	2	SENT_114	[p7l8t1741r365b1801],
2	effects	NNS	O	effect	_	0	SENT_114	[p7l395t1740r613b1801],
3	on	IN	O	on	_	0	SENT_114	[p7l644t1761r732b1801],
4	phenotypic	JJ	O	phenotypic	amod	7	SENT_114	[p7l758t1741r1153b1822],
5	or	CC	O	or	_	0	SENT_114	[p7l1184t1761r1256b1801],
6	clinical	JJ	O	clinical	amod	7	SENT_114	[p7l1285t1740r1530b1801],
7	responses	NNS	O	response	prep_on	2	SENT_114	[p7l1558t1761r1916b1822],
8	.	.	O	.	_	0	SENT_114	[p7l1558t1761r1916b1822],

1	These	DT	O	these	det	2	SENT_115	[p7l1949t1740r2150b1801],
2	scores	NNS	O	score	nsubj	4	SENT_115	[p7l8t1858r218b1898],
3	have	VBP	O	have	aux	4	SENT_115	[p7l247t1838r415b1898],
4	revealed	VBN	O	reveal	_	0	SENT_115	[p7l445t1838r743b1898],
5	that	IN	O	that	complm	18	SENT_115	[p7l772t1838r909b1898],
6	the	DT	O	the	det	7	SENT_115	[p7l937t1838r1044b1898],
7	pathways	NNS	O	pathway	nsubjpass	18	SENT_115	[p7l1073t1838r1416b1919],
8	to	TO	O	to	_	0	SENT_115	[p7l1446t1846r1512b1898],
9	the	DT	O	the	det	10	SENT_115	[p7l1542t1838r1649b1898],
10	emergence	NN	O	emergence	prep_to	7	SENT_115	[p7l1679t1858r2054b1919],
11	of	IN	O	of	_	0	SENT_115	[p7l2084t1837r2153b1898],
12	resistance	NN	O	resistance	prep_of	10	SENT_115	[p7l7t1937r348b1995],
13	to	TO	O	to	_	0	SENT_115	[p7l372t1942r439b1995],
14	both	DT	O	both	det	15	SENT_115	[p7l460t1934r622b1995],
15	agents	NNS	O	agent	prep_to	7	SENT_115	[p7l646t1942r870b2015],
16	can	MD	O	can	aux	18	SENT_115	[p7l895t1954r1015b1995],
17	be	VB	O	be	auxpass	18	SENT_115	[p7l1035t1934r1117b1995],
18	complicated	VBN	O	complicate	ccomp	4	SENT_115	[p7l1142t1934r1588b2015],
19	,	,	O	,	_	0	SENT_115	[p7l1142t1934r1588b2015],
20	often	RB	O	often	advmod	21	SENT_115	[p7l1614t1934r1791b1995],
21	involving	VBG	O	involve	xcomp	18	SENT_115	[p7l1814t1934r2151b2015],
22	clusters	NNS	O	cluster	dobj	21	SENT_115	[p7l8t2032r271b2092],
23	of	IN	O	of	_	0	SENT_115	[p7l299t2031r368b2092],
24	amino	NN	O	amino	nn	26	SENT_115	[p7l392t2034r611b2092],
25	acid	NN	O	acid	nn	26	SENT_115	[p7l639t2031r781b2092],
26	changes	NNS	O	change	prep_of	22	SENT_115	[p7l808t2032r1088b2113],
27	and	CC	O	and	_	0	SENT_115	[p7l1116t2031r1247b2091],
28	a	DT	O	a	det	29	SENT_115	[p7l1274t2052r1310b2092],
29	number	NN	O	number	dobj	21	SENT_115	[p7l1336t2031r1612b2092],
30	of	IN	O	of	_	0	SENT_115	[p7l1639t2031r1708b2092],
31	unique	JJ	O	unique	amod	32	SENT_115	[p7l1731t2034r1975b2113],
32	substitutions	NNS	O	substitution	prep_of	29	SENT_115	[p7l2002t2031r2151b2092, p7l8t2115r412b2190],
33	.16	CD	NUMBER	.16	dep	29	SENT_115	[p7l2002t2031r2151b2092, p7l8t2115r412b2190],

1	I	PRP	O	I	_	0	SENT_116	[p7l946t2357r982b2393],
2	Hypersusceptible	JJ	O	hypersusceptible	amod	4	SENT_116	[p7l1008t2353r1416b2404],
3	(	NN	O	(	nn	4	SENT_116	[p7l1436t2352r1554b2404],
4	HS	NN	O	h	dep	1	SENT_116	[p7l1436t2352r1554b2404],
5	)	CD	NUMBER	)	dep	4	SENT_116	[p7l1436t2352r1554b2404],
6	:	:	O	:	_	0	SENT_116	[p7l1436t2352r1554b2404],
7	TPV	NN	O	tpv	nn	8	SENT_116	[p7l1574t2353r1677b2392],
8	FC	NN	O	fc	dep	4	SENT_116	[p7l1697t2352r1763b2393],
9	<	JJR	O	<	dep	8	SENT_116	[p7l1782t2354r1884b2393],
10	0.5	CD	NUMBER	0.5	dep	1	SENT_116	[p7l1782t2354r1884b2393],

1	100	CD	NUMBER	100	num	4	SENT_117	[p7l102t2434r210b2486],
2	Susceptible	JJ	O	susceptible	amod	4	SENT_117	[p7l1007t2412r1281b2463],
3	(	NN	O	(	nn	4	SENT_117	[p7l1302t2412r1381b2463],
4	S	NN	O	s	_	0	SENT_117	[p7l1302t2412r1381b2463],
5	)	CD	NUMBER	)	dep	4	SENT_117	[p7l1302t2412r1381b2463],
6	:	:	O	:	_	0	SENT_117	[p7l1302t2412r1381b2463],
7	TPV	NN	O	tpv	nn	8	SENT_117	[p7l1400t2413r1504b2452],
8	FC	NN	O	fc	dep	9	SENT_117	[p7l1524t2412r1589b2453],
9	<	JJR	O	<	dep	4	SENT_117	[p7l1609t2414r1665b2452],
10	2	CD	NUMBER	2	dep	9	SENT_117	[p7l1609t2414r1665b2452],

1	I	PRP	O	I	nn	6	SENT_118	[p7l946t2478r981b2514],
2	Partially	RB	O	partially	advmod	3	SENT_118	[p7l1009t2472r1196b2523],
3	susceptible	JJ	O	susceptible	amod	1	SENT_118	[p7l1213t2472r1479b2522],
4	(	NN	O	(	nn	6	SENT_118	[p7l1499t2471r1614b2522],
5	PS	NNP	O	PS	nn	6	SENT_118	[p7l1499t2471r1614b2522],
6	)	NNP	O	)	_	0	SENT_118	[p7l1499t2471r1614b2522],
7	:	:	O	:	_	0	SENT_118	[p7l1499t2471r1614b2522],
8	2	CD	NUMBER	2	number	9	SENT_118	[p7l1635t2473r1661b2511],
9	8	CD	NUMBER	8	dep	6	SENT_118	[p7l1557t2532r1615b2571],

1	(	NN	O	(	nn	3	SENT_119	[p7l33t2702r72b2733],
2	D	NN	O	d	nn	3	SENT_119	[p7l33t2702r72b2733],
3	G	NN	O	g	dep	8	SENT_119	[p7l33t2738r72b2772],
4	)	CD	NUMBER	)	num	5	SENT_119	[p7l33t2738r72b2772],
5	E	NN	O	e	dep	3	SENT_119	[p7l20t2776r72b2845],
6	_	CD	NUMBER	_	num	7	SENT_119	[p7l20t2851r72b2934],
7	g	NN	O	g	dep	8	SENT_119	[p7l20t2851r72b2934],
8	60	CD	NUMBER	60	dep	15	SENT_119	[p7l137t2855r211b2907],
9	"	``	O	"	punct	11	SENT_119	[p7l19t2962r72b3017],
10	5	CD	NUMBER	5	num	11	SENT_119	[p7l19t2962r72b3017],
11	E	NN	O	e	dep	8	SENT_119	[p7l23t3044r72b3138],
12	40	CD	NUMBER	40	number	13	SENT_119	[p7l136t3068r211b3119],
13	2	CD	NUMBER	2	dep	11	SENT_119	[p7l33t3142r72b3190],
14	CD	NNP	O	CD	nn	15	SENT_119	[p7l33t3197r72b3231],
15	o.	NNP	O	o.	_	0	SENT_119	[p7l20t3237r71b3275],

1	(	NN	O	(	nn	2	SENT_120	[p7l273t3575r2138b3600],
2	DC/JUJICDCDUJIICDCDUJIICDCDCDIICDC/JCDIIUJC	NN	O	dc/jujicdcdujiicdcdujiicdcdcdiicdc/jcdiiujc	_	0	SENT_120	[p7l273t3575r2138b3600],
3	/	:	O	/	punct	10	SENT_120	[p7l273t3575r2138b3600],
4	JUDIIUDUJUDICDCDUJDCC	NN	O	judiiudujudicdcdujdcc	dep	10	SENT_120	[p7l273t3575r2138b3600],
5	/	:	O	/	punct	7	SENT_120	[p7l273t3575r2138b3600],
6	)	CD	NUMBER	)	number	7	SENT_120	[p7l273t3575r2138b3600],
7	(	CD	NUMBER	(	dep	4	SENT_120	[p7l273t3575r2138b3600],
8	/	:	O	/	punct	7	SENT_120	[p7l273t3575r2138b3600],
9	JCDEEUDUJUJIICDCDUJI	NNP	O	JCDEEUDUJUJIICDCDUJI	nn	10	SENT_120	[p7l273t3575r2138b3600],
10	ID	NNP	O	ID	dep	2	SENT_120	[p7l274t3603r2096b3630],
11	.	.	O	.	_	0	SENT_120	[p7l274t3603r2096b3630],

1	—	NN	O	—	_	0	SENT_121	[p7l274t3603r2096b3630],
2	.	.	O	.	_	0	SENT_121	[p7l274t3603r2096b3630],

1	Io	NNP	O	Io	_	0	SENT_122	[p7l274t3603r2096b3630],
2	.	.	O	.	_	0	SENT_122	[p7l274t3603r2096b3630],

1	—	NN	O	—	_	0	SENT_123	[p7l274t3603r2096b3630],
2	.	.	O	.	_	0	SENT_123	[p7l274t3603r2096b3630],

1	ID	NNP	O	ID	_	0	SENT_124	[p7l274t3603r2096b3630],
2	.	.	O	.	_	0	SENT_124	[p7l274t3603r2096b3630],

1	—	NN	O	—	_	0	SENT_125	[p7l274t3603r2096b3630],
2	.	.	O	.	_	0	SENT_125	[p7l274t3603r2096b3630],

1	Io	NNP	O	Io	_	0	SENT_126	[p7l274t3603r2096b3630],
2	.	.	O	.	_	0	SENT_126	[p7l274t3603r2096b3630],

1	—	NN	O	—	_	0	SENT_127	[p7l274t3603r2096b3630],
2	.	.	O	.	_	0	SENT_127	[p7l274t3603r2096b3630],

1	Io	NNP	O	Io	_	0	SENT_128	[p7l274t3603r2096b3630],
2	.	.	O	.	_	0	SENT_128	[p7l274t3603r2096b3630],

1	—	NN	O	—	_	0	SENT_129	[p7l274t3603r2096b3630],
2	.	.	O	.	_	0	SENT_129	[p7l274t3603r2096b3630],

1	Io	NNP	O	Io	_	0	SENT_130	[p7l274t3603r2096b3630],
2	.	.	O	.	_	0	SENT_130	[p7l274t3603r2096b3630],

1	—	NN	O	—	_	0	SENT_131	[p7l274t3603r2096b3630],
2	.	.	O	.	_	0	SENT_131	[p7l274t3603r2096b3630],

1	IflICLIllIo	NN	O	ifliclillio	_	0	SENT_132	[p7l274t3603r2096b3630],
2	.	.	O	.	_	0	SENT_132	[p7l274t3603r2096b3630],

1	—	NN	O	—	_	0	SENT_133	[p7l274t3603r2096b3630],
2	.	.	O	.	_	0	SENT_133	[p7l274t3603r2096b3630],

1	Io	NNP	O	Io	_	0	SENT_134	[p7l274t3603r2096b3630],
2	24	CD	NUMBER	24	number	3	SENT_134	[p7l311t3662r401b3713],
3	|	CD	NUMBER	|	dep	1	SENT_134	[p7l311t3662r401b3713],
4	47V	NN	O	47v	nn	13	SENT_134	[p7l463t3662r585b3713],
5	50L	NN	O	50l	nn	13	SENT_134	[p7l637t3662r751b3714],
6	50V	NN	O	50v	nn	13	SENT_134	[p7l808t3662r930b3714],
7	54L	NN	O	54l	nn	13	SENT_134	[p7l982t3662r1097b3714],
8	58E	NN	O	58e	nn	13	SENT_134	[p7l1148t3662r1268b3714],
9	74P	NN	O	74p	nn	13	SENT_134	[p7l1322t3662r1441b3713],
10	76V	NN	O	76v	nn	13	SENT_134	[p7l1494t3662r1616b3714],
11	82L	NN	O	82l	nn	13	SENT_134	[p7l1664t3662r1778b3714],
12	82T	NN	O	82t	nn	13	SENT_134	[p7l1829t3662r1948b3714],
13	83D	NN	O	83d	dep	3	SENT_134	[p7l1998t3662r2121b3714],

1	Mutation	NN	O	mutation	_	0	SENT_135	[p8l745t36r1005b88],
2	and	CC	O	and	_	0	SENT_135	[p8l1039t36r1151b88],
3	FC	NN	O	fc	nn	4	SENT_135	[p8l1181t34r1266b88],
4	category	NN	O	category	conj_and	1	SENT_135	[p8l1288t39r1555b102],

1	FIG	NNP	O	FIG	_	0	SENT_136	[p8l8t195r164b254],
2	.	.	O	.	_	0	SENT_136	[p8l8t195r164b254],

1	2	LS	NUMBER	2	_	0	SENT_137	[p8l223t198r279b253],
2	.	.	O	.	_	0	SENT_137	[p8l223t198r279b253],

1	Occurrence	NN	O	occurrence	_	0	SENT_138	[p8l363t194r760b254],
2	of	IN	O	of	_	0	SENT_138	[p8l818t193r887b254],
3	key	JJ	O	key	amod	4	SENT_138	[p8l939t193r1065b275],
4	mutations	NNS	O	mutation	prep_of	1	SENT_138	[p8l1119t196r1473b254],
5	across	IN	O	across	_	0	SENT_138	[p8l1530t214r1744b254],
6	tipranavir	NN	O	tipranavir	prep_across	4	SENT_138	[p8l1800t196r2150b275],
7	(	CD	NUMBER	(	num	8	SENT_138	[p8l10t283r208b359],
8	TPV	NN	O	tpv	dep	1	SENT_138	[p8l10t283r208b359],
9	)	CD	NUMBER	)	num	12	SENT_138	[p8l10t283r208b359],
10	phenotypic	JJ	O	phenotypic	amod	12	SENT_138	[p8l234t283r629b364],
11	resistance	NN	O	resistance	nn	12	SENT_138	[p8l653t285r994b343],
12	classifications	NNS	O	classification	dep	8	SENT_138	[p8l1019t282r1515b343],
13	.	.	O	.	_	0	SENT_138	[p8l1019t282r1515b343],

1	The	DT	O	the	det	2	SENT_139	[p8l1543t282r1673b343],
2	denominator	NN	O	denominator	nsubj	8	SENT_139	[p8l1698t282r2151b343],
3	for	IN	O	for	_	0	SENT_139	[p8l7t371r106b432],
4	all	DT	O	all	det	5	SENT_139	[p8l141t371r224b431],
5	participants	NNS	O	participant	prep_for	2	SENT_139	[p8l257t374r674b453],
6	is	VBZ	O	be	cop	8	SENT_139	[p8l710t374r763b432],
7	the	DT	O	the	det	8	SENT_139	[p8l798t371r905b432],
8	number	NN	O	number	_	0	SENT_139	[p8l939t371r1215b432],
9	of	IN	O	of	_	0	SENT_139	[p8l1251t371r1320b432],
10	isolates	NNS	O	isolate	prep_of	8	SENT_139	[p8l1352t371r1608b432],
11	with	IN	O	with	_	0	SENT_139	[p8l1643t371r1804b431],
12	that	DT	O	that	det	13	SENT_139	[p8l1838t371r1975b431],
13	mutation	NN	O	mutation	prep_with	10	SENT_139	[p8l2009t391r2151b431, p8l7t462r211b519],
14	and	CC	O	and	_	0	SENT_139	[p8l247t459r378b519],
15	the	DT	O	the	det	16	SENT_139	[p8l415t459r522b519],
16	numerator	NN	O	numerator	nsubj	19	SENT_139	[p8l558t467r931b519],
17	is	VBZ	O	be	cop	19	SENT_139	[p8l967t462r1021b519],
18	the	DT	O	the	det	19	SENT_139	[p8l1058t459r1165b519],
19	number	NN	O	number	conj_and	8	SENT_139	[p8l1201t459r1477b519],
20	of	IN	O	of	_	0	SENT_139	[p8l1514t459r1584b519],
21	isolates	NNS	O	isolate	prep_of	19	SENT_139	[p8l1618t459r1874b519],
22	in	IN	O	in	_	0	SENT_139	[p8l1912t462r1979b518],
23	that	DT	O	that	det	25	SENT_139	[p8l2015t459r2151b519],
24	phenotypic	JJ	O	phenotypic	amod	25	SENT_139	[p8l6t549r401b630],
25	classification	NN	O	classification	prep_in	21	SENT_139	[p8l432t548r880b609],
26	grouping	VBG	O	group	partmod	25	SENT_139	[p8l909t551r1234b630],
27	with	IN	O	with	_	0	SENT_139	[p8l1261t549r1423b609],
28	that	DT	O	that	det	29	SENT_139	[p8l1451t549r1588b609],
29	mutation	NN	O	mutation	prep_with	26	SENT_139	[p8l1616t551r1952b609],
30	.	.	O	.	_	0	SENT_139	[p8l1616t551r1952b609],

1	The	DT	O	the	det	2	SENT_140	[p8l96t645r226b706],
2	results	NNS	O	result	nsubj	16	SENT_140	[p8l267t646r496b706],
3	of	IN	O	of	_	0	SENT_140	[p8l539t645r608b706],
4	the	DT	O	the	det	6	SENT_140	[p8l646t645r753b706],
5	present	JJ	DATE	present	amod	6	SENT_140	[p8l793t654r1053b727],
6	study	NN	O	study	prep_of	2	SENT_140	[p8l1094t646r1292b727],
7	confirm	VBP	O	confirm	_	0	SENT_140	[p8l1332t645r1605b706],
8	previously	RB	DATE	previously	advmod	9	SENT_140	[p8l1644t646r2020b727],
9	reported	VBN	O	report	amod	10	SENT_140	[p8l2060t666r2153b706, p8l6t743r238b824],
10	associations	NNS	O	association	dobj	7	SENT_140	[p8l283t746r700b803],
11	between	IN	O	between	_	0	SENT_140	[p8l740t743r1039b803],
12	specific	JJ	O	specific	amod	13	SENT_140	[p8l1081t742r1338b824],
13	mutations	NNS	O	mutation	prep_between	10	SENT_140	[p8l1381t746r1735b803],
14	and	CC	O	and	_	0	SENT_140	[p8l1779t743r1911b803],
15	either	CC	O	either	advmod	16	SENT_140	[p8l1954t743r2153b803],
16	reduced	VBN	O	reduce	conj_and	7	SENT_140	[p8l7t841r290b902],
17	or	CC	O	or	_	0	SENT_140	[p8l325t861r397b902],
18	improved	VBN	O	improve	conj_and	7	SENT_140	[p8l429t841r774b922],
19	clinical	JJ	O	clinical	amod	20	SENT_140	[p8l808t841r1053b902],
20	response	NN	O	response	dobj	16	SENT_140	[p8l1085t861r1394b922],
21	to	TO	O	to	_	0	SENT_140	[p8l1427t849r1494b902],
22	TPV	NN	O	tpv	prep_to	16	SENT_140	[p8l1527t827r1762b901],
23	.17	CD	NUMBER	.17	num	24	SENT_140	[p8l1527t827r1762b901],
24	Mutations	NNS	O	mutation	nsubjpass	34	SENT_140	[p8l1793t843r2151b902],
25	associated	VBN	O	associate	partmod	24	SENT_140	[p8l7t939r365b999],
26	with	IN	O	with	_	0	SENT_140	[p8l394t939r556b999],
27	a	DT	O	a	det	30	SENT_140	[p8l585t959r621b999],
28	reduced	VBN	O	reduce	amod	30	SENT_140	[p8l652t938r936b999],
29	clinical	JJ	O	clinical	amod	30	SENT_140	[p8l966t938r1211b999],
30	response	NN	O	response	prep_with	25	SENT_140	[p8l1240t959r1548b1020],
31	were	VBD	O	be	auxpass	34	SENT_140	[p8l1577t959r1749b999],
32	most	RBS	O	most	advmod	33	SENT_140	[p8l1779t947r1951b999],
33	commonly	RB	O	commonly	advmod	34	SENT_140	[p8l1980t959r2153b999, p8l6t1036r232b1117],
34	found	VBN	O	find	rcmod	22	SENT_140	[p8l271t1035r480b1096],
35	in	IN	O	in	_	0	SENT_140	[p8l520t1039r588b1095],
36	the	DT	O	the	det	37	SENT_140	[p8l626t1036r733b1096],
37	isolates	NNS	O	isolate	prep_in	34	SENT_140	[p8l773t1036r1030b1096],
38	with	IN	O	with	_	0	SENT_140	[p8l1069t1036r1231b1096],
39	phenotypic	JJ	O	phenotypic	amod	40	SENT_140	[p8l1268t1036r1664b1117],
40	resistance	NN	O	resistance	prep_with	37	SENT_140	[p8l1704t1039r2045b1096],
41	to	TO	O	to	prep	34	SENT_140	[p8l2086t1044r2152b1096],

1	100	CD	NUMBER	100	num	4	SENT_141	[p8l101t1279r209b1331],
2	Susceptible	JJ	O	susceptible	amod	4	SENT_141	[p8l902t1294r1177b1345],
3	(	NN	O	(	nn	4	SENT_141	[p8l1197t1294r1277b1345],
4	s	NNS	O	s	_	0	SENT_141	[p8l1197t1294r1277b1345],
5	)	CD	NUMBER	)	dep	4	SENT_141	[p8l1197t1294r1277b1345],
6	;	:	O	;	_	0	SENT_141	[p8l1197t1294r1277b1345],
7	DRV	NNP	O	DRV	nn	8	SENT_141	[p8l1300t1294r1409b1334],
8	FC	NNP	O	FC	dep	5	SENT_141	[p8l1429t1294r1494b1335],
9	<	JJR	O	<	dep	8	SENT_141	[p8l1514t1294r1652b1335],
10	LCO	CD	NUMBER	lco	dep	4	SENT_141	[p8l1514t1294r1652b1335],

1	_	NN	O	_	nn	2	SENT_142	[p8l239t1301r267b1405],
2	l	NN	O	l	_	0	SENT_142	[p8l239t1301r267b1405],
3	I	PRP	O	I	npadvmod	5	SENT_142	[p8l840t1357r875b1392],
4	Partially	RB	O	partially	advmod	3	SENT_142	[p8l904t1354r1092b1404],
5	susceptible	JJ	O	susceptible	amod	2	SENT_142	[p8l1109t1353r1375b1404],
6	(	NN	O	(	dep	2	SENT_142	[p8l1395t1353r1510b1404],
7	PS	NNP	O	PS	nn	8	SENT_142	[p8l1395t1353r1510b1404],
8	)	NNP	O	)	rcmod	6	SENT_142	[p8l1395t1353r1510b1404],
9	:	:	O	:	_	0	SENT_142	[p8l1395t1353r1510b1404],
10	LCO	NN	O	lco	dep	14	SENT_142	[p8l1534t1353r1639b1394],
11	<	JJR	O	<	amod	10	SENT_142	[p8l1658t1353r1800b1393],
12	DRV	CD	NUMBER	drv	num	13	SENT_142	[p8l1658t1353r1800b1393],
13	FC	NN	O	fc	npadvmod	14	SENT_142	[p8l1820t1353r1886b1394],
14	<	JJR	O	<	dep	8	SENT_142	[p8l1905t1353r2052b1394],
15	UCO	CD	NUMBER	uco	dep	8	SENT_142	[p8l1905t1353r2052b1394],
16	'	''	O	'	_	0	SENT_142	[p8l627t1421r644b1422],

1	I	PRP	O	I	_	0	SENT_143	[p8l839t1428r875b1465],
2	Resistant	JJ	O	resistant	amod	4	SENT_143	[p8l904t1428r1124b1468],
3	(	NN	O	(	nn	4	SENT_143	[p8l1143t1427r1226b1479],
4	R	NN	O	r	dep	1	SENT_143	[p8l1143t1427r1226b1479],
5	)	CD	NUMBER	)	dep	4	SENT_143	[p8l1143t1427r1226b1479],
6	:	:	O	:	_	0	SENT_143	[p8l1143t1427r1226b1479],
7	DRV	NNP	O	DRV	nn	8	SENT_143	[p8l1249t1428r1357b1467],
8	FC	NNP	O	FC	dep	4	SENT_143	[p8l1378t1427r1444b1468],
9	>	JJR	O	>	amod	10	SENT_143	[p8l1463t1427r1610b1468],
10	UCO	NN	O	uco	dep	8	SENT_143	[p8l1463t1427r1610b1468],

1	co	NN	O	co	nn	2	SENT_144	[p8l31t1562r71b1594],
2	_	NN	O	_	_	0	SENT_144	[p8l283t1594r300b1595],
3	,	,	O	,	_	0	SENT_144	[p8l627t1594r644b1595],
4	9	CD	NUMBER	9	appos	2	SENT_144	[p8l22t1622r71b1678],
5	,	,	O	,	_	0	SENT_144	[p8l283t1619r301b1620],
6	,	,	O	,	_	0	SENT_144	[p8l627t1619r644b1620],
7	L5	NN	O	l5	nn	8	SENT_144	[p8l19t1680r71b1729],
8	.3	NN	NUMBER	.3	appos	2	SENT_144	[p8l19t1735r71b1819],
9	60	CD	NUMBER	60	dep	2	SENT_144	[p8l135t1740r209b1792],
10	"	``	O	"	punct	9	SENT_144	[p8l18t1846r71b1902],
11	5	CD	NUMBER	5	dep	9	SENT_144	[p8l18t1846r71b1902],

1	5	CD	NUMBER	5	_	0	SENT_145	[p8l31t1951r71b2022],
2	40	CD	NUMBER	40	number	3	SENT_145	[p8l134t1952r209b2004],
3	9	CD	NUMBER	9	dep	1	SENT_145	[p8l31t2026r71b2074],
4	CD	NNP	O	CD	nn	5	SENT_145	[p8l31t2082r71b2116],
5	o.	NNP	O	o.	dep	3	SENT_145	[p8l19t2122r70b2160],

1	O	NN	O	o	_	0	SENT_146	[p8l174t2376r209b2428],

1	mcér_JiIu	NN	O	mcér_jiiu	nsubj	30	SENT_147	[p8l279t2459r2135b2510],
2	)	CD	MONEY	)	num	1	SENT_147	[p8l279t2459r2135b2510],
3	$	$	MONEY	$	dep	4	SENT_147	[p8l279t2459r2135b2510],
4	n	NN	MONEY	n	dep	1	SENT_147	[p8l279t2459r2135b2510],
5	:	:	O	:	_	0	SENT_147	[p8l279t2459r2135b2510],
6	m	NN	O	m	dep	1	SENT_147	[p8l279t2459r2135b2510],
7	$	$	MONEY	$	dep	8	SENT_147	[p8l279t2459r2135b2510],
8	n	NN	MONEY	n	dep	6	SENT_147	[p8l279t2459r2135b2510],
9	:	:	O	:	_	0	SENT_147	[p8l279t2459r2135b2510],
10	cnc	NN	O	cnc	dep	6	SENT_147	[p8l279t2459r2135b2510],
11	‘	CD	NUMBER	‘	num	10	SENT_147	[p8l279t2459r2135b2510],
12	i	FW	O	i	dep	10	SENT_147	[p8l279t2459r2135b2510],
13	>	JJR	O	>	amod	14	SENT_147	[p8l279t2459r2135b2510],
14	n	NN	O	n	dep	10	SENT_147	[p8l279t2459r2135b2510],
15	:	:	O	:	_	0	SENT_147	[p8l279t2459r2135b2510],
16	n	NN	O	n	dep	6	SENT_147	[p8l279t2459r2135b2510],
17	:	:	O	:	_	0	SENT_147	[p8l279t2459r2135b2510],
18	u	FW	O	u	nn	19	SENT_147	[p8l279t2459r2135b2510],
19	)	FW	O	)	dep	16	SENT_147	[p8l279t2459r2135b2510],
20	ca	MD	O	can	aux	30	SENT_147	[p8l279t2459r2135b2510],
21	/	:	O	/	punct	24	SENT_147	[p8l279t2459r2135b2510],
22	_	CD	NUMBER	_	num	24	SENT_147	[p8l279t2459r2135b2510],
23	>	JJR	O	>	amod	24	SENT_147	[p8l279t2459r2135b2510],
24	o	NN	O	o	dep	30	SENT_147	[p8l279t2459r2135b2510],
25	:	:	O	:	_	0	SENT_147	[p8l279t2459r2135b2510],
26	a	DT	O	a	det	28	SENT_147	[p8l279t2459r2135b2510],
27	)	NN	O	)	nn	28	SENT_147	[p8l279t2459r2135b2510],
28	cn/3n	NN	O	cn/3n	dep	24	SENT_147	[p8l279t2459r2135b2510],
29	:	:	O	:	_	0	SENT_147	[p8l279t2459r2135b2510],
30	co	VB	O	co	_	0	SENT_147	[p8l279t2459r2135b2510],
31	$	$	MONEY	$	dobj	30	SENT_147	[p8l279t2459r2135b2510],
32	u	CD	MONEY	u	num	31	SENT_147	[p8l279t2459r2135b2510],
33	:	:	O	:	_	0	SENT_147	[p8l279t2459r2135b2510],
34	c	NN	O	c	dep	31	SENT_147	[p8l279t2459r2135b2510],
35	/	:	O	/	punct	37	SENT_147	[p8l279t2459r2135b2510],
36	)	CD	NUMBER	)	num	37	SENT_147	[p8l279t2459r2135b2510],
37	g	NN	O	g	dep	34	SENT_147	[p8l279t2459r2135b2510],
38	_	CD	NUMBER	_	num	40	SENT_147	[p8l279t2459r2135b2510],
39	)	NN	O	)	nn	40	SENT_147	[p8l279t2459r2135b2510],
40	o	NN	O	o	dep	37	SENT_147	[p8l279t2459r2135b2510],
41	:	:	O	:	_	0	SENT_147	[p8l279t2459r2135b2510],
42	c/Jgcccocn/3	NN	O	c/jgcccocn/3	dep	37	SENT_147	[p8l279t2459r2135b2510],
43	|	CD	NUMBER	|	num	42	SENT_147	[p8l279t2459r2135b2510],
44	:	:	O	:	_	0	SENT_147	[p8l279t2459r2135b2510],
45	24l	CD	NUMBER	24l	num	48	SENT_147	[p8l310t2546r400b2597],
46	47V	NN	O	47v	nn	48	SENT_147	[p8l458t2546r580b2597],
47	50L	NN	O	50l	nn	48	SENT_147	[p8l635t2545r749b2598],
48	50V	NN	O	50v	dep	42	SENT_147	[p8l805t2546r927b2598],
49	54L	NN	O	54l	nn	55	SENT_147	[p8l980t2546r1094b2598],
50	58E	NN	O	58e	nn	55	SENT_147	[p8l1146t2545r1266b2598],
51	74P	NN	O	74p	nn	55	SENT_147	[p8l1318t2546r1438b2597],
52	76V	NN	O	76v	nn	55	SENT_147	[p8l1491t2545r1613b2598],
53	82L	NN	O	82l	nn	55	SENT_147	[p8l1661t2546r1775b2598],
54	82T	NN	O	82t	nn	55	SENT_147	[p8l1826t2546r1944b2598],
55	83D	NN	O	83d	dep	34	SENT_147	[p8l1994t2546r2118b2598],

1	Mutation	NN	O	mutation	_	0	SENT_148	[p8l742t2654r1003b2706],
2	and	CC	O	and	_	0	SENT_148	[p8l1037t2654r1148b2706],
3	FC	NN	O	fc	nn	4	SENT_148	[p8l1178t2653r1264b2707],
4	category	NN	O	category	conj_and	1	SENT_148	[p8l1285t2658r1552b2721],

1	FIG	NNP	O	FIG	_	0	SENT_149	[p8l7t2814r164b2873],
2	.	.	O	.	_	0	SENT_149	[p8l7t2814r164b2873],

1	3	LS	NUMBER	3	_	0	SENT_150	[p8l222t2817r278b2873],
2	.	.	O	.	_	0	SENT_150	[p8l222t2817r278b2873],

1	Occurrence	NN	O	occurrence	dep	14	SENT_151	[p8l363t2813r760b2873],
2	of	IN	O	of	_	0	SENT_151	[p8l818t2812r887b2873],
3	key	JJ	O	key	amod	4	SENT_151	[p8l940t2812r1065b2894],
4	mutations	NNS	O	mutation	prep_of	1	SENT_151	[p8l1121t2815r1474b2873],
5	across	IN	O	across	_	0	SENT_151	[p8l1532t2833r1745b2873],
6	darunavir	NN	O	darunavir	nn	8	SENT_151	[p8l1803t2812r2153b2872],
7	(	CD	NUMBER	(	num	8	SENT_151	[p8l10t2901r227b2977],
8	DRV	NN	O	drv	prep_across	4	SENT_151	[p8l10t2901r227b2977],
9	)	CD	NUMBER	)	num	8	SENT_151	[p8l10t2901r227b2977],
10	phenotypic	JJ	O	phenotypic	amod	12	SENT_151	[p8l253t2901r648b2982],
11	resistance	NN	O	resistance	nn	12	SENT_151	[p8l673t2904r1014b2962],
12	classifications	NNS	O	classification	dep	14	SENT_151	[p8l1039t2901r1519b2962],
13	The	DT	O	the	det	14	SENT_151	[p8l1545t2901r1674b2962],
14	denominator	NN	O	denominator	dep	20	SENT_151	[p8l1700t2901r2153b2962],
15	for	IN	O	for	_	0	SENT_151	[p8l7t2990r105b3051],
16	all	DT	O	all	prep_for	14	SENT_151	[p8l141t2990r223b3050],
17	participants	NNS	O	participant	nsubj	20	SENT_151	[p8l257t2993r674b3072],
18	is	VBZ	O	be	cop	20	SENT_151	[p8l710t2993r763b3051],
19	the	DT	O	the	det	20	SENT_151	[p8l798t2990r905b3051],
20	number	NN	O	number	_	0	SENT_151	[p8l939t2990r1216b3051],
21	of	IN	O	of	_	0	SENT_151	[p8l1251t2990r1321b3051],
22	isolates	NNS	O	isolate	prep_of	20	SENT_151	[p8l1353t2990r1610b3051],
23	with	IN	O	with	_	0	SENT_151	[p8l1644t2990r1806b3050],
24	that	DT	O	that	det	25	SENT_151	[p8l1840t2990r1977b3050],
25	mutation	NN	O	mutation	prep_with	22	SENT_151	[p8l2010t3010r2153b3050, p8l7t3081r210b3138],
26	and	CC	O	and	_	0	SENT_151	[p8l246t3078r378b3138],
27	the	DT	O	the	det	28	SENT_151	[p8l415t3078r522b3138],
28	numerator	NN	O	numerator	nsubj	31	SENT_151	[p8l558t3086r931b3138],
29	is	VBZ	O	be	cop	31	SENT_151	[p8l968t3081r1021b3138],
30	the	DT	O	the	det	31	SENT_151	[p8l1058t3078r1165b3138],
31	number	NN	O	number	conj_and	20	SENT_151	[p8l1202t3078r1478b3138],
32	of	IN	O	of	_	0	SENT_151	[p8l1516t3078r1585b3138],
33	isolates	NNS	O	isolate	prep_of	31	SENT_151	[p8l1619t3078r1876b3138],
34	in	IN	O	in	_	0	SENT_151	[p8l1913t3081r1981b3137],
35	that	DT	O	that	det	37	SENT_151	[p8l2016t3078r2153b3138],
36	phenotypic	JJ	O	phenotypic	amod	37	SENT_151	[p8l6t3167r401b3249],
37	classification	NN	O	classification	prep_in	33	SENT_151	[p8l431t3167r880b3228],
38	grouping	VBG	O	group	partmod	37	SENT_151	[p8l909t3170r1234b3249],
39	with	IN	O	with	_	0	SENT_151	[p8l1262t3168r1424b3227],
40	that	DT	O	that	det	41	SENT_151	[p8l1452t3167r1589b3228],
41	mutation	NN	O	mutation	prep_with	38	SENT_151	[p8l1617t3170r1954b3228],
42	.	.	O	.	_	0	SENT_151	[p8l1617t3170r1954b3228],

1	1	CD	NUMBER	1	num	2	SENT_152	[p8l14t3289r40b3347],
2	022	CD	NUMBER	022	_	0	SENT_152	[p8l55t3290r183b3348],

1	TPV	NN	O	tpv	nsubjpass	12	SENT_153	[p9l10t86r177b155],
2	,	,	O	,	_	0	SENT_153	[p9l10t86r177b155],
3	whereas	IN	O	whereas	mark	5	SENT_153	[p9l206t84r490b144],
4	those	DT	O	those	nsubj	5	SENT_153	[p9l520t84r700b144],
5	associated	VBN	O	associate	dep	1	SENT_153	[p9l729t83r1075b144],
6	with	IN	O	with	_	0	SENT_153	[p9l1104t84r1262b143],
7	improved	JJ	O	improved	amod	8	SENT_153	[p9l1290t84r1624b165],
8	response	NN	O	response	prep_with	5	SENT_153	[p9l1654t104r1954b165],
9	were	VBD	O	be	auxpass	12	SENT_153	[p9l1982t104r2150b144],
10	most	RBS	O	most	advmod	11	SENT_153	[p9l10t189r179b241],
11	commonly	RB	O	commonly	advmod	12	SENT_153	[p9l217t181r582b262],
12	found	VBN	O	find	_	0	SENT_153	[p9l621t180r824b241],
13	in	IN	O	in	_	0	SENT_153	[p9l864t183r930b240],
14	the	DT	O	the	det	15	SENT_153	[p9l968t181r1072b241],
15	isolates	NNS	O	isolate	prep_in	12	SENT_153	[p9l1111t180r1359b241],
16	that	WDT	O	that	nsubj	20	SENT_153	[p9l1399t180r1532b240],
17	were	VBD	O	be	cop	20	SENT_153	[p9l1569t201r1738b241],
18	susceptible	JJ	O	susceptible	amod	20	SENT_153	[p9l1777t181r2150b262],
19	(	NN	O	(	nn	20	SENT_153	[p9l13t278r189b359],
20	Figs	NNS	O	fig	rcmod	15	SENT_153	[p9l13t278r189b359],
21	.	.	O	.	_	0	SENT_153	[p9l13t278r189b359],

1	2	CD	NUMBER	2	_	0	SENT_154	[p9l209t280r246b336],
2	and	CC	O	and	_	0	SENT_154	[p9l263t277r392b337],
3	3	CD	NUMBER	3	conj_and	1	SENT_154	[p9l408t277r485b353],
4	)	NN	O	)	dep	1	SENT_154	[p9l408t277r485b353],
5	.	.	O	.	_	0	SENT_154	[p9l408t277r485b353],

1	Of	IN	O	of	_	0	SENT_155	[p9l506t277r593b338],
2	the	DT	O	the	det	3	SENT_155	[p9l607t277r711b338],
3	mutations	NNS	O	mutation	prep_of	23	SENT_155	[p9l727t280r1070b338],
4	associated	VBN	O	associate	partmod	3	SENT_155	[p9l1088t277r1434b338],
5	with	IN	O	with	_	0	SENT_155	[p9l1449t277r1607b337],
6	reduced	VBN	O	reduce	amod	8	SENT_155	[p9l1621t277r1897b338],
7	clinical	JJ	O	clinical	amod	8	SENT_155	[p9l1914t277r2150b338],
8	response	NN	O	response	prep_with	4	SENT_155	[p9l10t395r327b456],
9	,	,	O	,	_	0	SENT_155	[p9l10t395r327b456],
10	more	JJR	O	more	mwe	11	SENT_155	[p9l353t395r531b435],
11	than	IN	O	than	quantmod	12	SENT_155	[p9l555t374r708b434],
12	80	CD	PERCENT	80	num	13	SENT_155	[p9l733t376r873b435],
13	%	NN	PERCENT	%	nsubj	23	SENT_155	[p9l733t376r873b435],
14	of	IN	O	of	_	0	SENT_155	[p9l900t374r968b435],
15	isolates	NNS	O	isolate	prep_of	13	SENT_155	[p9l990t375r1238b435],
16	that	WDT	O	that	nsubj	17	SENT_155	[p9l1263t375r1396b434],
17	encoded	VBD	O	encode	rcmod	15	SENT_155	[p9l1421t375r1707b435],
18	the	DT	O	the	det	20	SENT_155	[p9l1733t374r1837b435],
19	82L	NN	O	82l	nn	20	SENT_155	[p9l1863t377r1986b435],
20	mutation	NN	O	mutation	dobj	17	SENT_155	[p9l2011t395r2151b434, p9l10t475r208b532],
21	were	VBD	O	be	cop	23	SENT_155	[p9l238t492r407b532],
22	TPV	NN	O	tpv	npadvmod	23	SENT_155	[p9l441t474r592b531],
23	resistant	JJ	O	resistant	_	0	SENT_155	[p9l624t475r909b532],
24	(	NN	O	(	nn	26	SENT_155	[p9l945t472r1235b548],
25	TPV-R	NN	O	tpv-r	nn	26	SENT_155	[p9l945t472r1235b548],
26	)	NN	O	)	tmod	23	SENT_155	[p9l945t472r1235b548],
27	,	,	O	,	_	0	SENT_155	[p9l945t472r1235b548],
28	followed	VBN	O	follow	partmod	26	SENT_155	[p9l1271t471r1570b532],
29	by	IN	O	by	_	0	SENT_155	[p9l1602t472r1691b553],
30	82T	NN	O	82t	agent	28	SENT_155	[p9l1725t474r1849b532],
31	(	CD	PERCENT	(	number	32	SENT_155	[p9l1885t472r2149b548],
32	58.6	CD	PERCENT	58.6	num	33	SENT_155	[p9l1885t472r2149b548],
33	%	NN	PERCENT	%	dobj	28	SENT_155	[p9l1885t472r2149b548],
34	)	CD	NUMBER	)	dep	33	SENT_155	[p9l1885t472r2149b548],
35	,	,	O	,	_	0	SENT_155	[p9l1885t472r2149b548],
36	83D	NN	O	83d	dobj	28	SENT_155	[p9l11t570r147b627],
37	(	CD	PERCENT	(	number	38	SENT_155	[p9l190t567r454b643],
38	52.6	CD	PERCENT	52.6	num	39	SENT_155	[p9l190t567r454b643],
39	%	NN	PERCENT	%	dep	36	SENT_155	[p9l190t567r454b643],
40	)	CD	NUMBER	)	dep	36	SENT_155	[p9l190t567r454b643],
41	,	,	O	,	_	0	SENT_155	[p9l190t567r454b643],
42	74P	CD	PERCENT	74p	num	43	SENT_155	[p9l495t570r617b626],
43	(	CD	PERCENT	(	dobj	28	SENT_155	[p9l658t567r922b643],
44	49.9	CD	PERCENT	49.9	number	45	SENT_155	[p9l658t567r922b643],
45	%	NN	PERCENT	%	amod	43	SENT_155	[p9l658t567r922b643],
46	)	CD	NUMBER	)	dep	43	SENT_155	[p9l658t567r922b643],
47	,	,	O	,	_	0	SENT_155	[p9l658t567r922b643],
48	and	CC	O	and	_	0	SENT_155	[p9l964t567r1092b627],
49	47V	NN	O	47v	dobj	28	SENT_155	[p9l1129t570r1265b626],
50	(	CD	PERCENT	(	number	51	SENT_155	[p9l1306t567r1567b643],
51	42.1	CD	PERCENT	42.1	num	52	SENT_155	[p9l1306t567r1567b643],
52	%	NN	PERCENT	%	dep	49	SENT_155	[p9l1306t567r1567b643],
53	)	CD	NUMBER	)	dep	26	SENT_155	[p9l1306t567r1567b643],
54	.	.	O	.	_	0	SENT_155	[p9l1306t567r1567b643],

1	In	IN	O	in	_	0	SENT_156	[p9l1610t570r1681b626],
2	contrast	NN	O	contrast	prep_in	13	SENT_156	[p9l1717t575r2006b638],
3	,	,	O	,	_	0	SENT_156	[p9l1717t575r2006b638],
4	the	DT	O	the	det	5	SENT_156	[p9l2046t567r2150b627],
5	mutations	NNS	O	mutation	nsubjpass	13	SENT_156	[p9l10t667r353b725],
6	associated	VBN	O	associate	partmod	5	SENT_156	[p9l384t664r730b725],
7	with	IN	O	with	_	0	SENT_156	[p9l760t665r918b724],
8	improved	JJ	O	improved	amod	9	SENT_156	[p9l946t665r1281b746],
9	response	NN	O	response	prep_with	6	SENT_156	[p9l1312t685r1611b746],
10	were	VBD	O	be	auxpass	13	SENT_156	[p9l1640t685r1808b725],
11	most	RBS	O	most	advmod	12	SENT_156	[p9l1838t673r2007b725],
12	frequently	RB	O	frequently	advmod	13	SENT_156	[p9l2036t664r2151b725, p9l11t763r270b844],
13	found	VBN	O	find	_	0	SENT_156	[p9l287t762r491b823],
14	in	IN	O	in	_	0	SENT_156	[p9l510t766r576b822],
15	TPV	NN	O	tpv	npadvmod	17	SENT_156	[p9l593t765r1061b823],
16	—	CD	NUMBER	—	num	15	SENT_156	[p9l593t765r1061b823],
17	sensitive	JJ	O	sensitive	amod	18	SENT_156	[p9l593t765r1061b823],
18	isolates18	NN	O	isolates18	prep_in	13	SENT_156	[p9l1080t748r1400b823],
19	:	:	O	:	_	0	SENT_156	[p9l1080t748r1400b823],
20	50V	NN	O	50v	nsubj	64	SENT_156	[p9l1423t765r1556b823],
21	[	CD	PERCENT	[	number	22	SENT_156	[p9l1579t763r1798b837],
22	79.7	CD	PERCENT	79.7	num	23	SENT_156	[p9l1579t763r1798b837],
23	%	NN	PERCENT	%	nsubj	30	SENT_156	[p9l1579t763r1798b837],
24	of	IN	O	of	_	0	SENT_156	[p9l1819t762r1886b823],
25	isolates	NNS	O	isolate	prep_of	23	SENT_156	[p9l1902t763r2149b823],
26	with	IN	O	with	_	0	SENT_156	[p9l9t859r167b919],
27	that	DT	O	that	det	28	SENT_156	[p9l210t859r343b919],
28	mutation	NN	O	mutation	prep_with	25	SENT_156	[p9l385t862r699b920],
29	were	VBD	O	be	cop	30	SENT_156	[p9l741t880r910b920],
30	susceptible	JJ	O	susceptible	rcmod	20	SENT_156	[p9l954t859r1328b941],
31	to	TO	O	to	_	0	SENT_156	[p9l1371t868r1436b920],
32	TPV	NN	O	tpv	nn	34	SENT_156	[p9l1481t862r1631b919],
33	(	CD	NUMBER	(	num	34	SENT_156	[p9l1678t859r1980b935],
34	TPV-S	NN	O	tpv-s	prep_to	30	SENT_156	[p9l1678t859r1980b935],
35	)	CD	NUMBER	)	num	36	SENT_156	[p9l1678t859r1980b935],
36	]	NN	O	]	dep	34	SENT_156	[p9l1678t859r1980b935],
37	,	,	O	,	_	0	SENT_156	[p9l1678t859r1980b935],
38	50L	NN	O	50l	conj_and	34	SENT_156	[p9l2026t862r2150b920],
39	(	CD	PERCENT	(	number	40	SENT_156	[p9l13t956r278b1031],
40	74.9	CD	PERCENT	74.9	num	41	SENT_156	[p9l13t956r278b1031],
41	%	NN	PERCENT	%	dep	38	SENT_156	[p9l13t956r278b1031],
42	)	CD	NUMBER	)	dep	38	SENT_156	[p9l13t956r278b1031],
43	,	,	O	,	_	0	SENT_156	[p9l13t956r278b1031],
44	76V	CD	PERCENT	76v	conj_and	34	SENT_156	[p9l299t958r431b1015],
45	(	CD	PERCENT	(	number	46	SENT_156	[p9l451t956r716b1031],
46	63.1	CD	PERCENT	63.1	num	47	SENT_156	[p9l451t956r716b1031],
47	%	NN	PERCENT	%	dep	44	SENT_156	[p9l451t956r716b1031],
48	)	CD	NUMBER	)	dep	44	SENT_156	[p9l451t956r716b1031],
49	,	,	O	,	_	0	SENT_156	[p9l451t956r716b1031],
50	241	CD	PERCENT	241	number	51	SENT_156	[p9l735t958r838b1014],
51	(	CD	PERCENT	(	conj_and	34	SENT_156	[p9l859t956r1122b1031],
52	61.0	CD	PERCENT	61.0	num	53	SENT_156	[p9l859t956r1122b1031],
53	%	NN	PERCENT	%	dep	51	SENT_156	[p9l859t956r1122b1031],
54	)	CD	NUMBER	)	dep	51	SENT_156	[p9l859t956r1122b1031],
55	,	,	O	,	_	0	SENT_156	[p9l859t956r1122b1031],
56	and	CC	O	and	_	0	SENT_156	[p9l1142t956r1271b1015],
57	54L	NN	O	54l	conj_and	34	SENT_156	[p9l1289t958r1413b1015],
58	(	CD	PERCENT	(	number	59	SENT_156	[p9l1435t956r1679b1031],
59	50.4	CD	PERCENT	50.4	num	60	SENT_156	[p9l1435t956r1679b1031],
60	%	NN	PERCENT	%	dep	57	SENT_156	[p9l1435t956r1679b1031],
61	)	CD	NUMBER	)	tmod	30	SENT_156	[p9l1435t956r1679b1031],
62	were	VBD	O	be	cop	64	SENT_156	[p9l1697t976r1867b1015],
63	all	DT	O	all	det	64	SENT_156	[p9l1885t955r1965b1015],
64	most	JJS	O	most	parataxis	13	SENT_156	[p9l1983t964r2152b1015],
65	commonly	RB	O	commonly	advmod	66	SENT_156	[p9l11t1053r376b1134],
66	found	VBN	O	find	partmod	64	SENT_156	[p9l399t1052r604b1113],
67	in	IN	O	in	_	0	SENT_156	[p9l627t1056r693b1112],
68	isolates	NNS	O	isolate	prep_in	66	SENT_156	[p9l716t1053r964b1113],
69	that	WDT	O	that	nsubj	71	SENT_156	[p9l988t1053r1121b1113],
70	were	VBD	O	be	cop	71	SENT_156	[p9l1142t1073r1311b1113],
71	susceptible	JJ	O	susceptible	rcmod	68	SENT_156	[p9l1335t1053r1708b1134],
72	to	TO	O	to	_	0	SENT_156	[p9l1731t1061r1797b1113],
73	TPV	NN	O	tpv	prep_to	71	SENT_156	[p9l1821t1055r1986b1112],
74	.	.	O	.	_	0	SENT_156	[p9l1821t1055r1986b1112],

1	For	IN	O	for	_	0	SENT_157	[p9l99t1151r214b1209],
2	DRV	NNP	O	DRV	prep_for	12	SENT_157	[p9l232t1151r417b1220],
3	,	,	O	,	_	0	SENT_157	[p9l232t1151r417b1220],
4	the	DT	O	the	det	5	SENT_157	[p9l437t1149r541b1209],
5	mutations	NNS	O	mutation	nsubj	12	SENT_157	[p9l559t1152r900b1209],
6	associated	VBN	O	associate	partmod	5	SENT_157	[p9l921t1149r1262b1209],
7	with	IN	O	with	_	0	SENT_157	[p9l1280t1149r1437b1208],
8	resistance	NN	O	resistance	prep_with	6	SENT_157	[p9l1454t1152r1780b1209],
9	to	TO	O	to	_	0	SENT_157	[p9l1799t1157r1864b1209],
10	DRV	NNP	O	DRV	prep_to	6	SENT_157	[p9l1884t1151r2052b1208],
11	all	DT	O	all	advmod	12	SENT_157	[p9l2071t1149r2151b1208],
12	appeared	VBD	O	appear	_	0	SENT_157	[p9l11t1247r326b1329],
13	at	IN	O	at	prep	12	SENT_157	[p9l344t1256r406b1307],
14	about	IN	O	about	pcomp	13	SENT_157	[p9l422t1248r615b1308],
15	the	DT	O	the	det	17	SENT_157	[p9l631t1247r734b1308],
16	same	JJ	O	same	amod	17	SENT_157	[p9l752t1268r925b1308],
17	rate	NN	O	rate	pobj	14	SENT_157	[p9l942t1256r1068b1308],
18	across	IN	O	across	_	0	SENT_157	[p9l1086t1268r1290b1308],
19	the	DT	O	the	det	22	SENT_157	[p9l1308t1248r1411b1308],
20	phenotypic	JJ	O	phenotypic	amod	22	SENT_157	[p9l1426t1248r1806b1329],
21	resistance	NN	O	resistance	nn	22	SENT_157	[p9l1824t1250r2150b1308],
22	categories	NNS	O	category	prep_across	12	SENT_157	[p9l11t1348r359b1426],
23	.	.	O	.	_	0	SENT_157	[p9l11t1348r359b1426],

1	Isolates	VBZ	O	isolate	dep	19	SENT_158	[p9l433t1345r682b1405],
2	with	IN	O	with	_	0	SENT_158	[p9l750t1345r906b1405],
3	major	JJ	O	major	amod	4	SENT_158	[p9l974t1348r1169b1426],
4	TPV	NN	O	tpv	prep_with	1	SENT_158	[p9l1238t1347r1387b1404],
5	resistance-associated	JJ	O	resistance-associated	amod	6	SENT_158	[p9l1455t1345r2150b1405],
6	mutations	NNS	O	mutation	nsubjpass	19	SENT_158	[p9l10t1444r367b1512],
7	,	,	O	,	_	0	SENT_158	[p9l10t1444r367b1512],
8	such	JJ	O	such	_	0	SENT_158	[p9l389t1441r545b1501],
9	as	IN	O	as	_	0	SENT_158	[p9l564t1461r632b1501],
10	58E	NN	O	58e	prep_such_as	6	SENT_158	[p9l651t1443r792b1512],
11	,	,	O	,	_	0	SENT_158	[p9l651t1443r792b1512],
12	82T	NN	O	82t	prep_such_as	6	SENT_158	[p9l814t1443r953b1512],
13	,	,	O	,	_	0	SENT_158	[p9l814t1443r953b1512],
14	and	CC	O	and	_	0	SENT_158	[p9l975t1441r1103b1501],
15	83D	NN	O	83d	prep_such_as	6	SENT_158	[p9l1123t1443r1276b1512],
16	,	,	O	,	_	0	SENT_158	[p9l1123t1443r1276b1512],
17	were	VBD	O	be	auxpass	19	SENT_158	[p9l1296t1461r1463b1501],
18	commonly	RB	O	commonly	advmod	19	SENT_158	[p9l1483t1441r1845b1522],
19	found	VBN	O	find	_	0	SENT_158	[p9l1864t1441r2066b1502],
20	in	IN	O	in	_	0	SENT_158	[p9l2086t1444r2152b1500],
21	patients	NNS	O	patient	prep_in	19	SENT_158	[p9l9t1541r275b1620],
22	with	IN	O	with	_	0	SENT_158	[p9l298t1538r455b1598],
23	virus	NN	O	virus	prep_with	19	SENT_158	[p9l476t1541r647b1599],
24	predicted	VBN	O	predict	partmod	23	SENT_158	[p9l670t1538r990b1620],
25	to	TO	O	to	aux	27	SENT_158	[p9l1014t1547r1078b1599],
26	be	VB	O	be	cop	27	SENT_158	[p9l1100t1539r1180b1599],
27	sensitive	JJ	O	sensitive	xcomp	24	SENT_158	[p9l1205t1541r1493b1599],
28	to	TO	O	to	_	0	SENT_158	[p9l1517t1547r1581b1599],
29	DRV	NN	O	drv	prep_to	27	SENT_158	[p9l1606t1541r1788b1598],
30	.	.	O	.	_	0	SENT_158	[p9l1606t1541r1788b1598],

1	Patterns	NN	O	pattern	nsubj	6	SENT_159	[p9l99t1637r384b1695],
2	of	IN	O	of	_	0	SENT_159	[p9l413t1634r482b1695],
3	mutations	NNS	O	mutation	prep_of	1	SENT_159	[p9l507t1638r860b1695],
4	over	IN	O	over	_	0	SENT_159	[p9l889t1655r1044b1695],
5	time	NN	O	time	prep_over	3	SENT_159	[p9l1071t1638r1224b1695],
6	show	VBP	O	show	_	0	SENT_159	[p9l1254t1635r1439b1695],
7	that	IN	O	that	advmod	6	SENT_159	[p9l1468t1635r1604b1694],
8	the	DT	O	the	det	9	SENT_159	[p9l1631t1635r1738b1695],
9	crossresistance	NN	O	crossresistance	pobj	7	SENT_159	[p9l1767t1638r2150b1695, p9l10t1739r192b1792],

1	patterns	NNS	O	pattern	nsubj	11	SENT_160	[p9l211t1739r497b1812],
2	to	TO	O	to	_	0	SENT_160	[p9l517t1739r583b1791],
3	DRV	NNP	O	DRV	prep_to	1	SENT_160	[p9l604t1733r775b1791],
4	and	CC	O	and	_	0	SENT_160	[p9l794t1731r925b1791],
5	TPV	NNP	O	TPV	conj_and	3	SENT_160	[p9l945t1733r1097b1791],
6	have	VBP	O	have	aux	11	SENT_160	[p9l1115t1731r1282b1792],
7	remained	VBN	O	remain	cop	11	SENT_160	[p9l1302t1731r1633b1792],
8	fairly	RB	O	fairly	advmod	11	SENT_160	[p9l1653t1731r1838b1812],
9	constant	JJ	O	constant	amod	11	SENT_160	[p9l1857t1739r2151b1792],
10	(	CD	NUMBER	(	num	11	SENT_160	[p9l13t1827r227b1903],
11	Table	NNP	O	Table	_	0	SENT_160	[p9l13t1827r227b1903],
12	1	CD	NUMBER	1	num	11	SENT_160	[p9l267t1828r346b1903],
13	)	CD	NUMBER	)	tmod	11	SENT_160	[p9l267t1828r346b1903],
14	,	,	O	,	_	0	SENT_160	[p9l267t1828r346b1903],
15	with	IN	O	with	_	0	SENT_160	[p9l383t1828r545b1887],
16	40.2	CD	PERCENT	40.2	num	17	SENT_160	[p9l579t1829r785b1887],
17	%	NN	PERCENT	%	prep_with	11	SENT_160	[p9l579t1829r785b1887],
18	(	CD	NUMBER	(	num	19	SENT_160	[p9l826t1828r1025b1903],
19	2006	CD	DATE	2006	dep	17	SENT_160	[p9l826t1828r1025b1903],
20	,	,	O	,	_	0	SENT_160	[p9l826t1828r1025b1903],
21	40.2	CD	PERCENT	40.2	num	22	SENT_160	[p9l1062t1829r1288b1898],
22	%	NN	PERCENT	%	appos	19	SENT_160	[p9l1062t1829r1288b1898],
23	;	:	O	;	_	0	SENT_160	[p9l1062t1829r1288b1898],
24	2007	CD	DATE	2007	prep_with	11	SENT_160	[p9l1325t1830r1502b1898],
25	,	,	O	,	_	0	SENT_160	[p9l1325t1830r1502b1898],
26	39.1	CD	PERCENT	39.1	num	27	SENT_160	[p9l1540t1829r1764b1898],
27	%	NN	PERCENT	%	appos	24	SENT_160	[p9l1540t1829r1764b1898],
28	;	:	O	;	_	0	SENT_160	[p9l1540t1829r1764b1898],
29	and	CC	O	and	_	0	SENT_160	[p9l1804t1827r1934b1887],
30	2008	CD	DATE	2008	prep_with	11	SENT_160	[p9l1971t1830r2149b1898],
31	,	,	O	,	_	0	SENT_160	[p9l1971t1830r2149b1898],
32	42.0	CD	PERCENT	42.0	num	33	SENT_160	[p9l9t1924r238b1999],
33	%	NN	PERCENT	%	appos	30	SENT_160	[p9l9t1924r238b1999],
34	)	CD	NUMBER	)	dep	33	SENT_160	[p9l9t1924r238b1999],
35	of	IN	O	of	_	0	SENT_160	[p9l261t1923r330b1984],
36	isolates	NNS	O	isolate	prep_of	34	SENT_160	[p9l345t1924r602b1984],
37	sensitive	JJ	O	sensitive	amod	36	SENT_160	[p9l622t1927r923b1984],
38	to	TO	O	to	_	0	SENT_160	[p9l942t1932r1008b1984],
39	both	DT	O	both	det	40	SENT_160	[p9l1025t1924r1186b1984],
40	TPV	NN	O	tpv	prep_to	37	SENT_160	[p9l1203t1926r1355b1983],
41	and	CC	O	and	_	0	SENT_160	[p9l1374t1924r1505b1983],
42	DRV	NN	O	drv	prep_to	37	SENT_160	[p9l1525t1926r1711b1983],
43	.	.	O	.	_	0	SENT_160	[p9l1525t1926r1711b1983],

1	Overall	RB	O	overall	advmod	10	SENT_161	[p9l1734t1924r2011b1995],
2	,	,	O	,	_	0	SENT_161	[p9l1734t1924r2011b1995],
3	513	CD	PERCENT	513	number	4	SENT_161	[p9l2031t1926r2148b1984],
4	(	CD	PERCENT	(	nsubj	10	SENT_161	[p9l13t2020r224b2095],
5	6.6	CD	PERCENT	6.6	num	6	SENT_161	[p9l13t2020r224b2095],
6	%	NN	PERCENT	%	dep	4	SENT_161	[p9l13t2020r224b2095],
7	)	CD	NUMBER	)	num	8	SENT_161	[p9l13t2020r224b2095],
8	isolates	NNS	O	isolate	dep	4	SENT_161	[p9l262t2020r518b2080],
9	were	VBD	O	be	cop	10	SENT_161	[p9l552t2040r723b2080],
10	sensitive	JJ	O	sensitive	_	0	SENT_161	[p9l759t2023r1060b2080],
11	to	TO	O	to	_	0	SENT_161	[p9l1095t2028r1161b2080],
12	DRV	NN	O	drv	nn	97	SENT_161	[p9l1197t2022r1368b2079],
13	and	CC	O	and	_	0	SENT_161	[p9l1403t2020r1534b2079],
14	resistant	JJ	O	resistant	conj_and	12	SENT_161	[p9l1569t2023r1863b2080],
15	to	TO	O	to	_	0	SENT_161	[p9l1897t2028r1964b2080],
16	TPV	NN	O	tpv	nn	19	SENT_161	[p9l1999t2022r2151b2079],
17	(	CD	NUMBER	(	num	19	SENT_161	[p9l13t2117r601b2193],
18	DRV-S/TPV-R	NN	O	drv-s/tpv-r	nn	19	SENT_161	[p9l13t2117r601b2193],
19	)	NN	O	)	prep_to	14	SENT_161	[p9l13t2117r601b2193],
20	,	,	O	,	_	0	SENT_161	[p9l13t2117r601b2193],
21	with	IN	O	with	_	0	SENT_161	[p9l635t2117r796b2177],
22	a	DT	O	a	det	24	SENT_161	[p9l829t2137r865b2177],
23	slight	JJ	O	slight	amod	24	SENT_161	[p9l899t2117r1092b2199],
24	decrease	NN	O	decrease	prep_with	14	SENT_161	[p9l1125t2117r1422b2178],
25	observed	VBN	O	observe	partmod	24	SENT_161	[p9l1457t2117r1774b2178],
26	over	IN	O	over	_	0	SENT_161	[p9l1809t2137r1964b2178],
27	time	NN	O	time	prep_over	25	SENT_161	[p9l1996t2120r2150b2178],
28	(	CD	PERCENT	(	num	27	SENT_161	[p9l13t2215r220b2291],
29	8.1	CD	PERCENT	8.1	number	30	SENT_161	[p9l13t2215r220b2291],
30	%	NN	PERCENT	%	amod	27	SENT_161	[p9l13t2215r220b2291],
31	,	,	O	,	_	0	SENT_161	[p9l13t2215r220b2291],
32	6.4	CD	PERCENT	6.4	number	33	SENT_161	[p9l250t2216r432b2286],
33	%	NN	PERCENT	%	amod	27	SENT_161	[p9l250t2216r432b2286],
34	,	,	O	,	_	0	SENT_161	[p9l250t2216r432b2286],
35	and	CC	O	and	_	0	SENT_161	[p9l461t2215r592b2275],
36	5.5	CD	PERCENT	5.5	num	37	SENT_161	[p9l619t2216r783b2275],
37	%	NN	PERCENT	%	prep_over	25	SENT_161	[p9l619t2216r783b2275],
38	for	IN	O	for	_	0	SENT_161	[p9l811t2214r909b2275],
39	2006	CD	DATE	2006	prep_for	37	SENT_161	[p9l936t2217r1113b2286],
40	,	,	DATE	,	_	0	SENT_161	[p9l936t2217r1113b2286],
41	2007	CD	DATE	2007	num	39	SENT_161	[p9l1141t2217r1319b2286],
42	,	,	DATE	,	_	0	SENT_161	[p9l1141t2217r1319b2286],
43	and	CC	DATE	and	_	0	SENT_161	[p9l1348t2215r1479b2275],
44	2008	CD	DATE	2008	prep_for	37	SENT_161	[p9l1506t2217r1683b2286],
45	,	,	O	,	_	0	SENT_161	[p9l1506t2217r1683b2286],
46	respectively	RB	O	respectively	advmod	39	SENT_161	[p9l1712t2215r2149b2296],
47	;	:	O	;	_	0	SENT_161	[p9l1712t2215r2149b2296],
48	p	NN	O	p	dep	39	SENT_161	[p9l8t2311r385b2392],
49	=	JJ	O	=	amod	51	SENT_161	[p9l8t2311r385b2392],
50	0.0007	CD	NUMBER	0.0007	tmod	49	SENT_161	[p9l8t2311r385b2392],
51	)	NN	O	)	dep	48	SENT_161	[p9l8t2311r385b2392],
52	,	,	O	,	_	0	SENT_161	[p9l8t2311r385b2392],
53	whereas	IN	O	whereas	mark	61	SENT_161	[p9l412t2311r703b2371],
54	97	CD	PERCENT	97	number	55	SENT_161	[p9l731t2314r810b2371],
55	(	CD	PERCENT	(	nsubj	65	SENT_161	[p9l840t2311r1051b2387],
56	1.2	CD	PERCENT	1.2	num	57	SENT_161	[p9l840t2311r1051b2387],
57	%	NN	PERCENT	%	dep	55	SENT_161	[p9l840t2311r1051b2387],
58	)	CD	NUMBER	)	num	59	SENT_161	[p9l840t2311r1051b2387],
59	isolates	NNS	O	isolate	dep	55	SENT_161	[p9l1081t2311r1337b2371],
60	were	VBD	O	be	cop	61	SENT_161	[p9l1364t2331r1536b2372],
61	resistant	JJ	O	resistant	dep	39	SENT_161	[p9l1564t2314r1858b2372],
62	to	TO	O	to	_	0	SENT_161	[p9l1885t2319r1951b2371],
63	DRV	NN	O	drv	prep_to	61	SENT_161	[p9l1980t2313r2150b2371],
64	and	CC	O	and	_	0	SENT_161	[p9l11t2408r142b2468],
65	sensitive	JJ	O	sensitive	conj_and	61	SENT_161	[p9l171t2411r472b2469],
66	to	TO	O	to	_	0	SENT_161	[p9l501t2417r567b2469],
67	TPV	NN	O	tpv	nn	70	SENT_161	[p9l596t2411r748b2468],
68	(	CD	NUMBER	(	num	70	SENT_161	[p9l778t2408r1365b2484],
69	DRV-R/TPV-S	NN	O	drv-r/tpv-s	nn	70	SENT_161	[p9l778t2408r1365b2484],
70	)	NN	O	)	prep_to	65	SENT_161	[p9l778t2408r1365b2484],
71	,	,	O	,	_	0	SENT_161	[p9l778t2408r1365b2484],
72	with	IN	O	with	_	0	SENT_161	[p9l1394t2408r1556b2468],
73	a	DT	O	a	det	75	SENT_161	[p9l1584t2428r1620b2468],
74	slight	JJ	O	slight	amod	75	SENT_161	[p9l1649t2408r1842b2490],
75	increase	NN	O	increase	prep_with	61	SENT_161	[p9l1869t2411r2150b2469],
76	observed	VBN	O	observe	partmod	75	SENT_161	[p9l11t2506r328b2566],
77	over	IN	O	over	_	0	SENT_161	[p9l364t2526r518b2566],
78	time	NN	O	time	prep_over	76	SENT_161	[p9l551t2509r704b2566],
79	(	CD	PERCENT	(	num	78	SENT_161	[p9l741t2506r948b2581],
80	0.9	CD	PERCENT	0.9	number	81	SENT_161	[p9l741t2506r948b2581],
81	%	NN	PERCENT	%	amod	37	SENT_161	[p9l741t2506r948b2581],
82	,	,	O	,	_	0	SENT_161	[p9l741t2506r948b2581],
83	1.3	CD	PERCENT	1.3	num	84	SENT_161	[p9l986t2507r1166b2576],
84	%	NN	PERCENT	%	appos	37	SENT_161	[p9l986t2507r1166b2576],
85	,	,	O	,	_	0	SENT_161	[p9l986t2507r1166b2576],
86	and	CC	O	and	_	0	SENT_161	[p9l1202t2506r1333b2565],
87	1.4	CD	PERCENT	1.4	num	88	SENT_161	[p9l1370t2507r1531b2566],
88	%	NN	PERCENT	%	conj_and	84	SENT_161	[p9l1370t2507r1531b2566],
89	over	IN	O	over	_	0	SENT_161	[p9l1566t2526r1720b2566],
90	those	DT	O	those	det	92	SENT_161	[p9l1754t2506r1937b2566],
91	same	JJ	O	same	amod	92	SENT_161	[p9l1972t2526r2150b2566],
92	years	NNS	DURATION	year	prep_over	88	SENT_161	[p9l9t2622r213b2683],
93	;	:	O	;	_	0	SENT_161	[p9l9t2622r213b2683],
94	p	NN	O	p	dep	37	SENT_161	[p9l237t2602r611b2683],
95	=	JJ	O	=	amod	94	SENT_161	[p9l237t2602r611b2683],
96	0.1174	CD	NUMBER	0.1174	tmod	95	SENT_161	[p9l237t2602r611b2683],
97	)	NN	O	)	prep_to	10	SENT_161	[p9l237t2602r611b2683],
98	.	.	O	.	_	0	SENT_161	[p9l237t2602r611b2683],

1	For	IN	O	for	_	0	SENT_162	[p9l99t2702r217b2760],
2	patients	NNS	O	patient	prep_for	30	SENT_162	[p9l240t2702r517b2781],
3	with	IN	O	with	_	0	SENT_162	[p9l542t2699r703b2759],
4	discordant	JJ	O	discordant	prep_with	2	SENT_162	[p9l728t2699r1101b2760],
5	in	FW	O	in	nn	6	SENT_162	[p9l1126t2700r1186b2759],
6	vitro	FW	O	vitro	advmod	9	SENT_162	[p9l1214t2700r1364b2759],
7	phenotypic	JJ	O	phenotypic	amod	9	SENT_162	[p9l1389t2699r1783b2781],
8	resistance	NN	O	resistance	nn	9	SENT_162	[p9l1810t2702r2149b2760],
9	status	NN	O	status	rcmod	4	SENT_162	[p9l11t2805r214b2857],
10	for	IN	O	for	_	0	SENT_162	[p9l242t2796r341b2857],
11	DRV	NN	O	drv	prep_for	9	SENT_162	[p9l368t2799r539b2856],
12	and	CC	O	and	_	0	SENT_162	[p9l567t2797r698b2857],
13	TPV	NN	O	tpv	prep_for	9	SENT_162	[p9l726t2799r896b2868],
14	,	,	O	,	_	0	SENT_162	[p9l726t2799r896b2868],
15	the	DT	O	the	det	16	SENT_162	[p9l926t2797r1033b2857],
16	prevalences	NNS	O	prevalence	nsubjpass	30	SENT_162	[p9l1059t2797r1471b2878],
17	of	IN	O	of	_	0	SENT_162	[p9l1501t2796r1570b2857],
18	mutations	NNS	O	mutation	prep_of	16	SENT_162	[p9l1595t2800r1947b2857],
19	associated	VBN	O	associate	partmod	18	SENT_162	[p9l1977t2817r2150b2857, p9l11t2893r217b2953],
20	with	IN	O	with	_	0	SENT_162	[p9l241t2893r403b2953],
21	improved	VBN	O	improve	prep_with	19	SENT_162	[p9l426t2893r769b2974],
22	or	CC	O	or	_	0	SENT_162	[p9l796t2913r867b2953],
23	reduced	VBN	O	reduce	amod	25	SENT_162	[p9l892t2893r1175b2954],
24	clinical	JJ	O	clinical	amod	25	SENT_162	[p9l1200t2893r1445b2954],
25	response	NN	O	response	conj_or	21	SENT_162	[p9l1469t2913r1777b2974],
26	to	TO	O	to	_	0	SENT_162	[p9l1802t2901r1868b2954],
27	TPV/rbased	JJ	O	tpv/rbased	amod	28	SENT_162	[p9l1893t2893r2150b2961, p9l7t2990r211b3051],
28	therapy	NN	O	therapy	prep_to	25	SENT_162	[p9l238t2990r508b3072],
29	were	VBD	O	be	auxpass	30	SENT_162	[p9l533t3010r704b3051],
30	tabulated	VBN	O	tabulate	_	0	SENT_162	[p9l731t2990r1077b3051],
31	.	.	O	.	_	0	SENT_162	[p9l731t2990r1077b3051],

1	As	IN	O	as	mark	2	SENT_163	[p9l1107t2992r1200b3051],
2	seen	VBN	O	see	advcl	19	SENT_163	[p9l1227t3010r1380b3051],
3	in	IN	O	in	_	0	SENT_163	[p9l1405t2993r1472b3049],
4	Table	NNP	O	Table	prep_in	2	SENT_163	[p9l1496t2990r1687b3051],
5	2	CD	NUMBER	2	num	4	SENT_163	[p9l1713t2993r1770b3061],
6	,	,	O	,	_	0	SENT_163	[p9l1713t2993r1770b3061],
7	mutations	NNS	O	mutation	nsubj	19	SENT_163	[p9l1797t2993r2149b3051],
8	associated	VBN	O	associate	partmod	7	SENT_163	[p9l11t3088r367b3148],
9	with	IN	O	with	_	0	SENT_163	[p9l399t3088r561b3148],
10	an	DT	O	a	det	13	SENT_163	[p9l592t3108r676b3148],
11	improved	VBN	O	improve	amod	13	SENT_163	[p9l706t3088r1049b3169],
12	clinical	JJ	O	clinical	amod	13	SENT_163	[p9l1082t3088r1327b3148],
13	response	NN	O	response	prep_with	8	SENT_163	[p9l1358t3108r1665b3169],
14	to	TO	O	to	_	0	SENT_163	[p9l1698t3096r1764b3148],
15	TPV	NN	O	tpv	prep_to	13	SENT_163	[p9l1796t3090r1948b3147],
16	were	VBD	O	be	cop	19	SENT_163	[p9l1978t3108r2150b3148],
17	much	RB	O	much	advmod	19	SENT_163	[p9l10t3184r208b3245],
18	more	RBR	O	more	advmod	19	SENT_163	[p9l246t3204r425b3245],
19	prevalent	JJ	O	prevalent	_	0	SENT_163	[p9l464t3184r797b3265],
20	in	IN	O	in	_	0	SENT_163	[p9l835t3187r903b3243],
21	DRV	NNP	O	DRV	prep_in	19	SENT_163	[p9l940t3184r1460b3252],
22	.	.	O	.	_	0	SENT_163	[p9l940t3184r1460b3252],

1	—	NN	O	—	_	0	SENT_164	[p9l940t3184r1460b3252],
2	.	.	O	.	_	0	SENT_164	[p9l940t3184r1460b3252],

1	R/TPV-S	NN	O	r/tpv-s	nn	2	SENT_165	[p9l940t3184r1460b3252],
2	patients	NNS	O	patient	nsubjpass	8	SENT_165	[p9l1498t3187r1795b3265],
3	,	,	O	,	_	0	SENT_165	[p9l1498t3187r1795b3265],
4	e.g.	FW	O	e.g.	appos	2	SENT_165	[p9l1836t3204r1974b3265],
5	,	,	O	,	_	0	SENT_165	[p9l1836t3204r1974b3265],
6	50V	NN	O	50v	appos	4	SENT_165	[p9l2014t3186r2151b3244],
7	was	VBD	O	be	auxpass	8	SENT_165	[p9l9t3301r148b3342],
8	found	VBN	O	find	_	0	SENT_165	[p9l185t3281r393b3342],
9	in	IN	O	in	_	0	SENT_165	[p9l431t3284r498b3340],
10	60.8	CD	PERCENT	60.8	num	11	SENT_165	[p9l535t3282r737b3342],
11	%	NN	PERCENT	%	prep_in	8	SENT_165	[p9l535t3282r737b3342],
12	of	IN	O	of	_	0	SENT_165	[p9l776t3281r845b3342],
13	DRV	NN	O	drv	prep_of	11	SENT_165	[p9l879t3281r1398b3349],
14	.	.	O	.	_	0	SENT_165	[p9l879t3281r1398b3349],

1	—	NN	O	—	_	0	SENT_166	[p9l879t3281r1398b3349],
2	.	.	O	.	_	0	SENT_166	[p9l879t3281r1398b3349],

1	R/TPV-S	NN	O	r/tpv-s	nn	2	SENT_167	[p9l879t3281r1398b3349],
2	patients	NNS	O	patient	_	0	SENT_167	[p9l1435t3284r1711b3363],
3	vs.	IN	O	vs.	_	0	SENT_167	[p9l1748t3301r1841b3342],
4	o.	NN	O	o.	nn	6	SENT_167	[p9l1882t3282r2045b3342],
5	o	NN	PERCENT	o	nn	6	SENT_167	[p9l1882t3282r2045b3342],
6	%	NN	PERCENT	%	prep_vs.	2	SENT_167	[p9l1882t3282r2045b3342],
7	of	IN	O	of	_	0	SENT_167	[p9l2084t3281r2153b3342],
8	DRV-S/TPV-R	NN	O	drv-s/tpv-r	nn	9	SENT_167	[p9l10t3378r532b3447],
9	patients	NNS	O	patient	prep_of	2	SENT_167	[p9l574t3381r868b3460],
10	.	.	O	.	_	0	SENT_167	[p9l574t3381r868b3460],

1	Similar	JJ	O	similar	amod	2	SENT_168	[p9l917t3378r1165b3439],
2	trends	NNS	O	trend	_	0	SENT_168	[p9l1210t3378r1429b3439],
3	were	VBD	O	be	auxpass	4	SENT_168	[p9l1472t3399r1644b3439],
4	observed	VBN	O	observe	partmod	2	SENT_168	[p9l1690t3378r2007b3439],
5	for	IN	O	for	_	0	SENT_168	[p9l2053t3378r2150b3439],
6	other	JJ	O	other	amod	8	SENT_168	[p9l11t3475r192b3535],
7	such	JJ	O	such	amod	8	SENT_168	[p9l211t3475r372b3535],
8	mutations	NNS	O	mutation	prep_for	4	SENT_168	[p9l388t3478r758b3535],
9	:	:	O	:	_	0	SENT_168	[p9l388t3478r758b3535],
10	54L	NN	O	54l	dep	2	SENT_168	[p9l780t3477r907b3535],
11	(	CD	PERCENT	(	number	12	SENT_168	[p9l928t3475r1155b3550],
12	48.5	CD	PERCENT	48.5	num	13	SENT_168	[p9l928t3475r1155b3550],
13	%	NN	PERCENT	%	dep	10	SENT_168	[p9l928t3475r1155b3550],
14	vs.	CC	O	vs.	_	0	SENT_168	[p9l1173t3495r1267b3535],
15	1.0	CD	PERCENT	1.0	num	16	SENT_168	[p9l1293t3475r1478b3550],
16	%	NN	PERCENT	%	dep	2	SENT_168	[p9l1293t3475r1478b3550],
17	)	CD	NUMBER	)	number	20	SENT_168	[p9l1293t3475r1478b3550],
18	and	CC	O	and	_	0	SENT_168	[p9l1500t3475r1631b3534],
19	76V	CD	PERCENT	76v	num	16	SENT_168	[p9l1652t3477r1786b3535],
20	(	CD	PERCENT	(	num	16	SENT_168	[p9l1808t3475r2034b3550],
21	22.7	CD	PERCENT	22.7	number	22	SENT_168	[p9l1808t3475r2034b3550],
22	%	NN	PERCENT	%	dep	16	SENT_168	[p9l1808t3475r2034b3550],
23	vs.	CC	O	vs.	cc	22	SENT_168	[p9l2053t3495r2146b3535],

1	0.4	CD	PERCENT	0.4	num	2	SENT_169	[p10l11t18r217b94],
2	%	NN	PERCENT	%	_	0	SENT_169	[p10l11t18r217b94],
3	)	CD	NUMBER	)	dep	2	SENT_169	[p10l11t18r217b94],
4	.	.	O	.	_	0	SENT_169	[p10l11t18r217b94],

1	The	DT	O	the	det	2	SENT_170	[p10l253t18r382b79],
2	mutation	NN	O	mutation	nsubj	12	SENT_170	[p10l414t21r735b79],
3	241	CD	NUMBER	241	num	2	SENT_170	[p10l766t20r871b77],
4	that	WDT	O	that	nsubj	5	SENT_170	[p10l902t18r1039b78],
5	predicts	VBZ	O	predict	rcmod	2	SENT_170	[p10l1069t18r1349b100],
6	increased	VBN	O	increase	amod	7	SENT_170	[p10l1382t18r1710b79],
7	response	NN	O	response	dobj	5	SENT_170	[p10l1743t38r2051b99],
8	to	TO	O	to	_	0	SENT_170	[p10l2083t26r2149b79],
9	TPV	NN	O	tpv	prep_to	7	SENT_170	[p10l10t118r162b175],
10	was	VBD	O	be	cop	12	SENT_170	[p10l181t136r319b176],
11	least	RBS	O	least	advmod	12	SENT_170	[p10l340t115r499b176],
12	prevalent	JJ	O	prevalent	_	0	SENT_170	[p10l517t115r850b197],
13	with	IN	O	with	_	0	SENT_170	[p10l869t115r1030b175],
14	DRV-S	NN	O	drv-s	prep_with	12	SENT_170	[p10l1049t115r1330b184],
15	/	:	O	/	punct	16	SENT_170	[p10l1049t115r1330b184],
16	TPV-R	NN	O	tpv-r	dep	12	SENT_170	[p10l1338t118r1570b175],
17	(	CD	PERCENT	(	num	16	SENT_170	[p10l1593t115r1804b191],
18	4.1	CD	PERCENT	4.1	number	19	SENT_170	[p10l1593t115r1804b191],
19	%	NN	PERCENT	%	amod	16	SENT_170	[p10l1593t115r1804b191],
20	)	CD	NUMBER	)	advmod	16	SENT_170	[p10l1593t115r1804b191],
21	and	CC	O	and	_	0	SENT_170	[p10l1827t115r1958b175],
22	most	RBS	O	most	advmod	23	SENT_170	[p10l1979t124r2151b176],
23	prevalent	JJ	O	prevalent	conj_and	20	SENT_170	[p10l9t212r342b293],
24	with	IN	O	with	_	0	SENT_170	[p10l369t212r531b272],
25	DRV-R/TPV-S	NN	O	drv-r/tpv-s	prep_with	20	SENT_170	[p10l559t212r1079b280],
26	(	CD	PERCENT	(	number	27	SENT_170	[p10l1112t212r1381b288],
27	12.4	CD	PERCENT	12.4	num	28	SENT_170	[p10l1112t212r1381b288],
28	%	NN	PERCENT	%	dep	16	SENT_170	[p10l1112t212r1381b288],
29	)	CD	NUMBER	)	dep	16	SENT_170	[p10l1112t212r1381b288],
30	.	.	O	.	_	0	SENT_170	[p10l1112t212r1381b288],

1	Likewise	RB	O	likewise	advmod	4	SENT_171	[p10l1414t212r1744b283],
2	,	,	O	,	_	0	SENT_171	[p10l1414t212r1744b283],
3	there	EX	O	there	expl	4	SENT_171	[p10l1774t212r1950b273],
4	were	VBD	O	be	_	0	SENT_171	[p10l1978t232r2150b273],
5	similar	JJ	O	similar	amod	7	SENT_171	[p10l11t309r251b370],
6	prevalence	NN	O	prevalence	nn	7	SENT_171	[p10l285t309r664b390],
7	differences	NNS	O	difference	nsubj	4	SENT_171	[p10l702t309r1079b370],
8	for	IN	O	for	_	0	SENT_171	[p10l1115t309r1213b370],
9	DRV-PR/TPV-S	NN	O	drv-pr/tpv-s	nn	10	SENT_171	[p10l1249t309r1817b377],
10	patients	NNS	O	patient	prep_for	7	SENT_171	[p10l1852t312r2146b391],
11	.	.	O	.	_	0	SENT_171	[p10l1852t312r2146b391],

1	These	DT	O	these	det	2	SENT_172	[p10l10t406r210b467],
2	mutations	NNS	O	mutation	nsubj	9	SENT_172	[p10l249t409r601b467],
3	predict	VBP	O	predict	_	0	SENT_172	[p10l639t406r887b488],
4	diminished	VBN	O	diminish	dep	3	SENT_172	[p10l926t406r1320b467],
5	response	NN	O	response	dobj	4	SENT_172	[p10l1358t427r1666b488],
6	to	TO	O	to	_	0	SENT_172	[p10l1704t415r1770b467],
7	DRV	NN	O	drv	prep_to	4	SENT_172	[p10l1809t409r1980b466],
8	and	CC	O	and	_	0	SENT_172	[p10l2018t406r2149b466],
9	increased	VBD	O	increase	conj_and	3	SENT_172	[p10l10t503r339b564],
10	response	NN	O	response	dobj	9	SENT_172	[p10l384t523r691b584],
11	to	TO	O	to	_	0	SENT_172	[p10l736t511r802b564],
12	TPV	NN	O	tpv	prep_to	9	SENT_172	[p10l847t505r1015b563],
13	.	.	O	.	_	0	SENT_172	[p10l847t505r1015b563],

1	Equally	RB	O	equally	_	0	SENT_173	[p10l1063t503r1349b584],
2	,	,	O	,	_	0	SENT_173	[p10l1063t503r1349b584],
3	mutations	NNS	O	mutation	appos	1	SENT_173	[p10l1395t506r1747b563],
4	associated	VBN	O	associate	partmod	3	SENT_173	[p10l1793t503r2149b563],

1	BETHELL	NNP	PERSON	BETHELL	nn	3	SENT_174	[p10l1500t628r1863b686],
2	ET	NNP	O	ET	nn	3	SENT_174	[p10l1897t628r1994b686],
3	AL.	NNP	O	AL.	_	0	SENT_174	[p10l2023t628r2147b686],
4	.	.	O	.	_	0	SENT_174	[p10l2023t628r2147b686],

1	with	IN	O	with	_	0	SENT_175	[p10l9t840r171b900],
2	an	DT	O	a	det	5	SENT_175	[p10l187t861r272b900],
3	inferior	JJ	O	inferior	amod	5	SENT_175	[p10l287t840r546b901],
4	clinical	JJ	O	clinical	amod	5	SENT_175	[p10l563t840r807b901],
5	response	NN	O	response	prep_with	11	SENT_175	[p10l824t861r1131b922],
6	to	TO	O	to	_	0	SENT_175	[p10l1149t849r1215b901],
7	TPV	NN	O	tpv	prep_to	5	SENT_175	[p10l1233t843r1385b900],
8	were	VBD	O	be	auxpass	11	SENT_175	[p10l1400t861r1572b901],
9	most	RBS	O	most	advmod	10	SENT_175	[p10l1589t849r1761b901],
10	commonly	RB	O	commonly	advmod	11	SENT_175	[p10l1777t840r2151b922],
11	found	VBN	O	find	_	0	SENT_175	[p10l10t937r219b998],
12	in	IN	O	in	_	0	SENT_175	[p10l241t940r309b996],
13	viruses	NNS	O	virus	prep_in	11	SENT_175	[p10l327t940r576b998],
14	sensitive	JJ	O	sensitive	amod	13	SENT_175	[p10l599t940r901b998],
15	to	TO	O	to	_	0	SENT_175	[p10l923t946r989b998],
16	DRV	NN	O	drv	prep_to	14	SENT_175	[p10l1011t940r1182b997],
17	and	CC	O	and	_	0	SENT_175	[p10l1204t938r1335b997],
18	resistant	JJ	O	resistant	amod	32	SENT_175	[p10l1357t940r1651b998],
19	to	TO	O	to	_	0	SENT_175	[p10l1672t946r1738b998],
20	TPV	NN	O	tpv	prep_to	18	SENT_175	[p10l1760t940r1931b1008],
21	,	,	O	,	_	0	SENT_175	[p10l1760t940r1931b1008],
22	DRVS	NN	O	drv	appos	20	SENT_175	[p10l1954t940r2150b997, p10l10t1035r50b1095],
23	/	:	O	/	punct	24	SENT_175	[p10l57t1034r92b1102],
24	TPV-R	NN	O	tpv-r	dep	22	SENT_175	[p10l100t1036r333b1094],
25	versus	CC	O	versus	_	0	SENT_175	[p10l356t1054r583b1095],
26	DRV-R/TPV-S	NN	O	drv-r/tpv-s	dep	22	SENT_175	[p10l610t1034r1149b1105],
27	,	,	O	,	_	0	SENT_175	[p10l610t1034r1149b1105],
28	respectively	RB	O	respectively	dep	24	SENT_175	[p10l1177t1034r1613b1116],
29	,	,	O	,	_	0	SENT_175	[p10l1177t1034r1613b1116],
30	e.g.	FW	O	e.g.	dep	22	SENT_175	[p10l1642t1054r1780b1116],
31	,	,	O	,	_	0	SENT_175	[p10l1642t1054r1780b1116],
32	82L	NN	O	82l	conj_and	14	SENT_175	[p10l1808t1037r1933b1095],
33	(	CD	PERCENT	(	number	34	SENT_175	[p10l1962t1034r2149b1110],
34	7.4	CD	PERCENT	7.4	num	35	SENT_175	[p10l1962t1034r2149b1110],
35	%	NN	PERCENT	%	dep	14	SENT_175	[p10l1962t1034r2149b1110],
36	vs.	CC	O	vs.	prep	11	SENT_175	[p10l9t1150r102b1190],
37	o.	NN	O	o.	nn	39	SENT_175	[p10l132t1131r341b1205],
38	o	NN	O	o	nn	39	SENT_175	[p10l132t1131r341b1205],
39	%	NN	O	%	dep	36	SENT_175	[p10l132t1131r341b1205],
40	)	CD	NUMBER	)	nsubjpass	11	SENT_175	[p10l132t1131r341b1205],
41	,	,	O	,	_	0	SENT_175	[p10l132t1131r341b1205],
42	82T	NN	O	82t	appos	40	SENT_175	[p10l368t1133r494b1190],
43	(	CD	PERCENT	(	number	44	SENT_175	[p10l522t1130r748b1206],
44	37.0	CD	PERCENT	37.0	num	45	SENT_175	[p10l522t1130r748b1206],
45	%	NN	PERCENT	%	dep	42	SENT_175	[p10l522t1130r748b1206],
46	vs.	CC	O	vs.	prep	45	SENT_175	[p10l773t1150r867b1190],
47	o.	NN	O	o.	nn	48	SENT_175	[p10l897t1130r1106b1206],
48	o	NN	O	o	dep	46	SENT_175	[p10l897t1130r1106b1206],
49	%	NN	O	%	amod	45	SENT_175	[p10l897t1130r1106b1206],
50	)	CD	NUMBER	)	number	49	SENT_175	[p10l897t1130r1106b1206],
51	,	,	O	,	_	0	SENT_175	[p10l897t1130r1106b1206],
52	and	CC	O	and	_	0	SENT_175	[p10l1133t1130r1263b1190],
53	83D	NN	O	83d	dep	42	SENT_175	[p10l1290t1133r1429b1190],
54	(	CD	PERCENT	(	number	55	SENT_175	[p10l1457t1130r1643b1205],
55	5.8	CD	PERCENT	5.8	num	56	SENT_175	[p10l1457t1130r1643b1205],
56	%	NN	PERCENT	%	dep	53	SENT_175	[p10l1457t1130r1643b1205],
57	vs.	CC	O	vs.	_	0	SENT_175	[p10l1668t1150r1762b1190],
58	o.	NN	O	o.	nn	60	SENT_175	[p10l1791t1131r1997b1205],
59	o	NN	O	o	nn	60	SENT_175	[p10l1791t1131r1997b1205],
60	%	NN	O	%	conj_vs.	53	SENT_175	[p10l1791t1131r1997b1205],
61	)	CD	NUMBER	)	dep	60	SENT_175	[p10l1791t1131r1997b1205],
62	.	.	O	.	_	0	SENT_175	[p10l1791t1131r1997b1205],

1	The	DT	O	the	det	3	SENT_176	[p10l99t1228r229b1288],
2	mutation	NN	O	mutation	nn	3	SENT_176	[p10l254t1230r576b1288],
3	50L	NN	O	50l	nsubjpass	18	SENT_176	[p10l599t1230r726b1288],
4	that	WDT	O	that	nsubj	12	SENT_176	[p10l752t1228r888b1287],
5	predicts	VBZ	O	predict	rcmod	3	SENT_176	[p10l912t1227r1192b1309],
6	increased	VBN	O	increase	amod	7	SENT_176	[p10l1218t1227r1547b1288],
7	response	NN	O	response	dobj	5	SENT_176	[p10l1573t1248r1880b1309],
8	to	TO	O	to	_	0	SENT_176	[p10l1907t1236r1972b1288],
9	TPV	NN	O	tpv	prep_to	5	SENT_176	[p10l1999t1230r2151b1287],
10	and	CC	O	and	_	0	SENT_176	[p10l11t1324r142b1384],
11	is	VBZ	O	be	cop	12	SENT_176	[p10l167t1327r220b1385],
12	neutral	JJ	O	neutral	rcmod	3	SENT_176	[p10l244t1324r494b1385],
13	with	IN	O	with	_	0	SENT_176	[p10l516t1324r678b1384],
14	respect	NN	O	respect	prep_with	12	SENT_176	[p10l701t1332r948b1406],
15	to	TO	O	to	_	0	SENT_176	[p10l971t1333r1037b1385],
16	DRV	NN	ORGANIZATION	drv	prep_to	12	SENT_176	[p10l1062t1326r1233b1384],
17	was	VBD	O	be	auxpass	18	SENT_176	[p10l1256t1344r1395b1385],
18	observed	VBN	O	observe	_	0	SENT_176	[p10l1421t1324r1738b1385],
19	exclusively	RB	O	exclusively	advmod	18	SENT_176	[p10l1763t1324r2151b1406],
20	in	IN	O	in	_	0	SENT_176	[p10l10t1423r78b1479],
21	DRV-S	NN	O	drv-s	prep_in	18	SENT_176	[p10l102t1421r340b1480],
22	and	CC	O	and	_	0	SENT_176	[p10l367t1420r497b1480],
23	TPV	NN	O	tpv	conj_and	21	SENT_176	[p10l523t1421r781b1495],
24	-	:	O	-	_	0	SENT_176	[p10l523t1421r781b1495],
25	(	CD	NUMBER	(	num	26	SENT_176	[p10l523t1421r781b1495],
26	R	NN	O	r	nsubj	31	SENT_176	[p10l523t1421r781b1495],
27	or	CC	O	or	_	0	SENT_176	[p10l807t1440r878b1480],
28	PR	NN	O	pr	nn	30	SENT_176	[p10l903t1420r1025b1496],
29	)	NN	O	)	nn	30	SENT_176	[p10l903t1420r1025b1496],
30	isolates	NNS	O	isolate	nsubj	31	SENT_176	[p10l1053t1420r1309b1480],
31	(	VBP	O	(	parataxis	18	SENT_176	[p10l1339t1421r1479b1495],
32	N	NN	O	n	dobj	31	SENT_176	[p10l1339t1421r1479b1495],
33	:	:	O	:	_	0	SENT_176	[p10l1339t1421r1479b1495],
34	85	CD	NUMBER	85	dep	32	SENT_176	[p10l1495t1423r1591b1491],
35	;	:	O	;	_	0	SENT_176	[p10l1495t1423r1591b1491],
36	3.8	CD	PERCENT	3.8	num	37	SENT_176	[p10l1617t1421r1824b1495],
37	%	NN	PERCENT	%	dep	32	SENT_176	[p10l1617t1421r1824b1495],
38	)	CD	NUMBER	)	dep	37	SENT_176	[p10l1617t1421r1824b1495],
39	.	.	O	.	_	0	SENT_176	[p10l1617t1421r1824b1495],

1	The	DT	O	the	det	3	SENT_177	[p10l1853t1420r1983b1480],
2	mutation	NN	O	mutation	nn	3	SENT_177	[p10l2009t1440r2151b1480, p10l10t1520r213b1578],
3	47V	NN	O	47v	nsubjpass	14	SENT_177	[p10l230t1520r368b1577],
4	that	WDT	O	that	nsubj	5	SENT_177	[p10l386t1517r523b1577],
5	predicts	VBZ	O	predict	rcmod	3	SENT_177	[p10l541t1517r821b1599],
6	diminished	VBN	O	diminish	dep	5	SENT_177	[p10l842t1517r1236b1578],
7	response	NN	O	response	dobj	6	SENT_177	[p10l1256t1538r1564b1599],
8	to	TO	O	to	_	0	SENT_177	[p10l1584t1526r1650b1578],
9	both	DT	O	both	preconj	10	SENT_177	[p10l1667t1517r1829b1578],
10	TPV	NN	O	tpv	prep_to	6	SENT_177	[p10l1847t1520r1999b1577],
11	and	CC	O	and	_	0	SENT_177	[p10l2019t1517r2150b1577],
12	DRV	NN	ORGANIZATION	drv	conj_and	10	SENT_177	[p10l10t1617r181b1674],
13	was	VBD	O	be	auxpass	14	SENT_177	[p10l211t1634r350b1675],
14	observed	VBN	O	observe	dep	22	SENT_177	[p10l384t1614r701b1675],
15	in	IN	O	in	_	0	SENT_177	[p10l734t1617r801b1673],
16	a	DT	O	a	det	18	SENT_177	[p10l833t1634r868b1674],
17	higher	JJR	O	higher	amod	18	SENT_177	[p10l900t1614r1126b1696],
18	proportion	NN	O	proportion	prep_in	14	SENT_177	[p10l1156t1617r1538b1696],
19	of	IN	O	of	_	0	SENT_177	[p10l1570t1614r1639b1675],
20	TPV-sensitive	JJ	O	tpv-sensitive	amod	21	SENT_177	[p10l1668t1617r2149b1675],
21	isolates	NNS	O	isolate	prep_of	18	SENT_177	[p10l10t1711r266b1772],
22	(	VBP	O	(	_	0	SENT_177	[p10l295t1711r521b1787],
23	25.2	CD	PERCENT	25.2	num	24	SENT_177	[p10l295t1711r521b1787],
24	%	NN	PERCENT	%	dobj	22	SENT_177	[p10l295t1711r521b1787],
25	vs.	CC	O	vs.	prep	22	SENT_177	[p10l546t1732r639b1772],
26	9.2	CD	PERCENT	9.2	num	27	SENT_177	[p10l667t1712r851b1782],
27	%	NN	PERCENT	%	dep	25	SENT_177	[p10l667t1712r851b1782],
28	,	,	O	,	_	0	SENT_177	[p10l667t1712r851b1782],
29	respectively	RB	O	respectively	advmod	22	SENT_177	[p10l877t1711r1337b1793],
30	)	CD	NUMBER	)	nsubj	22	SENT_177	[p10l877t1711r1337b1793],
31	.	.	O	.	_	0	SENT_177	[p10l877t1711r1337b1793],

1	The	DT	O	the	det	3	SENT_178	[p10l1366t1711r1495b1772],
2	mutation	NN	O	mutation	nn	3	SENT_178	[p10l1520t1714r1840b1772],
3	58E	NN	O	58e	nsubj	29	SENT_178	[p10l1863t1714r1989b1772],
4	that	WDT	O	that	nsubj	5	SENT_178	[p10l2014t1711r2151b1771],
5	predicts	VBZ	O	predict	rcmod	3	SENT_178	[p10l9t1809r289b1890],
6	diminished	VBN	O	diminish	dep	5	SENT_178	[p10l326t1809r720b1869],
7	response	NN	O	response	dobj	6	SENT_178	[p10l756t1829r1064b1890],
8	to	TO	O	to	_	0	SENT_178	[p10l1099t1817r1165b1869],
9	TPV	NN	O	tpv	prep_to	6	SENT_178	[p10l1201t1811r1353b1868],
10	and	CC	O	and	_	0	SENT_178	[p10l1389t1808r1520b1868],
11	is	VBZ	O	be	cop	15	SENT_178	[p10l1556t1811r1609b1869],
12	not	RB	O	not	neg	15	SENT_178	[p10l1643t1817r1759b1869],
13	a	DT	O	a	det	15	SENT_178	[p10l1794t1829r1830b1868],
14	primary	JJ	O	primary	amod	15	SENT_178	[p10l1865t1811r2151b1890],
15	mutation	NN	O	mutation	rcmod	3	SENT_178	[p10l10t1909r331b1966],
16	for	IN	O	for	mark	19	SENT_178	[p10l364t1905r462b1966],
17	DRV	NN	O	drv	nsubjpass	19	SENT_178	[p10l496t1908r667b1965],
18	was	VBD	O	be	auxpass	19	SENT_178	[p10l700t1926r839b1966],
19	observed	VBN	O	observe	advcl	15	SENT_178	[p10l875t1906r1192b1966],
20	in	IN	O	in	_	0	SENT_178	[p10l1227t1909r1294b1965],
21	an	DT	O	a	det	23	SENT_178	[p10l1328t1926r1412b1966],
22	equal	JJ	O	equal	amod	23	SENT_178	[p10l1445t1906r1636b1987],
23	proportion	NN	O	proportion	prep_in	19	SENT_178	[p10l1668t1909r2050b1987],
24	of	IN	O	of	_	0	SENT_178	[p10l2084t1905r2153b1966],
25	TPV-S	NN	O	tpv-s	nn	28	SENT_178	[p10l10t2003r229b2063],
26	and	CC	O	and	_	0	SENT_178	[p10l249t2002r379b2062],
27	DRV-S	NN	O	drv-s	nn	28	SENT_178	[p10l399t2003r637b2063],
28	isolates	NNS	O	isolate	prep_of	23	SENT_178	[p10l655t2002r911b2063],
29	(	VBP	O	(	_	0	SENT_178	[p10l934t2002r1161b2078],
30	19.8	CD	PERCENT	19.8	num	31	SENT_178	[p10l934t2002r1161b2078],
31	%	NN	PERCENT	%	dobj	29	SENT_178	[p10l934t2002r1161b2078],
32	vs.	CC	O	vs.	prep	31	SENT_178	[p10l1179t2023r1272b2063],
33	19.6	CD	PERCENT	19.6	num	34	SENT_178	[p10l1297t2003r1518b2073],
34	%	NN	PERCENT	%	dep	32	SENT_178	[p10l1297t2003r1518b2073],
35	,	,	O	,	_	0	SENT_178	[p10l1297t2003r1518b2073],
36	respectively	RB	O	respectively	advmod	34	SENT_178	[p10l1538t2002r1997b2084],
37	)	CD	NUMBER	)	dep	34	SENT_178	[p10l1538t2002r1997b2084],
38	.	.	O	.	_	0	SENT_178	[p10l1538t2002r1997b2084],

1	The	DT	O	the	det	3	SENT_179	[p10l2021t2002r2150b2063],
2	mutation	NN	O	mutation	nn	3	SENT_179	[p10l10t2102r331b2160],
3	74P	NN	O	74p	nsubjpass	16	SENT_179	[p10l351t2102r475b2159],
4	that	WDT	O	that	nsubj	12	SENT_179	[p10l494t2100r630b2159],
5	predicts	VBZ	O	predict	rcmod	3	SENT_179	[p10l647t2100r927b2181],
6	diminished	VBN	O	diminish	dep	5	SENT_179	[p10l948t2099r1342b2160],
7	response	NN	O	response	dobj	6	SENT_179	[p10l1362t2120r1669b2181],
8	to	TO	O	to	_	0	SENT_179	[p10l1689t2108r1755b2160],
9	TPV	NN	O	tpv	prep_to	6	SENT_179	[p10l1775t2102r1926b2159],
10	and	CC	O	and	_	0	SENT_179	[p10l1946t2100r2077b2159],
11	is	VBZ	O	be	cop	12	SENT_179	[p10l2097t2102r2150b2160],
12	neutral	JJ	O	neutral	rcmod	3	SENT_179	[p10l9t2197r259b2257],
13	for	IN	O	for	_	0	SENT_179	[p10l277t2196r375b2257],
14	DRV	NN	ORGANIZATION	drv	prep_for	12	SENT_179	[p10l392t2199r563b2257],
15	was	VBD	O	be	auxpass	16	SENT_179	[p10l580t2217r719b2257],
16	observed	VBN	O	observe	dep	25	SENT_179	[p10l738t2197r1054b2257],
17	in	IN	O	in	_	0	SENT_179	[p10l1073t2200r1141b2256],
18	similar	JJ	O	similar	amod	19	SENT_179	[p10l1158t2197r1398b2257],
19	proportions	NNS	O	proportion	prep_in	16	SENT_179	[p10l1414t2200r1827b2278],
20	of	IN	O	of	_	0	SENT_179	[p10l1847t2196r1916b2257],
21	TPV-S	NN	O	tpv-s	nn	24	SENT_179	[p10l1931t2198r2150b2257],
22	and	CC	O	and	_	0	SENT_179	[p10l11t2293r142b2353],
23	DRV-S	NN	O	drv-s	nn	24	SENT_179	[p10l168t2294r406b2354],
24	isolates	NNS	O	isolate	prep_of	19	SENT_179	[p10l431t2293r687b2354],
25	(	VBP	O	(	_	0	SENT_179	[p10l716t2294r902b2369],
26	5.8	CD	PERCENT	5.8	num	27	SENT_179	[p10l716t2294r902b2369],
27	%	NN	PERCENT	%	dobj	25	SENT_179	[p10l716t2294r902b2369],
28	vs.	CC	O	vs.	prep	25	SENT_179	[p10l927t2314r1021b2354],
29	4.8	CD	PERCENT	4.8	num	30	SENT_179	[p10l1049t2294r1234b2364],
30	%	NN	PERCENT	%	dep	28	SENT_179	[p10l1049t2294r1234b2364],
31	,	,	O	,	_	0	SENT_179	[p10l1049t2294r1234b2364],
32	respectively	RB	O	respectively	advmod	25	SENT_179	[p10l1260t2293r1720b2375],
33	)	CD	NUMBER	)	nsubj	25	SENT_179	[p10l1260t2293r1720b2375],
34	.	.	O	.	_	0	SENT_179	[p10l1260t2293r1720b2375],

1	Discussion	NN	O	discussion	_	0	SENT_180	[p10l15t2536r432b2596],

1	TPV	NN	O	tpv	nsubjpass	6	SENT_181	[p10l99t2686r251b2743],
2	and	CC	O	and	_	0	SENT_181	[p10l268t2683r400b2743],
3	DRV	NN	O	drv	conj_and	1	SENT_181	[p10l416t2686r588b2743],
4	are	VBP	O	be	auxpass	6	SENT_181	[p10l605t2704r709b2744],
5	both	DT	O	both	advmod	6	SENT_181	[p10l724t2683r885b2744],
6	approved	VBN	O	approve	_	0	SENT_181	[p10l902t2684r1236b2765],
7	for	IN	O	for	_	0	SENT_181	[p10l1254t2683r1352b2744],
8	use	NN	O	use	prep_for	6	SENT_181	[p10l1368t2704r1484b2744],
9	in	IN	O	in	_	0	SENT_181	[p10l1501t2686r1569b2743],
10	patients	NNS	O	patient	prep_in	6	SENT_181	[p10l1583t2686r1859b2765],
11	infected	VBN	O	infect	partmod	10	SENT_181	[p10l1876t2683r2150b2744],
12	with	IN	O	with	_	0	SENT_181	[p10l9t2781r170b2841],
13	HIV-1	NN	MISC	hiv-1	prep_with	11	SENT_181	[p10l194t2783r402b2840],
14	that	WDT	O	that	nsubj	16	SENT_181	[p10l432t2781r567b2841],
15	is	VBZ	O	be	cop	16	SENT_181	[p10l591t2784r644b2841],
16	resistant	JJ	O	resistant	rcmod	13	SENT_181	[p10l670t2784r961b2841],
17	to	TO	O	to	_	0	SENT_181	[p10l986t2789r1052b2841],
18	multiple	JJ	O	multiple	amod	19	SENT_181	[p10l1078t2781r1370b2862],
19	Pls	NNS	O	pl	prep_to	16	SENT_181	[p10l1395t2783r1515b2841],
20	.	.	O	.	_	0	SENT_181	[p10l1395t2783r1515b2841],

1	Results	NNS	O	result	nsubj	6	SENT_182	[p10l1545t2781r1793b2841],
2	from	IN	O	from	_	0	SENT_182	[p10l1820t2780r1988b2841],
3	previous	JJ	O	previous	amod	4	SENT_182	[p10l2011t2801r2151b2862, p10l9t2880r199b2938],
4	studies	NNS	O	study	prep_from	1	SENT_182	[p10l236t2877r479b2937],
5	have	VBP	O	have	aux	6	SENT_182	[p10l515t2877r681b2937],
6	shown	VBN	O	show	dep	50	SENT_182	[p10l719t2877r951b2938],
7	these	DT	O	these	det	8	SENT_182	[p10l986t2877r1163b2938],
8	agents	NNS	O	agent	dobj	6	SENT_182	[p10l1200t2885r1422b2958],
9	to	TO	O	to	aux	10	SENT_182	[p10l1458t2885r1524b2937],
10	have	VB	O	have	xcomp	6	SENT_182	[p10l1560t2877r1726b2938],
11	little	JJ	O	little	amod	12	SENT_182	[p10l1763t2877r1916b2937],
12	crossresistance	NN	O	crossresistance	dobj	10	SENT_182	[p10l1953t2897r2151b2938, p10l10t2977r348b3035],
13	to	TO	O	to	_	0	SENT_182	[p10l382t2983r449b3035],
14	first-generation	JJ	O	first-generation	amod	15	SENT_182	[p10l484t2974r1018b3056],
15	PIs	NNS	O	pi	prep_to	12	SENT_182	[p10l1051t2977r1156b3035],
16	and	CC	O	and	_	0	SENT_182	[p10l1192t2975r1322b3034],
17	unique	JJ	O	unique	amod	19	SENT_182	[p10l1357t2977r1599b3056],
18	resistance	NN	O	resistance	nn	19	SENT_182	[p10l1634t2977r1971b3035],
19	profiles	NNS	O	profile	conj_and	12	SENT_182	[p10l2005t2995r2151b3056, p10l10t3059r314b3133],
20	.19	CD	NUMBER	.19	number	21	SENT_182	[p10l2005t2995r2151b3056, p10l10t3059r314b3133],
21	‘	CD	NUMBER	‘	dep	19	SENT_182	[p10l2005t2995r2151b3056, p10l10t3059r314b3133],
22	21	CD	NUMBER	21	dep	24	SENT_182	[p10l2005t2995r2151b3056, p10l10t3059r314b3133],
23	More	RBR	O	more	advmod	24	SENT_182	[p10l338t3075r522b3134],
24	recently	RB	DATE	recently	advmod	10	SENT_182	[p10l543t3073r837b3154],
25	,	,	O	,	_	0	SENT_182	[p10l543t3073r837b3154],
26	in	IN	O	in	_	0	SENT_182	[p10l859t3076r926b3132],
27	a	DT	O	a	det	28	SENT_182	[p10l947t3093r983b3133],
28	study	NN	O	study	prep_in	6	SENT_182	[p10l1005t3073r1202b3154],
29	comparing	VBG	O	compare	partmod	28	SENT_182	[p10l1222t3076r1597b3154],
30	the	DT	O	the	det	31	SENT_182	[p10l1617t3073r1724b3134],
31	correlations	NNS	O	correlation	dobj	29	SENT_182	[p10l1745t3073r2150b3134],
32	for	IN	O	for	_	0	SENT_182	[p10l10t3170r108b3231],
33	46	CD	NUMBER	46	num	35	SENT_182	[p10l131t3173r209b3231],
34	protease	NN	O	protease	nn	35	SENT_182	[p10l234t3179r527b3252],
35	mutations	NNS	O	mutation	prep_for	29	SENT_182	[p10l551t3173r902b3231],
36	between	IN	O	between	_	0	SENT_182	[p10l924t3170r1219b3231],
37	pairs	NNS	O	pair	prep_between	35	SENT_182	[p10l1242t3173r1413b3252],
38	of	IN	O	of	_	0	SENT_182	[p10l1439t3170r1508b3231],
39	all	DT	O	all	det	43	SENT_182	[p10l1531t3170r1613b3230],
40	eight	CD	NUMBER	eight	num	43	SENT_182	[p10l1638t3170r1810b3252],
41	currently	RB	DATE	currently	advmod	42	SENT_182	[p10l1835t3170r2151b3252],
42	approved	VBN	O	approve	amod	43	SENT_182	[p10l11t3268r346b3349],
43	Pls	NNS	O	pl	prep_of	37	SENT_182	[p10l372t3270r495b3339],
44	,	,	O	,	_	0	SENT_182	[p10l372t3270r495b3339],
45	the	DT	O	the	det	49	SENT_182	[p10l523t3268r630b3328],
46	TPV	NN	O	tpv	nn	49	SENT_182	[p10l654t3270r807b3327],
47	and	CC	O	and	_	0	SENT_182	[p10l832t3268r963b3328],
48	DRV	NN	O	drv	conj_and	46	SENT_182	[p10l988t3270r1160b3327],
49	pair	NN	O	pair	appos	43	SENT_182	[p10l1183t3271r1322b3349],
50	had	VBD	O	have	_	0	SENT_182	[p10l1346t3268r1479b3328],
51	the	DT	O	the	det	55	SENT_182	[p10l1505t3268r1612b3328],
52	lowest	JJS	O	lowest	amod	55	SENT_182	[p10l1637t3268r1864b3328],
53	correlation	NN	O	correlation	nn	55	SENT_182	[p10l1889t3268r2151b3328, p10l10t3367r146b3425],
54	coefficient	NN	O	coefficient	nn	55	SENT_182	[p10l162t3364r516b3425],
55	(	NN	O	(	dobj	50	SENT_182	[p10l534t3364r716b3440],
56	0.01	CD	NUMBER	0.01	num	57	SENT_182	[p10l534t3364r716b3440],
57	)	NN	O	)	nsubj	50	SENT_182	[p10l534t3364r716b3440],
58	among	IN	O	among	_	0	SENT_182	[p10l737t3384r976b3445],
59	the	DT	O	the	det	61	SENT_182	[p10l993t3364r1099b3425],
60	46	CD	NUMBER	46	num	61	SENT_182	[p10l1114t3366r1192b3425],
61	mutations	NNS	O	mutation	prep_among	57	SENT_182	[p10l1210t3367r1560b3425],
62	of	IN	O	of	_	0	SENT_182	[p10l1578t3364r1647b3425],
63	all	DT	O	all	det	66	SENT_182	[p10l1661t3364r1744b3424],
64	28	CD	NUMBER	28	num	66	SENT_182	[p10l1759t3367r1836b3425],
65	pairwise	JJ	O	pairwise	amod	66	SENT_182	[p10l1853t3367r2151b3445],
66	comparisons	NNS	O	comparison	prep_of	61	SENT_182	[p10l11t3448r530b3544],
67	.	.	O	.	_	0	SENT_182	[p10l11t3448r530b3544],

1	”	NN	O	”	nsubj	4	SENT_183	[p10l11t3448r530b3544],
2	Thus	RB	O	thus	advmod	1	SENT_183	[p10l559t3462r750b3533],
3	,	,	O	,	_	0	SENT_183	[p10l559t3462r750b3533],
4	utilizing	VBG	O	utilize	_	0	SENT_183	[p10l780t3462r1070b3544],
5	patient-specific	JJ	O	patient-specific	amod	6	SENT_183	[p10l1097t3462r1622b3543],
6	HIV	NN	MISC	hiv	dobj	4	SENT_183	[p10l1652t3465r1800b3522],
7	genotype	NN	O	genotype	dep	6	SENT_183	[p10l1829t3470r2150b3544],
8	and	CC	O	and	_	0	SENT_183	[p11l11t30r142b90],
9	/	:	O	/	punct	15	SENT_183	[p11l149t30r184b98],
10	or	CC	O	or	cc	15	SENT_183	[p11l193t50r265b90],
11	phenotype	NN	O	phenotype	nn	12	SENT_183	[p11l299t30r670b111],
12	data	NNS	O	datum	nsubj	15	SENT_183	[p11l708t30r859b90],
13	can	MD	O	can	aux	15	SENT_183	[p11l895t50r1015b90],
14	significantly	RB	O	significantly	advmod	15	SENT_183	[p11l1050t29r1475b111],
15	improve	VB	O	improve	dep	6	SENT_183	[p11l1510t33r1804b111],
16	the	DT	O	the	det	19	SENT_183	[p11l1840t30r1947b90],
17	drug	NN	O	drug	nn	19	SENT_183	[p11l1984t30r2151b111],
18	selection	NN	O	selection	nn	19	SENT_183	[p11l11t126r311b187],
19	process	NN	O	process	dobj	15	SENT_183	[p11l349t146r606b207],
20	for	IN	O	for	_	0	SENT_183	[p11l646t126r744b186],
21	a	DT	O	a	det	23	SENT_183	[p11l784t146r820b186],
22	particular	JJ	O	particular	amod	23	SENT_183	[p11l860t126r1200b207],
23	patient	NN	O	patient	prep_for	15	SENT_183	[p11l1238t129r1496b207],
24	.	.	O	.	_	0	SENT_183	[p11l1238t129r1496b207],

1	The	DT	O	the	det	2	SENT_184	[p11l1539t126r1669b187],
2	analyses	NNS	O	analysis	nsubj	8	SENT_184	[p11l1710t126r2001b207],
3	described	VBN	O	describe	partmod	2	SENT_184	[p11l2043t126r2151b187, p11l11t223r259b283],
4	in	IN	O	in	_	0	SENT_184	[p11l280t226r347b282],
5	these	DT	O	these	det	6	SENT_184	[p11l366t223r543b283],
6	studies	NNS	O	study	prep_in	3	SENT_184	[p11l565t223r808b283],
7	have	VBP	O	have	aux	8	SENT_184	[p11l829t223r995b283],
8	identified	VBN	O	identify	_	0	SENT_184	[p11l1016t223r1349b283],
9	a	DT	O	a	det	10	SENT_184	[p11l1371t243r1407b282],
10	set	NN	O	set	dobj	8	SENT_184	[p11l1429t231r1524b283],
11	of	IN	O	of	_	0	SENT_184	[p11l1545t223r1614b283],
12	HIV	NN	MISC	hiv	nn	13	SENT_184	[p11l1631t225r1780b282],
13	mutations	NNS	O	mutation	prep_of	10	SENT_184	[p11l1800t226r2150b283],
14	that	WDT	O	that	nsubj	16	SENT_184	[p11l10t321r147b381],
15	can	MD	O	can	aux	16	SENT_184	[p11l182t341r302b381],
16	help	VB	O	help	rcmod	10	SENT_184	[p11l335t321r484b402],
17	identify	VB	O	identify	xcomp	16	SENT_184	[p11l523t320r793b402],
18	isolates	NNS	O	isolate	dobj	17	SENT_184	[p11l828t321r1082b381],
19	with	IN	O	with	_	0	SENT_184	[p11l1117t321r1278b381],
20	different	JJ	O	different	amod	21	SENT_184	[p11l1314t320r1610b381],
21	sensitivities	NNS	O	sensitivity	prep_with	17	SENT_184	[p11l1646t324r2047b381],
22	to	TO	O	to	_	0	SENT_184	[p11l2084t329r2150b381],
23	TPV	NN	O	tpv	prep_to	17	SENT_184	[p11l10t419r162b476],
24	and	CC	O	and	_	0	SENT_184	[p11l180t417r311b476],
25	DRV	NN	O	drv	conj_and	23	SENT_184	[p11l329t419r514b476],
26	.	.	O	.	_	0	SENT_184	[p11l329t419r514b476],

1	These	DT	O	these	det	2	SENT_185	[p11l536t417r736b477],
2	results	NNS	O	result	nsubj	4	SENT_185	[p11l754t417r981b477],
3	are	VBP	O	be	cop	4	SENT_185	[p11l1000t437r1104b477],
4	consistent	JJ	O	consistent	_	0	SENT_185	[p11l1123t420r1467b477],
5	with	IN	O	with	_	0	SENT_185	[p11l1483t417r1644b476],
6	what	WP	O	what	nsubjpass	9	SENT_185	[p11l1659t417r1837b476],
7	has	VBZ	O	have	aux	9	SENT_185	[p11l1852t417r1970b477],
8	been	VBN	O	be	auxpass	9	SENT_185	[p11l1985t417r2151b477],
9	shown	VBN	O	show	prepc_with	4	SENT_185	[p11l11t515r244b576],
10	in	IN	O	in	_	0	SENT_185	[p11l267t518r334b574],
11	the	DT	O	the	det	14	SENT_185	[p11l357t515r464b576],
12	TPV-weighted	JJ	O	tpv-weighted	amod	14	SENT_185	[p11l488t515r991b597],
13	score	NN	NUMBER	score	nn	14	SENT_185	[p11l1016t535r1192b576],
14	development	NN	O	development	prep_in	9	SENT_185	[p11l1218t501r1751b597],
15	.	.	O	.	_	0	SENT_185	[p11l1218t501r1751b597],

1	”	NN	O	”	_	0	SENT_186	[p11l1218t501r1751b597],

1	At	IN	O	at	quantmod	3	SENT_187	[p11l99t614r186b672],
2	least	JJS	O	least	mwe	1	SENT_187	[p11l208t612r366b673],
3	one	CD	NUMBER	one	num	4	SENT_187	[p11l390t633r513b673],
4	PI	NN	O	pi	nsubj	7	SENT_187	[p11l537t615r609b671],
5	remained	VBD	O	remain	cop	7	SENT_187	[p11l632t612r963b673],
6	an	DT	O	a	det	7	SENT_187	[p11l987t633r1072b672],
7	option	NN	O	option	_	0	SENT_187	[p11l1095t615r1322b694],
8	for	IN	O	for	_	0	SENT_187	[p11l1343t612r1442b673],
9	treatment	NN	O	treatment	prep_for	7	SENT_187	[p11l1465t621r1803b673],
10	in	IN	O	in	_	0	SENT_187	[p11l1826t615r1893b671],
11	95	CD	PERCENT	95	num	12	SENT_187	[p11l1915t613r2059b673],
12	%	NN	PERCENT	%	nsubj	15	SENT_187	[p11l1915t613r2059b673],
13	of	IN	O	of	_	0	SENT_187	[p11l2084t612r2153b673],
14	patients	NNS	O	patient	prep_of	12	SENT_187	[p11l9t714r286b792],
15	seeking	VBG	O	seek	prepc_in	7	SENT_187	[p11l326t711r590b792],
16	both	CC	O	both	preconj	17	SENT_187	[p11l625t711r787b771],
17	phenotypic	JJ	O	phenotypic	amod	21	SENT_187	[p11l822t711r1217b792],
18	and	CC	O	and	_	0	SENT_187	[p11l1257t711r1388b771],
19	genotypic	JJ	O	genotypic	conj_and	17	SENT_187	[p11l1427t714r1770b792],
20	resistance	NN	O	resistance	nn	21	SENT_187	[p11l1810t714r2150b772],
21	testing	NN	O	testing	dobj	15	SENT_187	[p11l10t811r244b890],
22	in	IN	O	in	_	0	SENT_187	[p11l265t811r332b867],
23	2006	CD	DATE	2006	num	25	SENT_187	[p11l351t811r508b869],
24	to	TO	DATE	to	dep	25	SENT_187	[p11l530t816r596b869],
25	2008	CD	DATE	2008	prep_in	15	SENT_187	[p11l617t811r792b869],
26	.	.	O	.	_	0	SENT_187	[p11l617t811r792b869],

1	Even	RB	O	even	advmod	18	SENT_188	[p11l817t811r993b869],
2	with	IN	O	with	_	0	SENT_188	[p11l1011t808r1173b868],
3	resistance	NN	O	resistance	prep_with	1	SENT_188	[p11l1192t811r1532b869],
4	to	TO	O	to	_	0	SENT_188	[p11l1553t816r1619b869],
5	the	DT	O	the	det	6	SENT_188	[p11l1641t808r1748b869],
6	majority	NN	O	majority	prep_to	1	SENT_188	[p11l1768t811r2063b890],
7	of	IN	O	of	_	0	SENT_188	[p11l2084t808r2153b869],
8	the	DT	O	the	det	10	SENT_188	[p11l10t905r117b966],
9	other	JJ	O	other	amod	10	SENT_188	[p11l142t905r323b966],
10	Pls	NNS	O	pl	prep_of	6	SENT_188	[p11l348t908r472b976],
11	,	,	O	,	_	0	SENT_188	[p11l348t908r472b976],
12	54.8	CD	PERCENT	54.8	num	13	SENT_188	[p11l497t906r702b966],
13	%	NN	PERCENT	%	nsubj	18	SENT_188	[p11l497t906r702b966],
14	of	IN	O	of	_	0	SENT_188	[p11l728t905r797b966],
15	the	DT	O	the	det	17	SENT_188	[p11l818t905r925b966],
16	clinical	JJ	O	clinical	amod	17	SENT_188	[p11l951t905r1195b966],
17	isolates	NNS	O	isolate	prep_of	13	SENT_188	[p11l1219t905r1475b966],
18	remained	VBD	O	remain	_	0	SENT_188	[p11l1500t905r1831b966],
19	partially	RB	O	partially	advmod	18	SENT_188	[p11l1855t905r2151b987],
20	or	CC	O	or	_	0	SENT_188	[p11l11t1022r83b1063],
21	fully	RB	O	fully	advmod	22	SENT_188	[p11l108t1002r269b1083],
22	susceptible	JJ	O	susceptible	conj_or	18	SENT_188	[p11l295t1002r679b1083],
23	to	TO	O	to	_	0	SENT_188	[p11l706t1010r772b1062],
24	TPV	NN	O	tpv	prep_to	22	SENT_188	[p11l798t1004r965b1062],
25	.	.	O	.	_	0	SENT_188	[p11l798t1004r965b1062],

1	Susceptibility	NN	O	susceptibility	nn	4	SENT_189	[p11l995t1002r1467b1083],
2	or	CC	O	or	_	0	SENT_189	[p11l1494t1022r1565b1063],
3	partial	JJ	O	partial	nn	4	SENT_189	[p11l1589t1002r1818b1083],
4	susceptibility	NN	O	susceptibility	nsubjpass	8	SENT_189	[p11l1844t1005r2150b1083, p11l8t1099r191b1181],
5	to	TO	O	to	_	0	SENT_189	[p11l220t1107r286b1160],
6	TPV	NN	O	tpv	prep_to	4	SENT_189	[p11l315t1102r467b1159],
7	was	VBD	O	be	auxpass	8	SENT_189	[p11l495t1119r633b1160],
8	observed	VBN	O	observe	_	0	SENT_189	[p11l664t1099r981b1160],
9	in	IN	O	in	_	0	SENT_189	[p11l1010t1102r1078b1158],
10	31.5	CD	PERCENT	31.5	num	11	SENT_189	[p11l1106t1100r1310b1160],
11	%	NN	PERCENT	%	prep_in	8	SENT_189	[p11l1106t1100r1310b1160],
12	of	IN	O	of	_	0	SENT_189	[p11l1340t1099r1409b1160],
13	those	DT	O	those	prep_of	11	SENT_189	[p11l1436t1099r1619b1160],
14	resistant	JJ	O	resistant	amod	13	SENT_189	[p11l1649t1102r1943b1160],
15	to	TO	O	to	_	0	SENT_189	[p11l1971t1107r2037b1160],
16	all	DT	O	all	det	19	SENT_189	[p11l2068t1099r2151b1159],
17	four	CD	NUMBER	four	num	19	SENT_189	[p11l10t1196r156b1257],
18	first-generation	JJ	O	first-generation	amod	19	SENT_189	[p11l201t1196r739b1278],
19	Pls	NNS	O	pl	prep_to	14	SENT_189	[p11l783t1199r888b1257],
20	and	CC	O	and	_	0	SENT_189	[p11l934t1196r1064b1256],
21	DRV	NN	O	drv	prep_to	14	SENT_189	[p11l1110t1199r1296b1256],
22	.	.	O	.	_	0	SENT_189	[p11l1110t1199r1296b1256],

1	For	IN	O	for	_	0	SENT_190	[p11l1345t1199r1462b1257],
2	viruses	NNS	O	virus	pobj	1	SENT_190	[p11l1506t1199r1754b1257],
3	exhibiting	VBG	O	exhibit	partmod	2	SENT_190	[p11l1800t1196r2151b1278],
4	partial	JJ	O	partial	amod	5	SENT_190	[p11l9t1293r238b1374],
5	susceptibility	NN	O	susceptibility	dobj	3	SENT_190	[p11l268t1293r732b1374],
6	to	TO	O	to	_	0	SENT_190	[p11l762t1301r828b1354],
7	other	JJ	O	other	amod	8	SENT_190	[p11l859t1293r1040b1353],
8	proteases	NNS	O	protease	prep_to	3	SENT_190	[p11l1069t1301r1397b1374],
9	and	CC	O	and	_	0	SENT_190	[p11l1429t1293r1560b1353],
10	susceptibility	NN	O	susceptibility	prep_to	3	SENT_190	[p11l1591t1293r2054b1374],
11	to	TO	O	to	prep	3	SENT_190	[p11l2083t1301r2149b1353],

1	TABLE	NN	O	table	_	0	SENT_191	[p11l146t1450r246b1477],
2	1	CD	NUMBER	1	dep	1	SENT_191	[p11l262t1450r286b1477],
3	.	.	O	.	_	0	SENT_191	[p11l262t1450r286b1477],

1	CROSS-TABULATION	NN	O	cross-tabulation	_	0	SENT_192	[p11l307t1449r630b1477],
2	OF	IN	O	of	_	0	SENT_192	[p11l644t1457r682b1477],
3	DARUNAVIR	NN	O	darunavir	prep_of	1	SENT_192	[p11l696t1450r892b1477],
4	AND	CC	O	and	_	0	SENT_192	[p11l905t1457r974b1477],
5	TIPRANAVIR	NN	O	tipranavir	nn	6	SENT_192	[p11l989t1450r1188b1477],
6	PHENOTYPIC	NN	O	phenotypic	prep_of	1	SENT_192	[p11l1200t1450r1402b1477],
7	RESISTANCE	NN	O	resistance	nn	8	SENT_192	[p11l1416t1450r1609b1477],
8	CATEGORIES	NNS	O	category	dep	1	SENT_192	[p11l1624t1449r1820b1477],
9	OVER	IN	O	over	_	0	SENT_192	[p11l1836t1457r1918b1477],
10	TIME	NN	O	time	prep_over	8	SENT_192	[p11l1930t1450r2012b1477],

1	Year	NN	DURATION	year	_	0	SENT_193	[p11l10t1658r151b1714],
2	Overall	RB	O	overall	advmod	1	SENT_193	[p11l580t1656r826b1723],
3	,	,	O	,	_	0	SENT_193	[p11l580t1656r826b1723],
4	n	NN	O	n	nn	5	SENT_193	[p11l856t1676r900b1713],
5	DRV	NN	O	drv	appos	1	SENT_193	[p11l1403t1659r1572b1713],
6	l	NN	O	l	dep	1	SENT_193	[p11l1594t1658r1688b1714],
7	-	:	O	-	_	0	SENT_193	[p11l1594t1658r1688b1714],
8	"	``	O	"	punct	9	SENT_193	[p11l1594t1658r1688b1714],
9	C	NN	O	c	dep	6	SENT_193	[p11l1594t1658r1688b1714],

1	Overall	JJ	O	overall	amod	2	SENT_194	[p11l7t1816r258b1874],
2	7775	CD	NUMBER	7775	_	0	SENT_194	[p11l664t1819r813b1874],
3	<	JJR	O	<	dep	2	SENT_194	[p11l1232t1832r1271b1873],
4	LCO	CD	NUMBER	lco	dep	2	SENT_194	[p11l1287t1817r1447b1874],

1	>	JJR	O	>	amod	2	SENT_195	[p11l1232t1929r1271b1969],
2	LCD	NNS	O	lcd	dep	6	SENT_195	[p11l1287t1914r1447b1971],
3	and	CC	O	and	_	0	SENT_195	[p11l1476t1913r1602b1970],
4	<	JJR	O	<	dep	6	SENT_195	[p11l1644t1929r1683b1969],
5	UCO	NNP	ORGANIZATION	UCO	dep	6	SENT_195	[p11l1699t1914r1872b1971],
6	>	JJR	O	>	dep	11	SENT_195	[p11l1232t2026r1271b2066],
7	UCO	NNP	O	UCO	dep	6	SENT_195	[p11l1287t2011r1460b2068],
8	2006	CD	DATE	2006	num	7	SENT_195	[p11l7t2124r158b2179],
9	2081	CD	DATE	2081	num	10	SENT_195	[p11l661t2124r810b2179],
10	<	JJR	O	<	dep	7	SENT_195	[p11l1232t2137r1271b2178],
11	LCO	CD	NUMBER	lco	_	0	SENT_195	[p11l1287t2122r1447b2179],

1	>	JJR	O	>	amod	2	SENT_196	[p11l1232t2223r1271b2263],
2	LCO	NN	O	lco	dep	6	SENT_196	[p11l1287t2208r1447b2265],
3	and	CC	O	and	_	0	SENT_196	[p11l1476t2207r1602b2264],
4	<	JJR	O	<	dep	6	SENT_196	[p11l1644t2223r1683b2263],
5	UCO	NNP	O	UCO	dep	6	SENT_196	[p11l1699t2208r1872b2265],
6	>	JJR	O	>	dep	11	SENT_196	[p11l1232t2320r1271b2360],
7	UCO	NNP	O	UCO	dep	6	SENT_196	[p11l1287t2305r1460b2362],
8	2007	CD	DATE	2007	num	7	SENT_196	[p11l7t2418r161b2473],
9	3556	CD	NUMBER	3556	num	10	SENT_196	[p11l662t2418r813b2473],
10	<	JJR	O	<	dep	7	SENT_196	[p11l1232t2431r1271b2472],
11	LCO	CD	NUMBER	lco	_	0	SENT_196	[p11l1287t2417r1447b2473],

1	>	JJR	O	>	amod	2	SENT_197	[p11l1232t2517r1271b2557],
2	LCD	NNS	O	lcd	dep	6	SENT_197	[p11l1287t2502r1447b2559],
3	and	CC	O	and	_	0	SENT_197	[p11l1476t2501r1602b2558],
4	<	JJR	O	<	dep	6	SENT_197	[p11l1644t2517r1683b2557],
5	UCO	NNP	ORGANIZATION	UCO	dep	6	SENT_197	[p11l1699t2502r1872b2559],
6	>	JJR	O	>	dep	11	SENT_197	[p11l1232t2614r1271b2654],
7	UCO	NNP	O	UCO	dep	6	SENT_197	[p11l1287t2599r1460b2656],
8	2008	CD	DATE	2008	num	7	SENT_197	[p11l7t2712r158b2767],
9	2138	CD	DATE	2138	num	10	SENT_197	[p11l661t2711r813b2767],
10	<	JJR	O	<	dep	7	SENT_197	[p11l1232t2725r1271b2765],
11	LCO	CD	NUMBER	lco	_	0	SENT_197	[p11l1287t2710r1447b2767],

1	>	JJR	O	>	amod	2	SENT_198	[p11l1232t2811r1271b2851],
2	LCO	NN	O	lco	_	0	SENT_198	[p11l1287t2796r1447b2853],
3	and	CC	O	and	_	0	SENT_198	[p11l1476t2795r1602b2852],
4	<	JJR	O	<	conj_and	2	SENT_198	[p11l1644t2811r1683b2851],
5	UCO	NNP	O	UCO	dep	2	SENT_198	[p11l1699t2796r1872b2853],
6	>	JJR	O	>	amod	7	SENT_198	[p11l1232t2908r1271b2948],
7	UCO	NN	O	uco	dep	5	SENT_198	[p11l1287t2893r1460b2950],

1	TPV	NN	O	tpv	_	0	SENT_199	[p11l964t3006r1116b3063],
2	F	NN	O	f	nn	3	SENT_199	[p11l1139t3006r1183b3062],
3	C	NN	O	c	dep	1	SENT_199	[p11l1187t3005r1236b3063],

1	<	JJR	O	<	_	0	SENT_200	[p11l166t3177r207b3219],
2	LCO	CD	NUMBER	lco	num	4	SENT_200	[p11l223t3162r379b3220],
3	>	JJR	O	>	amod	4	SENT_200	[p11l829t3177r870b3219],
4	LCO	NN	O	lco	dep	1	SENT_200	[p11l886t3162r1042b3220],
5	and	CC	O	and	_	0	SENT_200	[p11l1070t3160r1188b3220],
6	<	JJR	O	<	dep	1	SENT_200	[p11l1230t3177r1271b3219],
7	UCO	NNP	O	UCO	dep	6	SENT_200	[p11l1292t3162r1460b3220],
8	>	JJR	O	>	amod	9	SENT_200	[p11l1863t3177r1903b3219],
9	UCO	NN	O	uco	dep	1	SENT_200	[p11l1925t3162r2092b3220],

1	»	NN	O	»	_	0	SENT_201	[p12l60t828r91b855],
2	~	NN	O	~	dep	1	SENT_201	[p12l60t828r91b855],
3	p	NN	O	p	nn	4	SENT_201	[p12l108t790r452b905],
4	B	NN	O	b	rcmod	2	SENT_201	[p12l108t790r452b905],
5	+	CC	O	+	_	0	SENT_201	[p12l108t790r452b905],
6	p	NN	O	p	nn	7	SENT_201	[p12l465t790r1856b947],
7	B	NN	O	b	rcmod	2	SENT_201	[p12l465t790r1856b947],
8	+	CC	O	+	rcmod	7	SENT_201	[p12l465t790r1856b947],
9	@	SYM	O	@	dep	4	SENT_201	[p12l2021t828r2100b856],

1	Mutation	NN	O	mutation	nn	4	SENT_202	[p12l7t1035r275b1086],
2	DRV	NN	O	drv	nn	4	SENT_202	[p12l386t1036r538b1086],
3	score	NN	NUMBER	score	nn	4	SENT_202	[p12l559t1051r698b1086],
4	weighta	NN	O	weighta	_	0	SENT_202	[p12l723t1032r936b1104],
5	TPV	NN	O	tpv	nn	8	SENT_202	[p12l1046t1036r1181b1086],
6	score	NN	NUMBER	score	nn	8	SENT_202	[p12l1202t1051r1341b1086],
7	weightb	NN	O	weightb	nn	8	SENT_202	[p12l1367t1020r1581b1104],
8	DRV	NN	O	drv	dep	4	SENT_202	[p12l1691t1033r2125b1093],
9	.	.	O	.	_	0	SENT_202	[p12l1691t1033r2125b1093],

1	—	NN	O	—	_	0	SENT_203	[p12l1691t1033r2125b1093],
2	.	.	O	.	_	0	SENT_203	[p12l1691t1033r2125b1093],

1	S/1	NN	O	s/1	_	0	SENT_204	[p12l1691t1033r2125b1093],
2	"	''	O	"	punct	1	SENT_204	[p12l1691t1033r2125b1093],
3	PV	NN	O	pv	dep	1	SENT_204	[p12l1691t1033r2125b1093],
4	.	.	O	.	_	0	SENT_204	[p12l1691t1033r2125b1093],

1	—	NN	O	—	_	0	SENT_205	[p12l1691t1033r2125b1093],
2	.	.	O	.	_	0	SENT_205	[p12l1691t1033r2125b1093],

1	R	NN	O	r	_	0	SENT_206	[p12l1691t1033r2125b1093],

1	Overall	JJ	O	overall	dep	4	SENT_207	[p12l10t1179r237b1232],
2	513	CD	NUMBER	513	num	3	SENT_207	[p12l1755t1182r1857b1232],
3	241	CD	NUMBER	241	dep	1	SENT_207	[p12l10t1270r101b1319],
4	o	NN	O	o	dep	7	SENT_207	[p12l644t1270r675b1321],
5	-2	CD	NUMBER	-2	num	4	SENT_207	[p12l1277t1270r1360b1319],
6	21	CD	NUMBER	21	num	7	SENT_207	[p12l1766t1270r1830b1319],
7	(	NN	O	(	dep	11	SENT_207	[p12l1863t1268r2047b1334],
8	4.1	CD	PERCENT	4.1	num	9	SENT_207	[p12l1863t1268r2047b1334],
9	%	NN	PERCENT	%	dep	7	SENT_207	[p12l1863t1268r2047b1334],
10	)	CD	NUMBER	)	num	11	SENT_207	[p12l1863t1268r2047b1334],
11	47V	NN	O	47v	dep	17	SENT_207	[p12l9t1357r129b1407],
12	1	CD	NUMBER	1	number	13	SENT_207	[p12l647t1357r672b1406],
13	4	CD	NUMBER	4	dep	11	SENT_207	[p12l1327t1357r1360b1406],
14	44	CD	NUMBER	44	num	15	SENT_207	[p12l1766t1357r1834b1407],
15	(	NN	O	(	dep	13	SENT_207	[p12l1863t1355r2047b1421],
16	8.6	CD	PERCENT	8.6	num	17	SENT_207	[p12l1863t1355r2047b1421],
17	%	NN	PERCENT	%	dep	20	SENT_207	[p12l1863t1355r2047b1421],
18	)	CD	NUMBER	)	num	19	SENT_207	[p12l1863t1355r2047b1421],
19	50L	NN	O	50l	dep	17	SENT_207	[p12l10t1445r120b1496],
20	o	NN	O	o	dep	23	SENT_207	[p12l644t1445r675b1496],
21	-4	CD	NUMBER	-4	num	20	SENT_207	[p12l1277t1445r1360b1494],
22	16	CD	NUMBER	16	num	23	SENT_207	[p12l1770t1445r1834b1496],
23	(	NN	O	(	dep	25	SENT_207	[p12l1863t1443r2047b1509],
24	3.1	CD	PERCENT	3.1	num	25	SENT_207	[p12l1863t1443r2047b1509],
25	%	NN	PERCENT	%	dep	29	SENT_207	[p12l1863t1443r2047b1509],
26	)	CD	NUMBER	)	num	27	SENT_207	[p12l1863t1443r2047b1509],
27	50V	NN	O	50v	dep	25	SENT_207	[p12l10t1534r129b1585],
28	1	CD	NUMBER	1	num	29	SENT_207	[p12l647t1534r672b1583],
29	-4	CD	NUMBER	-4	dep	34	SENT_207	[p12l1277t1534r1360b1583],
30	o	NN	O	o	nn	33	SENT_207	[p12l1802t1534r1833b1585],
31	(	CD	NUMBER	(	num	33	SENT_207	[p12l1863t1532r2047b1598],
32	o.	NN	O	o.	nn	33	SENT_207	[p12l1863t1532r2047b1598],
33	o	NN	PERCENT	o	dep	29	SENT_207	[p12l1863t1532r2047b1598],
34	%	NN	PERCENT	%	dep	36	SENT_207	[p12l1863t1532r2047b1598],
35	)	CD	NUMBER	)	num	34	SENT_207	[p12l1863t1532r2047b1598],
36	54L	NN	O	54l	dep	40	SENT_207	[p12l10t1621r120b1672],
37	1	CD	NUMBER	1	num	36	SENT_207	[p12l647t1621r672b1670],
38	-6	CD	NUMBER	-6	num	40	SENT_207	[p12l1277t1622r1360b1672],
39	5	CD	NUMBER	5	num	40	SENT_207	[p12l1801t1621r1833b1672],
40	(	NN	O	(	dep	45	SENT_207	[p12l1863t1619r2047b1685],
41	1.0	CD	PERCENT	1.0	num	42	SENT_207	[p12l1863t1619r2047b1685],
42	%	NN	PERCENT	%	dep	40	SENT_207	[p12l1863t1619r2047b1685],
43	)	CD	NUMBER	)	num	45	SENT_207	[p12l1863t1619r2047b1685],
44	58E	NN	O	58e	nn	45	SENT_207	[p12l10t1709r119b1760],
45	o	NN	O	o	dep	53	SENT_207	[p12l644t1709r675b1760],
46	3	CD	NUMBER	3	number	47	SENT_207	[p12l1328t1709r1359b1760],
47	124	CD	NUMBER	124	num	48	SENT_207	[p12l1735t1709r1834b1759],
48	(	NN	O	(	dep	45	SENT_207	[p12l1863t1707r2082b1773],
49	24.2	CD	PERCENT	24.2	number	50	SENT_207	[p12l1863t1707r2082b1773],
50	%	NN	PERCENT	%	amod	48	SENT_207	[p12l1863t1707r2082b1773],
51	)	CD	NUMBER	)	num	53	SENT_207	[p12l1863t1707r2082b1773],
52	74P	NN	O	74p	nn	53	SENT_207	[p12l11t1797r120b1847],
53	O	NN	O	o	dep	60	SENT_207	[p12l644t1798r675b1848],
54	4	CD	NUMBER	4	number	55	SENT_207	[p12l1327t1797r1360b1847],
55	42	CD	NUMBER	42	num	56	SENT_207	[p12l1766t1797r1834b1847],
56	(	NN	O	(	dep	53	SENT_207	[p12l1863t1795r2047b1861],
57	8.2	CD	PERCENT	8.2	number	58	SENT_207	[p12l1863t1795r2047b1861],
58	%	NN	PERCENT	%	amod	56	SENT_207	[p12l1863t1795r2047b1861],
59	)	CD	NUMBER	)	num	60	SENT_207	[p12l1863t1795r2047b1861],
60	76V	NN	O	76v	dep	62	SENT_207	[p12l11t1886r129b1937],
61	1	CD	PERCENT	1	num	62	SENT_207	[p12l647t1886r672b1935],
62	-2	CD	PERCENT	-2	dep	69	SENT_207	[p12l1277t1886r1360b1935],
63	2	CD	PERCENT	2	number	64	SENT_207	[p12l1801t1886r1834b1935],
64	(	CD	PERCENT	(	dep	62	SENT_207	[p12l1863t1884r2047b1950],
65	0.4	CD	PERCENT	0.4	num	66	SENT_207	[p12l1863t1884r2047b1950],
66	%	NN	PERCENT	%	dep	64	SENT_207	[p12l1863t1884r2047b1950],
67	)	CD	NUMBER	)	num	69	SENT_207	[p12l1863t1884r2047b1950],
68	82L	NN	O	82l	nn	69	SENT_207	[p12l11t1973r120b2024],
69	o	NN	O	o	dep	77	SENT_207	[p12l644t1973r675b2024],
70	4	CD	NUMBER	4	number	71	SENT_207	[p12l1327t1973r1360b2022],
71	38	CD	NUMBER	38	num	72	SENT_207	[p12l1767t1973r1833b2024],
72	(	NN	O	(	dep	69	SENT_207	[p12l1863t1971r2047b2037],
73	7.4	CD	PERCENT	7.4	number	74	SENT_207	[p12l1863t1971r2047b2037],
74	%	NN	PERCENT	%	amod	72	SENT_207	[p12l1863t1971r2047b2037],
75	)	CD	NUMBER	)	num	77	SENT_207	[p12l1863t1971r2047b2037],
76	82T	NN	O	82t	nn	77	SENT_207	[p12l11t2061r121b2112],
77	o	NN	O	o	dep	85	SENT_207	[p12l644t2062r675b2112],
78	4	CD	NUMBER	4	number	79	SENT_207	[p12l1327t2061r1360b2111],
79	190	CD	NUMBER	190	num	80	SENT_207	[p12l1735t2061r1834b2112],
80	(	NN	O	(	dep	77	SENT_207	[p12l1863t2059r2082b2125],
81	37.0	CD	PERCENT	37.0	num	82	SENT_207	[p12l1863t2059r2082b2125],
82	%	NN	PERCENT	%	dep	80	SENT_207	[p12l1863t2059r2082b2125],
83	)	CD	NUMBER	)	num	85	SENT_207	[p12l1863t2059r2082b2125],
84	83D	NN	O	83d	nn	85	SENT_207	[p12l11t2150r132b2201],
85	o	NN	O	o	dep	91	SENT_207	[p12l644t2150r675b2201],
86	4	CD	NUMBER	4	number	87	SENT_207	[p12l1327t2150r1360b2199],
87	30	CD	NUMBER	30	num	88	SENT_207	[p12l1767t2150r1834b2201],
88	(	NN	O	(	dep	85	SENT_207	[p12l1863t2148r2047b2214],
89	5.8	CD	PERCENT	5.8	num	90	SENT_207	[p12l1863t2148r2047b2214],
90	%	NN	PERCENT	%	dep	88	SENT_207	[p12l1863t2148r2047b2214],
91	)	CD	NUMBER	)	_	0	SENT_207	[p12l1863t2148r2047b2214],

1	DRV	NN	O	drv	_	0	SENT_208	[p12l110t2393r460b2469],
2	.	.	O	.	_	0	SENT_208	[p12l110t2393r460b2469],

1	—	NN	O	—	_	0	SENT_209	[p12l110t2393r460b2469],
2	.	.	O	.	_	0	SENT_209	[p12l110t2393r460b2469],

1	S/T	NN	O	s/t	nn	2	SENT_210	[p12l110t2393r460b2469],
2	P	NN	O	p	nsubj	3	SENT_210	[p12l458t2397r511b2460],
3	V	NN	O	v	_	0	SENT_210	[p12l518t2397r715b2460],
4	.	.	O	.	_	0	SENT_210	[p12l518t2397r715b2460],

1	—	NN	O	—	_	0	SENT_211	[p12l518t2397r715b2460],
2	.	.	O	.	_	0	SENT_211	[p12l518t2397r715b2460],

1	PR	NN	O	pr	_	0	SENT_212	[p12l518t2397r715b2460],
2	DRV	NN	O	drv	dep	1	SENT_212	[p12l854t2393r1269b2469],
3	.	.	O	.	_	0	SENT_212	[p12l854t2393r1269b2469],

1	—	NN	O	—	_	0	SENT_213	[p12l854t2393r1269b2469],
2	.	.	O	.	_	0	SENT_213	[p12l854t2393r1269b2469],

1	PR/T	NN	O	pr/t	_	0	SENT_214	[p12l854t2393r1269b2469],
2	P	NN	O	p	nn	5	SENT_214	[p12l1267t2397r1320b2460],
3	V-S	NN	O	v-s	nn	5	SENT_214	[p12l1326t2396r1458b2461],
4	DR	NN	O	dr	nn	5	SENT_214	[p12l1600t2397r1723b2460],
5	V	NN	O	v	dep	1	SENT_214	[p12l1732t2393r1961b2469],
6	.	.	O	.	_	0	SENT_214	[p12l1732t2393r1961b2469],

1	—	NN	O	—	_	0	SENT_215	[p12l1732t2393r1961b2469],
2	.	.	O	.	_	0	SENT_215	[p12l1732t2393r1961b2469],

1	R/T	NN	O	r/t	_	0	SENT_216	[p12l1732t2393r1961b2469],
2	P	NN	O	p	nn	3	SENT_216	[p12l1958t2397r2011b2460],
3	V-5	NN	O	v-5	dep	1	SENT_216	[p12l2018t2396r2149b2461],

1	“	RB	O	“	advmod	2	SENT_217	[p13l92t148r189b174],
2	Based	VBN	O	base	_	0	SENT_217	[p13l92t148r189b174],
3	on	IN	O	on	_	0	SENT_217	[p13l201t157r238b174],
4	De	NNP	PERSON	De	nn	5	SENT_217	[p13l249t150r289b174],
5	Meyer	NNP	PERSON	Meyer	prep_on	2	SENT_217	[p13l301t150r394b183],
6	et	FW	O	et	nn	7	SENT_217	[p13l405t152r428b174],
7	111.24	FW	NUMBER	111.24	dobj	2	SENT_217	[p13l439t143r496b174],
8	bBased	VBN	O	bbase	partmod	7	SENT_217	[p13l91t180r190b211],
9	on	IN	O	on	_	0	SENT_217	[p13l203t195r239b211],
10	Scherer	NNP	O	Scherer	prep_on	8	SENT_217	[p13l251t186r357b211],
11	et	FW	O	et	nn	12	SENT_217	[p13l369t189r392b211],
12	ul	FW	O	ul	nsubj	2	SENT_217	[p13l403t180r459b211],
13	.25	CD	NUMBER	.25	num	14	SENT_217	[p13l403t180r459b211],
14	DVR	NN	O	dvr	dep	12	SENT_217	[p13l92t224r170b253],
15	,	,	O	,	_	0	SENT_217	[p13l92t224r170b253],
16	darunavir	NN	O	darunavir	appos	14	SENT_217	[p13l182t223r334b253],
17	;	:	O	;	_	0	SENT_217	[p13l182t223r334b253],
18	TPV	NN	O	tpv	dep	14	SENT_217	[p13l345t224r416b253],
19	,	,	O	,	_	0	SENT_217	[p13l345t224r416b253],
20	tipranavir	NN	O	tipranavir	appos	18	SENT_217	[p13l428t224r580b257],
21	;	:	O	;	_	0	SENT_217	[p13l428t224r580b257],
22	DRV-S	NN	O	drv-s	dep	14	SENT_217	[p13l591t223r698b253],
23	,	,	O	,	_	0	SENT_217	[p13l591t223r698b253],
24	darunavir-susceptible	JJ	O	darunavir-susceptible	appos	22	SENT_217	[p13l710t223r1032b257],
25	;	:	O	;	_	0	SENT_217	[p13l710t223r1032b257],
26	TPV-R	NN	O	tpv-r	dep	14	SENT_217	[p13l1044t224r1147b253],
27	,	,	O	,	_	0	SENT_217	[p13l1044t224r1147b253],
28	tipranavir-resistant	JJ	O	tipranavir-resistant	appos	26	SENT_217	[p13l1159t224r1444b257],
29	;	:	O	;	_	0	SENT_217	[p13l1159t224r1444b257],
30	TPV-PR	NN	O	tpv-pr	dep	14	SENT_217	[p13l1455t224r1578b253],
31	,	,	O	,	_	0	SENT_217	[p13l1455t224r1578b253],
32	tipranavir-partially	RB	O	tipranavir-partially	rcmod	30	SENT_217	[p13l1590t223r1868b257],
33	resistant	JJ	O	resistant	dep	32	SENT_217	[p13l1878t224r2008b253],
34	;	:	O	;	_	0	SENT_217	[p13l1878t224r2008b253],
35	DRVPR	NN	LOCATION	drvpr	dep	14	SENT_217	[p13l2019t224r2101b248, p13l58t261r107b289],
36	,	,	O	,	_	0	SENT_217	[p13l2019t224r2101b248, p13l58t261r107b289],
37	darunavi_r	NN	O	darunavi_r	appos	35	SENT_217	[p13l120t260r398b294],
38	—	CD	NUMBER	—	num	37	SENT_217	[p13l120t260r398b294],
39	partially	RB	O	partially	advmod	40	SENT_217	[p13l120t260r398b294],
40	resistant	JJ	O	resistant	amod	37	SENT_217	[p13l409t261r538b289],
41	;	:	O	;	_	0	SENT_217	[p13l409t261r538b289],
42	TPV	NN	O	tpv	dep	37	SENT_217	[p13l551t261r649b290],
43	.	.	O	.	_	0	SENT_217	[p13l551t261r649b290],

1	—	NN	O	—	_	0	SENT_218	[p13l551t261r649b290],
2	.	.	O	.	_	0	SENT_218	[p13l551t261r649b290],

1	S	NN	O	s	_	0	SENT_219	[p13l551t261r649b290],
2	,	,	O	,	_	0	SENT_219	[p13l551t261r649b290],
3	tipranavi1	NN	O	tipranavi1	appos	1	SENT_219	[p13l661t260r984b294],
4	'	''	O	'	_	0	SENT_219	[p13l661t260r984b294],
5	.	.	O	.	_	0	SENT_219	[p13l661t260r984b294],

1	—	NN	O	—	_	0	SENT_220	[p13l661t260r984b294],
2	.	.	O	.	_	0	SENT_220	[p13l661t260r984b294],

1	susceptible	JJ	O	susceptible	_	0	SENT_221	[p13l661t260r984b294],
2	;	:	O	;	_	0	SENT_221	[p13l661t260r984b294],
3	DRV	NN	O	drv	dep	1	SENT_221	[p13l997t261r1108b290],
4	.	.	O	.	_	0	SENT_221	[p13l997t261r1108b290],

1	—	NN	O	—	_	0	SENT_222	[p13l997t261r1108b290],
2	.	.	O	.	_	0	SENT_222	[p13l997t261r1108b290],

1	R	NN	O	r	_	0	SENT_223	[p13l997t261r1108b290],
2	,	,	O	,	_	0	SENT_223	[p13l997t261r1108b290],
3	daru	NN	O	daru	appos	1	SENT_223	[p13l1121t260r1404b285],
4	.	.	O	.	_	0	SENT_223	[p13l1121t260r1404b285],

1	naVir	NN	O	navir	dep	3	SENT_224	[p13l1121t260r1404b285],
2	—	CD	NUMBER	—	num	1	SENT_224	[p13l1121t260r1404b285],
3	resistant	JJ	O	resistant	_	0	SENT_224	[p13l1121t260r1404b285],
4	.	.	O	.	_	0	SENT_224	[p13l1121t260r1404b285],

1	TPV	NN	O	tpv	nsubjpass	6	SENT_225	[p13l10t458r180b526],
2	,	,	O	,	_	0	SENT_225	[p13l10t458r180b526],
3	consideration	NN	O	consideration	appos	1	SENT_225	[p13l217t455r691b516],
4	might	MD	O	might	aux	6	SENT_225	[p13l723t455r931b537],
5	be	VB	O	be	auxpass	6	SENT_225	[p13l961t455r1043b516],
6	given	VBN	O	give	_	0	SENT_225	[p13l1078t458r1289b537],
7	,	,	O	,	_	0	SENT_225	[p13l1078t458r1289b537],
8	therefore	RB	O	therefore	advmod	6	SENT_225	[p13l1324t455r1656b526],
9	,	,	O	,	_	0	SENT_225	[p13l1324t455r1656b526],
10	to	TO	O	to	_	0	SENT_225	[p13l1692t464r1758b516],
11	the	DT	O	the	det	12	SENT_225	[p13l1792t455r1899b516],
12	use	NN	O	use	prep_to	6	SENT_225	[p13l1933t476r2050b516],
13	of	IN	O	of	_	0	SENT_225	[p13l2084t455r2153b516],
14	TPV	NN	O	tpv	prep_of	12	SENT_225	[p13l10t554r162b612],
15	in	IN	O	in	_	0	SENT_225	[p13l192t555r259b611],
16	a	DT	O	a	det	19	SENT_225	[p13l288t572r324b612],
17	subsequent	JJ	O	subsequent	amod	19	SENT_225	[p13l355t552r751b633],
18	antiretroviral	JJ	O	antiretroviral	amod	19	SENT_225	[p13l781t552r1243b612],
19	regimen	NN	O	regimen	prep_in	14	SENT_225	[p13l1272t555r1576b633],
20	.	.	O	.	_	0	SENT_225	[p13l1272t555r1576b633],

1	A	DT	O	a	det	3	SENT_226	[p13l1608t554r1668b611],
2	key	JJ	O	key	amod	3	SENT_226	[p13l1698t552r1823b633],
3	observation	NN	O	observation	nsubj	7	SENT_226	[p13l1853t552r2150b613, p13l10t652r147b710],
4	from	IN	O	from	_	0	SENT_226	[p13l176t649r345b710],
5	this	DT	O	this	det	6	SENT_226	[p13l373t649r498b710],
6	analysis	NN	O	analysis	prep_from	3	SENT_226	[p13l529t649r808b731],
7	was	VBD	O	be	_	0	SENT_226	[p13l837t669r975b710],
8	that	IN	O	that	complm	24	SENT_226	[p13l1006t649r1142b709],
9	while	IN	O	while	mark	13	SENT_226	[p13l1169t649r1363b710],
10	resistance	NN	O	resistance	nsubj	13	SENT_226	[p13l1394t652r1734b710],
11	to	TO	O	to	_	0	SENT_226	[p13l1763t657r1830b710],
12	TPV	NN	O	tpv	prep_to	10	SENT_226	[p13l1859t651r2011b709],
13	decreased	VBD	O	decrease	advcl	24	SENT_226	[p13l2042t649r2151b710, p13l11t746r271b807],
14	slightly	RB	O	slightly	advmod	13	SENT_226	[p13l300t746r559b828],
15	from	IN	O	from	_	0	SENT_226	[p13l587t746r756b807],
16	2006	CD	DATE	2006	num	18	SENT_226	[p13l782t749r939b807],
17	to	TO	DATE	to	dep	18	SENT_226	[p13l969t755r1035b807],
18	2008	CD	DATE	2008	prep_from	13	SENT_226	[p13l1063t749r1240b817],
19	,	,	O	,	_	0	SENT_226	[p13l1063t749r1240b817],
20	resistance	NN	O	resistance	nsubj	24	SENT_226	[p13l1269t749r1609b807],
21	to	TO	O	to	_	0	SENT_226	[p13l1638t755r1704b807],
22	DRV	NNP	ORGANIZATION	DRV	prep_to	20	SENT_226	[p13l1733t749r1904b806],
23	nearly	RB	O	nearly	advmod	24	SENT_226	[p13l1930t746r2151b828],
24	doubled	VBD	O	double	ccomp	7	SENT_226	[p13l11t843r300b904],
25	during	IN	O	during	_	0	SENT_226	[p13l336t843r573b924],
26	the	DT	O	the	det	28	SENT_226	[p13l607t843r714b903],
27	same	JJ	O	same	amod	28	SENT_226	[p13l749t863r926b904],
28	timeframe	NN	O	timeframe	prep_during	24	SENT_226	[p13l961t843r1338b914],
29	,	,	O	,	_	0	SENT_226	[p13l961t843r1338b914],
30	most	RBS	O	most	advmod	32	SENT_226	[p13l1374t851r1546b903],
31	likely	RB	O	likely	advmod	32	SENT_226	[p13l1579t843r1771b924],
32	due	JJ	O	due	acomp	24	SENT_226	[p13l1806t843r1936b903],
33	to	TO	O	to	_	0	SENT_226	[p13l1970t851r2036b904],
34	its	PRP$	O	its	poss	36	SENT_226	[p13l2070t846r2149b903],
35	wider	JJR	O	wider	amod	36	SENT_226	[p13l9t940r215b1000],
36	use	NN	O	use	prep_to	32	SENT_226	[p13l240t960r372b1000],
37	.	.	O	.	_	0	SENT_226	[p13l240t960r372b1000],

1	The	DT	O	the	det	2	SENT_227	[p13l99t1037r229b1097],
2	results	NNS	O	result	nsubjpass	5	SENT_227	[p13l248t1037r477b1097],
3	here	RB	O	here	advmod	5	SENT_227	[p13l495t1037r646b1097],
4	are	VBP	O	be	auxpass	5	SENT_227	[p13l666t1057r771b1097],
5	based	VBN	O	base	_	0	SENT_227	[p13l787t1037r991b1097],
6	on	IN	O	on	_	0	SENT_227	[p13l1011t1058r1099b1097],
7	the	DT	O	the	det	9	SENT_227	[p13l1116t1037r1223b1097],
8	clinical	JJ	O	clinical	amod	9	SENT_227	[p13l1243t1037r1487b1097],
9	isolates	NNS	O	isolate	prep_on	5	SENT_227	[p13l1505t1037r1761b1097],
10	sent	VBN	O	send	partmod	9	SENT_227	[p13l1782t1045r1922b1097],
11	to	TO	O	to	_	0	SENT_227	[p13l1940t1046r2006b1097],
12	one	CD	NUMBER	one	num	13	SENT_227	[p13l2027t1057r2150b1097],
13	laboratory	NN	O	laboratory	prep_to	10	SENT_227	[p13l10t1136r375b1217],
14	for	IN	O	for	_	0	SENT_227	[p13l412t1136r510b1196],
15	a	DT	O	a	det	16	SENT_227	[p13l549t1156r585b1196],
16	combination	NN	O	combination	prep_for	13	SENT_227	[p13l624t1136r1062b1197],
17	of	IN	O	of	_	0	SENT_227	[p13l1100t1136r1169b1197],
18	genotypic	JJ	O	genotypic	amod	21	SENT_227	[p13l1205t1139r1547b1217],
19	and	CC	O	and	_	0	SENT_227	[p13l1587t1136r1718b1196],
20	phenotypic	JJ	O	phenotypic	conj_and	18	SENT_227	[p13l1755t1136r2149b1217],
21	testing	NN	O	testing	prep_of	16	SENT_227	[p13l10t1236r260b1315],
22	.	.	O	.	_	0	SENT_227	[p13l10t1236r260b1315],

1	Doctor	NN	O	doctor	nn	4	SENT_228	[p13l287t1236r526b1294],
2	and	CC	O	and	_	0	SENT_228	[p13l550t1233r680b1293],
3	patient	NN	O	patient	conj_and	1	SENT_228	[p13l703t1236r948b1315],
4	judgments	NNS	O	judgment	nsubj	17	SENT_228	[p13l966t1233r1339b1315],
5	about	IN	O	about	_	0	SENT_228	[p13l1365t1233r1564b1294],
6	when	WRB	O	when	advmod	8	SENT_228	[p13l1584t1233r1781b1294],
7	to	TO	O	to	aux	8	SENT_228	[p13l1802t1242r1868b1294],
8	include	VB	O	include	prepc_about	4	SENT_228	[p13l1893t1233r2150b1294],
9	phenotypic	JJ	O	phenotypic	amod	14	SENT_228	[p13l9t1331r403b1413],
10	as	RB	O	as	_	0	SENT_228	[p13l440t1352r509b1392],
11	well	RB	O	well	_	0	SENT_228	[p13l543t1331r692b1392],
12	as	IN	O	as	_	0	SENT_228	[p13l727t1352r797b1392],
13	genotypic	JJ	O	genotypic	amod	14	SENT_228	[p13l834t1334r1177b1413],
14	assessment	NN	O	assessment	dobj	8	SENT_228	[p13l1212t1340r1602b1392],
15	have	VBP	O	have	aux	17	SENT_228	[p13l1634t1331r1801b1392],
16	therefore	RB	O	therefore	advmod	17	SENT_228	[p13l1837t1331r2150b1392],
17	determined	VBN	O	determine	_	0	SENT_228	[p13l11t1429r413b1489],
18	the	DT	O	the	det	19	SENT_228	[p13l436t1429r542b1489],
19	population	NN	O	population	dobj	17	SENT_228	[p13l563t1428r950b1510],
20	for	IN	O	for	_	0	SENT_228	[p13l970t1428r1068b1489],
21	this	DT	O	this	det	22	SENT_228	[p13l1090t1429r1215b1489],
22	study	NN	O	study	prep_for	19	SENT_228	[p13l1238t1429r1450b1510],
23	.	.	O	.	_	0	SENT_228	[p13l1238t1429r1450b1510],

1	Insurance	NN	O	insurance	nn	2	SENT_229	[p13l1475t1431r1816b1489],
2	coverage	NN	O	coverage	nsubj	6	SENT_229	[p13l1839t1449r2150b1510],
3	will	MD	O	will	aux	6	SENT_229	[p13l9t1525r143b1585],
4	also	RB	O	also	advmod	6	SENT_229	[p13l163t1525r299b1586],
5	have	VB	O	have	aux	6	SENT_229	[p13l318t1525r485b1586],
6	limited	VBN	O	limit	_	0	SENT_229	[p13l504t1525r751b1586],
7	the	DT	O	the	det	8	SENT_229	[p13l771t1525r878b1586],
8	availability	NN	O	availability	dobj	6	SENT_229	[p13l899t1525r1289b1607],
9	of	IN	O	of	_	0	SENT_229	[p13l1309t1525r1378b1586],
10	samples	NNS	O	sample	prep_of	8	SENT_229	[p13l1395t1525r1676b1607],
11	for	IN	O	for	_	0	SENT_229	[p13l1696t1525r1794b1586],
12	inclusion	NN	O	inclusion	prep_for	10	SENT_229	[p13l1813t1525r2146b1586],
13	.	.	O	.	_	0	SENT_229	[p13l1813t1525r2146b1586],

1	Although	IN	O	although	mark	6	SENT_230	[p13l10t1622r347b1704],
2	the	DT	O	the	det	4	SENT_230	[p13l370t1622r477b1683],
3	clinical	JJ	O	clinical	amod	4	SENT_230	[p13l502t1622r746b1683],
4	history	NN	O	history	nsubj	6	SENT_230	[p13l769t1622r1015b1704],
5	is	VBZ	O	be	cop	6	SENT_230	[p13l1039t1625r1092b1683],
6	undocumented	JJ	O	undocumented	advcl	10	SENT_230	[p13l1116t1622r1667b1693],
7	,	,	O	,	_	0	SENT_230	[p13l1116t1622r1667b1693],
8	it	PRP	O	it	nsubjpass	10	SENT_230	[p13l1693t1625r1740b1682],
9	is	VBZ	O	be	auxpass	10	SENT_230	[p13l1764t1625r1817b1683],
10	assumed	VBN	O	assume	_	0	SENT_230	[p13l1842t1622r2150b1683],
11	that	IN	O	that	complm	22	SENT_230	[p13l10t1721r147b1780],
12	patients	NNS	O	patient	nsubj	22	SENT_230	[p13l173t1723r450b1802],
13	whose	WP$	O	whose	poss	14	SENT_230	[p13l478t1721r704b1781],
14	samples	NNS	O	sample	nsubjpass	17	SENT_230	[p13l733t1720r1014b1802],
15	were	VBD	O	be	aux	17	SENT_230	[p13l1042t1741r1213b1781],
16	being	VBG	O	be	auxpass	17	SENT_230	[p13l1239t1720r1435b1802],
17	sent	VBN	O	send	rcmod	12	SENT_230	[p13l1463t1729r1604b1781],
18	for	IN	O	for	_	0	SENT_230	[p13l1630t1720r1728b1781],
19	phenotypic	JJ	O	phenotypic	amod	20	SENT_230	[p13l1755t1721r2149b1802],
20	assessment	NN	O	assessment	prep_for	17	SENT_230	[p13l11t1826r400b1878],
21	were	VBD	O	be	aux	22	SENT_230	[p13l428t1837r600b1878],
22	receiving	VBG	O	receive	ccomp	10	SENT_230	[p13l629t1820r949b1899],
23	adequate	JJ	O	adequate	amod	24	SENT_230	[p13l980t1817r1298b1899],
24	care	NN	O	care	dobj	22	SENT_230	[p13l1328t1837r1488b1888],
25	,	,	O	,	_	0	SENT_230	[p13l1328t1837r1488b1888],
26	and	CC	O	and	_	0	SENT_230	[p13l1520t1817r1651b1877],
27	that	IN	O	that	complm	32	SENT_230	[p13l1681t1817r1818b1877],
28	the	DT	O	the	det	29	SENT_230	[p13l1846t1817r1953b1878],
29	samples	NNS	O	sample	nsubjpass	32	SENT_230	[p13l1984t1837r2151b1878, p13l9t1914r149b1996],
30	were	VBD	O	be	auxpass	32	SENT_230	[p13l168t1935r340b1975],
31	therefore	RB	O	therefore	advmod	32	SENT_230	[p13l360t1914r673b1975],
32	sent	VBN	O	send	conj_and	22	SENT_230	[p13l694t1922r835b1975],
33	from	IN	O	from	_	0	SENT_230	[p13l854t1914r1023b1975],
34	patients	NNS	O	patient	prep_from	32	SENT_230	[p13l1041t1917r1319b1996],
35	who	WP	O	who	nsubj	37	SENT_230	[p13l1338t1914r1492b1975],
36	had	VBD	O	have	aux	37	SENT_230	[p13l1512t1914r1645b1974],
37	failed	VBN	O	fail	rcmod	34	SENT_230	[p13l1665t1914r1860b1975],
38	therapy	NN	O	therapy	dobj	37	SENT_230	[p13l1880t1914r2151b1996],
39	recently	RB	DATE	recently	advmod	37	SENT_230	[p13l10t2011r304b2093],
40	.	.	O	.	_	0	SENT_230	[p13l10t2011r304b2093],

1	Nevertheless	RB	O	nevertheless	advmod	7	SENT_231	[p13l345t2012r815b2082],
2	,	,	O	,	_	0	SENT_231	[p13l345t2012r815b2082],
3	all	DT	O	all	nsubjpass	20	SENT_231	[p13l854t2011r937b2071],
4	of	IN	O	of	_	0	SENT_231	[p13l974t2011r1043b2072],
5	these	DT	O	these	det	6	SENT_231	[p13l1077t2012r1254b2072],
6	factors	NNS	O	factor	prep_of	3	SENT_231	[p13l1292t2011r1523b2072],
7	represent	VBP	O	represent	_	0	SENT_231	[p13l1560t2020r1887b2093],
8	limitations	NNS	O	limitation	dobj	7	SENT_231	[p13l1923t2012r2151b2071, p13l10t2111r178b2169],
9	associated	VBN	O	associate	partmod	8	SENT_231	[p13l224t2108r581b2169],
10	with	IN	O	with	_	0	SENT_231	[p13l625t2108r786b2168],
11	database	NN	O	database	nn	12	SENT_231	[p13l830t2108r1136b2169],
12	analyses	NNS	O	analysis	prep_with	9	SENT_231	[p13l1182t2108r1475b2190],
13	of	IN	O	of	_	0	SENT_231	[p13l1522t2108r1590b2169],
14	this	DT	O	this	det	15	SENT_231	[p13l1631t2108r1756b2169],
15	type	NN	O	type	prep_of	12	SENT_231	[p13l1801t2116r1973b2190],
16	,	,	O	,	_	0	SENT_231	[p13l1801t2116r1973b2190],
17	and	CC	O	and	_	0	SENT_231	[p13l2019t2108r2150b2168],
18	should	MD	O	should	aux	20	SENT_231	[p13l11t2205r249b2266],
19	be	VB	O	be	auxpass	20	SENT_231	[p13l272t2205r354b2266],
20	considered	VBN	O	consider	conj_and	7	SENT_231	[p13l380t2205r760b2266],
21	when	WRB	O	when	advmod	22	SENT_231	[p13l785t2205r981b2266],
22	interpreting	VBG	O	interpret	advcl	20	SENT_231	[p13l1005t2208r1421b2287],
23	the	DT	O	the	det	25	SENT_231	[p13l1446t2205r1552b2266],
24	study	NN	O	study	nn	25	SENT_231	[p13l1579t2205r1776b2287],
25	findings	NNS	O	finding	dobj	22	SENT_231	[p13l1800t2205r2103b2287],
26	.	.	O	.	_	0	SENT_231	[p13l1800t2205r2103b2287],

1	The	DT	O	the	det	4	SENT_232	[p13l99t2303r229b2363],
2	historical	JJ	O	historical	amod	4	SENT_232	[p13l249t2302r570b2363],
3	resistance	NN	O	resistance	nn	4	SENT_232	[p13l591t2305r930b2363],
4	patterns	NNS	O	pattern	nsubj	10	SENT_232	[p13l950t2311r1235b2384],
5	for	IN	O	for	_	0	SENT_232	[p13l1257t2302r1355b2363],
6	TPV	NN	O	tpv	prep_for	4	SENT_232	[p13l1375t2305r1527b2362],
7	versus	CC	O	versus	prep	6	SENT_232	[p13l1546t2323r1772b2363],
8	DRV	NN	O	drv	dep	7	SENT_232	[p13l1793t2305r1964b2362],
9	have	VBP	O	have	aux	10	SENT_232	[p13l1982t2302r2150b2363],
10	shown	VBN	O	show	_	0	SENT_232	[p13l11t2400r245b2460],
11	little	JJ	O	little	amod	14	SENT_232	[p13l265t2400r420b2460],
12	cross	JJ	O	cross	amod	14	SENT_232	[p13l442t2403r1003b2471],
13	—	NN	O	—	nn	14	SENT_232	[p13l442t2403r1003b2471],
14	resistance	NN	O	resistance	dobj	10	SENT_232	[p13l442t2403r1003b2471],
15	,	,	O	,	_	0	SENT_232	[p13l442t2403r1003b2471],
16	and	CC	O	and	_	0	SENT_232	[p13l1028t2400r1159b2460],
17	this	DT	O	this	det	19	SENT_232	[p13l1180t2400r1305b2460],
18	new	JJ	O	new	amod	19	SENT_232	[p13l1326t2420r1475b2460],
19	analysis	NN	O	analysis	nsubj	20	SENT_232	[p13l1498t2400r1777b2481],
20	highlights	VBZ	O	highlight	conj_and	10	SENT_232	[p13l1798t2400r2149b2481],
21	a	DT	O	a	det	23	SENT_232	[p13l11t2517r47b2556],
22	few	JJ	O	few	amod	23	SENT_232	[p13l69t2496r196b2557],
23	mutations	NNS	O	mutation	dobj	20	SENT_232	[p13l218t2499r571b2557],
24	that	WDT	O	that	nsubj	25	SENT_232	[p13l593t2496r730b2556],
25	confer	VBP	O	confer	rcmod	23	SENT_232	[p13l751t2496r967b2557],
26	discordant	JJ	O	discordant	amod	28	SENT_232	[p13l989t2496r1361b2557],
27	resistance	NN	O	resistance	nn	28	SENT_232	[p13l1381t2499r1721b2557],
28	phenotypes	NNS	O	phenotype	dobj	25	SENT_232	[p13l1742t2496r2150b2578],
29	to	TO	O	to	_	0	SENT_232	[p13l10t2602r77b2654],
30	the	DT	O	the	det	32	SENT_232	[p13l117t2594r224b2654],
31	two	CD	NUMBER	two	num	32	SENT_232	[p13l264t2602r397b2654],
32	agents	NNS	O	agent	prep_to	25	SENT_232	[p13l438t2602r678b2675],
33	.	.	O	.	_	0	SENT_232	[p13l438t2602r678b2675],

1	Mutations	NNS	O	mutation	_	0	SENT_233	[p13l722t2596r1080b2654],
2	at	IN	O	at	_	0	SENT_233	[p13l1121t2602r1185b2653],
3	58E	NN	O	58e	prep_at	1	SENT_233	[p13l1223t2596r1368b2665],
4	,	,	O	,	_	0	SENT_233	[p13l1223t2596r1368b2665],
5	82L	NN	O	82l	appos	3	SENT_233	[p13l1410t2593r1579b2662],
6	/	:	O	/	punct	1	SENT_233	[p13l1410t2593r1579b2662],
7	T	NN	O	t	nsubjpass	13	SENT_233	[p13l1587t2596r1652b2665],
8	,	,	O	,	_	0	SENT_233	[p13l1587t2596r1652b2665],
9	and	CC	O	and	_	0	SENT_233	[p13l1694t2594r1824b2653],
10	83D	NN	O	83d	nsubjpass	13	SENT_233	[p13l1866t2596r2005b2654],
11	are	VBP	O	be	auxpass	13	SENT_233	[p13l2045t2614r2150b2654],
12	highly	RB	O	highly	advmod	13	SENT_233	[p13l9t2691r234b2772],
13	associated	VBN	O	associate	dep	1	SENT_233	[p13l294t2691r650b2751],
14	with	IN	O	with	_	0	SENT_233	[p13l709t2691r870b2751],
15	poor	JJ	O	poor	amod	17	SENT_233	[p13l926t2711r1091b2772],
16	clinical	JJ	O	clinical	amod	17	SENT_233	[p13l1150t2691r1394b2751],
17	responses	NNS	O	response	prep_with	13	SENT_233	[p13l1453t2711r1793b2772],
18	to	TO	O	to	_	0	SENT_233	[p13l1853t2699r1919b2751],
19	TPV	NN	O	tpv	prep_to	13	SENT_233	[p13l1979t2693r2149b2762],
20	,	,	O	,	_	0	SENT_233	[p13l1979t2693r2149b2762],
21	whereas	IN	O	whereas	mark	26	SENT_233	[p13l9t2787r300b2848],
22	these	DT	O	these	det	23	SENT_233	[p13l325t2787r503b2848],
23	isolates	NNS	O	isolate	nsubj	26	SENT_233	[p13l528t2787r784b2848],
24	are	VBP	O	be	cop	26	SENT_233	[p13l810t2808r915b2848],
25	still	RB	O	still	advmod	26	SENT_233	[p13l940t2787r1064b2848],
26	susceptible	JJ	O	susceptible	advcl	13	SENT_233	[p13l1089t2787r1473b2869],
27	to	TO	O	to	_	0	SENT_233	[p13l1499t2796r1565b2848],
28	DRV	NN	O	drv	prep_to	26	SENT_233	[p13l1589t2790r1776b2847],
29	.	.	O	.	_	0	SENT_233	[p13l1589t2790r1776b2847],

1	However	RB	O	however	advmod	12	SENT_234	[p13l1805t2790r2149b2858],
2	,	,	O	,	_	0	SENT_234	[p13l1805t2790r2149b2858],
3	mutations	NNS	O	mutation	nsubjpass	12	SENT_234	[p13l10t2887r363b2945],
4	at	IN	O	at	_	0	SENT_234	[p13l396t2893r460b2944],
5	50V	NN	O	50v	prep_at	3	SENT_234	[p13l490t2887r645b2955],
6	,	,	O	,	_	0	SENT_234	[p13l490t2887r645b2955],
7	54L	NN	O	54l	conj_and	5	SENT_234	[p13l677t2887r822b2956],
8	,	,	O	,	_	0	SENT_234	[p13l677t2887r822b2956],
9	and	CC	O	and	_	0	SENT_234	[p13l856t2884r987b2944],
10	76V	NN	O	76v	conj_and	5	SENT_234	[p13l1021t2887r1155b2945],
11	are	VBP	O	be	auxpass	12	SENT_234	[p13l1186t2905r1292b2945],
12	associated	VBN	O	associate	_	0	SENT_234	[p13l1325t2885r1681b2945],
13	with	IN	O	with	_	0	SENT_234	[p13l1712t2885r1874b2944],
14	a	DT	O	a	det	17	SENT_234	[p13l1905t2905r1941b2944],
15	good	JJ	O	good	amod	17	SENT_234	[p13l1974t2884r2150b2966],
16	clinical	JJ	O	clinical	amod	17	SENT_234	[p13l11t2982r255b3042],
17	response	NN	O	response	conj_and	17	SENT_234	[p13l286t3002r593b3063],
18	to	TO	O	to	_	0	SENT_234	[p13l625t2990r691b3042],
19	TPV	NN	O	tpv	prep_to	17	SENT_234	[p13l722t2984r874b3041],
20	and	CC	O	and	_	0	SENT_234	[p13l906t2982r1037b3042],
21	with	IN	O	with	_	0	SENT_234	[p13l1067t2982r1229b3042],
22	resistance	NN	O	resistance	prep_with	17	SENT_234	[p13l1258t2985r1598b3042],
23	to	TO	O	to	_	0	SENT_234	[p13l1630t2990r1696b3042],
24	DRV	NN	O	drv	prep_to	12	SENT_234	[p13l1728t2984r1914b3041],
25	.	.	O	.	_	0	SENT_234	[p13l1728t2984r1914b3041],

1	These	DT	O	these	det	2	SENT_235	[p13l1950t2982r2150b3042],
2	results	NNS	O	result	nsubjpass	4	SENT_235	[p13l10t3080r238b3141],
3	are	VBP	O	be	auxpass	4	SENT_235	[p13l267t3101r372b3141],
4	supported	VBN	O	support	_	0	SENT_235	[p13l399t3080r758b3162],
5	by	IN	O	by	_	0	SENT_235	[p13l782t3080r872b3162],
6	previous	JJ	O	previous	amod	7	SENT_235	[p13l896t3083r1203b3162],
7	work	NN	O	work	agent	4	SENT_235	[p13l1228t3080r1414b3141],
8	relating	VBG	O	relate	xcomp	4	SENT_235	[p13l1439t3080r1707b3162],
9	genotype	NN	O	genotype	dobj	8	SENT_235	[p13l1734t3089r2057b3162],
10	to	TO	O	to	_	0	SENT_235	[p13l2083t3089r2150b3141],
11	response	NN	O	response	prep_to	8	SENT_235	[p13l10t3228r318b3289],
12	for	IN	O	for	_	0	SENT_235	[p13l344t3207r442b3268],
13	both	DT	O	both	det	14	SENT_235	[p13l464t3207r625b3268],
14	drugs	NNS	O	drug	prep_for	11	SENT_235	[p13l650t3208r867b3289],
15	.	.	O	.	_	0	SENT_235	[p13l650t3208r867b3289],

1	Discordant	JJ	O	discordant	amod	2	SENT_236	[p13l100t3305r486b3365],
2	resistance	NN	O	resistance	nsubjpass	11	SENT_236	[p13l519t3308r859b3365],
3	to	TO	O	to	_	0	SENT_236	[p13l894t3313r960b3365],
4	TPV	NN	O	tpv	prep_to	2	SENT_236	[p13l995t3307r1147b3364],
5	and	CC	O	and	_	0	SENT_236	[p13l1181t3305r1311b3365],
6	DRV	NN	O	drv	prep_to	2	SENT_236	[p13l1346t3307r1517b3364],
7	has	VBZ	O	have	aux	11	SENT_236	[p13l1549t3305r1667b3365],
8	also	RB	O	also	advmod	11	SENT_236	[p13l1702t3305r1838b3365],
9	recently	RB	DATE	recently	advmod	11	SENT_236	[p13l1872t3305r2151b3386],
10	been	VBN	O	be	auxpass	11	SENT_236	[p13l8t3401r175b3462],
11	reported	VBN	O	report	_	0	SENT_236	[p13l198t3401r498b3483],
12	in	IN	O	in	_	0	SENT_236	[p13l523t3404r591b3461],
13	a	DT	O	a	det	15	SENT_236	[p13l615t3422r651b3461],
14	laboratory	NN	O	laboratory	nn	15	SENT_236	[p13l677t3401r1041b3483],
15	strain	NN	O	strain	prep_in	11	SENT_236	[p13l1066t3404r1263b3462],
16	of	IN	O	of	_	0	SENT_236	[p13l1288t3401r1357b3462],
17	HIV	NN	MISC	hiv	prep_of	15	SENT_236	[p13l1379t3404r1527b3461],
18	that	WDT	O	that	nsubjpass	20	SENT_236	[p13l1551t3401r1688b3461],
19	was	VBD	O	be	auxpass	20	SENT_236	[p13l1710t3422r1849b3462],
20	selected	VBN	O	select	rcmod	15	SENT_236	[p13l1875t3401r2149b3462],
21	after	IN	O	after	_	0	SENT_236	[p13l11t3498r169b3559],
22	50	CD	NUMBER	50	num	23	SENT_236	[p13l210t3501r287b3559],
23	passages	NNS	O	passage	prep_after	20	SENT_236	[p13l328t3519r636b3580],
24	with	IN	O	with	_	0	SENT_236	[p13l678t3498r839b3558],
25	the	DT	O	the	det	27	SENT_236	[p13l880t3499r986b3559],
26	novel	JJ	O	novel	amod	27	SENT_236	[p13l1026t3499r1221b3559],
27	PI	NN	O	pi	prep_with	23	SENT_236	[p13l1262t3501r1352b3570],
28	,	,	O	,	_	0	SENT_236	[p13l1262t3501r1352b3570],
29	GRL-216	NN	O	grl-216	appos	27	SENT_236	[p13l1396t3500r1719b3559],
30	.	.	O	.	_	0	SENT_236	[p13l1396t3500r1719b3559],

1	This	DT	O	this	det	2	SENT_237	[p13l1764t3498r1911b3559],
2	strain	NN	O	strain	nsubj	3	SENT_237	[p13l1955t3501r2152b3559],
3	harbors	VBZ	O	harbor	_	0	SENT_237	[p13l9t3596r277b3656],
4	the	DT	O	the	det	5	SENT_237	[p13l321t3596r428b3656],
5	L101	NN	O	l101	dobj	3	SENT_237	[p13l471t3598r644b3666],
6	,	,	O	,	_	0	SENT_237	[p13l471t3598r644b3666],
7	L241	NN	O	l241	conj_and	5	SENT_237	[p13l688t3598r860b3666],
8	,	,	O	,	_	0	SENT_237	[p13l688t3598r860b3666],
9	M46L	NN	O	m46l	dobj	3	SENT_237	[p13l904t3598r1125b3667],
10	,	,	O	,	_	0	SENT_237	[p13l904t3598r1125b3667],
11	V821	NN	O	v821	conj_and	5	SENT_237	[p13l1169t3598r1351b3666],
12	,	,	O	,	_	0	SENT_237	[p13l1169t3598r1351b3666],
13	and	CC	O	and	_	0	SENT_237	[p13l1396t3596r1527b3655],
14	184V	NN	O	184v	nn	15	SENT_237	[p13l1571t3598r1734b3656],
15	mutations	NNS	O	mutation	conj_and	5	SENT_237	[p13l1777t3599r2148b3666],
16	,	,	O	,	_	0	SENT_237	[p13l1777t3599r2148b3666],

1	leading	VBG	O	lead	_	0	SENT_238	[p14l10t20r270b101],
2	to	TO	O	to	_	0	SENT_238	[p14l289t28r355b81],
3	a	DT	O	a	det	5	SENT_238	[p14l377t40r412b80],
4	diminished	VBN	O	diminish	amod	5	SENT_238	[p14l434t20r827b81],
5	response	NN	O	response	prep_to	1	SENT_238	[p14l848t40r1155b101],
6	to	TO	O	to	_	0	SENT_238	[p14l1174t28r1241b81],
7	DRV	NNP	O	DRV	prep_to	5	SENT_238	[p14l1261t22r1432b80],
8	(	CD	NUMBER	(	num	7	SENT_238	[p14l1454t20r1541b96],
9	3	LS	NUMBER	3	dep	11	SENT_238	[p14l1454t20r1541b96],
10	-	:	O	-	_	0	SENT_238	[p14l1454t20r1541b96],
11	to	TO	O	to	amod	5	SENT_238	[p14l1559t28r1625b80],
12	5-fold	JJ	O	5-fold	amod	13	SENT_238	[p14l1646t20r1849b80],
13	increase	NN	O	increase	pobj	11	SENT_238	[p14l1869t23r2150b81],
14	in	IN	O	in	_	0	SENT_238	[p14l10t120r78b177],
15	EC50	NN	O	ec50	nn	16	SENT_238	[p14l102t118r309b193],
16	)	NN	O	)	prep_in	13	SENT_238	[p14l102t118r309b193],
17	,	,	O	,	_	0	SENT_238	[p14l102t118r309b193],
18	and	CC	O	and	_	0	SENT_238	[p14l337t118r467b177],
19	a	DT	O	a	det	21	SENT_238	[p14l494t138r530b177],
20	10-fold	JJ	O	10-fold	amod	21	SENT_238	[p14l559t117r800b178],
21	increase	NN	O	increase	conj_and	13	SENT_238	[p14l825t120r1106b178],
22	in	IN	O	in	_	0	SENT_238	[p14l1131t120r1199b177],
23	sensitivity	NN	O	sensitivity	prep_in	21	SENT_238	[p14l1223t120r1580b199],
24	to	TO	O	to	_	0	SENT_238	[p14l1605t126r1671b178],
25	TPV	NN	O	tpv	prep_to	11	SENT_238	[p14l1697t103r1927b177],
26	.18	CD	NUMBER	.18	num	25	SENT_238	[p14l1697t103r1927b177],

1	The	DT	O	the	det	3	SENT_239	[p14l99t215r229b275],
2	present	JJ	DATE	present	amod	3	SENT_239	[p14l268t223r527b296],
3	study	NN	O	study	nsubj	4	SENT_239	[p14l567t215r765b296],
4	identified	VBD	O	identify	_	0	SENT_239	[p14l804t214r1138b275],
5	unique	JJ	O	unique	amod	6	SENT_239	[p14l1179t218r1422b296],
6	mutations	NNS	O	mutation	dobj	4	SENT_239	[p14l1463t218r1815b275],
7	that	WDT	O	that	nsubj	9	SENT_239	[p14l1856t215r1992b275],
8	can	MD	O	can	aux	9	SENT_239	[p14l2032t235r2152b275],
9	help	VB	O	help	rcmod	6	SENT_239	[p14l9t313r160b394],
10	predict	VB	O	predict	xcomp	9	SENT_239	[p14l209t313r457b394],
11	discordant	JJ	O	discordant	amod	13	SENT_239	[p14l507t313r879b373],
12	phenotypic	JJ	O	phenotypic	amod	13	SENT_239	[p14l926t313r1320b394],
13	resistance	NN	O	resistance	dobj	10	SENT_239	[p14l1369t316r1709b374],
14	in	IN	O	in	_	0	SENT_239	[p14l1759t316r1826b372],
15	patients	NNS	O	patient	prep_in	10	SENT_239	[p14l1872t316r2149b394],
16	whose	WP$	O	whose	poss	17	SENT_239	[p14l9t440r235b500],
17	testing	NN	O	testing	nsubjpass	19	SENT_239	[p14l262t442r496b521],
18	is	VBZ	O	be	auxpass	19	SENT_239	[p14l523t442r576b500],
19	limited	VBN	O	limit	rcmod	15	SENT_239	[p14l603t440r850b500],
20	to	TO	O	to	_	0	SENT_239	[p14l878t448r944b500],
21	genotyping	NN	O	genotyping	prep_to	19	SENT_239	[p14l972t442r1390b521],
22	,	,	O	,	_	0	SENT_239	[p14l972t442r1390b521],
23	reinforcing	VBG	O	reinforce	partmod	4	SENT_239	[p14l1418t439r1802b521],
24	the	DT	O	the	det	25	SENT_239	[p14l1828t439r1935b500],
25	belief	NN	O	belief	dobj	23	SENT_239	[p14l1959t439r2153b500],
26	that	IN	O	that	complm	40	SENT_239	[p14l10t537r147b597],
27	many	JJ	O	many	nsubjpass	40	SENT_239	[p14l172t557r372b618],
28	of	IN	O	of	_	0	SENT_239	[p14l399t536r468b597],
29	the	DT	O	the	det	30	SENT_239	[p14l493t537r599b597],
30	substitutions	NNS	O	substitution	prep_of	27	SENT_239	[p14l627t537r1075b597],
31	associated	VBN	O	associate	partmod	30	SENT_239	[p14l1105t537r1461b597],
32	with	IN	O	with	_	0	SENT_239	[p14l1487t537r1649b597],
33	either	CC	O	either	preconj	34	SENT_239	[p14l1675t537r1873b597],
34	TPV	NN	O	tpv	prep_with	31	SENT_239	[p14l1900t539r2052b596],
35	or	CC	O	or	_	0	SENT_239	[p14l2079t557r2151b597],
36	DRV	NN	O	drv	nn	37	SENT_239	[p14l10t635r181b692],
37	resistance	NN	O	resistance	prep_with	31	SENT_239	[p14l216t636r556b693],
38	are	VBP	O	be	auxpass	40	SENT_239	[p14l593t653r697b693],
39	not	RB	O	not	neg	40	SENT_239	[p14l731t641r847b693],
40	associated	VBN	O	associate	ccomp	23	SENT_239	[p14l881t633r1238b693],
41	with	IN	O	with	_	0	SENT_239	[p14l1272t633r1433b692],
42	cross-resistance	NN	O	cross-resistance	prep_with	40	SENT_239	[p14l1468t636r2009b693],
43	between	IN	O	between	_	0	SENT_239	[p14l2042t633r2150b693, p14l8t740r221b792],
44	the	DT	O	the	det	46	SENT_239	[p14l249t731r356b792],
45	two	CD	NUMBER	two	num	46	SENT_239	[p14l386t740r519b792],
46	agents	NNS	O	agent	prep_between	42	SENT_239	[p14l550t740r790b813],
47	.	.	O	.	_	0	SENT_239	[p14l550t740r790b813],

1	Since	IN	O	since	mark	6	SENT_240	[p14l824t732r1004b792],
2	resistance	NN	O	resistance	nsubjpass	6	SENT_240	[p14l1034t734r1375b792],
3	to	TO	O	to	_	0	SENT_240	[p14l1404t740r1471b792],
4	TPV	NN	O	tpv	prep_to	2	SENT_240	[p14l1500t734r1653b791],
5	is	VBZ	O	be	auxpass	6	SENT_240	[p14l1682t734r1735b792],
6	based	VBN	O	base	advcl	28	SENT_240	[p14l1762t731r1966b792],
7	on	IN	O	on	_	0	SENT_240	[p14l1997t752r2085b792],
8	a	DT	O	a	det	10	SENT_240	[p14l2113t752r2150b791],
9	unique	JJ	O	unique	amod	10	SENT_240	[p14l7t832r251b910],
10	set	NN	O	set	prep_on	6	SENT_240	[p14l275t837r370b890],
11	of	IN	O	of	_	0	SENT_240	[p14l393t829r462b889],
12	mutations	NNS	O	mutation	prep_of	10	SENT_240	[p14l482t832r835b889],
13	that	WDT	O	that	nsubj	15	SENT_240	[p14l859t829r996b889],
14	is	VBZ	O	be	cop	15	SENT_240	[p14l1018t832r1071b889],
15	distinct	JJ	O	distinct	rcmod	12	SENT_240	[p14l1096t829r1353b890],
16	from	IN	O	from	_	0	SENT_240	[p14l1376t829r1545b890],
17	those	DT	O	those	prep_from	15	SENT_240	[p14l1567t829r1751b890],
18	that	WDT	O	that	nsubj	19	SENT_240	[p14l1775t829r1912b889],
19	confer	VBP	O	confer	rcmod	17	SENT_240	[p14l1934t829r2151b890],
20	resistance	NN	O	resistance	dobj	19	SENT_240	[p14l8t930r348b987],
21	to	TO	O	to	_	0	SENT_240	[p14l379t936r445b987],
22	the	DT	O	the	det	24	SENT_240	[p14l476t927r583b987],
23	other	JJ	O	other	amod	24	SENT_240	[p14l615t927r796b987],
24	Pls	NNS	O	pl	prep_to	19	SENT_240	[p14l826t930r950b998],
25	,	,	O	,	_	0	SENT_240	[p14l826t930r950b998],
26	these	DT	O	these	det	27	SENT_240	[p14l982t927r1160b987],
27	data	NNS	O	datum	nsubj	28	SENT_240	[p14l1192t927r1342b987],
28	indicate	VBP	O	indicate	_	0	SENT_240	[p14l1374t927r1650b987],
29	that	IN	O	that	complm	36	SENT_240	[p14l1681t927r1817b987],
30	TPV	NN	O	tpv	nsubj	36	SENT_240	[p14l1846t930r1999b986],
31	is	VBZ	O	be	cop	36	SENT_240	[p14l2029t930r2082b987],
32	a	DT	O	a	det	36	SENT_240	[p14l2113t947r2150b987],
33	rational	JJ	O	rational	amod	36	SENT_240	[p14l8t1025r278b1086],
34	next	JJ	O	next	amod	36	SENT_240	[p14l298t1034r449b1086],
35	choice	NN	O	choice	nn	36	SENT_240	[p14l470t1025r687b1086],
36	therapy	NN	O	therapy	ccomp	28	SENT_240	[p14l709t1025r980b1107],
37	for	IN	O	for	_	0	SENT_240	[p14l1001t1025r1099b1086],
38	patients	NNS	O	patient	prep_for	36	SENT_240	[p14l1119t1028r1396b1107],
39	who	WP	O	who	nsubj	41	SENT_240	[p14l1418t1025r1573b1086],
40	have	VBP	O	have	aux	41	SENT_240	[p14l1594t1025r1761b1086],
41	developed	VBN	O	develop	rcmod	38	SENT_240	[p14l1785t1025r2150b1107],
42	resistance	NN	O	resistance	dobj	41	SENT_240	[p14l8t1126r348b1183],
43	to	TO	O	to	_	0	SENT_240	[p14l373t1131r440b1183],
44	other	JJ	O	other	amod	45	SENT_240	[p14l467t1123r648b1183],
45	Pls	NNS	O	pl	prep_to	41	SENT_240	[p14l672t1125r794b1183],
46	.	.	O	.	_	0	SENT_240	[p14l672t1125r794b1183],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_241	[p14l8t1315r714b1391],

1	Editorial	NN	O	editorial	nsubjpass	6	SENT_242	[p14l97t1462r401b1523],
2	and	CC	O	and	_	0	SENT_242	[p14l434t1462r565b1522],
3	writing	VBG	O	write	amod	4	SENT_242	[p14l597t1465r856b1543],
4	assistance	NN	O	assistance	conj_and	1	SENT_242	[p14l890t1465r1234b1523],
5	was	VBD	O	be	auxpass	6	SENT_242	[p14l1266t1482r1405b1522],
6	provided	VBN	O	provide	_	0	SENT_242	[p14l1438t1462r1760b1543],
7	by	IN	O	by	_	0	SENT_242	[p14l1791t1462r1882b1543],
8	Jose	NNP	PERSON	Jose	nn	10	SENT_242	[p14l1911t1464r2051b1537],
9	L.	NNP	PERSON	L.	nn	10	SENT_242	[p14l2084t1464r2147b1521],
10	Walewski	NNP	PERSON	Walewski	agent	6	SENT_242	[p14l7t1559r372b1630],
11	,	,	O	,	_	0	SENT_242	[p14l7t1559r372b1630],
12	Ph.D.	NNP	O	Ph.D.	appos	10	SENT_242	[p14l399t1559r610b1630],
13	,	,	O	,	_	0	SENT_242	[p14l399t1559r610b1630],
14	of	IN	O	of	_	0	SENT_242	[p14l637t1559r706b1619],
15	Envision	NNP	ORGANIZATION	Envision	nn	17	SENT_242	[p14l728t1562r1035b1619],
16	Scientific	NNP	ORGANIZATION	Scientific	nn	17	SENT_242	[p14l1058t1559r1370b1619],
17	Solutions	NNPS	ORGANIZATION	Solutions	prep_of	10	SENT_242	[p14l1396t1559r1739b1630],
18	,	,	ORGANIZATION	,	_	0	SENT_242	[p14l1396t1559r1739b1630],
19	Inc.	NNP	ORGANIZATION	Inc.	appos	17	SENT_242	[p14l1766t1562r1910b1630],
20	,	,	O	,	_	0	SENT_242	[p14l1766t1562r1910b1630],
21	which	WDT	O	which	nsubjpass	23	SENT_242	[p14l1935t1559r2152b1619],
22	was	VBD	O	be	auxpass	23	SENT_242	[p14l7t1677r145b1717],
23	contracted	VBN	O	contract	rcmod	17	SENT_242	[p14l181t1657r547b1717],
24	by	IN	O	by	_	0	SENT_242	[p14l579t1657r669b1738],
25	Boehringer	NNP	PERSON	Boehringer	nn	26	SENT_242	[p14l703t1657r1089b1738],
26	Ingelheim	NNP	PERSON	Ingelheim	agent	23	SENT_242	[p14l1124t1657r1476b1738],
27	for	IN	O	for	_	0	SENT_242	[p14l1511t1656r1609b1717],
28	these	DT	O	these	det	29	SENT_242	[p14l1643t1657r1821b1717],
29	services	NNS	O	service	prep_for	26	SENT_242	[p14l1857t1660r2146b1717],
30	.	.	O	.	_	0	SENT_242	[p14l1857t1660r2146b1717],

1	The	DT	O	the	det	2	SENT_243	[p14l8t1753r137b1813],
2	authors	NNS	O	author	nsubjpass	33	SENT_243	[p14l162t1753r426b1813],
3	meet	VBP	O	meet	_	0	SENT_243	[p14l451t1761r621b1814],
4	criteria	NNS	O	criterion	dobj	3	SENT_243	[p14l645t1756r887b1814],
5	for	IN	O	for	_	0	SENT_243	[p14l912t1753r1011b1813],
6	authorship	NN	O	authorship	prep_for	3	SENT_243	[p14l1035t1753r1414b1834],
7	as	IN	O	as	mark	8	SENT_243	[p14l1441t1773r1511b1813],
8	recommended	VBN	O	recommend	advcl	3	SENT_243	[p14l1536t1753r2039b1814],
9	by	IN	O	by	_	0	SENT_243	[p14l2061t1753r2151b1834],
10	the	DT	O	the	det	12	SENT_243	[p14l8t1850r115b1910],
11	International	NNP	ORGANIZATION	International	nn	12	SENT_243	[p14l172t1850r624b1910],
12	Committee	NNP	ORGANIZATION	Committee	prep_by	8	SENT_243	[p14l681t1851r1070b1910],
13	of	IN	ORGANIZATION	of	_	0	SENT_243	[p14l1128t1850r1197b1910],
14	Medical	NNP	ORGANIZATION	Medical	nn	16	SENT_243	[p14l1251t1850r1531b1910],
15	Journal	NNP	ORGANIZATION	Journal	nn	16	SENT_243	[p14l1585t1850r1843b1924],
16	Editors	NNP	ORGANIZATION	Editors	prep_of	12	SENT_243	[p14l1899t1850r2150b1910],
17	(	CD	NUMBER	(	num	19	SENT_243	[p14l11t1948r288b2024],
18	ICMJE	NN	O	icmje	nn	19	SENT_243	[p14l11t1948r288b2024],
19	)	NN	O	)	dep	16	SENT_243	[p14l11t1948r288b2024],
20	and	CC	O	and	_	0	SENT_243	[p14l324t1948r455b2008],
21	were	VBD	O	be	cop	23	SENT_243	[p14l487t1968r659b2008],
22	fully	RB	O	fully	advmod	23	SENT_243	[p14l692t1947r853b2029],
23	responsible	JJ	O	responsible	conj_and	3	SENT_243	[p14l886t1948r1283b2029],
24	for	IN	O	for	_	0	SENT_243	[p14l1316t1947r1415b2008],
25	all	DT	O	all	det	29	SENT_243	[p14l1448t1948r1531b2008],
26	content	NN	O	content	nn	29	SENT_243	[p14l1563t1956r1821b2008],
27	and	CC	O	and	_	0	SENT_243	[p14l1854t1948r1985b2008],
28	editorial	NN	O	editorial	nn	29	SENT_243	[p14l2018t1948r2151b2008, p14l8t2044r192b2104],
29	decisions	NNS	O	decision	prep_for	23	SENT_243	[p14l212t2044r551b2115],
30	,	,	O	,	_	0	SENT_243	[p14l212t2044r551b2115],
31	and	CC	O	and	_	0	SENT_243	[p14l573t2044r704b2104],
32	were	VBD	O	be	auxpass	33	SENT_243	[p14l724t2064r895b2105],
33	involved	VBN	O	involve	conj_and	3	SENT_243	[p14l916t2044r1225b2104],
34	at	IN	O	at	_	0	SENT_243	[p14l1246t2052r1310b2104],
35	all	DT	O	all	det	36	SENT_243	[p14l1330t2044r1413b2104],
36	stages	NNS	O	stage	prep_at	33	SENT_243	[p14l1433t2052r1645b2125],
37	of	IN	O	of	_	0	SENT_243	[p14l1666t2044r1735b2104],
38	manuscript	NN	O	manuscript	nn	39	SENT_243	[p14l1752t2047r2151b2125],
39	development	NN	O	development	prep_of	36	SENT_243	[p14l9t2142r484b2224],
40	.	.	O	.	_	0	SENT_243	[p14l9t2142r484b2224],

1	Author	NN	O	author	_	0	SENT_244	[p14l8t2369r269b2428],
2	Disclosure	NN	O	disclosure	nn	3	SENT_244	[p14l302t2368r706b2428],
3	Statement	NN	O	statement	dep	1	SENT_244	[p14l737t2367r1120b2428],

1	The	DT	O	the	det	2	SENT_245	[p14l97t2515r227b2576],
2	studies	NNS	O	study	nsubjpass	8	SENT_245	[p14l267t2515r513b2576],
3	described	VBN	O	describe	partmod	2	SENT_245	[p14l554t2515r889b2576],
4	in	IN	O	in	_	0	SENT_245	[p14l930t2518r997b2574],
5	this	DT	O	this	det	6	SENT_245	[p14l1035t2515r1160b2576],
6	article	NN	O	article	prep_in	3	SENT_245	[p14l1201t2515r1413b2576],
7	were	VBD	O	be	auxpass	8	SENT_245	[p14l1452t2536r1623b2576],
8	supported	VBN	O	support	_	0	SENT_245	[p14l1664t2515r2024b2597],
9	by	IN	O	by	_	0	SENT_245	[p14l2061t2515r2151b2597],
10	Boehringer	NNP	PERSON	Boehringer	nn	15	SENT_245	[p14l8t2612r394b2694],
11	Ingelheim	NNP	PERSON	Ingelheim	nn	15	SENT_245	[p14l413t2612r765b2694],
12	(	NNP	O	(	nn	15	SENT_245	[p14l786t2613r1102b2689],
13	Canada	NNP	LOCATION	Canada	nn	15	SENT_245	[p14l786t2613r1102b2689],
14	)	NNP	O	)	nn	15	SENT_245	[p14l786t2613r1102b2689],
15	Ltd.	NNP	ORGANIZATION	Ltd.	agent	8	SENT_245	[p14l1123t2613r1283b2684],
16	,	,	O	,	_	0	SENT_245	[p14l1123t2613r1283b2684],
17	who	WP	O	who	nsubj	20	SENT_245	[p14l1302t2612r1456b2673],
18	is	VBZ	O	be	cop	20	SENT_245	[p14l1476t2615r1529b2673],
19	the	DT	O	the	det	20	SENT_245	[p14l1548t2613r1655b2673],
20	manufacturer	NN	O	manufacturer	rcmod	15	SENT_245	[p14l1673t2612r2151b2673],
21	of	IN	O	of	_	0	SENT_245	[p14l9t2709r77b2770],
22	Tipranavir	NNP	O	Tipranavir	prep_of	20	SENT_245	[p14l99t2712r488b2791],
23	.	.	O	.	_	0	SENT_245	[p14l99t2712r488b2791],

1	References	NNS	O	reference	_	0	SENT_246	[p14l12t2906r436b2966],

1	1	LS	NUMBER	1	_	0	SENT_247	[p14l48t3056r96b3109],
2	.	.	O	.	_	0	SENT_247	[p14l48t3056r96b3109],

1	Hirsch	NNP	PERSON	Hirsch	nn	2	SENT_248	[p14l140t3053r361b3111],
2	HH	NNP	O	HH	_	0	SENT_248	[p14l397t3056r537b3121],
3	,	,	O	,	_	0	SENT_248	[p14l397t3056r537b3121],
4	Drechsler	NNP	PERSON	Drechsler	nn	5	SENT_248	[p14l576t3053r892b3111],
5	H	NNP	PERSON	H	appos	2	SENT_248	[p14l930t3056r1007b3121],
6	,	,	O	,	_	0	SENT_248	[p14l930t3056r1007b3121],
7	Holbro	NNP	O	Holbro	nn	8	SENT_248	[p14l1046t3053r1280b3111],
8	A	NNP	O	A	appos	2	SENT_248	[p14l1317t3055r1392b3121],
9	,	,	O	,	_	0	SENT_248	[p14l1317t3055r1392b3121],
10	et	FW	O	et	nn	11	SENT_248	[p14l1430t3059r1482b3110],
11	al.	FW	O	al.	appos	2	SENT_248	[p14l1518t3053r1607b3110],
12	:	:	O	:	_	0	SENT_248	[p14l1518t3053r1607b3110],
13	Genotypic	JJ	O	genotypic	amod	17	SENT_248	[p14l1646t3054r1987b3131],
14	and	CC	O	and	_	0	SENT_248	[p14l2027t3053r2150b3110],
15	phenotypic	JJ	O	phenotypic	conj_and	13	SENT_248	[p14l139t3147r512b3224],
16	resistance	NN	O	resistance	nn	17	SENT_248	[p14l555t3150r877b3204],
17	testing	NN	O	testing	dep	2	SENT_248	[p14l920t3149r1141b3224],
18	of	IN	O	of	_	0	SENT_248	[p14l1184t3146r1249b3204],
19	HIV-1	NN	O	hiv-1	prep_of	17	SENT_248	[p14l1289t3149r1487b3203],
20	in	IN	O	in	_	0	SENT_248	[p14l1534t3150r1598b3203],
21	routine	JJ	O	routine	amod	23	SENT_248	[p14l1639t3149r1877b3204],
22	clinical	JJ	O	clinical	amod	23	SENT_248	[p14l1920t3147r2151b3204],
23	care	NN	O	care	prep_in	19	SENT_248	[p14l141t3260r289b3298],
24	.	.	O	.	_	0	SENT_248	[p14l141t3260r289b3298],

1	Eur	NNP	O	Eur	nn	6	SENT_249	[p14l321t3243r439b3297],
2	[	NNP	O	[	nn	6	SENT_249	[p14l474t3243r482b3314],
3	Clin	NNP	O	Clin	nn	6	SENT_249	[p14l516t3241r655b3298],
4	Microbiol	NNP	O	Microbiol	nn	6	SENT_249	[p14l682t3241r1002b3298],
5	Infect	NNP	O	Infect	nn	6	SENT_249	[p14l1030t3240r1214b3297],
6	Dis	NNP	O	Dis	_	0	SENT_249	[p14l1242t3243r1350b3297],
7	2005	CD	DATE	2005	num	6	SENT_249	[p14l1378t3243r1923b3308],
8	;	:	O	;	_	0	SENT_249	[p14l1378t3243r1923b3308],
9	24:733	CD	NUMBER	24:733	number	10	SENT_249	[p14l1378t3243r1923b3308],
10	-738	CD	NUMBER	-738	dep	6	SENT_249	[p14l1378t3243r1923b3308],
11	.	.	O	.	_	0	SENT_249	[p14l1378t3243r1923b3308],

1	2	LS	NUMBER	2	_	0	SENT_250	[p14l45t3337r96b3390],
2	.	.	O	.	_	0	SENT_250	[p14l45t3337r96b3390],

1	Bagnarelli	JJ	PERSON	bagnarelli	amod	2	SENT_251	[p14l141t3334r475b3411],
2	P	NN	PERSON	p	_	0	SENT_251	[p14l512t3336r573b3401],
3	,	,	O	,	_	0	SENT_251	[p14l512t3336r573b3401],
4	Vecchi	NNP	PERSON	Vecchi	nn	5	SENT_251	[p14l610t3334r831b3392],
5	M	NNP	O	M	appos	2	SENT_251	[p14l868t3336r955b3401],
6	,	,	O	,	_	0	SENT_251	[p14l868t3336r955b3401],
7	Burighel	NNP	PERSON	Burighel	nn	8	SENT_251	[p14l994t3334r1276b3411],
8	N	NNP	PERSON	N	appos	2	SENT_251	[p14l1313t3336r1391b3401],
9	,	,	O	,	_	0	SENT_251	[p14l1313t3336r1391b3401],
10	et	FW	O	et	nn	11	SENT_251	[p14l1429t3340r1481b3391],
11	al.	FW	O	al.	appos	2	SENT_251	[p14l1518t3334r1606b3391],
12	:	:	O	:	_	0	SENT_251	[p14l1518t3334r1606b3391],
13	Genotypic	JJ	O	genotypic	amod	16	SENT_251	[p14l1646t3335r1987b3411],
14	and	CC	O	and	_	0	SENT_251	[p14l2026t3334r2150b3391],
15	phenotypic	JJ	O	phenotypic	conj_and	13	SENT_251	[p14l139t3426r512b3502],
16	correlates	NNS	O	correlate	dep	2	SENT_251	[p14l539t3426r855b3483],
17	of	IN	O	of	_	0	SENT_251	[p14l881t3426r946b3483],
18	the	DT	O	the	det	24	SENT_251	[p14l969t3426r1070b3483],
19	HIV	NN	O	hiv	nn	24	SENT_251	[p14l1095t3428r1236b3482],
20	Type	NN	O	type	nn	24	SENT_251	[p14l1260t3428r1426b3502],
21	1	CD	NUMBER	1	num	24	SENT_251	[p14l1455t3428r1482b3481],
22	env	NN	O	env	nn	24	SENT_251	[p14l1513t3445r1631b3483],
23	gene	NN	O	gene	nn	24	SENT_251	[p14l1658t3445r1811b3502],
24	evolution	NN	O	evolution	prep_of	16	SENT_251	[p14l1837t3426r2152b3483],
25	in	IN	O	in	_	0	SENT_251	[p14l140t3522r204b3575],
26	infected	JJ	O	infected	amod	27	SENT_251	[p14l261t3519r522b3577],
27	children	NNS	O	child	prep_in	24	SENT_251	[p14l582t3519r854b3577],
28	with	IN	O	with	_	0	SENT_251	[p14l910t3519r1062b3576],
29	discordant	JJ	O	discordant	amod	30	SENT_251	[p14l1120t3519r1473b3577],
30	response	NN	O	response	prep_with	27	SENT_251	[p14l1530t3539r1821b3597],
31	to	TO	O	to	_	0	SENT_251	[p14l1879t3527r1942b3577],
32	antiretroviral	JJ	O	antiretroviral	amod	33	SENT_251	[p14l2002t3522r2151b3576, p14l140t3614r451b3670],
33	therapy	NN	O	therapy	prep_to	30	SENT_251	[p14l497t3614r767b3690],
34	.	.	O	.	_	0	SENT_251	[p14l497t3614r767b3690],

1	AIDS	NNP	O	AIDS	nn	4	SENT_252	[p14l817t3615r998b3670],
2	Res	NNP	O	Res	nn	4	SENT_252	[p14l1045t3616r1159b3670],
3	Hum	NNP	O	Hum	nn	4	SENT_252	[p14l1206t3616r1379b3670],
4	Retroviruses	NNP	O	Retroviruses	_	0	SENT_252	[p14l1424t3616r1840b3670],
5	2004	CD	DATE	2004	num	4	SENT_252	[p14l1886t3616r2147b3680],
6	;	:	O	;	_	0	SENT_252	[p14l1886t3616r2147b3680],
7	20	CD	NUMBER	20	num	9	SENT_252	[p14l1886t3616r2147b3680],
8	:	:	O	:	_	0	SENT_252	[p14l1886t3616r2147b3680],
9	1306-1313	CD	DATE	1306-1313	dep	4	SENT_252	[p14l144t3708r495b3763],
10	.	.	O	.	_	0	SENT_252	[p14l144t3708r495b3763],

1	3	LS	NUMBER	3	_	0	SENT_253	[p15l45t27r96b81],
2	.	.	O	.	_	0	SENT_253	[p15l45t27r96b81],

1	Zolopa	NN	O	zolopa	nn	2	SENT_254	[p15l140t24r374b101],
2	AR	NNS	O	ar	_	0	SENT_254	[p15l426t26r548b80],
3	:	:	O	:	_	0	SENT_254	[p15l426t26r548b80],
4	Incorporating	VBG	O	incorporate	dep	2	SENT_254	[p15l603t26r1058b101],
5	drug	NN	O	drug	nn	8	SENT_254	[p15l1111t24r1618b101],
6	—	NN	O	—	nn	8	SENT_254	[p15l1111t24r1618b101],
7	resistance	NN	O	resistance	nn	8	SENT_254	[p15l1111t24r1618b101],
8	measurements	NNS	O	measurement	dobj	4	SENT_254	[p15l1668t32r2149b82],
9	into	IN	O	into	prep	8	SENT_254	[p15l140t121r268b176],
10	the	DT	O	the	det	12	SENT_254	[p15l294t118r395b176],
11	clinical	JJ	O	clinical	amod	12	SENT_254	[p15l421t118r653b176],
12	management	NN	O	management	dep	9	SENT_254	[p15l678t126r1110b195],
13	of	IN	O	of	_	0	SENT_254	[p15l1135t118r1201b176],
14	HIV-1	NN	O	hiv-1	nn	15	SENT_254	[p15l1224t120r1421b175],
15	infection	NN	O	infection	prep_of	12	SENT_254	[p15l1452t118r1754b176],
16	.	.	O	.	_	0	SENT_254	[p15l1452t118r1754b176],
17	]	SYM	O	]	dep	8	SENT_254	[p15l1791t121r1799b193],

1	Infect	VB	O	infect	_	0	SENT_255	[p15l1831t118r2016b176],
2	Dis	NNP	O	Dis	dep	1	SENT_255	[p15l2042t120r2150b176],
3	2006	CD	DATE	2006	num	2	SENT_255	[p15l140t212r644b290],
4	;	:	O	;	_	0	SENT_255	[p15l140t212r644b290],
5	194	CD	NUMBER	194	num	7	SENT_255	[p15l140t212r644b290],
6	(	CD	NUMBER	(	num	7	SENT_255	[p15l140t212r644b290],
7	Suppl	NN	O	suppl	dep	2	SENT_255	[p15l140t212r644b290],
8	1	CD	NUMBER	1	num	9	SENT_255	[p15l674t213r995b285],
9	)	NN	O	)	dep	7	SENT_255	[p15l674t213r995b285],
10	:	:	O	:	_	0	SENT_255	[p15l674t213r995b285],
11	S59-64	NN	O	s59-64	dep	2	SENT_255	[p15l674t213r995b285],
12	.	.	O	.	_	0	SENT_255	[p15l674t213r995b285],

1	.	.	O	.	_	0	SENT_256	[p15l87t352r96b361],

1	Agwale	NNP	O	Agwale	nn	2	SENT_257	[p15l140t305r397b383],
2	SM	NNP	O	SM	_	0	SENT_257	[p15l432t306r558b373],
3	,	,	O	,	_	0	SENT_257	[p15l432t306r558b373],
4	Zeh	NNP	PERSON	Zeh	nn	5	SENT_257	[p15l595t305r724b363],
5	C	NNP	O	C	appos	2	SENT_257	[p15l758t306r827b373],
6	,	,	O	,	_	0	SENT_257	[p15l758t306r827b373],
7	Paxinos	NNP	PERSON	Paxinos	nn	8	SENT_257	[p15l864t308r1120b363],
8	E	NNP	O	E	appos	2	SENT_257	[p15l1157t308r1218b373],
9	,	,	O	,	_	0	SENT_257	[p15l1157t308r1218b373],
10	et	FW	O	et	nn	11	SENT_257	[p15l1254t311r1306b362],
11	al.	FW	O	al.	appos	2	SENT_257	[p15l1340t305r1429b362],
12	:	:	O	:	_	0	SENT_257	[p15l1340t305r1429b362],
13	Genotypic	JJ	O	genotypic	amod	16	SENT_257	[p15l1466t306r1807b383],
14	and	CC	O	and	_	0	SENT_257	[p15l1845t305r1968b362],
15	phenotypic	JJ	O	phenotypic	conj_and	13	SENT_257	[p15l2003t305r2151b383, p15l139t402r388b477],
16	analyses	NNS	O	analysis	dep	2	SENT_257	[p15l421t400r699b477],
17	of	IN	O	of	_	0	SENT_257	[p15l732t399r797b457],
18	human	JJ	O	human	amod	21	SENT_257	[p15l824t400r1060b457],
19	immunodeficiency	NN	O	immunodeficiency	nn	21	SENT_257	[p15l1091t399r1709b477],
20	virus	NN	O	virus	nn	21	SENT_257	[p15l1739t403r1907b457],
21	type	NN	O	type	prep_of	16	SENT_257	[p15l1939t408r2083b477],
22	1	CD	NUMBER	1	dep	2	SENT_257	[p15l2118t402r2146b456],

1	in	IN	O	in	_	0	SENT_258	[p15l140t518r204b571],
2	antiretroviral	JJ	O	antiretroviral	amod	5	SENT_258	[p15l250t516r687b572],
3	drug-naive	JJ	O	drug-naive	amod	5	SENT_258	[p15l734t516r1098b592],
4	Nigerian	JJ	MISC	nigerian	amod	5	SENT_258	[p15l1144t518r1437b592],
5	patients	NNS	O	patient	pobj	1	SENT_258	[p15l1481t518r1759b592],
6	.	.	O	.	_	0	SENT_258	[p15l1481t518r1759b592],

1	AIDS	NNP	O	AIDS	nn	4	SENT_259	[p15l1809t517r1989b572],
2	Res	NNP	O	Res	nn	4	SENT_259	[p15l2035t518r2150b572],
3	Hum	NNP	O	Hum	nn	4	SENT_259	[p15l140t610r313b665],
4	Retroviruses	NNP	O	Retroviruses	_	0	SENT_259	[p15l340t610r755b665],
5	2006	CD	DATE	2006	num	4	SENT_259	[p15l783t611r1253b675],
6	;	:	O	;	_	0	SENT_259	[p15l783t611r1253b675],
7	22:22	CD	TIME	22:22	number	8	SENT_259	[p15l783t611r1253b675],
8	—	CD	NUMBER	—	dep	4	SENT_259	[p15l783t611r1253b675],
9	26	CD	NUMBER	26	dep	8	SENT_259	[p15l783t611r1253b675],
10	.	.	O	.	_	0	SENT_259	[p15l783t611r1253b675],

1	.	.	O	.	_	0	SENT_260	[p15l87t748r96b757],

1	Van	NNP	PERSON	Van	nn	3	SENT_261	[p15l139t703r275b758],
2	Marck	NNP	PERSON	Marck	nn	3	SENT_261	[p15l312t701r525b758],
3	H	NNP	PERSON	H	_	0	SENT_261	[p15l561t703r639b768],
4	,	,	O	,	_	0	SENT_261	[p15l561t703r639b768],
5	Dierynck	NNP	O	Dierynck	nn	9	SENT_261	[p15l679t701r983b778],
6	I	PRP	O	I	dep	9	SENT_261	[p15l1019t703r1060b768],
7	,	,	O	,	_	0	SENT_261	[p15l1019t703r1060b768],
8	Kraus	NNP	PERSON	Kraus	dep	9	SENT_261	[p15l1099t703r1295b758],
9	G	NNP	O	G	appos	3	SENT_261	[p15l1333t702r1407b768],
10	,	,	O	,	_	0	SENT_261	[p15l1333t702r1407b768],
11	et	FW	O	et	nn	12	SENT_261	[p15l1445t707r1497b758],
12	al.	FW	O	al.	appos	3	SENT_261	[p15l1534t701r1622b758],
13	:	:	O	:	_	0	SENT_261	[p15l1534t701r1622b758],
14	The	DT	O	the	det	15	SENT_261	[p15l1662t701r1785b758],
15	impact	NN	O	impact	nsubjpass	30	SENT_261	[p15l1823t704r2050b778],
16	of	IN	O	of	_	0	SENT_261	[p15l2088t701r2153b758],
17	individual	JJ	O	individual	amod	24	SENT_261	[p15l140t794r485b851],
18	human	JJ	O	human	amod	24	SENT_261	[p15l514t794r751b851],
19	immunodeficiency	NN	O	immunodeficiency	nn	24	SENT_261	[p15l781t794r1400b872],
20	virus	NN	O	virus	nn	24	SENT_261	[p15l1429t797r1598b852],
21	type	NN	O	type	nn	24	SENT_261	[p15l1629t802r1774b872],
22	1	CD	NUMBER	1	num	24	SENT_261	[p15l1808t797r1836b850],
23	protease	NN	O	protease	nn	24	SENT_261	[p15l1871t802r2150b872],
24	mutations	NNS	O	mutation	prep_of	15	SENT_261	[p15l137t1132r471b1187],
25	on	IN	O	on	_	0	SENT_261	[p15l516t1149r599b1187],
26	drug	NN	O	drug	nn	27	SENT_261	[p15l642t1130r802b1207],
27	susceptibility	NN	O	susceptibility	prep_on	15	SENT_261	[p15l846t1129r1284b1207],
28	is	VBZ	O	be	auxpass	30	SENT_261	[p15l1327t1132r1378b1187],
29	highly	RB	O	highly	advmod	30	SENT_261	[p15l1421t1130r1634b1207],
30	inﬂuenced	VBN	O	inﬂuenced	dep	3	SENT_261	[p15l1677t1129r2024b1187],
31	by	IN	O	by	_	0	SENT_261	[p15l2066t1130r2151b1207],
32	complex	JJ	O	complex	amod	33	SENT_261	[p15l137t1222r417b1300],
33	interactions	NNS	O	interaction	agent	30	SENT_261	[p15l471t1225r856b1280],
34	with	IN	O	with	_	0	SENT_261	[p15l911t1222r1064b1279],
35	the	DT	O	the	det	38	SENT_261	[p15l1117t1222r1217b1280],
36	background	NN	O	background	nn	38	SENT_261	[p15l1270t1222r1672b1300],
37	protease	NN	O	protease	nn	38	SENT_261	[p15l1726t1230r2006b1300],
38	sequence	NN	O	sequence	prep_with	30	SENT_261	[p15l2061t1242r2150b1280, p15l138t1336r385b1394],
39	.	.	O	.	_	0	SENT_261	[p15l2061t1242r2150b1280, p15l138t1336r385b1394],

1	I	PRP	O	I	_	0	SENT_262	[p15l424t1319r432b1391],
2	Virol	NNP	O	Virol	dep	1	SENT_262	[p15l466t1317r633b1374],
3	2009	CD	DATE	2009	num	2	SENT_262	[p15l660t1319r1282b1384],
4	;	:	O	;	_	0	SENT_262	[p15l660t1319r1282b1384],
5	83:9512	CD	DURATION	83:9512	num	6	SENT_262	[p15l660t1319r1282b1384],
6	-9520	CD	DURATION	-9520	dep	1	SENT_262	[p15l660t1319r1282b1384],
7	.	.	O	.	_	0	SENT_262	[p15l660t1319r1282b1384],

1	.	.	O	.	_	0	SENT_263	[p15l83t1458r93b1467],

1	Cheung	NNP	O	Cheung	nn	2	SENT_264	[p15l137t1411r399b1488],
2	PK	NNP	O	PK	_	0	SENT_264	[p15l434t1413r549b1478],
3	,	,	O	,	_	0	SENT_264	[p15l434t1413r549b1478],
4	Wynhoven	NNP	O	Wynhoven	nn	5	SENT_264	[p15l585t1411r953b1488],
5	B	NNP	O	B	conj_and	2	SENT_264	[p15l987t1413r1048b1478],
6	,	,	O	,	_	0	SENT_264	[p15l987t1413r1048b1478],
7	and	CC	O	and	_	0	SENT_264	[p15l1085t1411r1210b1468],
8	Harrigan	NNP	PERSON	Harrigan	nn	9	SENT_264	[p15l1245t1413r1548b1488],
9	PR	NN	O	pr	conj_and	2	SENT_264	[p15l1582t1413r1692b1467],
10	:	:	O	:	_	0	SENT_264	[p15l1582t1413r1692b1467],
11	2004	CD	DATE	2004	dep	2	SENT_264	[p15l1730t1413r1895b1468],
12	:	:	O	:	_	0	SENT_264	[p15l1730t1413r1895b1468],
13	Which	WDT	O	which	dobj	19	SENT_264	[p15l1934t1411r2152b1468],
14	HIV-1	NN	O	hiv-1	nn	17	SENT_264	[p15l137t1505r335b1560],
15	drug	NN	O	drug	nn	17	SENT_264	[p15l385t1503r544b1580],
16	resistance	NN	O	resistance	nn	17	SENT_264	[p15l588t1506r910b1561],
17	mutations	NNS	O	mutation	nsubj	19	SENT_264	[p15l955t1506r1288b1561],
18	are	VBP	O	be	cop	19	SENT_264	[p15l1334t1522r1434b1561],
19	common	JJ	O	common	rcmod	11	SENT_264	[p15l1478t1522r1769b1561],
20	in	IN	O	in	_	0	SENT_264	[p15l1812t1506r1876b1559],
21	clinical	JJ	O	clinical	amod	22	SENT_264	[p15l1919t1503r2151b1561],
22	practice	NN	O	practice	prep_in	19	SENT_264	[p15l136t1597r427b1671],
23	?	.	O	?	_	0	SENT_264	[p15l136t1597r427b1671],

1	AIDS	NNP	MISC	AIDS	nn	2	SENT_265	[p15l456t1596r637b1652],
2	Rev	NN	O	rev	_	0	SENT_265	[p15l664t1597r790b1652],
3	2004	CD	DATE	2004	num	2	SENT_265	[p15l819t1597r1326b1661],
4	;	:	O	;	_	0	SENT_265	[p15l819t1597r1326b1661],
5	6:107	CD	NUMBER	6:107	num	6	SENT_265	[p15l819t1597r1326b1661],
6	—	NN	O	—	dep	2	SENT_265	[p15l819t1597r1326b1661],
7	116	CD	NUMBER	116	dep	6	SENT_265	[p15l819t1597r1326b1661],
8	.	.	O	.	_	0	SENT_265	[p15l819t1597r1326b1661],

1	Dunn	NNP	ORGANIZATION	Dunn	nn	2	SENT_266	[p15l137t1691r327b1745],
2	D	NNP	ORGANIZATION	D	nsubj	29	SENT_266	[p15l358t1691r432b1756],
3	,	,	O	,	_	0	SENT_266	[p15l358t1691r432b1756],
4	Geretti	NNP	ORGANIZATION	Geretti	nn	5	SENT_266	[p15l465t1689r692b1746],
5	AM	NNP	ORGANIZATION	AM	appos	2	SENT_266	[p15l723t1690r869b1756],
6	,	,	O	,	_	0	SENT_266	[p15l723t1690r869b1756],
7	Green	NNP	PERSON	Green	nn	8	SENT_266	[p15l903t1689r1104b1746],
8	H	NNP	PERSON	H	appos	2	SENT_266	[p15l1135t1691r1212b1756],
9	,	,	O	,	_	0	SENT_266	[p15l1135t1691r1212b1756],
10	et	FW	O	et	nn	11	SENT_266	[p15l1245t1694r1297b1745],
11	al.	FW	O	al.	appos	2	SENT_266	[p15l1328t1688r1417b1745],
12	:	:	O	:	_	0	SENT_266	[p15l1328t1688r1417b1745],
13	Population	NNP	O	Population	nn	14	SENT_266	[p15l1450t1688r1816b1766],
14	trends	NNS	O	trend	conj_and	2	SENT_266	[p15l1847t1688r2055b1746],
15	in	IN	O	in	_	0	SENT_266	[p15l2087t1691r2151b1744],
16	the	DT	O	the	det	17	SENT_266	[p15l137t1781r238b1839],
17	prevalence	NN	O	prevalence	prep_in	14	SENT_266	[p15l262t1781r621b1859],
18	and	CC	O	and	_	0	SENT_266	[p15l648t1781r772b1838],
19	patterns	NNS	O	pattern	nsubj	23	SENT_266	[p15l796t1789r1067b1859],
20	of	IN	O	of	_	0	SENT_266	[p15l1094t1781r1159b1839],
21	protease	NN	O	protease	nn	22	SENT_266	[p15l1180t1789r1460b1859],
22	resistance	NN	O	resistance	prep_of	19	SENT_266	[p15l1485t1784r1807b1839],
23	related	JJ	O	related	_	0	SENT_266	[p15l1833t1781r2061b1839],
24	to	TO	O	to	_	0	SENT_266	[p15l2086t1789r2149b1839],
25	exposure	NN	O	exposure	prep_to	23	SENT_266	[p15l137t1894r437b1952],
26	to	TO	O	to	_	0	SENT_266	[p15l487t1882r550b1932],
27	unboosted	JJ	O	unboosted	prep_to	23	SENT_266	[p15l600t1875r948b1932],
28	and	CC	O	and	_	0	SENT_266	[p15l1000t1875r1124b1932],
29	boosted	VBD	O	boost	conj_and	23	SENT_266	[p15l1172t1875r1434b1932],
30	protease	NN	O	protease	nn	31	SENT_266	[p15l1483t1883r1763b1952],
31	inhibitors	NNS	O	inhibitor	dobj	29	SENT_266	[p15l1813t1875r2146b1932],
32	.	.	O	.	_	0	SENT_266	[p15l1813t1875r2146b1932],

1	Antivir	NNP	O	Antivir	nn	2	SENT_267	[p15l137t1969r377b2024],
2	Ther	NNP	O	Ther	_	0	SENT_267	[p15l404t1968r557b2025],
3	2008	CD	DATE	2008	num	2	SENT_267	[p15l584t1970r1130b2035],
4	;	:	O	;	_	0	SENT_267	[p15l584t1970r1130b2035],
5	13:771	CD	NUMBER	13:771	number	6	SENT_267	[p15l584t1970r1130b2035],
6	-777	CD	NUMBER	-777	dep	2	SENT_267	[p15l584t1970r1130b2035],
7	.	.	O	.	_	0	SENT_267	[p15l584t1970r1130b2035],

1	.	.	O	.	_	0	SENT_268	[p15l83t2107r93b2116],

1	Sista	NNP	O	Sista	nn	2	SENT_269	[p15l137t2061r286b2118],
2	P	NN	O	p	_	0	SENT_269	[p15l312t2062r373b2127],
3	,	,	O	,	_	0	SENT_269	[p15l312t2062r373b2127],
4	Rinehart	NNP	PERSON	Rinehart	nn	5	SENT_269	[p15l398t2060r679b2118],
5	A	NNP	O	A	conj_and	2	SENT_269	[p15l702t2062r776b2127],
6	,	,	O	,	_	0	SENT_269	[p15l702t2062r776b2127],
7	Wasikowski	NNP	PERSON	Wasikowski	nn	8	SENT_269	[p15l801t2060r1203b2118],
8	B	NNP	PERSON	B	conj_and	2	SENT_269	[p15l1228t2062r1288b2127],
9	,	,	O	,	_	0	SENT_269	[p15l1228t2062r1288b2127],
10	Winters	NNP	DATE	Winters	nn	11	SENT_269	[p15l1313t2062r1570b2118],
11	B	NNP	O	B	conj_and	2	SENT_269	[p15l1595t2062r1656b2127],
12	,	,	O	,	_	0	SENT_269	[p15l1595t2062r1656b2127],
13	Pattery	NNP	ORGANIZATION	Pattery	nn	14	SENT_269	[p15l1682t2062r1916b2137],
14	T	NN	ORGANIZATION	t	conj_and	2	SENT_269	[p15l1939t2062r2001b2127],
15	,	,	O	,	_	0	SENT_269	[p15l1939t2062r2001b2127],
16	and	CC	O	and	_	0	SENT_269	[p15l2027t2060r2149b2117],
17	Bacheler	NN	O	bacheler	nn	18	SENT_269	[p15l137t2153r413b2210],
18	L	NN	O	l	conj_and	2	SENT_269	[p15l450t2155r509b2209],
19	:	:	O	:	_	0	SENT_269	[p15l450t2155r509b2209],
20	Nine-year	JJ	DURATION	nine-year	amod	21	SENT_269	[p15l550t2155r877b2230],
21	trends	NNS	O	trend	dep	2	SENT_269	[p15l914t2153r1118b2210],
22	in	IN	O	in	_	0	SENT_269	[p15l1157t2156r1221b2209],
23	clinically	RB	O	clinically	advmod	24	SENT_269	[p15l1258t2153r1547b2230],
24	relevant	JJ	O	relevant	prep_in	21	SENT_269	[p15l1584t2153r1849b2210],
25	reduced	VBN	O	reduce	partmod	2	SENT_269	[p15l1886t2153r2150b2210],
26	susceptibility	NN	O	susceptibility	dobj	25	SENT_269	[p15l138t2246r567b2324],
27	of	IN	O	of	prep	26	SENT_269	[p15l592t2246r658b2304],
28	HIV-1	NN	O	hiv-1	dep	27	SENT_269	[p15l679t2249r875b2303],
29	to	TO	O	to	_	0	SENT_269	[p15l904t2254r967b2304],
30	antiretrovirals	NNS	O	antiretroviral	prep_to	28	SENT_269	[p15l993t2246r1467b2304],
31	.	.	O	.	_	0	SENT_269	[p15l993t2246r1467b2304],
32	]	SYM	O	]	dep	26	SENT_269	[p15l1503t2249r1511b2321],

1	Clin	NNP	O	Clin	nn	2	SENT_270	[p15l1543t2246r1680b2304],
2	Virol	NNP	O	Virol	_	0	SENT_270	[p15l1702t2246r1867b2304],
3	2009	CD	DATE	2009	num	2	SENT_270	[p15l1891t2249r2147b2314],
4	;	:	O	;	_	0	SENT_270	[p15l1891t2249r2147b2314],
5	44	CD	NUMBER	44	num	7	SENT_270	[p15l1891t2249r2147b2314],
6	:	:	O	:	_	0	SENT_270	[p15l1891t2249r2147b2314],
7	190-194	CD	NUMBER	190-194	dep	2	SENT_270	[p15l140t2342r412b2396],
8	.	.	O	.	_	0	SENT_270	[p15l140t2342r412b2396],

1	.	.	O	.	_	0	SENT_271	[p15l83t2480r93b2489],

1	Parkin	NNP	PERSON	Parkin	nn	2	SENT_272	[p15l137t2433r356b2490],
2	N	NNP	O	N	_	0	SENT_272	[p15l385t2435r464b2500],
3	,	,	O	,	_	0	SENT_272	[p15l385t2435r464b2500],
4	Chappey	NNP	O	Chappey	nn	5	SENT_272	[p15l497t2433r799b2510],
5	C	NNP	O	C	conj_and	2	SENT_272	[p15l830t2434r899b2500],
6	,	,	O	,	_	0	SENT_272	[p15l830t2434r899b2500],
7	Maroldo	NNP	O	Maroldo	nn	8	SENT_272	[p15l932t2433r1217b2490],
8	L	NNP	O	L	conj_and	2	SENT_272	[p15l1250t2435r1311b2500],
9	,	,	O	,	_	0	SENT_272	[p15l1250t2435r1311b2500],
10	Bates	NNP	PERSON	Bates	nn	11	SENT_272	[p15l1344t2435r1517b2490],
11	M	NNP	O	M	conj_and	2	SENT_272	[p15l1549t2435r1636b2500],
12	,	,	O	,	_	0	SENT_272	[p15l1549t2435r1636b2500],
13	Hellmann	NNP	ORGANIZATION	Hellmann	nn	14	SENT_272	[p15l1669t2433r2000b2490],
14	NS	NNP	ORGANIZATION	NS	conj_and	2	SENT_272	[p15l2031t2434r2149b2500],
15	,	,	O	,	_	0	SENT_272	[p15l2031t2434r2149b2500],
16	and	CC	O	and	_	0	SENT_272	[p15l138t2526r262b2583],
17	Petropoulos	NNP	PERSON	Petropoulos	nn	18	SENT_272	[p15l291t2526r690b2603],
18	C	NNP	O	C	conj_and	2	SENT_272	[p15l721t2527r812b2597],
19	]	CD	NUMBER	]	num	18	SENT_272	[p15l721t2527r812b2597],
20	:	:	O	:	_	0	SENT_272	[p15l721t2527r812b2597],
21	Phenotypic	JJ	O	phenotypic	nsubj	28	SENT_272	[p15l845t2526r1217b2603],
22	and	CC	O	and	_	0	SENT_272	[p15l1248t2526r1372b2583],
23	genotypic	JJ	O	genotypic	amod	27	SENT_272	[p15l1403t2528r1727b2603],
24	HIV-1	NN	MISC	hiv-1	nn	27	SENT_272	[p15l1758t2528r1956b2582],
25	drug	NN	O	drug	nn	27	SENT_272	[p15l1991t2526r2151b2603],
26	resistance	NN	O	resistance	nn	27	SENT_272	[p15l137t2623r459b2678],
27	assays	NNS	O	assay	conj_and	21	SENT_272	[p15l514t2639r723b2697],
28	provide	VBP	O	provide	dep	2	SENT_272	[p15l776t2620r1036b2697],
29	complementary	JJ	O	complementary	amod	30	SENT_272	[p15l1089t2620r1610b2697],
30	information	NN	O	information	dobj	28	SENT_272	[p15l1662t2620r2070b2678],
31	.	.	O	.	_	0	SENT_272	[p15l1662t2620r2070b2678],

1	1	CD	NUMBER	1	_	0	SENT_273	[p15l2125t2622r2151b2695],

1	Acguir	NNP	MISC	Acguir	nn	4	SENT_274	[p15l137t2742r365b2817],
2	Immune	NNP	MISC	Immune	nn	4	SENT_274	[p15l393t2742r673b2797],
3	Defic	NNP	MISC	Defic	nn	4	SENT_274	[p15l701t2740r871b2797],
4	Syndr	NNP	MISC	Syndr	_	0	SENT_274	[p15l900t2740r1099b2817],
5	2002	CD	DATE	2002	num	4	SENT_274	[p15l1125t2742r1671b2807],
6	;	:	O	;	_	0	SENT_274	[p15l1125t2742r1671b2807],
7	31:128	CD	NUMBER	31:128	number	8	SENT_274	[p15l1125t2742r1671b2807],
8	-136	CD	NUMBER	-136	dep	4	SENT_274	[p15l1125t2742r1671b2807],
9	.	.	O	.	_	0	SENT_274	[p15l1125t2742r1671b2807],

1	Parkin	NNP	PERSON	Parkin	nn	2	SENT_275	[p15l137t2834r356b2891],
2	NT	NNP	O	NT	_	0	SENT_275	[p15l386t2837r510b2902],
3	,	,	O	,	_	0	SENT_275	[p15l386t2837r510b2902],
4	Gupta	NNP	PERSON	Gupta	nn	5	SENT_275	[p15l544t2835r752b2912],
5	S	NNP	O	S	conj_and	2	SENT_275	[p15l785t2835r840b2902],
6	,	,	O	,	_	0	SENT_275	[p15l785t2835r840b2902],
7	Chappey	NNP	O	Chappey	nn	8	SENT_275	[p15l874t2834r1176b2912],
8	C	NNP	O	C	conj_and	2	SENT_275	[p15l1207t2835r1276b2902],
9	,	,	O	,	_	0	SENT_275	[p15l1207t2835r1276b2902],
10	and	CC	O	and	_	0	SENT_275	[p15l1311t2834r1435b2891],
11	Petropoulos	NNP	PERSON	Petropoulos	nn	12	SENT_275	[p15l1468t2834r1866b2912],
12	C	NNP	O	C	conj_and	2	SENT_275	[p15l1900t2835r1991b2905],
13	]	CD	NUMBER	]	num	12	SENT_275	[p15l1900t2835r1991b2905],
14	:	:	O	:	_	0	SENT_275	[p15l1900t2835r1991b2905],
15	The	DT	O	the	det	19	SENT_275	[p15l2027t2834r2150b2892],
16	K101P	NN	O	k101p	nn	19	SENT_275	[p15l137t2930r349b2985],
17	and	CC	O	and	_	0	SENT_275	[p15l391t2928r515b2984],
18	K103R/V179D	NN	O	k103r/v179d	nn	19	SENT_275	[p15l556t2928r1047b2993],
19	mutations	NNS	O	mutation	dep	2	SENT_275	[p15l1087t2930r1422b2985],
20	in	IN	O	in	_	0	SENT_275	[p15l1464t2930r1528b2984],
21	human	JJ	O	human	amod	24	SENT_275	[p15l1566t2928r1803b2984],
22	immunodeficiency	NN	O	immunodeficiency	nn	24	SENT_275	[p15l1843t2930r2150b2985, p15l138t3021r472b3099],
23	virus	NN	O	virus	nn	24	SENT_275	[p15l512t3024r680b3079],
24	type	NN	O	type	prep_in	19	SENT_275	[p15l723t3030r867b3099],
25	1	CD	NUMBER	1	num	27	SENT_275	[p15l912t3024r940b3078],
26	reverse	JJ	O	reverse	amod	27	SENT_275	[p15l986t3041r1224b3079],
27	transcriptase	NN	O	transcriptase	nsubj	28	SENT_275	[p15l1266t3024r1689b3099],
28	confer	VB	O	confer	rcmod	24	SENT_275	[p15l1732t3021r1937b3079],
29	resistance	NN	O	resistance	dobj	28	SENT_275	[p15l1978t3024r2150b3079, p15l137t3122r310b3172],
30	to	TO	O	to	_	0	SENT_275	[p15l369t3122r432b3172],
31	nonnucleoside	JJ	O	nonnucleoside	amod	34	SENT_275	[p15l491t3114r972b3172],
32	reverse	JJ	O	reverse	amod	34	SENT_275	[p15l1032t3133r1270b3172],
33	transcriptase	NN	O	transcriptase	nn	34	SENT_275	[p15l1330t3117r1753b3191],
34	inhibitors	NNS	O	inhibitor	prep_to	28	SENT_275	[p15l1813t3114r2146b3172],
35	.	.	O	.	_	0	SENT_275	[p15l1813t3114r2146b3172],

1	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_276	[p15l137t3208r515b3265],
2	Agents	NNPS	O	Agents	nn	3	SENT_276	[p15l544t3210r777b3285],
3	Chemother	NNP	O	Chemother	_	0	SENT_276	[p15l806t3208r1178b3265],
4	2006	CD	DATE	2006	dep	3	SENT_276	[p15l1205t3210r1751b3275],
5	;	:	O	;	_	0	SENT_276	[p15l1205t3210r1751b3275],
6	50:351	CD	NUMBER	50:351	num	7	SENT_276	[p15l1205t3210r1751b3275],
7	-354	CD	NUMBER	-354	dep	3	SENT_276	[p15l1205t3210r1751b3275],
8	.	.	O	.	_	0	SENT_276	[p15l1205t3210r1751b3275],

1	Petropoulos	NNP	PERSON	Petropoulos	nn	3	SENT_277	[p15l137t3302r528b3380],
2	C	NNP	O	C	nn	3	SENT_277	[p15l555t3303r647b3373],
3	]	NN	O	]	_	0	SENT_277	[p15l555t3303r647b3373],
4	,	,	O	,	_	0	SENT_277	[p15l555t3303r647b3373],
5	Parkin	NNP	PERSON	Parkin	nn	6	SENT_277	[p15l675t3302r889b3359],
6	NT	NNP	O	NT	appos	3	SENT_277	[p15l914t3305r1037b3370],
7	,	,	O	,	_	0	SENT_277	[p15l914t3305r1037b3370],
8	Limoli	NNP	LOCATION	Limoli	nn	9	SENT_277	[p15l1065t3302r1277b3360],
9	KL	NNP	LOCATION	KL	appos	3	SENT_277	[p15l1302t3305r1417b3370],
10	,	,	O	,	_	0	SENT_277	[p15l1302t3305r1417b3370],
11	et	FW	O	et	nn	12	SENT_277	[p15l1443t3308r1496b3359],
12	al.	FW	O	al.	appos	3	SENT_277	[p15l1520t3302r1607b3359],
13	:	:	O	:	_	0	SENT_277	[p15l1520t3302r1607b3359],
14	A	DT	O	a	det	19	SENT_277	[p15l1634t3304r1691b3358],
15	novel	JJ	O	novel	amod	19	SENT_277	[p15l1716t3302r1897b3360],
16	phenotypic	JJ	O	phenotypic	amod	19	SENT_277	[p15l1921t3302r2151b3380, p15l137t3399r298b3474],
17	drug	NN	O	drug	nn	19	SENT_277	[p15l325t3396r483b3474],
18	susceptibility	NN	O	susceptibility	nn	19	SENT_277	[p15l509t3396r938b3474],
19	assay	NN	O	assay	dep	3	SENT_277	[p15l965t3416r1142b3474],
20	for	IN	O	for	_	0	SENT_277	[p15l1166t3396r1258b3454],
21	human	JJ	O	human	amod	23	SENT_277	[p15l1283t3396r1517b3453],
22	immunodeficiency	NN	O	immunodeficiency	nn	23	SENT_277	[p15l1541t3396r2151b3474],
23	virus	NN	O	virus	prep_for	19	SENT_277	[p16l136t30r302b85],
24	type	NN	O	type	amod	23	SENT_277	[p16l325t36r468b105],
25	1	CD	NUMBER	1	number	24	SENT_277	[p16l494t30r542b84],
26	.	.	O	.	_	0	SENT_277	[p16l494t30r542b84],

1	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_278	[p16l567t28r939b85],
2	Agents	NNPS	O	Agents	nn	3	SENT_278	[p16l963t29r1193b105],
3	Chemother	NNP	O	Chemother	_	0	SENT_278	[p16l1217t28r1583b85],
4	2000	CD	DATE	2000	dep	3	SENT_278	[p16l1605t30r2140b95],
5	;	:	O	;	_	0	SENT_278	[p16l1605t30r2140b95],
6	44:920	CD	NUMBER	44:920	num	7	SENT_278	[p16l1605t30r2140b95],
7	-928	CD	NUMBER	-928	dep	3	SENT_278	[p16l1605t30r2140b95],
8	.	.	O	.	_	0	SENT_278	[p16l1605t30r2140b95],

1	Coakley	NNP	PERSON	Coakley	nn	2	SENT_279	[p16l137t122r410b199],
2	E	NNP	O	E	_	0	SENT_279	[p16l441t124r503b189],
3	,	,	O	,	_	0	SENT_279	[p16l441t124r503b189],
4	Chappey	NNP	O	Chappey	nn	5	SENT_279	[p16l537t122r839b199],
5	C	NNP	O	C	appos	2	SENT_279	[p16l871t123r940b189],
6	,	,	O	,	_	0	SENT_279	[p16l871t123r940b189],
7	Maa	NNP	O	Maa	nn	8	SENT_279	[p16l973t124r1118b179],
8	]	NNP	O	]	appos	2	SENT_279	[p16l1148t124r1190b193],
9	,	,	O	,	_	0	SENT_279	[p16l1148t124r1190b193],
10	et	FW	O	et	nn	11	SENT_279	[p16l1224t128r1276b179],
11	al.	FW	O	al.	appos	2	SENT_279	[p16l1307t121r1396b178],
12	:	:	O	:	_	0	SENT_279	[p16l1307t121r1396b178],
13	Evaluation	NN	O	evaluation	dep	2	SENT_279	[p16l1430t122r1791b179],
14	of	IN	O	of	_	0	SENT_279	[p16l1823t121r1889b179],
15	phenotypic	JJ	O	phenotypic	amod	17	SENT_279	[p16l1918t122r2150b199, p16l137t217r300b291],
16	clinical	JJ	O	clinical	amod	17	SENT_279	[p16l326t214r558b272],
17	cutoff	NN	O	cutoff	prep_of	13	SENT_279	[p16l583t214r776b272],
18	for	IN	O	for	_	0	SENT_279	[p16l799t214r892b272],
19	atazanavir/ritonavir	NN	O	atazanavir/ritonavir	prep_for	17	SENT_279	[p16l918t214r1604b279],
20	in	IN	O	in	_	0	SENT_279	[p16l1629t217r1693b270],
21	patients	NNS	O	patient	prep_in	19	SENT_279	[p16l1716t217r1978b291],
22	who	WP	O	who	nsubj	23	SENT_279	[p16l2003t214r2150b272],
23	changed	VBD	O	change	rcmod	13	SENT_279	[p16l137t307r416b384],
24	only	RB	O	only	advmod	28	SENT_279	[p16l445t307r591b384],
25	the	DT	O	the	det	28	SENT_279	[p16l617t307r718b364],
26	protease	NN	O	protease	nn	28	SENT_279	[p16l745t315r1024b384],
27	inhibitor	NN	O	inhibitor	nn	28	SENT_279	[p16l1053t307r1339b364],
28	component	NN	O	component	dobj	23	SENT_279	[p16l1367t315r1739b384],
29	of	IN	O	of	_	0	SENT_279	[p16l1767t307r1832b364],
30	HAART	NNP	O	HAART	prep_of	28	SENT_279	[p16l1857t309r2146b363],
31	:	:	O	:	_	0	SENT_279	[p16l1857t309r2146b363],
32	A	NNP	O	A	dep	28	SENT_279	[p16l137t402r194b456],
33	confirmatory	JJ	O	confirmatory	amod	34	SENT_279	[p16l235t400r668b478],
34	week	NN	DURATION	week	tmod	32	SENT_279	[p16l707t400r884b458],
35	2	CD	NUMBER	2	num	36	SENT_279	[p16l923t403r958b457],
36	analysis	NN	O	analysis	tmod	23	SENT_279	[p16l1001t400r1265b478],
37	of	IN	O	of	_	0	SENT_279	[p16l1308t400r1373b458],
38	A1424-045	NN	O	a1424-045	prep_of	36	SENT_279	[p16l1411t402r1761b458],
39	.	.	O	.	_	0	SENT_279	[p16l1411t402r1761b458],

1	13th	JJ	ORDINAL	13th	amod	2	SENT_280	[p16l1809t400r1949b458],
2	Conference	NN	MISC	conference	_	0	SENT_280	[p16l1989t401r2150b458, p16l137t493r372b551],
3	on	IN	MISC	on	_	0	SENT_280	[p16l405t513r487b551],
4	Retroviruses	NNP	MISC	Retroviruses	nn	7	SENT_280	[p16l517t496r933b551],
5	and	CC	O	and	_	0	SENT_280	[p16l967t493r1090b550],
6	Opportunistic	NNP	O	Opportunistic	conj_and	4	SENT_280	[p16l1122t494r1585b571],
7	Infections	NNPS	O	Infections	prep_on	2	SENT_280	[p16l1617t493r1957b561],
8	,	,	O	,	_	0	SENT_280	[p16l1617t493r1957b561],
9	Denver	NNP	LOCATION	Denver	appos	2	SENT_280	[p16l1990t496r2151b551, p16l136t606r260b654],
10	,	,	O	,	_	0	SENT_280	[p16l1990t496r2151b551, p16l136t606r260b654],
11	CO	NNP	LOCATION	CO	nn	13	SENT_280	[p16l289t588r418b654],
12	,	,	O	,	_	0	SENT_280	[p16l289t588r418b654],
13	February	NNP	DATE	February	appos	2	SENT_280	[p16l447t587r749b664],
14	5-8	CD	DATE	5-8	num	13	SENT_280	[p16l776t589r906b654],
15	,	,	DATE	,	_	0	SENT_280	[p16l776t589r906b654],
16	2006	CD	DATE	2006	num	13	SENT_280	[p16l934t589r1100b644],
17	.	.	O	.	_	0	SENT_280	[p16l934t589r1100b644],

1	Coakley	NNP	PERSON	Coakley	nn	2	SENT_281	[p16l137t680r410b757],
2	EP	NNP	O	EP	_	0	SENT_281	[p16l432t682r539b747],
3	,	,	O	,	_	0	SENT_281	[p16l432t682r539b747],
4	Chappey	NNP	O	Chappey	nn	5	SENT_281	[p16l564t680r866b757],
5	C	NNP	O	C	appos	2	SENT_281	[p16l889t681r958b747],
6	,	,	O	,	_	0	SENT_281	[p16l889t681r958b747],
7	Flandre	NNP	O	Flandre	nn	8	SENT_281	[p16l983t680r1236b737],
8	P	NN	O	p	appos	2	SENT_281	[p16l1260t682r1320b747],
9	,	,	O	,	_	0	SENT_281	[p16l1260t682r1320b747],
10	et	FW	O	et	nn	11	SENT_281	[p16l1345t686r1397b736],
11	al.	FW	O	al.	appos	2	SENT_281	[p16l1419t679r1507b736],
12	:	:	O	:	_	0	SENT_281	[p16l1419t679r1507b736],
13	Defining	VBG	O	define	dep	2	SENT_281	[p16l1533t679r1822b757],
14	lower	JJR	O	lower	acomp	13	SENT_281	[p16l1845t680r2034b737],
15	(	CD	NUMBER	(	num	17	SENT_281	[p16l2060t680r2148b752],
16	L	NN	O	l	nn	17	SENT_281	[p16l2060t680r2148b752],
17	)	NN	O	)	dep	14	SENT_281	[p16l2060t680r2148b752],
18	and	CC	O	and	_	0	SENT_281	[p16l138t772r262b829],
19	upper	JJ	O	upper	amod	25	SENT_281	[p16l292t791r490b849],
20	(	NN	O	(	nn	25	SENT_281	[p16l523t772r623b844],
21	U	NNP	O	U	nn	25	SENT_281	[p16l523t772r623b844],
22	)	NNP	O	)	nn	25	SENT_281	[p16l523t772r623b844],
23	phenotypic	JJ	O	phenotypic	amod	25	SENT_281	[p16l654t772r1027b849],
24	clinical	JJ	O	clinical	amod	25	SENT_281	[p16l1058t772r1290b830],
25	cutoffs	NNS	O	cutoff	dep	14	SENT_281	[p16l1319t772r1541b830],
26	(	VBP	O	(	dep	13	SENT_281	[p16l1574t772r1815b844],
27	CCOs	NNS	O	cco	nsubj	28	SENT_281	[p16l1574t772r1815b844],
28	)	VB	O	)	ccomp	26	SENT_281	[p16l1574t772r1815b844],
29	for	IN	O	for	_	0	SENT_281	[p16l1847t772r1940b830],
30	tipranavir	NN	O	tipranavir	prep_for	28	SENT_281	[p16l1969t775r2150b849, p16l136t868r310b922],
31	/	:	O	/	punct	35	SENT_281	[p16l317t865r350b930],
32	r	NN	O	r	nn	35	SENT_281	[p16l358t884r386b921],
33	(	CD	NUMBER	(	num	35	SENT_281	[p16l419t865r626b937],
34	TPV	NN	O	tpv	nn	35	SENT_281	[p16l419t865r626b937],
35	)	NN	O	)	dep	30	SENT_281	[p16l419t865r626b937],
36	,	,	O	,	_	0	SENT_281	[p16l419t865r626b937],
37	lopinavir	NN	O	lopinavir	appos	35	SENT_281	[p16l658t865r960b942],
38	/	:	O	/	punct	35	SENT_281	[p16l968t865r1000b930],
39	r	NN	O	r	nn	42	SENT_281	[p16l1008t884r1036b921],
40	(	CD	NUMBER	(	num	42	SENT_281	[p16l1069t865r1088b937],
41	LPV	NN	O	lpv	nn	42	SENT_281	[p16l1119t865r1305b937],
42	)	NN	O	)	nsubj	13	SENT_281	[p16l1119t865r1305b937],
43	,	,	O	,	_	0	SENT_281	[p16l1119t865r1305b937],
44	saquinavir	NN	O	saquinavir	appos	42	SENT_281	[p16l1337t868r1688b942],
45	/	:	O	/	punct	49	SENT_281	[p16l1695t865r1728b930],
46	r	NN	O	r	nn	49	SENT_281	[p16l1736t884r1763b921],
47	(	CD	NUMBER	(	num	49	SENT_281	[p16l1796t865r1991b937],
48	SQV	NN	O	sqv	nn	49	SENT_281	[p16l1796t865r1991b937],
49	)	NN	O	)	dep	44	SENT_281	[p16l1796t865r1991b937],
50	and	CC	O	and	_	0	SENT_281	[p16l2026t865r2150b922],
51	amprenavir	NN	O	amprenavir	dep	44	SENT_281	[p16l138t961r525b1036],
52	/	:	O	/	punct	49	SENT_281	[p16l532t958r565b1023],
53	r	NN	O	r	nn	55	SENT_281	[p16l573t978r600b1014],
54	(	CD	NUMBER	(	num	55	SENT_281	[p16l623t958r823b1031],
55	APV	NNP	ORGANIZATION	APV	dep	44	SENT_281	[p16l623t958r823b1031],
56	)	CD	NUMBER	)	num	57	SENT_281	[p16l623t958r823b1031],
57	co-administration	NN	O	co-administration	dep	44	SENT_281	[p16l846t958r1435b1016],
58	with	IN	O	with	_	0	SENT_281	[p16l1453t958r1606b1015],
59	ritonavir	NN	O	ritonavir	prep_with	57	SENT_281	[p16l1625t961r1915b1016],
60	within	IN	O	within	_	0	SENT_281	[p16l1934t958r2151b1015],
61	the	DT	O	the	det	63	SENT_281	[p16l137t1051r238b1109],
62	RESIST	NNP	O	RESIST	nn	63	SENT_281	[p16l272t1052r517b1109],
63	dataset	NN	O	dataset	prep_within	59	SENT_281	[p16l551t1051r787b1109],
64	by	IN	O	by	_	0	SENT_281	[p16l817t1051r902b1129],
65	the	DT	O	the	det	67	SENT_281	[p16l934t1051r1035b1109],
66	PhenoSense	NN	O	phenosense	nn	67	SENT_281	[p16l1069t1051r1462b1109],
67	assay	NN	O	assay	prep_by	63	SENT_281	[p16l1496t1071r1690b1129],
68	.	.	O	.	_	0	SENT_281	[p16l1496t1071r1690b1129],

1	46th	JJ	ORDINAL	46th	amod	2	SENT_282	[p16l1726t1051r1870b1109],
2	ICAAC	NN	O	icaac	_	0	SENT_282	[p16l1902t1052r2148b1109],
3	(	CD	NUMBER	(	num	5	SENT_282	[p16l140t1145r552b1217],
4	Interscience	NNP	O	Interscience	nn	5	SENT_282	[p16l140t1145r552b1217],
5	Conference	NNP	O	Conference	dep	2	SENT_282	[p16l617t1144r990b1202],
6	on	IN	O	on	_	0	SENT_282	[p16l1056t1164r1139b1202],
7	Antimicrobial	NNP	O	Antimicrobial	nn	8	SENT_282	[p16l1202t1145r1663b1202],
8	Agents	NNPS	O	Agents	prep_on	5	SENT_282	[p16l1726t1146r1960b1222],
9	and	CC	O	and	_	0	SENT_282	[p16l2026t1145r2150b1202],
10	Chemotherapy	NNP	O	Chemotherapy	prep_on	5	SENT_282	[p16l137t1238r676b1315],
11	)	CD	NUMBER	)	dep	2	SENT_282	[p16l137t1238r676b1315],
12	,	,	O	,	_	0	SENT_282	[p16l137t1238r676b1315],
13	San	NNP	LOCATION	San	nn	14	SENT_282	[p16l706t1239r826b1295],
14	Francisco	NNP	LOCATION	Francisco	appos	11	SENT_282	[p16l852t1240r1181b1305],
15	,	,	O	,	_	0	SENT_282	[p16l852t1240r1181b1305],
16	CA	NNP	LOCATION	CA	nn	18	SENT_282	[p16l1210t1239r1338b1305],
17	,	,	O	,	_	0	SENT_282	[p16l1210t1239r1338b1305],
18	September	NNP	DATE	September	appos	2	SENT_282	[p16l1367t1238r1719b1315],
19	27-30	CD	DATE	27-30	num	18	SENT_282	[p16l1746t1240r1952b1305],
20	,	,	DATE	,	_	0	SENT_282	[p16l1746t1240r1952b1305],
21	2006	CD	DATE	2006	num	18	SENT_282	[p16l1981t1240r2146b1295],
22	.	.	O	.	_	0	SENT_282	[p16l1981t1240r2146b1295],

1	Coakley	NNP	PERSON	Coakley	nn	2	SENT_283	[p16l137t1330r410b1407],
2	E	NNP	O	E	nsubj	11	SENT_283	[p16l449t1332r510b1397],
3	,	,	O	,	_	0	SENT_283	[p16l449t1332r510b1397],
4	Chappey	NNP	O	Chappey	nn	5	SENT_283	[p16l551t1330r853b1407],
5	C	NNP	O	C	appos	2	SENT_283	[p16l892t1331r962b1397],
6	,	,	O	,	_	0	SENT_283	[p16l892t1331r962b1397],
7	Benhamida	NNP	O	Benhamida	appos	5	SENT_283	[p16l1003t1330r1378b1387],
8	]	CD	NUMBER	]	num	7	SENT_283	[p16l1416t1332r1459b1401],
9	,	,	O	,	_	0	SENT_283	[p16l1416t1332r1459b1401],
10	et	FW	O	et	nn	11	SENT_283	[p16l1499t1336r1551b1387],
11	al.	FW	O	al.	_	0	SENT_283	[p16l1589t1329r1679b1387],
12	:	:	O	:	_	0	SENT_283	[p16l1589t1329r1679b1387],
13	Defining	VBG	O	define	dep	11	SENT_283	[p16l1720t1330r2009b1407],
14	the	DT	O	the	det	20	SENT_283	[p16l2049t1330r2150b1387],
15	upper	JJ	O	upper	amod	20	SENT_283	[p16l137t1443r336b1501],
16	and	CC	O	and	_	0	SENT_283	[p16l357t1424r481b1481],
17	lower	JJR	O	lower	amod	20	SENT_283	[p16l503t1424r692b1481],
18	phenotypic	JJ	O	phenotypic	amod	20	SENT_283	[p16l712t1424r1085b1501],
19	clinical	JJ	O	clinical	amod	20	SENT_283	[p16l1108t1424r1340b1481],
20	cut-offs	NNS	O	cut-off	dobj	13	SENT_283	[p16l1361t1424r1607b1481],
21	for	IN	O	for	_	0	SENT_283	[p16l1630t1424r1723b1481],
22	darunavir	NN	O	darunavir	prep_for	20	SENT_283	[p16l1745t1424r2075b1481],
23	/	:	O	/	punct	27	SENT_283	[p16l2083t1424r2116b1489],
24	r	NN	O	r	nn	27	SENT_283	[p16l2123t1443r2151b1480],
25	(	CD	NUMBER	(	num	27	SENT_283	[p16l140t1517r420b1590],
26	DRV/r	NN	O	drv/r	nn	27	SENT_283	[p16l140t1517r420b1590],
27	)	NN	O	)	dep	11	SENT_283	[p16l140t1517r420b1590],
28	by	IN	O	by	_	0	SENT_283	[p16l466t1517r551b1595],
29	the	DT	O	the	det	31	SENT_283	[p16l596t1517r697b1575],
30	PhenoSense	NN	O	phenosense	nn	31	SENT_283	[p16l743t1517r1135b1575],
31	assay	NN	O	assay	prep_by	27	SENT_283	[p16l1183t1537r1377b1595],
32	.	.	O	.	_	0	SENT_283	[p16l1183t1537r1377b1595],

1	The	DT	O	the	det	3	SENT_284	[p16l1426t1517r1548b1575],
2	14th	JJ	ORDINAL	14th	amod	3	SENT_284	[p16l1598t1517r1738b1574],
3	CROI	NN	O	crous	_	0	SENT_284	[p16l1782t1518r1986b1585],
4	,	,	O	,	_	0	SENT_284	[p16l1782t1518r1986b1585],
5	Los	NNP	LOCATION	Los	nn	6	SENT_284	[p16l2033t1520r2149b1575],
6	Angeles	NNP	LOCATION	Angeles	appos	3	SENT_284	[p16l137t1610r421b1688],
7	,	,	O	,	_	0	SENT_284	[p16l137t1610r421b1688],
8	2007	CD	DATE	2007	appos	6	SENT_284	[p16l450t1613r615b1668],
9	.	.	O	.	_	0	SENT_284	[p16l450t1613r615b1668],

1	Abstract	JJ	O	abstract	_	0	SENT_285	[p16l646t1610r927b1668],
2	610	CD	NUMBER	610	dep	1	SENT_285	[p16l955t1613r1081b1668],
3	.	.	O	.	_	0	SENT_285	[p16l955t1613r1081b1668],

1	Coakley	NNP	PERSON	Coakley	nn	2	SENT_286	[p16l137t1704r402b1781],
2	E	NNP	O	E	_	0	SENT_286	[p16l436t1706r478b1760],
3	and	CC	O	and	_	0	SENT_286	[p16l514t1704r636b1761],
4	Parkin	NNP	PERSON	Parkin	nn	5	SENT_286	[p16l670t1704r882b1761],
5	N	NNP	O	N	conj_and	2	SENT_286	[p16l915t1706r989b1761],
6	:	:	O	:	_	0	SENT_286	[p16l915t1706r989b1761],
7	Tipranavir	NNP	O	Tipranavir	dep	2	SENT_286	[p16l1027t1706r1368b1781],
8	(	CD	NUMBER	(	num	7	SENT_286	[p16l1405t1704r1587b1776],
9	TPV	NN	O	tpv	nn	12	SENT_286	[p16l1405t1704r1587b1776],
10	)	CD	NUMBER	)	num	12	SENT_286	[p16l1405t1704r1587b1776],
11	phenotype	NN	O	phenotype	nn	12	SENT_286	[p16l1622t1704r1967b1781],
12	variability	NN	O	variability	dep	7	SENT_286	[p16l2000t1706r2150b1761, p16l138t1797r338b1874],
13	in	IN	O	in	_	0	SENT_286	[p16l352t1799r416b1853],
14	HIV-1	NN	O	hiv-1	prep_in	12	SENT_286	[p16l429t1799r622b1853],
15	with	IN	O	with	_	0	SENT_286	[p16l641t1797r790b1853],
16	similar	JJ	O	similar	amod	18	SENT_286	[p16l805t1797r1024b1854],
17	mutation	NN	O	mutation	nn	18	SENT_286	[p16l1038t1799r1335b1854],
18	scores	NNS	O	score	prep_with	14	SENT_286	[p16l1348t1816r1556b1854],
19	:	:	O	:	_	0	SENT_286	[p16l1348t1816r1556b1854],
20	Efforts	NNS	O	effort	dep	2	SENT_286	[p16l1574t1796r1785b1854],
21	to	TO	O	to	aux	22	SENT_286	[p16l1800t1805r1862b1854],
22	improve	VB	O	improve	infmod	20	SENT_286	[p16l1878t1799r2150b1874],
23	genotype	NN	O	genotype	nn	24	SENT_286	[p16l138t1897r435b1966],
24	interpretation	NN	O	interpretation	dobj	22	SENT_286	[p16l470t1892r923b1966],
25	.	.	O	.	_	0	SENT_286	[p16l470t1892r923b1966],

1	4th	JJ	ORDINAL	4th	amod	6	SENT_287	[p16l959t1889r1063b1946],
2	European	JJ	MISC	european	amod	6	SENT_287	[p16l1096t1891r1410b1966],
3	HIV	NN	MISC	hiv	nn	6	SENT_287	[p16l1443t1891r1582b1946],
4	Drug	NN	MISC	drug	nn	6	SENT_287	[p16l1615t1891r1785b1966],
5	Resistance	NN	MISC	resistance	nn	6	SENT_287	[p16l1818t1891r2150b1946],
6	Workshop	NNP	MISC	Workshop	_	0	SENT_287	[p16l136t1982r493b2059],
7	,	,	O	,	_	0	SENT_287	[p16l136t1982r493b2059],
8	Monte	NNP	PERSON	Monte	nn	9	SENT_287	[p16l514t1984r723b2039],
9	Carlo	NNP	PERSON	Carlo	appos	6	SENT_287	[p16l743t1982r936b2049],
10	,	,	O	,	_	0	SENT_287	[p16l743t1982r936b2049],
11	Monaco	NNP	LOCATION	Monaco	nn	13	SENT_287	[p16l957t1984r1234b2049],
12	,	,	O	,	_	0	SENT_287	[p16l957t1984r1234b2049],
13	March	NNP	DATE	March	appos	9	SENT_287	[p16l1254t1982r1464b2039],
14	29-31	CD	DATE	29-31	num	13	SENT_287	[p16l1482t1984r1683b2049],
15	,	,	DATE	,	_	0	SENT_287	[p16l1482t1984r1683b2049],
16	2006	CD	DATE	2006	num	13	SENT_287	[p16l1703t1984r1863b2039],
17	.	.	O	.	_	0	SENT_287	[p16l1703t1984r1863b2039],

1	BETHELL	NNP	PERSON	BETHELL	nn	3	SENT_288	[p16l1499t2104r1862b2162],
2	ET	NNP	O	ET	nn	3	SENT_288	[p16l1897t2104r1994b2162],
3	AL.	NNP	O	AL.	_	0	SENT_288	[p16l2023t2104r2147b2162],
4	.	.	O	.	_	0	SENT_288	[p16l2023t2104r2147b2162],

1	Marcelin	NNP	ORGANIZATION	Marcelin	nn	2	SENT_289	[p16l140t2320r433b2378],
2	AG	NNP	ORGANIZATION	AG	_	0	SENT_289	[p16l459t2321r591b2388],
3	,	,	O	,	_	0	SENT_289	[p16l459t2321r591b2388],
4	Masquelier	NNP	O	Masquelier	nn	5	SENT_289	[p16l620t2320r989b2398],
5	B	NNP	O	B	appos	2	SENT_289	[p16l1018t2323r1079b2388],
6	,	,	O	,	_	0	SENT_289	[p16l1018t2323r1079b2388],
7	Descamps	NNP	PERSON	Descamps	nn	8	SENT_289	[p16l1108t2323r1445b2398],
8	D	NNP	O	D	appos	2	SENT_289	[p16l1474t2323r1547b2388],
9	,	,	O	,	_	0	SENT_289	[p16l1474t2323r1547b2388],
10	et	FW	O	et	nn	11	SENT_289	[p16l1576t2326r1629b2377],
11	al.	FW	O	al.	appos	2	SENT_289	[p16l1655t2320r1744b2377],
12	:	:	O	:	_	0	SENT_289	[p16l1655t2320r1744b2377],
13	Tipranavirritonavir	NNP	O	Tipranavirritonavir	nn	16	SENT_289	[p16l1774t2323r2151b2398, p16l140t2417r429b2472],
14	genotypic	JJ	O	genotypic	amod	16	SENT_289	[p16l472t2417r797b2492],
15	resistance	NN	O	resistance	nn	16	SENT_289	[p16l840t2417r1161b2472],
16	score	NN	NUMBER	score	dep	2	SENT_289	[p16l1205t2434r1372b2472],
17	in	IN	O	in	dep	2	SENT_289	[p16l1414t2417r1478b2470],
18	protease	NN	O	protease	pobj	17	SENT_289	[p16l1518t2422r1798b2492],
19	inhibitorexperienced	VBD	O	inhibitorexperience	partmod	18	SENT_289	[p16l1840t2414r2150b2472, p16l141t2535r537b2611],

1	patients	NNS	O	patient	_	0	SENT_290	[p16l624t2537r901b2611],
2	.	.	O	.	_	0	SENT_290	[p16l624t2537r901b2611],

1	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_291	[p16l992t2535r1369b2591],
2	Agents	NNPS	O	Agents	nn	3	SENT_291	[p16l1458t2536r1691b2611],
3	Chemother	NNP	O	Chemother	_	0	SENT_291	[p16l1779t2535r2150b2591],
4	2008	CD	DATE	2008	dep	3	SENT_291	[p16l140t2630r761b2694],
5	;	:	O	;	_	0	SENT_291	[p16l140t2630r761b2694],
6	52:3237	CD	DURATION	52:3237	num	7	SENT_291	[p16l140t2630r761b2694],
7	-3243	CD	DURATION	-3243	dep	3	SENT_291	[p16l140t2630r761b2694],
8	.	.	O	.	_	0	SENT_291	[p16l140t2630r761b2694],

1	Johnson	NNP	ORGANIZATION	Johnson	nn	2	SENT_292	[p16l138t2721r408b2792],
2	VA	NNP	ORGANIZATION	VA	_	0	SENT_292	[p16l436t2723r566b2788],
3	,	,	O	,	_	0	SENT_292	[p16l436t2723r566b2788],
4	Brun-Vezinet	NNP	O	Brun-Vezinet	nn	5	SENT_292	[p16l598t2723r1038b2778],
5	F	NN	O	f	appos	2	SENT_292	[p16l1067t2723r1124b2788],
6	,	,	O	,	_	0	SENT_292	[p16l1067t2723r1124b2788],
7	Clotet	NN	O	clotet	nn	8	SENT_292	[p16l1156t2721r1355b2778],
8	B	NN	O	b	appos	2	SENT_292	[p16l1385t2723r1446b2788],
9	,	,	O	,	_	0	SENT_292	[p16l1385t2723r1446b2788],
10	et	FW	O	et	nn	11	SENT_292	[p16l1478t2727r1530b2778],
11	al.	FW	O	al.	appos	2	SENT_292	[p16l1558t2720r1647b2778],
12	:	:	O	:	_	0	SENT_292	[p16l1558t2720r1647b2778],
13	Update	NNP	O	Update	dep	2	SENT_292	[p16l1679t2721r1925b2798],
14	of	IN	O	of	_	0	SENT_292	[p16l1956t2721r2022b2778],
15	the	DT	O	the	det	18	SENT_292	[p16l2049t2721r2150b2778],
16	drug	NN	O	drug	nn	18	SENT_292	[p16l141t2815r301b2891],
17	resistance	NN	O	resistance	nn	18	SENT_292	[p16l340t2818r661b2872],
18	mutations	NNS	O	mutation	prep_of	13	SENT_292	[p16l701t2818r1034b2872],
19	in	IN	O	in	_	0	SENT_292	[p16l1075t2818r1139b2870],
20	HIV-1	NN	O	hiv-1	prep_in	18	SENT_292	[p16l1177t2817r1395b2871],
21	:	:	O	:	_	0	SENT_292	[p16l1177t2817r1395b2871],
22	December	NNP	DATE	December	dep	2	SENT_292	[p16l1439t2815r1773b2872],
23	2010	CD	DATE	2010	dep	22	SENT_292	[p16l1812t2817r1977b2872],
24	.	.	O	.	_	0	SENT_292	[p16l1812t2817r1977b2872],

1	T_op	NN	MISC	t_op	nn	2	SENT_293	[p16l2019t2817r2152b2891],
2	HIV	NN	MISC	hiv	nsubj	3	SENT_293	[p16l140t2911r281b2965],
3	Med	VBD	O	med	_	0	SENT_293	[p16l307t2908r458b2965],
4	2010	CD	DATE	2010	dobj	3	SENT_293	[p16l486t2911r1031b2975],
5	;	:	O	;	_	0	SENT_293	[p16l486t2911r1031b2975],
6	18:156	CD	NUMBER	18:156	num	7	SENT_293	[p16l486t2911r1031b2975],
7	-163	CD	NUMBER	-163	dep	4	SENT_293	[p16l486t2911r1031b2975],
8	.	.	O	.	_	0	SENT_293	[p16l486t2911r1031b2975],

1	Tojo	NNP	PERSON	Tojo	nn	2	SENT_294	[p16l140t3004r281b3078],
2	Y	NN	PERSON	y	_	0	SENT_294	[p16l299t3003r366b3069],
3	,	,	O	,	_	0	SENT_294	[p16l299t3003r366b3069],
4	Koh	NNP	O	Koh	nn	5	SENT_294	[p16l385t3002r522b3059],
5	Y	NN	O	y	appos	2	SENT_294	[p16l538t3003r605b3069],
6	,	,	O	,	_	0	SENT_294	[p16l538t3003r605b3069],
7	Amano	NNP	PERSON	Amano	nn	8	SENT_294	[p16l624t3004r867b3059],
8	M	NNP	O	M	appos	2	SENT_294	[p16l885t3004r971b3069],
9	,	,	O	,	_	0	SENT_294	[p16l885t3004r971b3069],
10	et	FW	O	et	nn	11	SENT_294	[p16l991t3008r1043b3058],
11	al.	FW	O	al.	appos	2	SENT_294	[p16l1059t3001r1146b3058],
12	:	:	O	:	_	0	SENT_294	[p16l1059t3001r1146b3058],
13	Novel	JJ	O	novel	amod	15	SENT_294	[p16l1166t3002r1365b3059],
14	protease	NN	O	protease	nn	15	SENT_294	[p16l1382t3010r1656b3078],
15	inhibitors	NNS	O	inhibitor	nsubj	16	SENT_294	[p16l1675t3002r1986b3059],
16	(	VBP	O	(	dep	2	SENT_294	[p16l2008t3002r2149b3073],
17	Pls	NNS	O	pl	nsubj	37	SENT_294	[p16l2008t3002r2149b3073],
18	)	CD	NUMBER	)	num	17	SENT_294	[p16l2008t3002r2149b3073],
19	containing	VBG	O	contain	partmod	17	SENT_294	[p16l141t3098r484b3173],
20	macrocyclic	JJ	O	macrocyclic	amod	21	SENT_294	[p16l542t3096r926b3173],
21	components	NNS	O	component	dobj	19	SENT_294	[p16l985t3103r1381b3173],
22	and	CC	O	and	_	0	SENT_294	[p16l1442t3096r1564b3152],
23	3	CD	NUMBER	3	num	25	SENT_294	[p16l1624t3096r2151b3168, p16l137t3188r1129b3266],
24	(	NN	O	(	nn	25	SENT_294	[p16l1624t3096r2151b3168, p16l137t3188r1129b3266],
25	R	NN	O	r	conj_and	21	SENT_294	[p16l1624t3096r2151b3168, p16l137t3188r1129b3266],
26	)	CD	NUMBER	)	number	27	SENT_294	[p16l1624t3096r2151b3168, p16l137t3188r1129b3266],
27	,3	CD	NUMBER	,3	num	30	SENT_294	[p16l1624t3096r2151b3168, p16l137t3188r1129b3266],
28	a	DT	O	a	det	30	SENT_294	[p16l1624t3096r2151b3168, p16l137t3188r1129b3266],
29	(	NN	O	(	nn	30	SENT_294	[p16l1624t3096r2151b3168, p16l137t3188r1129b3266],
30	S	NN	O	s	dep	25	SENT_294	[p16l1624t3096r2151b3168, p16l137t3188r1129b3266],
31	)	CD	NUMBER	)	number	32	SENT_294	[p16l1624t3096r2151b3168, p16l137t3188r1129b3266],
32	,6	CD	NUMBER	,6	num	35	SENT_294	[p16l1624t3096r2151b3168, p16l137t3188r1129b3266],
33	a	DT	O	a	det	35	SENT_294	[p16l1624t3096r2151b3168, p16l137t3188r1129b3266],
34	(	NN	O	(	nn	35	SENT_294	[p16l1624t3096r2151b3168, p16l137t3188r1129b3266],
35	R	NN	O	r	dep	25	SENT_294	[p16l1624t3096r2151b3168, p16l137t3188r1129b3266],
36	)	CD	NUMBER	)	num	37	SENT_294	[p16l1624t3096r2151b3168, p16l137t3188r1129b3266],
37	bis-tetrahydrofuranylurethane	NN	O	bis-tetrahydrofuranylurethane	xcomp	16	SENT_294	[p16l1624t3096r2151b3168, p16l137t3188r1129b3266],
38	that	WDT	O	that	nsubj	40	SENT_294	[p16l1161t3188r1289b3245],
39	are	VBP	O	be	cop	40	SENT_294	[p16l1319t3208r1417b3246],
40	potent	JJ	O	potent	rcmod	37	SENT_294	[p16l1448t3196r1659b3266],
41	against	IN	O	against	_	0	SENT_294	[p16l1690t3191r1923b3266],
42	multiPI-resistant	JJ	O	multipi-resistant	amod	44	SENT_294	[p16l1953t3189r2151b3245, p16l140t3285r506b3340],
43	HIV-1	NN	O	hiv-1	nn	44	SENT_294	[p16l563t3285r758b3339],
44	variants	NNS	O	variant	prep_against	40	SENT_294	[p16l819t3286r1082b3340],
45	in	FW	O	in	nn	46	SENT_294	[p16l1141t3286r1203b3338],
46	vitro	FW	O	vitro	advmod	40	SENT_294	[p16l1259t3286r1429b3340],
47	.	.	O	.	_	0	SENT_294	[p16l1259t3286r1429b3340],

1	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_295	[p16l1489t3283r1861b3340],
2	Agents	NNPS	O	Agents	nn	3	SENT_295	[p16l1920t3285r2150b3359],
3	Chemother	NNP	O	Chemother	_	0	SENT_295	[p16l140t3376r506b3433],
4	2010	CD	DATE	2010	dep	3	SENT_295	[p16l528t3378r1137b3443],
5	;	:	O	;	_	0	SENT_295	[p16l528t3378r1137b3443],
6	541:3460	CD	DURATION	541:3460	num	7	SENT_295	[p16l528t3378r1137b3443],
7	-3470	CD	DURATION	-3470	dep	3	SENT_295	[p16l528t3378r1137b3443],
8	.	.	O	.	_	0	SENT_295	[p16l528t3378r1137b3443],

1	Poveda	NNP	PERSON	Poveda	nn	2	SENT_296	[p16l140t3528r385b3585],
2	E	NNP	O	E	_	0	SENT_296	[p16l420t3531r481b3595],
3	,	,	O	,	_	0	SENT_296	[p16l420t3531r481b3595],
4	de	FW	PERSON	de	nn	6	SENT_296	[p16l517t3528r595b3585],
5	Mendoza	FW	PERSON	mendoza	nn	6	SENT_296	[p16l628t3528r939b3585],
6	C	NN	O	c	appos	2	SENT_296	[p16l973t3529r1042b3595],
7	,	,	O	,	_	0	SENT_296	[p16l973t3529r1042b3595],
8	Martin-Carbonero	NNP	PERSON	Martin-Carbonero	nn	9	SENT_296	[p16l1076t3528r1679b3585],
9	L	NNP	O	L	appos	2	SENT_296	[p16l1714t3531r1775b3595],
10	,	,	O	,	_	0	SENT_296	[p16l1714t3531r1775b3595],
11	et	FW	O	et	nn	12	SENT_296	[p16l1810t3534r1862b3585],
12	al.	FW	O	al.	appos	2	SENT_296	[p16l1894t3528r1983b3584],
13	:	:	O	:	_	0	SENT_296	[p16l1894t3528r1983b3584],
14	Prevalence	NN	O	prevalence	dep	2	SENT_296	[p16l2018t3531r2150b3585, p16l139t3621r387b3678],
15	of	IN	O	of	_	0	SENT_296	[p16l415t3621r481b3678],
16	darunavir	JJ	O	darunavir	amod	18	SENT_296	[p16l505t3621r835b3677],
17	resistance	NN	O	resistance	nn	18	SENT_296	[p16l861t3624r1183b3678],
18	mutations	NNS	O	mutation	prep_of	14	SENT_296	[p16l1209t3624r1543b3678],
19	in	IN	O	in	_	0	SENT_296	[p16l1569t3624r1634b3677],
20	HIV-1-infected	JJ	O	hiv-1-infected	amod	21	SENT_296	[p16l1659t3621r2149b3678],
21	patients	NNS	O	patient	prep_in	18	SENT_296	[p17l139t28r401b103],
22	failing	VBG	O	fail	partmod	21	SENT_296	[p17l430t25r640b103],
23	other	JJ	O	other	amod	25	SENT_296	[p17l669t26r840b83],
24	protease	NN	O	protease	nn	25	SENT_296	[p17l866t34r1145b103],
25	inhibitors	NNS	O	inhibitor	dobj	22	SENT_296	[p17l1174t25r1506b83],
26	.	.	O	.	_	0	SENT_296	[p17l1174t25r1506b83],

1	I	PRP	O	I	nsubj	2	SENT_297	[p17l1546t28r1553b100],
2	Antimicrob	VBP	O	antimicrob	_	0	SENT_297	[p17l1588t26r1965b83],
3	Chemother	JJ	O	chemother	amod	4	SENT_297	[p17l1995t26r2150b83, p17l140t120r379b177],
4	2007	CD	DATE	2007	dobj	2	SENT_297	[p17l406t122r951b186],
5	;	:	O	;	_	0	SENT_297	[p17l406t122r951b186],
6	60:885	CD	NUMBER	60:885	num	7	SENT_297	[p17l406t122r951b186],
7	-888	CD	NUMBER	-888	dep	4	SENT_297	[p17l406t122r951b186],
8	.	.	O	.	_	0	SENT_297	[p17l406t122r951b186],

1	Tremblay	NNP	O	Tremblay	nn	2	SENT_298	[p17l140t270r459b346],
2	CL	NN	O	cl	_	0	SENT_298	[p17l504t271r616b327],
3	:	:	O	:	_	0	SENT_298	[p17l504t271r616b327],
4	Combating	VBG	O	combate	amod	8	SENT_298	[p17l666t270r1037b346],
5	HIV	NN	O	hiv	nn	8	SENT_298	[p17l1082t272r1223b326],
6	resistance	NN	O	resistance	nn	8	SENT_298	[p17l1268t270r1840b327],
7	—	NN	O	—	nn	8	SENT_298	[p17l1268t270r1840b327],
8	focus	NN	O	focus	dep	2	SENT_298	[p17l1268t270r1840b327],
9	on	IN	O	on	_	0	SENT_298	[p17l1888t289r1971b327],
10	darunavir	NN	O	darunavir	prep_on	8	SENT_298	[p17l2016t270r2151b326, p17l140t365r373b418],
11	.	.	O	.	_	0	SENT_298	[p17l2016t270r2151b326, p17l140t365r373b418],

1	Ther	NNP	O	Ther	nn	4	SENT_299	[p17l404t362r557b419],
2	Clin	NNP	O	Clin	nn	4	SENT_299	[p17l584t362r723b419],
3	Risk	NNP	O	Risk	nn	4	SENT_299	[p17l750t362r894b419],
4	Manag	NNP	O	Manag	_	0	SENT_299	[p17l920t364r1151b438],
5	2008	CD	DATE	2008	num	4	SENT_299	[p17l1178t364r1686b428],
6	;	:	O	;	_	0	SENT_299	[p17l1178t364r1686b428],
7	41:759	CD	NUMBER	41:759	number	8	SENT_299	[p17l1178t364r1686b428],
8	-766	CD	NUMBER	-766	dep	4	SENT_299	[p17l1178t364r1686b428],
9	.	.	O	.	_	0	SENT_299	[p17l1178t364r1686b428],

1	Talbot	NNP	PERSON	Talbot	nn	2	SENT_300	[p17l140t455r348b513],
2	A	NNP	O	A	_	0	SENT_300	[p17l377t457r452b523],
3	,	,	O	,	_	0	SENT_300	[p17l377t457r452b523],
4	Grant	NNP	PERSON	Grant	nn	5	SENT_300	[p17l484t456r672b513],
5	P	NN	PERSON	p	appos	2	SENT_300	[p17l702t458r763b523],
6	,	,	O	,	_	0	SENT_300	[p17l702t458r763b523],
7	Taylor	NNP	PERSON	Taylor	nn	8	SENT_300	[p17l794t455r1007b533],
8	]	NNP	O	]	appos	2	SENT_300	[p17l1034t458r1076b526],
9	,	,	O	,	_	0	SENT_300	[p17l1034t458r1076b526],
10	et	FW	O	et	nn	11	SENT_300	[p17l1107t461r1159b512],
11	al.	FW	O	al.	appos	2	SENT_300	[p17l1188t455r1276b512],
12	:	:	O	:	_	0	SENT_300	[p17l1188t455r1276b512],
13	Predicting	VBG	O	predict	amod	14	SENT_300	[p17l1308t455r1642b533],
14	tipranavir	NN	O	tipranavir	dep	2	SENT_300	[p17l1672t458r1997b533],
15	and	CC	O	and	_	0	SENT_300	[p17l2028t455r2150b512],
16	darunavir	NN	O	darunavir	nn	17	SENT_300	[p17l141t550r466b606],
17	resistance	NN	O	resistance	dep	2	SENT_300	[p17l486t552r803b606],
18	using	VBG	O	use	partmod	14	SENT_300	[p17l824t552r1003b626],
19	genotypic	JJ	O	genotypic	dep	25	SENT_300	[p17l1025t552r1362b626],
20	,	,	O	,	_	0	SENT_300	[p17l1025t552r1362b626],
21	phenotypic	JJ	O	phenotypic	conj_and	25	SENT_300	[p17l1383t550r1768b626],
22	,	,	O	,	_	0	SENT_300	[p17l1383t550r1768b626],
23	and	CC	O	and	_	0	SENT_300	[p17l1790t550r1912b606],
24	virtual	JJ	O	virtual	conj_and	25	SENT_300	[p17l1934t550r2152b606],
25	phenotypic	JJ	O	phenotypic	amod	27	SENT_300	[p17l139t669r507b746],
26	resistance	NN	O	resistance	nn	27	SENT_300	[p17l534t671r850b726],
27	patterns	NNS	O	pattern	dobj	18	SENT_300	[p17l877t677r1157b746],
28	:	:	O	:	_	0	SENT_300	[p17l877t677r1157b746],
29	An	DT	O	a	det	32	SENT_300	[p17l1188t670r1290b725],
30	independent	JJ	O	independent	amod	32	SENT_300	[p17l1316t668r1729b746],
31	cohort	NN	O	cohort	nn	32	SENT_300	[p17l1756t669r1964b726],
32	analysis	NN	O	analysis	dep	14	SENT_300	[p17l1991t669r2151b725, p17l139t764r261b837],
33	of	IN	O	of	_	0	SENT_300	[p17l297t761r362b818],
34	clinical	JJ	O	clinical	amod	35	SENT_300	[p17l392t761r618b818],
35	isolates	NNS	O	isolate	prep_of	32	SENT_300	[p17l651t761r889b818],
36	highly	RB	O	highly	advmod	37	SENT_300	[p17l921t761r1130b837],
37	resistant	JJ	O	resistant	amod	35	SENT_300	[p17l1163t764r1436b818],
38	to	TO	O	to	_	0	SENT_300	[p17l1468t769r1531b818],
39	all	DT	O	all	det	42	SENT_300	[p17l1566t761r1642b817],
40	other	JJ	O	other	amod	42	SENT_300	[p17l1675t761r1844b818],
41	protease	NN	O	protease	nn	42	SENT_300	[p17l1876t769r2151b837],
42	inhibitors	NNS	O	inhibitor	prep_to	37	SENT_300	[p17l140t854r466b911],
43	.	.	O	.	_	0	SENT_300	[p17l140t854r466b911],

1	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_301	[p17l494t854r865b911],
2	Agents	NNPS	O	Agents	nn	3	SENT_301	[p17l892t856r1122b930],
3	Chemother	NNP	O	Chemother	_	0	SENT_301	[p17l1148t854r1514b911],
4	2010	CD	DATE	2010	dep	3	SENT_301	[p17l1538t856r2147b921],
5	;	:	O	;	_	0	SENT_301	[p17l1538t856r2147b921],
6	541:2473	CD	DURATION	541:2473	num	7	SENT_301	[p17l1538t856r2147b921],
7	-2479	CD	DURATION	-2479	dep	3	SENT_301	[p17l1538t856r2147b921],
8	.	.	O	.	_	0	SENT_301	[p17l1538t856r2147b921],

1	Rhee	NNP	PERSON	Rhee	nn	2	SENT_302	[p17l140t947r303b1005],
2	SY	NNP	PERSON	SY	_	0	SENT_302	[p17l325t948r430b1015],
3	,	,	O	,	_	0	SENT_302	[p17l325t948r430b1015],
4	Taylor	NNP	PERSON	Taylor	nn	5	SENT_302	[p17l453t947r729b1025],
5	]	NNP	O	]	appos	2	SENT_302	[p17l453t947r729b1025],
6	,	,	O	,	_	0	SENT_302	[p17l453t947r729b1025],
7	Fessel	NNP	PERSON	Fessel	nn	9	SENT_302	[p17l753t947r948b1005],
8	W	NNP	O	W	nn	9	SENT_302	[p17l968t949r1085b1018],
9	]	NN	O	]	appos	2	SENT_302	[p17l968t949r1085b1018],
10	,	,	O	,	_	0	SENT_302	[p17l968t949r1085b1018],
11	et	FW	O	et	nn	12	SENT_302	[p17l1108t953r1160b1004],
12	al.	FW	O	al.	appos	2	SENT_302	[p17l1180t947r1268b1004],
13	:	:	O	:	_	0	SENT_302	[p17l1180t947r1268b1004],
14	HIV-1	NN	MISC	hiv-1	nn	16	SENT_302	[p17l1292t950r1490b1004],
15	protease	NN	O	protease	nn	16	SENT_302	[p17l1515t955r1795b1025],
16	mutations	NNS	O	mutation	dep	2	SENT_302	[p17l1816t950r2149b1005],
17	and	CC	O	and	_	0	SENT_302	[p17l141t1041r265b1098],
18	protease	NN	O	protease	nn	20	SENT_302	[p17l300t1049r579b1118],
19	inhibitor	NN	O	inhibitor	nn	20	SENT_302	[p17l614t1041r900b1099],
20	cross	NN	O	cross	dep	2	SENT_302	[p17l935t1044r1463b1099],
21	—	CD	NUMBER	—	num	22	SENT_302	[p17l935t1044r1463b1099],
22	resistance	NN	O	resistance	dep	20	SENT_302	[p17l935t1044r1463b1099],
23	.	.	O	.	_	0	SENT_302	[p17l935t1044r1463b1099],

1	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_303	[p17l1502t1041r1880b1099],
2	Agents	NNPS	O	Agents	nn	3	SENT_303	[p17l1916t1043r2149b1118],
3	Chemother	NNP	O	Chemother	_	0	SENT_303	[p17l140t1135r512b1193],
4	2010	CD	DATE	2010	dep	3	SENT_303	[p17l539t1138r1160b1203],
5	;	:	O	;	_	0	SENT_303	[p17l539t1138r1160b1203],
6	541:4253	CD	DURATION	541:4253	num	7	SENT_303	[p17l539t1138r1160b1203],
7	-4261	CD	DURATION	-4261	dep	3	SENT_303	[p17l539t1138r1160b1203],
8	.	.	O	.	_	0	SENT_303	[p17l539t1138r1160b1203],

1	Schapiro	NNP	PERSON	Schapiro	nn	2	SENT_304	[p17l140t1287r428b1364],
2	IM	NNP	O	IM	_	0	SENT_304	[p17l462t1289r576b1357],
3	,	,	O	,	_	0	SENT_304	[p17l462t1289r576b1357],
4	Scherer	NNP	PERSON	Scherer	nn	8	SENT_304	[p17l614t1287r858b1344],
5	I	PRP	O	I	dep	8	SENT_304	[p17l891t1289r934b1357],
6	,	,	O	,	_	0	SENT_304	[p17l891t1289r934b1357],
7	Boucher	NNP	PERSON	Boucher	dep	8	SENT_304	[p17l972t1287r1243b1344],
8	CA	NNP	O	CA	appos	2	SENT_304	[p17l1280t1288r1407b1354],
9	,	,	O	,	_	0	SENT_304	[p17l1280t1288r1407b1354],
10	et	FW	O	et	nn	11	SENT_304	[p17l1444t1292r1496b1343],
11	al.	FW	O	al.	appos	2	SENT_304	[p17l1531t1286r1620b1343],
12	:	:	O	:	_	0	SENT_304	[p17l1531t1286r1620b1343],
13	Improving	NN	O	improving	dep	2	SENT_304	[p17l1658t1289r2013b1364],
14	the	DT	O	the	det	15	SENT_304	[p17l2049t1287r2150b1344],
15	prediction	NN	O	prediction	dep	13	SENT_304	[p17l139t1379r480b1455],
16	of	IN	O	of	_	0	SENT_304	[p17l512t1379r578b1436],
17	Virological	JJ	MISC	virological	amod	18	SENT_304	[p17l606t1379r958b1455],
18	response	NN	O	response	prep_of	15	SENT_304	[p17l990t1398r1281b1455],
19	to	TO	O	to	_	0	SENT_304	[p17l1314t1387r1377b1436],
20	tipranavir	NN	O	tipranavir	prep_to	18	SENT_304	[p17l1410t1382r1755b1455],
21	:	:	O	:	_	0	SENT_304	[p17l1410t1382r1755b1455],
22	The	DT	O	the	det	23	SENT_304	[p17l1792t1379r1914b1436],
23	development	NN	O	development	dep	2	SENT_304	[p17l1948t1379r2150b1436, p17l141t1479r395b1547],
24	and	CC	O	and	_	0	SENT_304	[p17l433t1471r557b1527],
25	validation	NN	O	validation	dep	2	SENT_304	[p17l594t1471r932b1528],
26	of	IN	O	of	_	0	SENT_304	[p17l969t1471r1034b1528],
27	a	DT	O	a	det	30	SENT_304	[p17l1071t1490r1104b1527],
28	tipranavir-weighted	JJ	O	tipranavir-weighted	amod	30	SENT_304	[p17l1143t1471r1809b1547],
29	mutation	NN	O	mutation	nn	30	SENT_304	[p17l1848t1474r2151b1528],
30	score	NN	NUMBER	score	prep_of	23	SENT_304	[p17l141t1584r324b1621],
31	.	.	O	.	_	0	SENT_304	[p17l141t1584r324b1621],

1	Antivir	NNP	O	Antivir	nn	2	SENT_305	[p17l355t1566r595b1621],
2	Ther	NNP	O	Ther	_	0	SENT_305	[p17l622t1564r775b1621],
3	2010	CD	DATE	2010	num	2	SENT_305	[p17l802t1567r1423b1631],
4	;	:	O	;	_	0	SENT_305	[p17l802t1567r1423b1631],
5	15:1011	CD	NUMBER	15:1011	number	6	SENT_305	[p17l802t1567r1423b1631],
6	—	CD	NUMBER	—	dep	2	SENT_305	[p17l802t1567r1423b1631],
7	1019	CD	DATE	1019	dep	6	SENT_305	[p17l802t1567r1423b1631],
8	.	.	O	.	_	0	SENT_305	[p17l802t1567r1423b1631],

1	De	NNP	PERSON	De	nn	3	SENT_306	[p17l140t1660r232b1715],
2	Meyer	NNP	PERSON	Meyer	nn	3	SENT_306	[p17l263t1660r476b1735],
3	SI	NNP	O	SI	_	0	SENT_306	[p17l508t1658r588b1725],
4	,	,	O	,	_	0	SENT_306	[p17l508t1658r588b1725],
5	Dierynck	NNP	O	Dierynck	nn	6	SENT_306	[p17l621t1657r925b1735],
6	E	NNP	O	E	appos	3	SENT_306	[p17l956t1660r1017b1725],
7	,	,	O	,	_	0	SENT_306	[p17l956t1660r1017b1725],
8	Lathouwers	NNP	O	Lathouwers	nn	9	SENT_306	[p17l1050t1657r1445b1715],
9	B	NNP	O	B	appos	3	SENT_306	[p17l1479t1660r1539b1725],
10	,	,	O	,	_	0	SENT_306	[p17l1479t1660r1539b1725],
11	et	FW	O	et	nn	12	SENT_306	[p17l1572t1663r1624b1714],
12	al.	FW	O	al.	appos	3	SENT_306	[p17l1655t1657r1744b1714],
13	:	:	O	:	_	0	SENT_306	[p17l1655t1657r1744b1714],
14	Phenotypic	JJ	O	phenotypic	amod	17	SENT_306	[p17l1777t1657r2149b1735],
15	and	CC	O	and	_	0	SENT_306	[p17l141t1751r265b1808],
16	genotypic	JJ	O	genotypic	conj_and	14	SENT_306	[p17l320t1754r644b1828],
17	determinants	NNS	O	determinant	dep	3	SENT_306	[p17l700t1751r1136b1808],
18	of	IN	O	of	_	0	SENT_306	[p17l1191t1750r1256b1808],
19	resistance	NN	O	resistance	prep_of	17	SENT_306	[p17l1307t1754r1629b1808],
20	to	TO	O	to	aux	21	SENT_306	[p17l1683t1759r1746b1808],
21	darunavir	VB	O	darunavir	infmod	17	SENT_306	[p17l1801t1751r2146b1808],
22	:	:	O	:	_	0	SENT_306	[p17l1801t1751r2146b1808],
23	Analysis	NN	O	analysis	dep	3	SENT_306	[p17l139t1844r425b1921],
24	of	IN	O	of	_	0	SENT_306	[p17l472t1843r537b1901],
25	data	NNS	O	datum	prep_of	23	SENT_306	[p17l581t1844r723b1901],
26	from	IN	O	from	_	0	SENT_306	[p17l769t1843r929b1901],
27	treatment	NN	O	treatment	nn	29	SENT_306	[p17l973t1852r1294b1901],
28	experienced	JJ	O	experienced	amod	29	SENT_306	[p17l1339t1844r1734b1921],
29	patients	NNS	O	patient	prep_from	25	SENT_306	[p17l1780t1846r2042b1921],
30	in	IN	O	in	_	0	SENT_306	[p17l2087t1846r2151b1900],
31	POWER	NN	O	power	prep_in	29	SENT_306	[p17l140t1938r416b1994],
32	1	CD	NUMBER	1	num	31	SENT_306	[p17l439t1939r489b2004],
33	,	,	O	,	_	0	SENT_306	[p17l439t1939r489b2004],
34	2	CD	NUMBER	2	dep	3	SENT_306	[p17l511t1940r564b2004],
35	,	,	O	,	_	0	SENT_306	[p17l511t1940r564b2004],
36	3	CD	NUMBER	3	conj_and	34	SENT_306	[p17l586t1940r621b1994],
37	and	CC	O	and	_	0	SENT_306	[p17l644t1937r768b1994],
38	DUET-1	NN	O	duet-1	conj_and	34	SENT_306	[p17l789t1939r1053b1994],
39	and	CC	O	and	_	0	SENT_306	[p17l1080t1937r1203b1994],
40	2	CD	NUMBER	2	dep	3	SENT_306	[p17l1225t1940r1276b1993],
41	.	.	O	.	_	0	SENT_306	[p17l1225t1940r1276b1993],

1	Antivir	NNP	O	Antivir	nn	2	SENT_307	[p17l1300t1939r1540b1994],
2	Ther	NNP	O	Ther	_	0	SENT_307	[p17l1560t1937r1712b1994],
3	2008	CD	DATE	2008	num	5	SENT_307	[p17l1732t1939r2146b2004],
4	;	:	O	;	_	0	SENT_307	[p17l1732t1939r2146b2004],
5	13	CD	NUMBER	13	dep	2	SENT_307	[p17l1732t1939r2146b2004],
6	:	:	O	:	_	0	SENT_307	[p17l1732t1939r2146b2004],
7	A33	NN	O	a33	dep	2	SENT_307	[p17l1732t1939r2146b2004],
8	.	.	O	.	_	0	SENT_307	[p17l1732t1939r2146b2004],

1	Scherer	NNP	PERSON	Scherer	nn	2	SENT_308	[p17l140t2030r384b2088],
2	J	NNP	PERSON	J	_	0	SENT_308	[p17l411t2032r453b2101],
3	,	,	O	,	_	0	SENT_308	[p17l411t2032r453b2101],
4	Schapiro	NNP	PERSON	Schapiro	nn	5	SENT_308	[p17l484t2030r772b2107],
5	J	NNP	O	J	appos	2	SENT_308	[p17l799t2032r841b2101],
6	,	,	O	,	_	0	SENT_308	[p17l799t2032r841b2101],
7	Maggiolo	NNP	O	Maggiolo	nn	8	SENT_308	[p17l871t2030r1187b2107],
8	F	NN	O	f	appos	2	SENT_308	[p17l1217t2032r1274b2097],
9	,	,	O	,	_	0	SENT_308	[p17l1217t2032r1274b2097],
10	et	FW	O	et	nn	11	SENT_308	[p17l1304t2036r1356b2087],
11	al.	FW	O	al.	appos	2	SENT_308	[p17l1384t2030r1473b2087],
12	:	:	O	:	_	0	SENT_308	[p17l1384t2030r1473b2087],
13	Improving	NN	O	improving	dep	2	SENT_308	[p17l1504t2032r1859b2107],
14	the	DT	O	the	det	15	SENT_308	[p17l1888t2030r1989b2088],
15	prediction	NN	O	prediction	dep	13	SENT_308	[p17l2017t2049r2150b2107, p17l141t2124r370b2182],
16	of	IN	O	of	_	0	SENT_308	[p17l393t2124r458b2182],
17	virologic	JJ	O	virologic	amod	18	SENT_308	[p17l478t2124r770b2202],
18	response	NN	O	response	prep_of	15	SENT_308	[p17l794t2144r1085b2202],
19	to	TO	O	to	_	0	SENT_308	[p17l1109t2133r1171b2182],
20	tipranavir	NN	O	tipranavir	prep_to	18	SENT_308	[p17l1195t2127r1541b2202],
21	:	:	O	:	_	0	SENT_308	[p17l1195t2127r1541b2202],
22	The	DT	O	the	det	23	SENT_308	[p17l1568t2125r1691b2182],
23	development	NN	O	development	dep	2	SENT_308	[p17l1716t2124r2151b2202],
24	of	IN	O	of	_	0	SENT_308	[p17l141t2217r206b2275],
25	a	DT	O	a	det	29	SENT_308	[p17l231t2237r265b2274],
26	tipranavir	NN	O	tipranavir	nn	29	SENT_308	[p17l293t2220r624b2295],
27	weighted	JJ	O	weighted	amod	29	SENT_308	[p17l650t2217r960b2295],
28	mutation	NN	O	mutation	nn	29	SENT_308	[p17l987t2220r1291b2275],
29	score	NN	NUMBER	score	prep_of	23	SENT_308	[p17l1317t2237r1501b2275],
30	.	.	O	.	_	0	SENT_308	[p17l1317t2237r1501b2275],

1	7th	JJ	ORDINAL	7th	amod	6	SENT_309	[p17l1533t2217r1636b2274],
2	European	JJ	MISC	european	amod	6	SENT_309	[p17l1662t2220r1984b2295],
3	HIV	NN	MISC	hiv	nn	6	SENT_309	[p17l2010t2220r2151b2274],
4	Drug	NN	MISC	drug	nn	6	SENT_309	[p17l140t2312r313b2386],
5	Resistance	NN	MISC	resistance	nn	6	SENT_309	[p17l338t2312r681b2366],
6	Workshop	NNP	MISC	Workshop	_	0	SENT_309	[p17l706t2310r1072b2386],
7	,	,	O	,	_	0	SENT_309	[p17l706t2310r1072b2386],
8	Stockholm	NNP	LOCATION	Stockholm	appos	6	SENT_309	[p17l1099t2310r1467b2376],
9	,	,	O	,	_	0	SENT_309	[p17l1099t2310r1467b2376],
10	Sweden	NNP	LOCATION	Sweden	nn	12	SENT_309	[p17l1495t2310r1773b2376],
11	,	,	O	,	_	0	SENT_309	[p17l1495t2310r1773b2376],
12	March	NNP	DATE	March	appos	8	SENT_309	[p17l1800t2310r2014b2366],
13	2527	CD	DATE	2527	num	12	SENT_309	[p17l2038t2312r2152b2366, p17l140t2405r231b2470],
14	,	,	DATE	,	_	0	SENT_309	[p17l2038t2312r2152b2366, p17l140t2405r231b2470],
15	2009	CD	DATE	2009	num	12	SENT_309	[p17l260t2405r425b2460],
16	.	.	O	.	_	0	SENT_309	[p17l260t2405r425b2460],

1	Address	NN	O	address	nn	2	SENT_310	[p17l1159t2612r1451b2673],
2	correspondence	NN	O	correspondence	_	0	SENT_310	[p17l1482t2612r2033b2693],
3	to	TO	O	to	dep	2	SENT_310	[p17l2063t2621r2146b2673],
4	:	:	O	:	_	0	SENT_310	[p17l2063t2621r2146b2673],
5	David	NNP	PERSON	David	nn	11	SENT_310	[p17l1787t2709r1983b2769],
6	Hall	NNP	PERSON	Hall	nn	11	SENT_310	[p17l2010t2709r2150b2768],
7	Boehringer	NNP	ORGANIZATION	Boehringer	nn	11	SENT_310	[p17l898t2806r1251b2887],
8	Ingelheim	NNP	ORGANIZATION	Ingelheim	nn	11	SENT_310	[p17l1278t2806r1593b2887],
9	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	11	SENT_310	[p17l1623t2806r2148b2866],
10	900	CD	NUMBER	900	num	11	SENT_310	[p17l1494t2905r1611b2963],
11	Ridgeﬁeld	NNP	LOCATION	Ridgeﬁeld	dep	2	SENT_310	[p17l1639t2902r1959b2984],
12	Road	NNP	LOCATION	Road	nn	15	SENT_310	[p17l1988t2903r2150b2963],
13	Ridgefield	NNP	LOCATION	Ridgefield	nn	15	SENT_310	[p17l1163t3000r1501b3081],
14	,	,	O	,	_	0	SENT_310	[p17l1163t3000r1501b3081],
15	Connecticut	NNP	LOCATION	Connecticut	dep	11	SENT_310	[p17l1535t3001r1922b3061],
16	06877	CD	NUMBER	06877	num	15	SENT_310	[p17l1953t3002r2152b3060],

1	E	NN	O	e	nn	3	SENT_311	[p17l544t3147r774b3207],
2	—	CD	NUMBER	—	num	3	SENT_311	[p17l544t3147r774b3207],
3	mail	NN	O	mail	_	0	SENT_311	[p17l544t3147r774b3207],
4	:	:	O	:	_	0	SENT_311	[p17l544t3147r774b3207],
5	david.hall@boehringer-ingelheim.com	NN	O	david.hall@boehringer-ingelheim.com	dep	3	SENT_311	[p17l807t3147r2150b3229],

